BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy6523
(713 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|4B4T|H Chain H, Near-Atomic Resolution Structural Model Of The Yeast 26s
Proteasome
Length = 467
Score = 204 bits (520), Expect = 9e-53, Method: Compositional matrix adjust.
Identities = 95/130 (73%), Positives = 114/130 (87%)
Query: 498 LLHLDGFDPRGNIKVLMATNRPDTLDPALMRPGRLDRKVEFGLPDLEGRTHIFKIHARSM 557
+ LDGFDPRGNIKV+ ATNRP+TLDPAL+RPGR+DRKVEF LPDLEGR +IF+IH++SM
Sbjct: 337 ITQLDGFDPRGNIKVMFATNRPNTLDPALLRPGRIDRKVEFSLPDLEGRANIFRIHSKSM 396
Query: 558 SVERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIRARRKVASEKDFLEAVNKVARCTKI 617
SVER IR+EL++RLCPNSTGAE+RSVCTEAGMFAIRARRKVA+EKDFL+AV+KV K
Sbjct: 397 SVERGIRWELISRLCPNSTGAELRSVCTEAGMFAIRARRKVATEKDFLKAVDKVISGYKK 456
Query: 618 INADSENPKY 627
++ S +Y
Sbjct: 457 FSSTSRYMQY 466
Score = 153 bits (386), Expect = 4e-37, Method: Compositional matrix adjust.
Identities = 92/209 (44%), Positives = 121/209 (57%), Gaps = 41/209 (19%)
Query: 540 LPDLEGRTHIFKIH------ARSMSVERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIR 593
+P EG + K + A+ E D++ ++ AR+ + E + + ++ I
Sbjct: 27 VPLTEGDIQVLKSYGAAPYAAKLKQTENDLK-DIEARIKEKAGVKESDTGLAPSHLWDIM 85
Query: 594 ARRKVASEKDFLEAVNKVARCTKIINADSEN----------------------------- 624
R+ E+ L+ VARCTKII + E+
Sbjct: 86 GDRQRLGEEHPLQ----VARCTKIIKGNGESDETTTDNNNSGNSNSNSNQQSTDADEDDE 141
Query: 625 -PKYIINVKQFAKFVVDLADSVAPTDIEEGMRVGVDRNKYQIHIPLPPKIDPTVTMMQVE 683
KY+IN+KQ AKFVV L + V+PTDIEEGMRVGVDR+KY I +PLPP+IDP+VTMM VE
Sbjct: 142 DAKYVINLKQIAKFVVGLGERVSPTDIEEGMRVGVDRSKYNIELPLPPRIDPSVTMMTVE 201
Query: 684 EKPDVTYSDIGGCKEQIEKLREVVETPLL 712
EKPDVTYSD+GGCK+QIEKLREVVE PLL
Sbjct: 202 EKPDVTYSDVGGCKDQIEKLREVVELPLL 230
Score = 108 bits (270), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 53/72 (73%), Positives = 60/72 (83%), Gaps = 1/72 (1%)
Query: 107 EVQRTMLEL-INQPEKFVNLGIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSE 165
E R ++EL + PE+F LGI+PPKG+LL+GPPGTGKTLCARAVANRTDA FIRVIGSE
Sbjct: 219 EKLREVVELPLLSPERFATLGIDPPKGILLYGPPGTGKTLCARAVANRTDATFIRVIGSE 278
Query: 166 LVQKYVGERVLM 177
LVQKYVGE M
Sbjct: 279 LVQKYVGEGARM 290
Score = 90.9 bits (224), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 41/54 (75%), Positives = 47/54 (87%)
Query: 451 QIHIPLPPKIDPTVTMMQVEEKPDVTYSDIGGCKEQIEKLREVVETPLLHLDGF 504
I +PLPP+IDP+VTMM VEEKPDVTYSD+GGCK+QIEKLREVVE PLL + F
Sbjct: 182 NIELPLPPRIDPSVTMMTVEEKPDVTYSDVGGCKDQIEKLREVVELPLLSPERF 235
Score = 79.7 bits (195), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 36/73 (49%), Positives = 47/73 (64%)
Query: 380 VTLDEADIALLKSYGQGQYTKSIKAVEDDIQAVIKRVNELTGIKESDTGLAPPALWDLTA 439
V L E DI +LKSYG Y +K E+D++ + R+ E G+KESDTGLAP LWD+
Sbjct: 27 VPLTEGDIQVLKSYGAAPYAAKLKQTENDLKDIEARIKEKAGVKESDTGLAPSHLWDIMG 86
Query: 440 DKQTLQNEQPLQI 452
D+Q L E PLQ+
Sbjct: 87 DRQRLGEEHPLQV 99
Score = 65.5 bits (158), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 48/102 (47%), Positives = 52/102 (50%), Gaps = 22/102 (21%)
Query: 29 KNIARGAVANRTDACFIRVIGSELVQKYVGEGA--------VANRTDACFIRVIGSELVQ 80
K + AVANRTDA FIRVIGSELVQKYVGEGA +A AC I + V
Sbjct: 256 KTLCARAVANRTDATFIRVIGSELVQKYVGEGARMVRELFEMARTKKACIIFFDEIDAVG 315
Query: 81 KYVGEGARMIXXXXXXXXXXXXXXXNEVQRTMLELINQPEKF 122
GAR NEVQRTMLELI Q + F
Sbjct: 316 -----GARF---------DDGAGGDNEVQRTMLELITQLDGF 343
>pdb|4A3V|B Chain B, Yeast Regulatory Particle Proteasome Assembly Chaperone
Hsm3 In Complex With Rpt1 C-Terminal Fragment
pdb|4A3V|D Chain D, Yeast Regulatory Particle Proteasome Assembly Chaperone
Hsm3 In Complex With Rpt1 C-Terminal Fragment
Length = 95
Score = 132 bits (332), Expect = 6e-31, Method: Composition-based stats.
Identities = 62/88 (70%), Positives = 76/88 (86%)
Query: 540 LPDLEGRTHIFKIHARSMSVERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIRARRKVA 599
LPDLEGR +IF+IH++SMSVER IR+EL++RLCPNSTGAE+RSVCTEAGMFAIRARRKVA
Sbjct: 7 LPDLEGRANIFRIHSKSMSVERGIRWELISRLCPNSTGAELRSVCTEAGMFAIRARRKVA 66
Query: 600 SEKDFLEAVNKVARCTKIINADSENPKY 627
+EKDFL+AV+KV K ++ S +Y
Sbjct: 67 TEKDFLKAVDKVISGYKKFSSTSRYMQY 94
>pdb|2WPI|S Chain S, Factor Ixa Superactive Double Mutant
Length = 235
Score = 129 bits (324), Expect = 6e-30, Method: Compositional matrix adjust.
Identities = 70/191 (36%), Positives = 112/191 (58%), Gaps = 14/191 (7%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
+VGG + ++PW V L FCGG+++++++++TAAHCV + + + VV EHN
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVK---ITVVAGEHN 57
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
T+ + R V++++ H YNA +++HDIALL+LD PL V+P+C+ +
Sbjct: 58 IEETEHTE-QKRNVIRIIPHHNYNA-AINTYNHDIALLELDEPLVLNSYVTPICIAD--K 113
Query: 314 KFTQ-----RTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCA 368
++T +G V GWGRV G+ A L+ +VP++ C + F +T NM CA
Sbjct: 114 EYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKF--TITNNMFCA 171
Query: 369 GYVEGGKDSCQ 379
G+ EGG+DSCQ
Sbjct: 172 GFHEGGRDSCQ 182
>pdb|2WPM|S Chain S, Factor Ixa Superactive Mutant, Egr-Cmk Inhibited
Length = 235
Score = 128 bits (321), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 69/191 (36%), Positives = 112/191 (58%), Gaps = 14/191 (7%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
+VGG + ++PW V L FCGG+++++++++TAAHCV + + + VV EHN
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVK---ITVVAGEHN 57
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
T+ + R V++++ H +NA +++HDIALL+LD PL V+P+C+ +
Sbjct: 58 IEETEHTE-QKRNVIRIIPHHNFNA-AINTYNHDIALLELDEPLVLNSYVTPICIAD--K 113
Query: 314 KFTQ-----RTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCA 368
++T +G V GWGRV G+ A L+ +VP++ C + F +T NM CA
Sbjct: 114 EYTNIFLKFGSGYVSGWGRVFHKGRAALVLQYLRVPLVDRATCLRSTKF--TITNNMFCA 171
Query: 369 GYVEGGKDSCQ 379
G+ EGG+DSCQ
Sbjct: 172 GFHEGGRDSCQ 182
>pdb|2WPH|S Chain S, Factor Ixa Superactive Triple Mutant
pdb|2WPJ|S Chain S, Factor Ixa Superactive Triple Mutant, Nacl-Soaked
pdb|2WPK|S Chain S, Factor Ixa Superactive Triple Mutant, Ethylene
Glycol-Soaked
pdb|2WPL|S Chain S, Factor Ixa Superactive Triple Mutant, Edta-Soaked
Length = 235
Score = 127 bits (320), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 69/191 (36%), Positives = 112/191 (58%), Gaps = 14/191 (7%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
+VGG + ++PW V L FCGG+++++++++TAAHCV + + + VV EHN
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVK---ITVVAGEHN 57
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
T+ + R V++++ H +NA +++HDIALL+LD PL V+P+C+ +
Sbjct: 58 IEETEHTE-QKRNVIRIIPHHNFNA-AINTYNHDIALLELDEPLVLNSYVTPICIAD--K 113
Query: 314 KFTQ-----RTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCA 368
++T +G V GWGRV G+ A L+ +VP++ C + F +T NM CA
Sbjct: 114 EYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKF--TITNNMFCA 171
Query: 369 GYVEGGKDSCQ 379
G+ EGG+DSCQ
Sbjct: 172 GFHEGGRDSCQ 182
>pdb|4AN7|A Chain A, Kunitz Type Trypsin Inhibitor Complex With Porcine Trypsin
Length = 231
Score = 127 bits (320), Expect = 2e-29, Method: Composition-based stats.
Identities = 74/193 (38%), Positives = 111/193 (57%), Gaps = 22/193 (11%)
Query: 192 DRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISE 251
D+IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E
Sbjct: 7 DKIVGGYTCAANSIPYQVSL-NSGSHFCGGSLINSQWVVSAAHCYKSR-----IQVRLGE 60
Query: 252 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQL 311
HN V E + K++THP +N + D+DI L+KL +P V+ V LP
Sbjct: 61 HN-IDVLEGNEQFINAAKIITHPNFNGN---TLDNDIMLIKLSSPATLNSRVATVSLP-- 114
Query: 312 GEKFTQRTGT---VVGWGRVEESGQ-IASDLRATQVPVMSNQECRQ-FPGFEAKLTGNMM 366
+ GT + GWG + SG S L+ + PV+S+ C+ +PG ++TGNM+
Sbjct: 115 --RSCAAAGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYPG---QITGNMI 169
Query: 367 CAGYVEGGKDSCQ 379
C G++EGGKDSCQ
Sbjct: 170 CVGFLEGGKDSCQ 182
>pdb|3KCG|H Chain H, Crystal Structure Of The Antithrombin-Factor Ixa-
Pentasaccharide Complex
Length = 235
Score = 126 bits (317), Expect = 4e-29, Method: Compositional matrix adjust.
Identities = 70/191 (36%), Positives = 111/191 (58%), Gaps = 14/191 (7%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
+VGG + ++PW V L FCGG+++++++++TAAHCV + + + VV EHN
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVK---ITVVAGEHN 57
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
T+ + R V++++ H YNA K ++HDIALL+LD PL V+P+C+ +
Sbjct: 58 IEETEHTE-QKRNVIRIIPHHNYNAAINK-YNHDIALLELDEPLVLNSYVTPICIAD--K 113
Query: 314 KFTQ-----RTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCA 368
++T +G V GWGRV G+ A L+ +VP++ C + F + NM CA
Sbjct: 114 EYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKF--TIYNNMFCA 171
Query: 369 GYVEGGKDSCQ 379
G+ EGG+DSCQ
Sbjct: 172 GFHEGGRDSCQ 182
>pdb|1RFN|A Chain A, Human Coagulation Factor Ixa In Complex With P-Amino
Benzamidine
pdb|3LC3|A Chain A, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC3|C Chain C, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC5|A Chain A, Selective Benzothiophine Inhibitors Of Factor Ixa
Length = 235
Score = 126 bits (317), Expect = 4e-29, Method: Compositional matrix adjust.
Identities = 70/191 (36%), Positives = 111/191 (58%), Gaps = 14/191 (7%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
+VGG + ++PW V L FCGG+++++++++TAAHCV + + + VV EHN
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVK---ITVVAGEHN 57
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
T+ + R V++++ H YNA K ++HDIALL+LD PL V+P+C+ +
Sbjct: 58 IEETEHTE-QKRNVIRIIPHHNYNAAINK-YNHDIALLELDEPLVLNSYVTPICIAD--K 113
Query: 314 KFTQ-----RTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCA 368
++T +G V GWGRV G+ A L+ +VP++ C + F + NM CA
Sbjct: 114 EYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKF--TIYNNMFCA 171
Query: 369 GYVEGGKDSCQ 379
G+ EGG+DSCQ
Sbjct: 172 GFHEGGRDSCQ 182
>pdb|1PFX|C Chain C, Porcine Factor Ixa
pdb|1X7A|C Chain C, Porcine Factor Ixa Complexed To 1-{3-[amino(Imino)
Methyl]phenyl}-N-[4-(1h-Benzimidazol-1-Yl)-2-
Fluorophenyl]-
3-(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide
Length = 235
Score = 125 bits (314), Expect = 9e-29, Method: Compositional matrix adjust.
Identities = 71/191 (37%), Positives = 108/191 (56%), Gaps = 14/191 (7%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG + ++PW V L FCGG++I++++V+TAAHC+ + + VV E+N
Sbjct: 1 IVGGENAKPGQFPWQVLLNGKIDAFCGGSIINEKWVVTAAHCIEPGVK---ITVVAGEYN 57
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
T+ + R V++ + H YNA + HDIALL+LD PL V+P+C+ +
Sbjct: 58 TEETEPTE-QRRNVIRAIPHHSYNAT-VNKYSHDIALLELDEPLTLNSYVTPICIAD--K 113
Query: 314 KFTQ-----RTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCA 368
++T +G V GWGRV G+ A+ L+ +VP++ C + F + NM CA
Sbjct: 114 EYTNIFLKFGSGYVSGWGRVFNRGRSATILQYLKVPLVDRATCLRSTKF--TIYSNMFCA 171
Query: 369 GYVEGGKDSCQ 379
G+ EGGKDSCQ
Sbjct: 172 GFHEGGKDSCQ 182
>pdb|1MCT|A Chain A, The Refined 1.6 Angstroms Resolution Crystal Structure Of
The Complex Formed Between Porcine Beta-trypsin And
Mcti-a, A Trypsin Inhibitor Of Squash Family
pdb|1QQU|A Chain A, Crystal Structure Of Porcine Beta Trypsin With Bound
Acetate Ion
pdb|1FMG|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.04%
Polydocanol
pdb|1FN6|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.1%
Polydocanol
pdb|1FNI|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01%
Polydocanol
Length = 223
Score = 125 bits (313), Expect = 1e-28, Method: Composition-based stats.
Identities = 73/191 (38%), Positives = 109/191 (57%), Gaps = 22/191 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + EHN
Sbjct: 1 IVGGYTCAANSIPYQVSL-NSGSHFCGGSLINSQWVVSAAHCYKSR-----IQVRLGEHN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K++THP +N + D+DI L+KL +P V+ V LP
Sbjct: 55 -IDVLEGNEQFINAAKIITHPNFNGN---TLDNDIMLIKLSSPATLNSRVATVSLP---- 106
Query: 314 KFTQRTGT---VVGWGRVEESGQ-IASDLRATQVPVMSNQECRQ-FPGFEAKLTGNMMCA 368
+ GT + GWG + SG S L+ + PV+SN C+ +PG ++TGNM+C
Sbjct: 107 RSCAAAGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSNSSCKSSYPG---QITGNMICV 163
Query: 369 GYVEGGKDSCQ 379
G+++GGKDSCQ
Sbjct: 164 GFLQGGKDSCQ 174
>pdb|3H4M|A Chain A, Aaa Atpase Domain Of The Proteasome- Activating
Nucleotidase
pdb|3H4M|B Chain B, Aaa Atpase Domain Of The Proteasome- Activating
Nucleotidase
pdb|3H4M|C Chain C, Aaa Atpase Domain Of The Proteasome- Activating
Nucleotidase
Length = 285
Score = 124 bits (312), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 56/114 (49%), Positives = 78/114 (68%)
Query: 498 LLHLDGFDPRGNIKVLMATNRPDTLDPALMRPGRLDRKVEFGLPDLEGRTHIFKIHARSM 557
L +DGFD RG++K++ ATNRPD LDPA++RPGR DR +E PD +GR I KIH R M
Sbjct: 145 LAEMDGFDARGDVKIIGATNRPDILDPAILRPGRFDRIIEVPAPDEKGRLEILKIHTRKM 204
Query: 558 SVERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIRARRKVASEKDFLEAVNKV 611
++ D+ E +A++ GAE++++CTEAGM AIR R + DF +AV K+
Sbjct: 205 NLAEDVNLEEIAKMTEGCVGAELKAICTEAGMNAIRELRDYVTMDDFRKAVEKI 258
Score = 91.7 bits (226), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 42/65 (64%), Positives = 54/65 (83%), Gaps = 1/65 (1%)
Query: 110 RTMLEL-INQPEKFVNLGIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQ 168
R ++EL + PE F +GIEPPKG+LL+GPPGTGKTL A+AVA T+A FIRV+GSELV+
Sbjct: 30 REVVELPLKHPELFEKVGIEPPKGILLYGPPGTGKTLLAKAVATETNATFIRVVGSELVK 89
Query: 169 KYVGE 173
K++GE
Sbjct: 90 KFIGE 94
Score = 48.9 bits (115), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 21/42 (50%), Positives = 33/42 (78%)
Query: 467 MQVEEKPDVTYSDIGGCKEQIEKLREVVETPLLHLDGFDPRG 508
M+V+E+P+V Y DIGG ++Q++++REVVE PL H + F+ G
Sbjct: 6 MEVDERPNVRYEDIGGLEKQMQEIREVVELPLKHPELFEKVG 47
Score = 47.4 bits (111), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 19/34 (55%), Positives = 29/34 (85%)
Query: 680 MQVEEKPDVTYSDIGGCKEQIEKLREVVETPLLH 713
M+V+E+P+V Y DIGG ++Q++++REVVE PL H
Sbjct: 6 MEVDERPNVRYEDIGGLEKQMQEIREVVELPLKH 39
Score = 45.8 bits (107), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 19/30 (63%), Positives = 26/30 (86%)
Query: 61 AVANRTDACFIRVIGSELVQKYVGEGARMI 90
AVA T+A FIRV+GSELV+K++GEGA ++
Sbjct: 70 AVATETNATFIRVVGSELVKKFIGEGASLV 99
Score = 45.1 bits (105), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 20/33 (60%), Positives = 26/33 (78%)
Query: 29 KNIARGAVANRTDACFIRVIGSELVQKYVGEGA 61
K + AVA T+A FIRV+GSELV+K++GEGA
Sbjct: 64 KTLLAKAVATETNATFIRVVGSELVKKFIGEGA 96
>pdb|3MYW|A Chain A, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
pdb|3MYW|B Chain B, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
Length = 223
Score = 124 bits (311), Expect = 2e-28, Method: Composition-based stats.
Identities = 73/191 (38%), Positives = 109/191 (57%), Gaps = 22/191 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + EHN
Sbjct: 1 IVGGYTCAANSVPYQVSL-NSGSHFCGGSLINSQWVVSAAHCYKSR-----IQVRLGEHN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K++THP +N + D+DI L+KL +P V+ V LP
Sbjct: 55 -IDVLEGNEQFINAAKIITHPNFNGN---TLDNDIMLIKLSSPATLNSRVATVSLP---- 106
Query: 314 KFTQRTGT---VVGWGRVEESGQ-IASDLRATQVPVMSNQECRQ-FPGFEAKLTGNMMCA 368
+ GT + GWG + SG S L+ + PV+S+ C+ +PG ++TGNM+C
Sbjct: 107 RSCAAAGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSAYPG---QITGNMICV 163
Query: 369 GYVEGGKDSCQ 379
G++EGGKDSCQ
Sbjct: 164 GFLEGGKDSCQ 174
>pdb|1TFX|A Chain A, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1TFX|B Chain B, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1LDT|T Chain T, Complex Of Leech-Derived Tryptase Inhibitor With Porcine
Trypsin
pdb|1AVW|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Orthorhombic Crystal Form
pdb|1AVX|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Tetragonal Crystal Form
pdb|1EJA|A Chain A, Structure Of Porcine Trypsin Complexed With Bdellastasin,
An Antistasin-Type Inhibitor
pdb|1S5S|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S6F|A Chain A, Porcine Trypsin Covalent Complex With Borate And
Guanidine- 3 Inhibitor
pdb|1S6H|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S81|A Chain A, Porcine Trypsin With No Inhibitor Bound
pdb|1S82|A Chain A, Porcine Trypsin Complexed With Borate And Ethylene Glycol
pdb|1S83|A Chain A, Porcine Trypsin Complexed With 4-amino Propanol
pdb|1S84|A Chain A, Porcine Trypsin Covalent Complex With 4-Amino Butanol,
Borate And Ethylene Glycol
pdb|1S85|A Chain A, Porcine Trypsin Complexed With P-Hydroxymethyl Benzamidine
And Borate
pdb|1H9I|E Chain E, Complex Of Eeti-Ii Mutant With Porcine Trypsin
pdb|1V6D|A Chain A, The Crystal Structure Of The Trypsin Complex With
Synthetic Heterochiral Peptide
pdb|1TX6|A Chain A, Trypsin:bbi Complex
pdb|1TX6|B Chain B, Trypsin:bbi Complex
pdb|1TX6|C Chain C, Trypsin:bbi Complex
pdb|1TX6|D Chain D, Trypsin:bbi Complex
pdb|1Z7K|A Chain A, Crystal Structure Of Trypsin- Ovomucoid Turkey Egg White
Inhibitor Complex
pdb|1YF4|A Chain A, Crystal Structure Of Trypsin-Vasopressin Complex
Length = 223
Score = 124 bits (311), Expect = 2e-28, Method: Composition-based stats.
Identities = 73/191 (38%), Positives = 109/191 (57%), Gaps = 22/191 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + EHN
Sbjct: 1 IVGGYTCAANSIPYQVSL-NSGSHFCGGSLINSQWVVSAAHCYKSR-----IQVRLGEHN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K++THP +N + D+DI L+KL +P V+ V LP
Sbjct: 55 -IDVLEGNEQFINAAKIITHPNFNGN---TLDNDIMLIKLSSPATLNSRVATVSLP---- 106
Query: 314 KFTQRTGT---VVGWGRVEESGQ-IASDLRATQVPVMSNQECRQ-FPGFEAKLTGNMMCA 368
+ GT + GWG + SG S L+ + PV+S+ C+ +PG ++TGNM+C
Sbjct: 107 RSCAAAGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYPG---QITGNMICV 163
Query: 369 GYVEGGKDSCQ 379
G++EGGKDSCQ
Sbjct: 164 GFLEGGKDSCQ 174
>pdb|1AN1|E Chain E, Leech-Derived Tryptase InhibitorTRYPSIN COMPLEX
pdb|1C9P|A Chain A, Complex Of Bdellastasin With Porcine Trypsin
Length = 223
Score = 124 bits (310), Expect = 2e-28, Method: Composition-based stats.
Identities = 73/191 (38%), Positives = 109/191 (57%), Gaps = 22/191 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + EHN
Sbjct: 1 IVGGYTCAANSIPYQVSL-NSGSHFCGGSLINSQWVVSAAHCYKSR-----IQVRLGEHN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K++THP +N + D+DI L+KL +P V+ V LP
Sbjct: 55 -IDVLEGNEQFINAAKIITHPNFNGN---TLDNDIMLIKLSSPATLXSRVATVSLP---- 106
Query: 314 KFTQRTGT---VVGWGRVEESGQ-IASDLRATQVPVMSNQECRQ-FPGFEAKLTGNMMCA 368
+ GT + GWG + SG S L+ + PV+S+ C+ +PG ++TGNM+C
Sbjct: 107 RSCAAAGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYPG---QITGNMICV 163
Query: 369 GYVEGGKDSCQ 379
G++EGGKDSCQ
Sbjct: 164 GFLEGGKDSCQ 174
>pdb|3VLF|B Chain B, Crystal Structure Of Yeast Proteasome Interacting Protein
pdb|3VLF|D Chain D, Crystal Structure Of Yeast Proteasome Interacting Protein
Length = 88
Score = 123 bits (308), Expect = 4e-28, Method: Composition-based stats.
Identities = 58/86 (67%), Positives = 72/86 (83%)
Query: 542 DLEGRTHIFKIHARSMSVERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIRARRKVASE 601
DLEGR +IF+IH++S SVER IR+EL++RLCPNSTGAE+RSVCTEAG FAIRARRKVA+E
Sbjct: 2 DLEGRANIFRIHSKSXSVERGIRWELISRLCPNSTGAELRSVCTEAGXFAIRARRKVATE 61
Query: 602 KDFLEAVNKVARCTKIINADSENPKY 627
KDFL+AV+KV K ++ S +Y
Sbjct: 62 KDFLKAVDKVISGYKKFSSTSRYXQY 87
>pdb|4B4T|L Chain L, Near-Atomic Resolution Structural Model Of The Yeast 26s
Proteasome
Length = 437
Score = 122 bits (307), Expect = 5e-28, Method: Compositional matrix adjust.
Identities = 61/120 (50%), Positives = 76/120 (63%)
Query: 498 LLHLDGFDPRGNIKVLMATNRPDTLDPALMRPGRLDRKVEFGLPDLEGRTHIFKIHARSM 557
L +DGFD G K++MATNRPDTLDPAL+RPGRLDRKVE LP+ GR IFKIH +
Sbjct: 309 LTQMDGFDNLGQTKIIMATNRPDTLDPALLRPGRLDRKVEIPLPNEAGRLEIFKIHTAKV 368
Query: 558 SVERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIRARRKVASEKDFLEAVNKVARCTKI 617
+ FE ++ GA+IR+ TEAG FAIR R + D ++AV KVA K+
Sbjct: 369 KKTGEFDFEAAVKMSDGFNGADIRNCATEAGFFAIRDDRDHINPDDLMKAVRKVAEVKKL 428
Score = 72.8 bits (177), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 39/72 (54%), Positives = 50/72 (69%), Gaps = 3/72 (4%)
Query: 110 RTMLEL-INQPEKFVNLGIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQ 168
R ++EL + PE F +GI+PPKGVLL+GPPGTGKTL A+AVA A FI S +V
Sbjct: 194 REVIELPLKNPEIFQRVGIKPPKGVLLYGPPGTGKTLLAKAVAATIGANFIFSPASGIVD 253
Query: 169 KYVGE--RVLME 178
KY+GE R++ E
Sbjct: 254 KYIGESARIIRE 265
Score = 60.8 bits (146), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 33/107 (30%), Positives = 59/107 (55%)
Query: 605 LEAVNKVARCTKIINADSENPKYIINVKQFAKFVVDLADSVAPTDIEEGMRVGVDRNKYQ 664
++A+ + + + + KYI+ +++V + +SV + +++G+RV +D
Sbjct: 95 IKALQSIGQLIGEVMKELSEEKYIVKASSGPRYIVGVRNSVDRSKLKKGVRVTLDITTLT 154
Query: 665 IHIPLPPKIDPTVTMMQVEEKPDVTYSDIGGCKEQIEKLREVVETPL 711
I LP + DP V M E+ ++T+ IGG EQI +LREV+E PL
Sbjct: 155 IMRILPRETDPLVYNMTSFEQGEITFDGIGGLTEQIRELREVIELPL 201
Score = 43.5 bits (101), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 21/43 (48%), Positives = 28/43 (65%)
Query: 456 LPPKIDPTVTMMQVEEKPDVTYSDIGGCKEQIEKLREVVETPL 498
LP + DP V M E+ ++T+ IGG EQI +LREV+E PL
Sbjct: 159 LPRETDPLVYNMTSFEQGEITFDGIGGLTEQIRELREVIELPL 201
Score = 35.0 bits (79), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 26/86 (30%), Positives = 34/86 (39%), Gaps = 20/86 (23%)
Query: 61 AVANRTDACFIRVIGSELVQKYVGEGARMIXXXXXXXXXXX------------------- 101
AVA A FI S +V KY+GE AR+I
Sbjct: 234 AVAATIGANFIFSPASGIVDKYIGESARIIREMFAYAKEHEPCIIFMDEVDAIGGRRFSE 293
Query: 102 -XXXXNEVQRTMLELINQPEKFVNLG 126
E+QRT++EL+ Q + F NLG
Sbjct: 294 GTSADREIQRTLMELLTQMDGFDNLG 319
>pdb|2A31|A Chain A, Trypsin In Complex With Borate
pdb|2A32|A Chain A, Trypsin In Complex With Benzene Boronic Acid
Length = 223
Score = 122 bits (307), Expect = 5e-28, Method: Composition-based stats.
Identities = 72/190 (37%), Positives = 108/190 (56%), Gaps = 22/190 (11%)
Query: 195 VGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHNR 254
VGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + EHN
Sbjct: 2 VGGYTCAANSIPYQVSL-NSGSHFCGGSLINSQWVVSAAHCYKSR-----IQVRLGEHN- 54
Query: 255 ATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGEK 314
V E + K++THP +N + D+DI L+KL +P V+ V LP +
Sbjct: 55 IDVLEGNEQFINAAKIITHPNFNGN---TLDNDIMLIKLSSPATLNSRVATVSLP----R 107
Query: 315 FTQRTGT---VVGWGRVEESGQ-IASDLRATQVPVMSNQECRQ-FPGFEAKLTGNMMCAG 369
GT + GWG + SG S L+ + PV+S+ C+ +PG ++TGNM+C G
Sbjct: 108 SCAAAGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYPG---QITGNMICVG 164
Query: 370 YVEGGKDSCQ 379
++EGGKDSCQ
Sbjct: 165 FLEGGKDSCQ 174
>pdb|3T2N|A Chain A, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
pdb|3T2N|B Chain B, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
Length = 372
Score = 122 bits (306), Expect = 7e-28, Method: Compositional matrix adjust.
Identities = 68/191 (35%), Positives = 101/191 (52%), Gaps = 2/191 (1%)
Query: 191 MDRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVIS 250
+DRIVGG T + +PW V+L G CGG+L+S +VLTAAHC R V +
Sbjct: 115 VDRIVGGRDTSLGRWPWQVSLRYDGAHLCGGSLLSGDWVLTAAHCFPERNRVLSRWRVFA 174
Query: 251 EH-NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLP 309
+A+ + Q+ + VV + + ++ + +DIAL+ L +PL + PVCLP
Sbjct: 175 GAVAQASPHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQPVCLP 234
Query: 310 QLGEKFTQ-RTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCA 368
G+ + TV GWG + GQ A L+ +VP++SN C + ++ M CA
Sbjct: 235 AAGQALVDGKICTVTGWGNTQYYGQQAGVLQEARVPIISNDVCNGADFYGNQIKPKMFCA 294
Query: 369 GYVEGGKDSCQ 379
GY EGG D+CQ
Sbjct: 295 GYPEGGIDACQ 305
>pdb|1Z8G|A Chain A, Crystal Structure Of The Extracellular Region Of The
Transmembrane Serine Protease Hepsin With Covalently
Bound Preferred Substrate
Length = 372
Score = 122 bits (306), Expect = 8e-28, Method: Compositional matrix adjust.
Identities = 68/191 (35%), Positives = 101/191 (52%), Gaps = 2/191 (1%)
Query: 191 MDRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVIS 250
+DRIVGG T + +PW V+L G CGG+L+S +VLTAAHC R V +
Sbjct: 115 VDRIVGGRDTSLGRWPWQVSLRYDGAHLCGGSLLSGDWVLTAAHCFPERNRVLSRWRVFA 174
Query: 251 EH-NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLP 309
+A+ + Q+ + VV + + ++ + +DIAL+ L +PL + PVCLP
Sbjct: 175 GAVAQASPHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQPVCLP 234
Query: 310 QLGEKFTQ-RTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCA 368
G+ + TV GWG + GQ A L+ +VP++SN C + ++ M CA
Sbjct: 235 AAGQALVDGKICTVTGWGNTQYYGQQAGVLQEARVPIISNDVCNGADFYGNQIKPKMFCA 294
Query: 369 GYVEGGKDSCQ 379
GY EGG D+CQ
Sbjct: 295 GYPEGGIDACQ 305
>pdb|2BQ6|B Chain B, Crystal Structure Of Factor Xa In Complex With 21
pdb|2BQ7|B Chain B, Crystal Structure Of Factor Xa In Complex With 43
pdb|2BQW|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound 45
Length = 249
Score = 121 bits (304), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 79/243 (32%), Positives = 125/243 (51%), Gaps = 23/243 (9%)
Query: 189 NRMDRIVGGWTTEVNEYPW-VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIV 247
N + RIVGG + E PW + + + + FCGGT++S+ Y+LTAAHC+ +KR K
Sbjct: 11 NNLTRIVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFK---- 66
Query: 248 VISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVC 307
+ +R T E E V+V+ K+N +++D DIA+L+L TP+ F+ V+P C
Sbjct: 67 -VRVGDRNTEQEEGGEAVHEVEVVI--KHNRFTKETYDFDIAVLRLKTPITFRMNVAPAC 123
Query: 308 LPQLGEK----FTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTG 363
LP+ TQ+TG V G+GR E G+ ++ L+ +VP + C+ F +T
Sbjct: 124 LPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSF--IITQ 181
Query: 364 NMMCAGYVEGGKDSCQVTLDEADIALLK---------SYGQGQYTKSIKAVEDDIQAVIK 414
NM CAGY +D+CQ + K S+G+G K + + A +K
Sbjct: 182 NMFCAGYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLK 241
Query: 415 RVN 417
++
Sbjct: 242 WID 244
>pdb|4B4T|J Chain J, Near-Atomic Resolution Structural Model Of The Yeast 26s
Proteasome
Length = 405
Score = 121 bits (304), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 57/114 (50%), Positives = 78/114 (68%)
Query: 498 LLHLDGFDPRGNIKVLMATNRPDTLDPALMRPGRLDRKVEFGLPDLEGRTHIFKIHARSM 557
L LDGF+ NIK++MATNR D LDPAL+RPGR+DRK+EF P + R I +IH+R M
Sbjct: 276 LNQLDGFETSKNIKIIMATNRLDILDPALLRPGRIDRKIEFPPPSVAARAEILRIHSRKM 335
Query: 558 SVERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIRARRKVASEKDFLEAVNKV 611
++ R I +A +GA+++ VCTEAGM+A+R RR +++DF AV KV
Sbjct: 336 NLTRGINLRKVAEKMNGCSGADVKGVCTEAGMYALRERRIHVTQEDFELAVGKV 389
Score = 88.2 bits (217), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 40/58 (68%), Positives = 47/58 (81%)
Query: 116 INQPEKFVNLGIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQKYVGE 173
+ PE F +LGI PKGV+L+GPPGTGKTL ARAVA+ TD FIRV G+ELVQKY+GE
Sbjct: 168 VKHPELFESLGIAQPKGVILYGPPGTGKTLLARAVAHHTDCKFIRVSGAELVQKYIGE 225
Score = 70.1 bits (170), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 32/90 (35%), Positives = 56/90 (62%)
Query: 624 NPKYIINVKQFAKFVVDLADSVAPTDIEEGMRVGVDRNKYQIHIPLPPKIDPTVTMMQVE 683
+ K ++ V+ K++VD+A + D++ RV + + Y +H L K DP V++M VE
Sbjct: 81 DKKVLVKVQPEGKYIVDVAKDINVKDLKASQRVCLRSDSYMLHKVLENKADPLVSLMMVE 140
Query: 684 EKPDVTYSDIGGCKEQIEKLREVVETPLLH 713
+ PD TY +GG +QI++++EV+E P+ H
Sbjct: 141 KVPDSTYDMVGGLTKQIKEIKEVIELPVKH 170
Score = 56.2 bits (134), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 27/73 (36%), Positives = 43/73 (58%)
Query: 436 DLTADKQTLQNEQPLQIHIPLPPKIDPTVTMMQVEEKPDVTYSDIGGCKEQIEKLREVVE 495
DL A ++ +H L K DP V++M VE+ PD TY +GG +QI++++EV+E
Sbjct: 106 DLKASQRVCLRSDSYMLHKVLENKADPLVSLMMVEKVPDSTYDMVGGLTKQIKEIKEVIE 165
Query: 496 TPLLHLDGFDPRG 508
P+ H + F+ G
Sbjct: 166 LPVKHPELFESLG 178
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 38/96 (39%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 27 GHKNIARGAVANRTDACFIRVIGSELVQKYVGEGAVANRTDACFIRVIGSELVQKYVGEG 86
G +AR AVA+ TD FIRV G+ELVQKY+GEG+ R R ++ ++ E
Sbjct: 194 GKTLLAR-AVAHHTDCKFIRVSGAELVQKYIGEGSRMVRELFVMAREHAPSII--FMDE- 249
Query: 87 ARMIXXXXXXXXXXXXXXXNEVQRTMLELINQPEKF 122
I +EVQRTMLEL+NQ + F
Sbjct: 250 ---IDSIGSTRVEGSGGGDSEVQRTMLELLNQLDGF 282
>pdb|1EKB|B Chain B, The Serine Protease Domain Of Enteropeptidase Bound To
Inhibitor Val- Asp-asp-asp-asp-lys-chloromethane
Length = 235
Score = 120 bits (302), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 66/189 (34%), Positives = 107/189 (56%), Gaps = 8/189 (4%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQ-KDLIVVISEH 252
IVGG + +PWVVAL + CG +L+S ++++AAHCV + V+ H
Sbjct: 1 IVGGSDSREGAWPWVVALYFDDQQVCGASLVSRDWLVSAAHCVYGRNMEPSKWKAVLGLH 60
Query: 253 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLG 312
+ + QIETR + +++ +P YN + ++DIA++ L+ + + + P+CLP+
Sbjct: 61 MASNLTSPQIETRLIDQIVINPHYN---KRRKNNDIAMMHLEMKVNYTDYIQPICLPEEN 117
Query: 313 EKFTQ-RTGTVVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEAKLTGNMMCAGY 370
+ F R ++ GWG + G A L+ VP++SN++C +Q P E +T NM+CAGY
Sbjct: 118 QVFPPGRICSIAGWGALIYQGSTADVLQEADVPLLSNEKCQQQMP--EYNITENMVCAGY 175
Query: 371 VEGGKDSCQ 379
GG DSCQ
Sbjct: 176 EAGGVDSCQ 184
>pdb|1FAX|A Chain A, Coagulation Factor Xa Inhibitor Complex
Length = 254
Score = 118 bits (295), Expect = 1e-26, Method: Compositional matrix adjust.
Identities = 79/238 (33%), Positives = 125/238 (52%), Gaps = 23/238 (9%)
Query: 194 IVGGWTTEVNEYPW-VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEH 252
IVGG + E PW + + + + FCGGT++S+ Y+LTAAHC+ +KR K +
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFK-----VRVG 55
Query: 253 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQL- 311
+R T E E V+V+ K+N +++D DIA+L+L TP+ F+ V+P CLP+
Sbjct: 56 DRNTAAEEGGEAVHEVEVVI--KHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD 113
Query: 312 ---GEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCA 368
TQ+TG V G+GR E G+ ++ L+ +VP + C+ F +T NM CA
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSF--IITQNMFCA 171
Query: 369 GYVEGGKDSCQ-------VTL--DEADIALLKSYGQGQYTKSIKAVEDDIQAVIKRVN 417
GY +D+CQ VT D + + S+G+G K + + A +K ++
Sbjct: 172 GYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWID 229
>pdb|1A0J|A Chain A, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|B Chain B, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|C Chain C, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|D Chain D, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species
Length = 223
Score = 118 bits (295), Expect = 1e-26, Method: Composition-based stats.
Identities = 75/188 (39%), Positives = 103/188 (54%), Gaps = 16/188 (8%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+ N + +L Q+G FCGG+LIS +V++AAHC +S + V + EHN
Sbjct: 1 IVGGYECRKNSASYQASL-QSGYHFCGGSLISSTWVVSAAHCYKSR-----IQVRLGEHN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
A V E + VKV+ HP YN+ ++ D+DI L+KL P VS V LP
Sbjct: 55 IA-VNEGTEQFIDSVKVIMHPSYNS---RNLDNDIMLIKLSKPASLNSYVSTVALPSSCA 110
Query: 314 KFTQRTGTVVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEAKLTGNMMCAGYV 371
R V GWG + S D LR +P++S+ C +PG ++T NM CAG++
Sbjct: 111 SSGTRC-LVSGWGNLSGSSSNYPDTLRCLDLPILSSSSCNSAYPG---QITSNMFCAGFM 166
Query: 372 EGGKDSCQ 379
EGGKDSCQ
Sbjct: 167 EGGKDSCQ 174
>pdb|4B4T|I Chain I, Near-Atomic Resolution Structural Model Of The Yeast 26s
Proteasome
Length = 437
Score = 117 bits (294), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 59/136 (43%), Positives = 88/136 (64%), Gaps = 4/136 (2%)
Query: 478 SDIGGCKEQIEKLREVVETPLLHLDGFDPRGNIKVLMATNRPDTLDPALMRPGRLDRKVE 537
S+ GG +E + E+ L LDGFD RG++KV+MATN+ +TLDPAL+RPGR+DRK+
Sbjct: 294 SNSGGEREIQRTMLEL----LNQLDGFDDRGDVKVIMATNKIETLDPALIRPGRIDRKIL 349
Query: 538 FGLPDLEGRTHIFKIHARSMSVERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIRARRK 597
F PDL + I IH M++ D+ E L + +GA+I+++CTEAG+ A+R RR
Sbjct: 350 FENPDLSTKKKILGIHTSKMNLSEDVNLETLVTTKDDLSGADIQAMCTEAGLLALRERRM 409
Query: 598 VASEKDFLEAVNKVAR 613
+ +DF +A +V +
Sbjct: 410 QVTAEDFKQAKERVMK 425
Score = 86.3 bits (212), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 36/67 (53%), Positives = 54/67 (80%)
Query: 107 EVQRTMLELINQPEKFVNLGIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSEL 166
E++ ++ + PE + +GI+PPKGV+L+G PGTGKTL A+AVAN+T A F+R++GSEL
Sbjct: 193 EIKESVELPLTHPELYEEMGIKPPKGVILYGAPGTGKTLLAKAVANQTSATFLRIVGSEL 252
Query: 167 VQKYVGE 173
+QKY+G+
Sbjct: 253 IQKYLGD 259
Score = 54.3 bits (129), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 36/108 (33%), Positives = 51/108 (47%), Gaps = 26/108 (24%)
Query: 29 KNIARGAVANRTDACFIRVIGSELVQKYVGEG----------AVANRTDACFIRVIGSEL 78
K + AVAN+T A F+R++GSEL+QKY+G+G A N FI I +
Sbjct: 229 KTLLAKAVANQTSATFLRIVGSELIQKYLGDGPRLCRQIFKVAGENAPSIVFIDEIDAIG 288
Query: 79 VQKYVGEGARMIXXXXXXXXXXXXXXXNEVQRTMLELINQPEKFVNLG 126
++Y E+QRTMLEL+NQ + F + G
Sbjct: 289 TKRYDSNSG----------------GEREIQRTMLELLNQLDGFDDRG 320
Score = 48.1 bits (113), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 20/48 (41%), Positives = 35/48 (72%)
Query: 461 DPTVTMMQVEEKPDVTYSDIGGCKEQIEKLREVVETPLLHLDGFDPRG 508
DP V++M++++ P +YSDIGG + QI++++E VE PL H + ++ G
Sbjct: 165 DPMVSVMKMDKSPTESYSDIGGLESQIQEIKESVELPLTHPELYEEMG 212
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 19/40 (47%), Positives = 31/40 (77%)
Query: 674 DPTVTMMQVEEKPDVTYSDIGGCKEQIEKLREVVETPLLH 713
DP V++M++++ P +YSDIGG + QI++++E VE PL H
Sbjct: 165 DPMVSVMKMDKSPTESYSDIGGLESQIQEIKESVELPLTH 204
>pdb|4DGJ|A Chain A, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|B Chain B, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|C Chain C, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|D Chain D, Structure Of A Human Enteropeptidase Light Chain Variant
Length = 235
Score = 117 bits (294), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 63/189 (33%), Positives = 103/189 (54%), Gaps = 8/189 (4%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQ-KDLIVVISEH 252
IVGG + +PWVV L + CG +L+S ++++AAHCV + ++ H
Sbjct: 1 IVGGSDAKEGAWPWVVGLYYDDRLLCGASLVSSDWLVSAAHCVYGRNLEPSKWTAILGLH 60
Query: 253 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLG 312
++ + Q R + +++ +P YN + D+DIA++ L+ + + + P+ LP+
Sbjct: 61 MKSNLTSPQTVPRLIDEIVINPHYN---RRRKDNDIAMMHLEFKVNYTDYIQPISLPEEN 117
Query: 313 EKFTQ-RTGTVVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEAKLTGNMMCAGY 370
+ F R ++ GWG V G A L+ VP++SN+ C +Q P E +T NM+CAGY
Sbjct: 118 QVFPPGRNCSIAGWGTVVYQGTTADILQEADVPLLSNERCQQQMP--EYNITENMICAGY 175
Query: 371 VEGGKDSCQ 379
EGG DSCQ
Sbjct: 176 EEGGIDSCQ 184
>pdb|2GD4|H Chain H, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
pdb|2GD4|B Chain B, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
Length = 241
Score = 117 bits (293), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 77/238 (32%), Positives = 122/238 (51%), Gaps = 23/238 (9%)
Query: 194 IVGGWTTEVNEYPW-VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEH 252
IVGG + E PW + + + + FCGGT++S+ Y+LTAAHC+ +KR K +
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFK-----VRVG 55
Query: 253 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLG 312
+R T E E V+V+ K+N +++D DIA+L+L TP+ F+ V+P CLP+
Sbjct: 56 DRNTEQEEGGEAVHEVEVVI--KHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD 113
Query: 313 EK----FTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCA 368
TQ+TG V G+GR E G+ ++ L+ +VP + C+ F +T NM CA
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSF--IITQNMFCA 171
Query: 369 GYVEGGKDSCQVTLDEADIALLK---------SYGQGQYTKSIKAVEDDIQAVIKRVN 417
GY +D+CQ + K S+G+G K + + A +K ++
Sbjct: 172 GYDTKQEDACQGDAGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWID 229
>pdb|1H9H|E Chain E, Complex Of Eeti-Ii With Porcine Trypsin
Length = 231
Score = 117 bits (293), Expect = 2e-26, Method: Composition-based stats.
Identities = 68/189 (35%), Positives = 103/189 (54%), Gaps = 15/189 (7%)
Query: 194 IVGGWT-TEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEH 252
IVGG+T + N P+ V+L F GG+LI+ ++V++AAHC S+ Q V + EH
Sbjct: 1 IVGGYTCSAANSIPYQVSLNSGSHFCSGGSLINSQWVVSAAHCSYKSRIQ----VRLGEH 56
Query: 253 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLG 312
N V E + K++THP +N + D+DI L+KL +P V+ V LP+
Sbjct: 57 N-IDVLEGNEQFINAAKIITHPNFNGN---TLDNDIMLIKLSSPATLNSRVATVSLPRSC 112
Query: 313 EKFTQRTGTVVGWGRVEESGQIASDLR--ATQVPVMSNQECRQ-FPGFEAKLTGNMMCAG 369
+ GWG + SG L + + PV+S+ C+ +PG ++TGNM+C G
Sbjct: 113 AAAGTECSLISGWGNTKSSGSSYPSLLQCSLKAPVLSDSSCKSSYPG---QITGNMICVG 169
Query: 370 YVEGGKDSC 378
++EGGKDSC
Sbjct: 170 FLEGGKDSC 178
>pdb|3TGJ|E Chain E, S195a Trypsinogen Complexed With Bovine Pancreatic Trypsin
Inhibitor (Bpti)
Length = 233
Score = 117 bits (293), Expect = 2e-26, Method: Composition-based stats.
Identities = 71/193 (36%), Positives = 109/193 (56%), Gaps = 22/193 (11%)
Query: 192 DRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISE 251
D+IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + V + E
Sbjct: 9 DKIVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSR-----IQVRLGE 62
Query: 252 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQL 311
HN V E + K++ HP ++ K+ ++DI L+KL +P++ V+ V LP
Sbjct: 63 HN-INVLEGNEQFVNAAKIIKHPNFDR---KTLNNDIMLIKLSSPVKLNARVATVALPS- 117
Query: 312 GEKFTQRTGT---VVGWGRVEESGQIASDL-RATQVPVMSNQECR-QFPGFEAKLTGNMM 366
GT + GWG SG DL + P++ +C +PG K+T NM+
Sbjct: 118 ---SCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG---KITDNMV 171
Query: 367 CAGYVEGGKDSCQ 379
C G++EGGKDSCQ
Sbjct: 172 CVGFLEGGKDSCQ 184
>pdb|1EZQ|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr128515
pdb|1F0R|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208815
pdb|1F0S|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208707
pdb|1KSN|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Fxv673
pdb|1NFU|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr132747
pdb|1NFW|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr209685
pdb|1NFX|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208944
pdb|1NFY|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr200095
pdb|1LPG|B Chain B, Crystal Structure Of Fxa In Complex With 79.
pdb|1LPK|B Chain B, Crystal Structure Of Fxa In Complex With 125.
pdb|1LPZ|B Chain B, Crystal Structure Of Fxa In Complex With 41.
pdb|1LQD|B Chain B, Crystal Structure Of Fxa In Complex With 45.
pdb|1P0S|H Chain H, Crystal Structure Of Blood Coagulation Factor Xa In
Complex With Ecotin M84r
pdb|2BOH|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound
"1"
pdb|2CJI|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J2U|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J34|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J38|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J4I|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J94|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J95|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2UWL|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWO|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWP|A Chain A, Factor Xa Inhibitor Complex
pdb|2VH0|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Biaryl Pyrrolidin-2-Ones Incorporating Basic
Heterocyclic Motifs
pdb|2VH6|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Biaryl P4 Motifs
pdb|2WYG|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2WYJ|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2Y7X|A Chain A, The Discovery Of Potent And Long-Acting Oral Factor Xa
Inhibitors With Tetrahydroisoquinoline And Benzazepine
P4 Motifs
pdb|2Y7Z|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y80|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y81|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y82|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|4A7I|B Chain B, Factor Xa In Complex With A Potent 2-Amino-Ethane
Sulfonamide Inhibitor
Length = 254
Score = 117 bits (293), Expect = 2e-26, Method: Compositional matrix adjust.
Identities = 77/238 (32%), Positives = 122/238 (51%), Gaps = 23/238 (9%)
Query: 194 IVGGWTTEVNEYPW-VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEH 252
IVGG + E PW + + + + FCGGT++S+ Y+LTAAHC+ +KR K +
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFK-----VRVG 55
Query: 253 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQL- 311
+R T E E V+V+ K+N +++D DIA+L+L TP+ F+ V+P CLP+
Sbjct: 56 DRNTEQEEGGEAVHEVEVVI--KHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD 113
Query: 312 ---GEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCA 368
TQ+TG V G+GR E G+ ++ L+ +VP + C+ F +T NM CA
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSF--IITQNMFCA 171
Query: 369 GYVEGGKDSCQVTLDEADIALLK---------SYGQGQYTKSIKAVEDDIQAVIKRVN 417
GY +D+CQ + K S+G+G K + + A +K ++
Sbjct: 172 GYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWID 229
>pdb|2Y5F|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5G|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5H|A Chain A, Factor Xa - Cation Inhibitor Complex
Length = 234
Score = 117 bits (293), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 80/238 (33%), Positives = 126/238 (52%), Gaps = 23/238 (9%)
Query: 194 IVGGWTTEVNEYPW-VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEH 252
IVGG + E PW + + + + FCGGT++S+ Y+LTAAHC+ +KR K +
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFK-----VRVG 55
Query: 253 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQ-- 310
+R T E E V+V+ K+N +++D DIA+L+L TP+ F+ V+P CLP+
Sbjct: 56 DRNTEQEEGGEAVHEVEVVI--KHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD 113
Query: 311 LGEK--FTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCA 368
E TQ+TG V G+GR E G+ ++ L+ +VP + C+ F +T NM CA
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSF--IITQNMFCA 171
Query: 369 GYVEGGKDSCQ-------VTL--DEADIALLKSYGQGQYTKSIKAVEDDIQAVIKRVN 417
GY +D+CQ VT D + + S+G+G K + + A +K ++
Sbjct: 172 GYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWID 229
>pdb|1C5M|D Chain D, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
Length = 255
Score = 117 bits (292), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 79/238 (33%), Positives = 125/238 (52%), Gaps = 23/238 (9%)
Query: 194 IVGGWTTEVNEYPW-VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEH 252
IVGG + E PW + + + + FCGGT++S+ Y+LTAAHC+ +KR K +
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFK-----VRVG 55
Query: 253 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQL- 311
+R T E E V+V+ K+N +++D DIA+L+L TP+ F+ V+P CLP+
Sbjct: 56 DRNTEQEEGGEAVHEVEVVI--KHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD 113
Query: 312 ---GEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCA 368
TQ+TG V G+GR E G+ ++ L+ +VP + C+ F +T NM CA
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSF--IITQNMFCA 171
Query: 369 GYVEGGKDSCQ-------VTL--DEADIALLKSYGQGQYTKSIKAVEDDIQAVIKRVN 417
GY +D+CQ VT D + + S+G+G K + + A +K ++
Sbjct: 172 GYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWID 229
>pdb|3ENS|B Chain B, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3ENS|D Chain D, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3HPT|B Chain B, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3HPT|D Chain D, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3K9X|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3K9X|D Chain D, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3SW2|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
6-Chloro-N-((3s)-
2-Oxo-1-(2-Oxo-2-((5s)-8-Oxo-5,6-Dihydro-1h-1,
5-Methanopyrido[1,2-
A][1,5]diazocin-3(2h,4h,
8h)-Yl)ethyl)piperidin-3-Yl)naphthalene-2- Sulfonamide
Length = 238
Score = 117 bits (292), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 80/238 (33%), Positives = 126/238 (52%), Gaps = 23/238 (9%)
Query: 194 IVGGWTTEVNEYPW-VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEH 252
IVGG + E PW + + + + FCGGT++S+ Y+LTAAHC+ +KR K +
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFK-----VRVG 55
Query: 253 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQ-- 310
+R T E E V+V+ K+N +++D DIA+L+L TP+ F+ V+P CLP+
Sbjct: 56 DRNTEQEEGGEAVHEVEVVI--KHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD 113
Query: 311 LGEK--FTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCA 368
E TQ+TG V G+GR E G+ ++ L+ +VP + C+ F +T NM CA
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSF--IITQNMFCA 171
Query: 369 GYVEGGKDSCQ-------VTL--DEADIALLKSYGQGQYTKSIKAVEDDIQAVIKRVN 417
GY +D+CQ VT D + + S+G+G K + + A +K ++
Sbjct: 172 GYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWID 229
>pdb|2BOK|A Chain A, Factor Xa- Cation
pdb|2JKH|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2VVC|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVC|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVU|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVV|A Chain A, Aminopyrrolidine-Related Triazole Factor Xa Inhibitor
pdb|2VWL|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWN|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWO|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2XBV|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 117 bits (292), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 80/238 (33%), Positives = 126/238 (52%), Gaps = 23/238 (9%)
Query: 194 IVGGWTTEVNEYPW-VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEH 252
IVGG + E PW + + + + FCGGT++S+ Y+LTAAHC+ +KR K +
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFK-----VRVG 55
Query: 253 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQ-- 310
+R T E E V+V+ K+N +++D DIA+L+L TP+ F+ V+P CLP+
Sbjct: 56 DRNTEQEEGGEAVHEVEVVI--KHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD 113
Query: 311 LGEK--FTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCA 368
E TQ+TG V G+GR E G+ ++ L+ +VP + C+ F +T NM CA
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSF--IITQNMFCA 171
Query: 369 GYVEGGKDSCQ-------VTL--DEADIALLKSYGQGQYTKSIKAVEDDIQAVIKRVN 417
GY +D+CQ VT D + + S+G+G K + + A +K ++
Sbjct: 172 GYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWID 229
>pdb|1O5E|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5F|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1P57|B Chain B, Extracellular Domain Of Human Hepsin
Length = 255
Score = 117 bits (292), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 66/188 (35%), Positives = 98/188 (52%), Gaps = 2/188 (1%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEH- 252
IVGG T + +PW V+L G CGG+L+S +VLTAAHC R V +
Sbjct: 1 IVGGRDTSLGRWPWQVSLRYDGAHLCGGSLLSGDWVLTAAHCFPERNRVLSRWRVFAGAV 60
Query: 253 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLG 312
+A+ + Q+ + VV + + ++ + +DIAL+ L +PL + PVCLP G
Sbjct: 61 AQASPHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQPVCLPAAG 120
Query: 313 EKFTQ-RTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCAGYV 371
+ + TV GWG + GQ A L+ +VP++SN C + ++ M CAGY
Sbjct: 121 QALVDGKICTVTGWGNTQYYGQQAGVLQEARVPIISNDVCNGADFYGNQIKPKMFCAGYP 180
Query: 372 EGGKDSCQ 379
EGG D+CQ
Sbjct: 181 EGGIDACQ 188
>pdb|1XKA|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|D Chain D, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1G2L|A Chain A, Factor Xa Inhibitor Complex
pdb|1G2M|A Chain A, Factor Xa Inhibitor Complex
pdb|1IOE|A Chain A, Human Coagulation Factor Xa In Complex With M55532
pdb|1IQE|A Chain A, Human Coagulation Factor Xa In Complex With M55590
pdb|1IQF|A Chain A, Human Coagulation Factor Xa In Complex With M55165
pdb|1IQG|A Chain A, Human Coagulation Factor Xa In Complex With M55159
pdb|1IQH|A Chain A, Human Coagulation Factor Xa In Complex With M55143
pdb|1IQI|A Chain A, Human Coagulation Factor Xa In Complex With M55125
pdb|1IQJ|A Chain A, Human Coagulation Factor Xa In Complex With M55124
pdb|1IQK|A Chain A, Human Coagulation Factor Xa In Complex With M55113
pdb|1IQL|A Chain A, Human Coagulation Factor Xa In Complex With M54476
pdb|1IQM|A Chain A, Human Coagulation Factor Xa In Complex With M54471
pdb|1IQN|A Chain A, Human Coagulation Factor Xa In Complex With M55192
pdb|2P3F|H Chain H, Crystal Structure Of The Factor XaNAP5 COMPLEX
Length = 235
Score = 117 bits (292), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 80/238 (33%), Positives = 126/238 (52%), Gaps = 23/238 (9%)
Query: 194 IVGGWTTEVNEYPW-VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEH 252
IVGG + E PW + + + + FCGGT++S+ Y+LTAAHC+ +KR K +
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFK-----VRVG 55
Query: 253 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQ-- 310
+R T E E V+V+ K+N +++D DIA+L+L TP+ F+ V+P CLP+
Sbjct: 56 DRNTEQEEGGEAVHEVEVVI--KHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD 113
Query: 311 LGEK--FTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCA 368
E TQ+TG V G+GR E G+ ++ L+ +VP + C+ F +T NM CA
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSF--IITQNMFCA 171
Query: 369 GYVEGGKDSCQ-------VTL--DEADIALLKSYGQGQYTKSIKAVEDDIQAVIKRVN 417
GY +D+CQ VT D + + S+G+G K + + A +K ++
Sbjct: 172 GYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWID 229
>pdb|1FXY|A Chain A, Coagulation Factor Xa-Trypsin Chimera Inhibited With
D-Phe-Pro-Arg- Chloromethylketone
Length = 228
Score = 117 bits (292), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 74/192 (38%), Positives = 107/192 (55%), Gaps = 20/192 (10%)
Query: 194 IVGGWTTEVNEYPW-VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEH 252
IVGG+ + E PW + + + + FCGGT++S+ Y+LTAAHC+ +KR K +
Sbjct: 1 IVGGYNCKDGEVPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFK-----VRVG 55
Query: 253 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLG 312
+R T E E V+V+ K+N +++D DIA+L+L TP+ F+ V+P LP
Sbjct: 56 DRNTEQEEGGEAVHEVEVVI--KHNRFTKETYDFDIAVLRLKTPITFRMNVAPASLPTA- 112
Query: 313 EKFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECR-QFPGFEAKLTGNMMC 367
TGT + GWG SG D L+ PV+S +C +PG K+T NM C
Sbjct: 113 ---PPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPG---KITSNMFC 166
Query: 368 AGYVEGGKDSCQ 379
G++EGGKDSCQ
Sbjct: 167 VGFLEGGKDSCQ 178
>pdb|1MQ5|A Chain A, Crystal Structure Of
3-chloro-n-[4-chloro-2-[[(4-chlorophenyl)
Amino]carbonyl]phenyl]-4-[(4-methyl-1-
piperazinyl)methyl]-2- Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1MQ6|A Chain A, Crystal Structure Of
3-Chloro-N-[4-Chloro-2-[[(5-Chloro-2-Pyridinyl)
Amino]carbonyl]-6-Methoxyphenyl]-4-[[(4,
5-Dihydro-2-Oxazolyl)
Methylamino]methyl]-2-Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1V3X|A Chain A, Factor Xa In Complex With The Inhibitor
1-[6-Methyl-4,5,6,7-
Tetrahydrothiazolo(5,4-C)pyridin-2-Yl] Carbonyl-2-
Carbamoyl-4-(6-Chloronaphth-2-Ylsulphonyl)piperazine
pdb|1WU1|A Chain A, Factor Xa In Complex With The Inhibitor
4-[(5-Chloroindol-2-Yl)
Sulfonyl]-2-(2-Methylpropyl)-1-[[5-(Pyridin-4-Yl)
Pyrimidin-2- Yl]carbonyl]piperazine
pdb|2D1J|A Chain A, Factor Xa In Complex With The Inhibitor 2-[[4-[(5-
Chloroindol-2-Yl)sulfonyl]piperazin-1-Yl]
Carbonyl]thieno[3,2-B]pyridine N-Oxide
pdb|2H9E|H Chain H, Crystal Structure Of FxaSELECTIDENAPC2 TERNARY COMPLEX
pdb|2P3U|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-N-(4-Chloro-2-{[(5-Chloropyridin-2-Yl)
Amino]carbonyl}-6-Methoxyphenyl)-4-[(1-Methyl-1h-
Imidazol- 2-Yl)methyl]thiophene-2-Carboxamide {pfizer
320663}
pdb|2P3T|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-4-(2-Methylamino-Imidazol-1-Ylmethyl)-Thiophene-
2- Carboxylic Acid [4-Chloro-2-(5-Chloro-Pyridin-2-
Ylcarbamoyl)-6-Methoxy-Phenyl]-Amide
pdb|2EI6|A Chain A, Factor Xa In Complex With The Inhibitor (-)-Cis-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI7|A Chain A, Factor Xa In Complex With The Inhibitor Trans-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI8|A Chain A, Factor Xa In Complex With The Inhibitor (1s,2r,4s)-N1-[(5-
Chloroindol-2-Yl)carbonyl]-4-(N,N-Dimethylcarbamoyl)-N2-
[(5-Methyl-4,5,6,7-Tetrahydrothiazolo[5,
4-C]pyridin-2-Yl) Carbonyl]-1,2-Cyclohexanediamine
pdb|3IIT|A Chain A, Factor Xa In Complex With A Cis-1,2-Diaminocyclohexane
Derivative
pdb|3Q3K|A Chain A, Factor Xa In Complex With A Phenylenediamine Derivative
pdb|3TK5|A Chain A, Factor Xa In Complex With D102-4380
pdb|3TK6|A Chain A, Factor Xa In Complex With D46-5241
Length = 233
Score = 117 bits (292), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 80/238 (33%), Positives = 126/238 (52%), Gaps = 23/238 (9%)
Query: 194 IVGGWTTEVNEYPW-VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEH 252
IVGG + E PW + + + + FCGGT++S+ Y+LTAAHC+ +KR K +
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFK-----VRVG 55
Query: 253 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQ-- 310
+R T E E V+V+ K+N +++D DIA+L+L TP+ F+ V+P CLP+
Sbjct: 56 DRNTEQEEGGEAVHEVEVVI--KHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD 113
Query: 311 LGEK--FTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCA 368
E TQ+TG V G+GR E G+ ++ L+ +VP + C+ F +T NM CA
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSF--IITQNMFCA 171
Query: 369 GYVEGGKDSCQ-------VTL--DEADIALLKSYGQGQYTKSIKAVEDDIQAVIKRVN 417
GY +D+CQ VT D + + S+G+G K + + A +K ++
Sbjct: 172 GYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWID 229
>pdb|1HCG|A Chain A, Structure Of Human Des(1-45) Factor Xa At 2.2 Angstroms
Resolution
pdb|3KL6|A Chain A, Discovery Of Tetrahydropyrimidin-2(1h)-One Derivative
Tak-44 Potent, Selective And Orally Active Factor Xa
Inhibitor
pdb|2XBW|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBX|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBY|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC0|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC4|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC5|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 117 bits (292), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 80/238 (33%), Positives = 126/238 (52%), Gaps = 23/238 (9%)
Query: 194 IVGGWTTEVNEYPW-VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEH 252
IVGG + E PW + + + + FCGGT++S+ Y+LTAAHC+ +KR K +
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFK-----VRVG 55
Query: 253 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQ-- 310
+R T E E V+V+ K+N +++D DIA+L+L TP+ F+ V+P CLP+
Sbjct: 56 DRNTEQEEGGEAVHEVEVVI--KHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD 113
Query: 311 LGEK--FTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCA 368
E TQ+TG V G+GR E G+ ++ L+ +VP + C+ F +T NM CA
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSF--IITQNMFCA 171
Query: 369 GYVEGGKDSCQ-------VTL--DEADIALLKSYGQGQYTKSIKAVEDDIQAVIKRVN 417
GY +D+CQ VT D + + S+G+G K + + A +K ++
Sbjct: 172 GYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWID 229
>pdb|1FJS|A Chain A, Crystal Structure Of The Inhibitor Zk-807834 (Ci-1031)
Complexed With Factor Xa
pdb|1Z6E|A Chain A, Factor Xa In Complex With The Inhibitor
1-(3'-Amino-1,2-Benzisoxazol-
5'-Yl)-N-(4-(2'-((Dimethylamino)methyl)-1h-Imidazol-1-
Yl)-2-
Fluorophenyl)-3-(Trifluoromethyl)-1h-Pyrazole-5-
Carboxamide (Razaxaban; Dpc906; Bms-561389)
pdb|2BMG|B Chain B, Crystal Structure Of Factor Xa In Complex With 50
pdb|2FZZ|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-Amino-1,2-
Benzisoxazol-5-Yl)-6-(2'-(((3r)-3-Hydroxy-1-
Pyrrolidinyl)
Methyl)-4-Biphenylyl)-3-(Trifluoromethyl)-1,4,5,6-
Tetrahydro-7h-Pyrazolo[3,4-C]pyridin-7-One
pdb|2G00|A Chain A, Factor Xa In Complex With The Inhibitor 3-(6-(2'-
((Dimethylamino)methyl)-4-Biphenylyl)-7-Oxo-3-
(Trifluoromethyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3,4-
C]pyridin-1-Yl)benzamide
pdb|2P93|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-(2-(4-(2-
Oxopyridin-1(2h)-Yl)benzamido)ethyl)thiophene-2-
Carboxamide
pdb|2P94|A Chain A, Factor Xa In Complex With The Inhibitor
3-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido)cyclohexyl)-1h-
Indole-6-Carboxamide
pdb|2P95|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido) Cyclopentyl)
Thiophene-2-Carboxamide
pdb|2PR3|A Chain A, Factor Xa Inhibitor
pdb|2Q1J|A Chain A, The Discovery Of Glycine And Related Amino Acid-Based
Factor Xa Inhibitors
pdb|2P16|A Chain A, Factor Xa In Complex With The Inhibitor Apixaban (Bms-
562247) Aka 1-(4-Methoxyphenyl)-7-Oxo-6-(4-(2-Oxo-1-
Piperidinyl)phenyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3, 4-
C]pyridine-3-Carboxamide
pdb|2RA0|A Chain A, X-Ray Structure Of Fxa In Complex With 7-Fluoroindazole
pdb|2PHB|A Chain A, An Orally Efficacious Factor Xa Inhibitor
pdb|3CEN|A Chain A, Factor Xa In Complex With The Inhibitor
N-(2-(((5-Chloro-2- Pyridinyl)
Amino)sulfonyl)phenyl)-4-(2-Oxo-1(2h)-
Pyridinyl)benzamide
pdb|3CS7|A Chain A, Factor Xa In Complex With The Inhibitor
1-(4-Methoxyphenyl)-
6-(4-(1-(Pyrrolidin-1-Ylmethyl)cyclopropyl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|2W26|A Chain A, Factor Xa In Complex With Bay59-7939
pdb|2W3I|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-disubstituted
Pyrrolidine-1,2-dicarboxamide Inhibitor 2
pdb|2W3K|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-Disubstituted
Pyrrolidine-1,2-Dicarboxamide Inhibitor 1
pdb|3FFG|A Chain A, Factor Xa In Complex With The Inhibitor (R)-6-(2'-((3-
Hydroxypyrrolidin-1-Yl)methyl)biphenyl-4-Yl)-1-(3-(5-
Oxo-4, 5-Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|3KQB|A Chain A, Factor Xa In Complex With The Inhibitor N-(3-Fluoro-2'-
(Methylsulfonyl)biphenyl-4-Yl)-1-(3-(5-Oxo-4,
5-Dihydro-1h-
Triazol-3-Yl)phenyl)-3-(Trifluoromethyl)-1h-
Pyrazole-5-Car
pdb|3KQC|A Chain A, Factor Xa In Complex With The Inhibitor 6-(2'-
(Methylsulfon Biphenyl-4-Yl)-1-(3-(5-Oxo-4,5-Dihydro-1h-
1,2,4-Triazol-3- Phenyl)-3-(Trifluoromethyl)-5,6-
Dihydro-1h-Pyrazolo[3,4-C] 7(4h)-One
pdb|3KQD|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-(5-Oxo-4,5-
Dih 2,4-Triazol-3-Yl)phenyl)-6-(2'-(Pyrrolidin-1-
Ylmethyl)biph Yl)-3-(Trifluoromethyl)-5,6-Dihydro-
1h-Pyrazolo[3,4-C]pyri One
pdb|3KQE|A Chain A, Factor Xa In Complex With The Inhibitor 3-Methyl-1-(3-(5-
Ox Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-6-(2'-
(Pyrrolidin-1- Biphenyl-4-Yl)-5,6-Dihydro-1h-
Pyrazolo[3,4-C]pyridin-7(4h)
pdb|3LIW|A Chain A, Factor Xa In Complex With
(R)-2-(1-Adamantylcarbamoylamino)-
3-(3-Carbamidoyl-Phenyl)-N-Phenethyl-Propionic Acid
Amide
pdb|3M36|A Chain A, Factor Xa In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3M37|A Chain A, Factor Xa In Complex With The Inhibitor 1-[2-(Aminomethyl)
Phenyl]-N-(3-Fluoro-2'-Sulfamoylbiphenyl-4-Yl)-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc602)
Length = 234
Score = 116 bits (291), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 79/238 (33%), Positives = 125/238 (52%), Gaps = 23/238 (9%)
Query: 194 IVGGWTTEVNEYPW-VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEH 252
IVGG + E PW + + + + FCGGT++S+ Y+LTAAHC+ +KR K +
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFK-----VRVG 55
Query: 253 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLG 312
+R T E E V+V+ K+N +++D DIA+L+L TP+ F+ V+P CLP+
Sbjct: 56 DRNTEQEEGGEAVHEVEVVI--KHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERD 113
Query: 313 EK----FTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCA 368
TQ+TG V G+GR E G+ ++ L+ +VP + C+ F +T NM CA
Sbjct: 114 WAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSF--IITQNMFCA 171
Query: 369 GYVEGGKDSCQ-------VTL--DEADIALLKSYGQGQYTKSIKAVEDDIQAVIKRVN 417
GY +D+CQ VT D + + S+G+G K + + A +K ++
Sbjct: 172 GYDTKQEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWID 229
>pdb|1F7Z|A Chain A, Rat Trypsinogen K15a Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 233
Score = 115 bits (289), Expect = 6e-26, Method: Composition-based stats.
Identities = 71/193 (36%), Positives = 108/193 (55%), Gaps = 22/193 (11%)
Query: 192 DRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISE 251
D IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + V + E
Sbjct: 9 DAIVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSR-----IQVRLGE 62
Query: 252 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQL 311
HN V E + K++ HP ++ K+ ++DI L+KL +P++ V+ V LP
Sbjct: 63 HN-INVLEGNEQFVNAAKIIKHPNFDR---KTLNNDIMLIKLSSPVKLNARVATVALPS- 117
Query: 312 GEKFTQRTGT---VVGWGRVEESGQIASDL-RATQVPVMSNQECR-QFPGFEAKLTGNMM 366
GT + GWG SG DL + P++ +C +PG K+T NM+
Sbjct: 118 ---SCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG---KITDNMV 171
Query: 367 CAGYVEGGKDSCQ 379
C G++EGGKDSCQ
Sbjct: 172 CVGFLEGGKDSCQ 184
>pdb|1F0T|A Chain A, Bovine Trypsin Complexed With Rpr131247
pdb|1F0U|A Chain A, Bovine Trypsin Complexed With Rpr128515
pdb|1EZX|C Chain C, Crystal Structure Of A Serpin:protease Complex
pdb|1LQE|A Chain A, Crystal Structure Of Trypsin In Complex With 79.
pdb|1UTN|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTO|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-ray Structures And Association Constant Measurements
pdb|1UTP|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTQ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|2BY5|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY6|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY7|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY8|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY9|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BYA|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
Length = 243
Score = 115 bits (289), Expect = 6e-26, Method: Compositional matrix adjust.
Identities = 70/191 (36%), Positives = 106/191 (55%), Gaps = 18/191 (9%)
Query: 192 DRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISE 251
D+IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E
Sbjct: 19 DKIVGGYTCGANTVPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQ-----VRLGE 72
Query: 252 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLP-Q 310
N V E + K + HP YN+ + ++DI L+KL + V+ + LP
Sbjct: 73 DN-INVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVASISLPTS 128
Query: 311 LGEKFTQRTGTVVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEAKLTGNMMCA 368
TQ + GWG + SG D L+ + P++S+ C+ +PG ++T NM CA
Sbjct: 129 CASAGTQCL--ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMFCA 183
Query: 369 GYVEGGKDSCQ 379
GY+EGGKDSCQ
Sbjct: 184 GYLEGGKDSCQ 194
>pdb|1OPH|B Chain B, Non-Covalent Complex Between Alpha-1-Pi-Pittsburgh And
S195a Trypsin
Length = 243
Score = 115 bits (289), Expect = 6e-26, Method: Compositional matrix adjust.
Identities = 70/191 (36%), Positives = 106/191 (55%), Gaps = 18/191 (9%)
Query: 192 DRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISE 251
D+IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E
Sbjct: 19 DKIVGGYTCGANTVPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSGIQ-----VRLGE 72
Query: 252 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLP-Q 310
N V E + K + HP YN+ + ++DI L+KL + V+ + LP
Sbjct: 73 DN-INVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVASISLPTS 128
Query: 311 LGEKFTQRTGTVVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEAKLTGNMMCA 368
TQ + GWG + SG D L+ + P++S+ C+ +PG ++T NM CA
Sbjct: 129 CASAGTQCL--ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMFCA 183
Query: 369 GYVEGGKDSCQ 379
GY+EGGKDSCQ
Sbjct: 184 GYLEGGKDSCQ 194
>pdb|1CO7|E Chain E, R117h Mutant Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
Length = 245
Score = 115 bits (288), Expect = 7e-26, Method: Compositional matrix adjust.
Identities = 69/190 (36%), Positives = 108/190 (56%), Gaps = 16/190 (8%)
Query: 192 DRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISE 251
D+IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + V + E
Sbjct: 21 DKIVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQ-----VRLGE 74
Query: 252 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQL 311
HN V E + K++ HP ++ K+ ++DI L+KL +P++ V+ V LP
Sbjct: 75 HN-INVLEGNEQFVNAAKIIKHPNFDR---KTLNNDIMLIKLSSPVKLNAHVATVALPSS 130
Query: 312 GEKFTQRTGTVVGWGRVEESGQIASDL-RATQVPVMSNQECR-QFPGFEAKLTGNMMCAG 369
+ + GWG SG DL + P++ +C +PG K+T NM+C G
Sbjct: 131 CAPAGTQC-LISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG---KITDNMVCVG 186
Query: 370 YVEGGKDSCQ 379
++EGGKDSCQ
Sbjct: 187 FLEGGKDSCQ 196
>pdb|1DAN|H Chain H, Complex Of Active Site Inhibited Human Blood Coagulation
Factor Viia With Human Recombinant Soluble Tissue Factor
pdb|1QFK|H Chain H, Structure Of Human Factor Viia And Its Implications For
The Triggering Of Blood Coagulation
pdb|1CVW|H Chain H, Crystal Structure Of Active Site-inhibited Human
Coagulation Factor Viia (des-gla)
pdb|1FAK|H Chain H, Human Tissue Factor Complexed With Coagulation Factor Viia
Inhibited With A Bpti-Mutant
pdb|1DVA|H Chain H, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1DVA|I Chain I, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1JBU|H Chain H, Coagulation Factor Vii Zymogen (Egf2PROTEASE) IN COMPLEX
WITH Inhibitory Exosite Peptide A-183
pdb|1KLI|H Chain H, Cofactor-And Substrate-Assisted Activation Of Factor Viia
pdb|1KLJ|H Chain H, Crystal Structure Of Uninhibited Factor Viia
pdb|1J9C|H Chain H, Crystal Structure Of Tissue Factor-Factor Viia Complex
pdb|1W0Y|H Chain H, Tf7a_3771 Complex
pdb|1YGC|H Chain H, Short Factor Viia With A Small Molecule Inhibitor
pdb|1Z6J|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
Viia/tissue Factor/pyrazinone Inhibitor
pdb|1W2K|H Chain H, Tf7a_4380 Complex
pdb|1WQV|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Propylsulfonamide-D- Thr-Met-P-Aminobenzamidine
pdb|1W7X|H Chain H, Factor7- 413 Complex
pdb|1W8B|H Chain H, Factor7 - 413 Complex
pdb|1WSS|H Chain H, Human Factor Viia-Tissue Factor In Complex With Peprid
Mimetic Inhibitor That Has Two Charge Groups In P2 And
P4
pdb|1WTG|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Biphenylalanine-Gln-P-
Aminobenzamidine
pdb|1WUN|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Trp-Gln-P-Aminobenzamidine
pdb|1WV7|H Chain H, Human Factor Viia-tissue Factor Complexed With
Ethylsulfonamide-d-5-propoxy-trp-gln-p-aminobenzamidine
pdb|2B7D|H Chain H, Factor Viia Inhibitors: Chemical Optimization, Preclinical
Pharmacokinetics, Pharmacodynamics, And Efficacy In A
Baboon Thrombosis Model
pdb|2F9B|H Chain H, Discovery Of Novel Heterocyclic Factor Viia Inhibitors
pdb|2FLB|H Chain H, Discovery Of A Novel Hydroxy Pyrazole Based Factor Ixa
Inhibitor
pdb|2A2Q|H Chain H, Complex Of Active-Site Inhibited Human Coagulation Factor
Viia With Human Soluble Tissue Factor In The Presence Of
Ca2+, Mg2+, Na+, And Zn2+
pdb|2AER|H Chain H, Crystal Structure Of Benzamidine-Factor ViiaSOLUBLE TISSUE
Factor Complex.
pdb|2AEI|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
ViiaTISSUE FACTOR And
2-[[6-[3-(Aminoiminomethyl)phenoxy]-3,
5-Difluro-4-[(1-Methyl-3-
Phenylpropyl)amino]-2-Pyridinyl]oxy]-Benzoic Acid
pdb|2FIR|H Chain H, Crystal Structure Of Dfpr-ViiaSTF
pdb|2C4F|H Chain H, Crystal Structure Of Factor Vii.Stf Complexed With
Pd0297121
pdb|2FLR|H Chain H, Novel 5-azaindole Factor Viia Inhibitors
pdb|2B8O|H Chain H, Crystal Structure Of Glu-gly-arg-chloromethyl
Ketone-factor Viia/soluble Tissue Factor Complex
pdb|2PUQ|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia In Complex With Soluble Tissue Factor
pdb|2EC9|H Chain H, Crystal Structure Analysis Of Human Factor Viia , Souluble
Tissue Factor Complexed With Bcx-3607
pdb|2ZP0|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Benzylsulfonamide-D- Ile-Gln-P-Aminobenzamidine
pdb|2ZWL|H Chain H, Human Factor Viia-Tissue Factor Complexed With Highly
Selective Peptide Inhibitor
pdb|2ZZU|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-5-
(3-Carboxybenzyloxy)-Trp-Gln-P-Aminobenzamidine
pdb|3TH2|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH3|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH4|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|1O5D|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|2BZ6|H Chain H, Orally Available Factor7a Inhibitor
pdb|4ISI|H Chain H, Structure Of Factor Viia In Complex With The Inhibitor
(6s)-n-(4-
Carbamimidoylbenzyl)-1-chloro-3-(cyclobutylamino)-8,
8-diethyl-4-oxo-
4,6,7,8-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide
Length = 254
Score = 115 bits (288), Expect = 8e-26, Method: Compositional matrix adjust.
Identities = 72/195 (36%), Positives = 104/195 (53%), Gaps = 15/195 (7%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG E PW V L G CGGTLI+ +V++AAHC K ++LI V+ EH+
Sbjct: 1 IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHD 60
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
+ ++ ++RRV +V+ Y + +HDIALL+L P+ V P+CLP+
Sbjct: 61 LSE-HDGDEQSRRVAQVIIPSTYV---PGTTNHDIALLRLHQPVVLTDHVVPLCLPE--R 114
Query: 314 KFTQRT------GTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFP---GFEAKLTGN 364
F++RT V GWG++ + G A +L VP + Q+C Q G +T
Sbjct: 115 TFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEY 174
Query: 365 MMCAGYVEGGKDSCQ 379
M CAGY +G KDSC+
Sbjct: 175 MFCAGYSDGSKDSCK 189
>pdb|1QL9|A Chain A, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99rt
pdb|1J14|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99rt
Length = 223
Score = 115 bits (288), Expect = 8e-26, Method: Composition-based stats.
Identities = 69/191 (36%), Positives = 108/191 (56%), Gaps = 22/191 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + V + EHN
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSR-----IQVRLGEHN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K++ HP ++ + ++++DI L+KL +P++ V+ V LP
Sbjct: 55 -INVLEGNEQFVNAAKIIKHPNFDRE---TYNNDIMLIKLSSPVKLNARVATVALPS--- 107
Query: 314 KFTQRTGT---VVGWGRVEESGQIASDL-RATQVPVMSNQECR-QFPGFEAKLTGNMMCA 368
GT + GWG SG DL + P++ +C +PG K+T NM+C
Sbjct: 108 -SCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG---KITDNMVCV 163
Query: 369 GYVEGGKDSCQ 379
G++EGGKDSCQ
Sbjct: 164 GFLEGGKDSCQ 174
>pdb|1ZZZ|A Chain A, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
Length = 237
Score = 115 bits (288), Expect = 9e-26, Method: Composition-based stats.
Identities = 70/193 (36%), Positives = 106/193 (54%), Gaps = 22/193 (11%)
Query: 192 DRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISE 251
D+IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E
Sbjct: 13 DKIVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGE 66
Query: 252 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQL 311
N V E + K + HP YN+ + ++DI L+KL + V+ + LP
Sbjct: 67 DN-INVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVASISLP-- 120
Query: 312 GEKFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEAKLTGNMM 366
GT + GWG + SG D L+ + P++S+ C+ +PG ++T NM
Sbjct: 121 --TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMF 175
Query: 367 CAGYVEGGKDSCQ 379
CAGY+EGGKDSCQ
Sbjct: 176 CAGYLEGGKDSCQ 188
>pdb|1G3B|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Magnesium(Ii) Chelate
pdb|1G3C|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff Base
Iron(Iii) Chelate
pdb|1G3D|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Copper (Ii) Chelate
pdb|1G3E|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff-Base
Copper (Ii) Chelate
Length = 228
Score = 115 bits (288), Expect = 9e-26, Method: Composition-based stats.
Identities = 70/193 (36%), Positives = 106/193 (54%), Gaps = 22/193 (11%)
Query: 192 DRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISE 251
D+IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E
Sbjct: 4 DKIVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGE 57
Query: 252 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQL 311
N V E + K + HP YN+ + ++DI L+KL + V+ + LP
Sbjct: 58 DN-INVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVASISLP-- 111
Query: 312 GEKFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEAKLTGNMM 366
GT + GWG + SG D L+ + P++S+ C+ +PG ++T NM
Sbjct: 112 --TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMF 166
Query: 367 CAGYVEGGKDSCQ 379
CAGY+EGGKDSCQ
Sbjct: 167 CAGYLEGGKDSCQ 179
>pdb|1TGS|Z Chain Z, Three-Dimensional Structure Of The Complex Between
Pancreatic Secretory Inhibitor (Kazal Type) And
Trypsinogen At 1.8 Angstroms Resolution. Structure
Solution, Crystallographic Refinement And Preliminary
Structural Interpretation
pdb|2TGP|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2TPI|Z Chain Z, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3TPI|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|4TPI|Z Chain Z, The Refined 2.2-angstroms (0.22-nm) X-ray Crystal
Structure Of The Ternary Complex Formed By Bovine
Trypsinogen, Valine-valine And The Arg15 Analogue Of
Bovine Pancreatic Trypsin Inhibitor
pdb|1BTZ|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTX|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTW|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTP|A Chain A, Unique Binding Of A Novel Synthetic Inhibitor, N-[3-[4-[4-
(Amidinophenoxy)-Carbonyl]phenyl]-2-Methyl-2-Propenoyl]-
N- Allylglycine Methanesulfonate To Bovine Trypsin,
Revealed By The Crystal Structure Of The Complex
pdb|1BTY|A Chain A, Crystal Structure Of Beta-Trypsin In Complex With
Benzamidine
pdb|1TGB|A Chain A, Crystal Structure Of Bovine Trypsinogen At 1.8 Angstroms
Resolution. Ii. Crystallographic Refinement, Refined
Crystal Structure And Comparison With Bovine Trypsin
pdb|1TGC|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TGN|A Chain A, Structure Of Bovine Trypsinogen At 1.9 Angstroms
Resolution
pdb|1TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TNG|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNH|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNI|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNJ|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNK|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNL|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|2TGA|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|2TGD|A Chain A, Lack Of The Transition State Stabilization Site Is A
Factor In The Inactivity Of Trypsinogen, A Serine
Protease Zymogen. Structure Of Dfp Inhibited Bovine
Trypsinogen At 2.1 Angstroms Resolution
pdb|2TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
Length = 229
Score = 115 bits (288), Expect = 9e-26, Method: Composition-based stats.
Identities = 70/193 (36%), Positives = 106/193 (54%), Gaps = 22/193 (11%)
Query: 192 DRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISE 251
D+IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E
Sbjct: 5 DKIVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGE 58
Query: 252 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQL 311
N V E + K + HP YN+ + ++DI L+KL + V+ + LP
Sbjct: 59 DN-INVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVASISLP-- 112
Query: 312 GEKFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEAKLTGNMM 366
GT + GWG + SG D L+ + P++S+ C+ +PG ++T NM
Sbjct: 113 --TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMF 167
Query: 367 CAGYVEGGKDSCQ 379
CAGY+EGGKDSCQ
Sbjct: 168 CAGYLEGGKDSCQ 180
>pdb|2ANY|A Chain A, Expression, Crystallization And The Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 115 bits (287), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 69/196 (35%), Positives = 111/196 (56%), Gaps = 21/196 (10%)
Query: 194 IVGGWTTEVNEYPWVVALE---QAGKFFCGGTLISDRYVLTAAHC-----VRSSKRQKDL 245
IVGG + E+PW V+L+ A + CGG+LI ++VLTAAHC ++ R
Sbjct: 1 IVGGTESSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSG 60
Query: 246 IVVISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
I+ +S+ + T + ++ +++ H Y +HDIAL+KL PLE+ P
Sbjct: 61 ILELSDITKDTPFS------QIKEIIIHQNYKV---SEGNHDIALIKLQAPLEYTEFQKP 111
Query: 306 VCLPQLGEKFTQRTGT-VVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEAKLTG 363
+ LP G+ T T V GWG +E G+I + L+ +P+++N+EC +++ + K+T
Sbjct: 112 ISLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDY--KITQ 169
Query: 364 NMMCAGYVEGGKDSCQ 379
M+CAGY EGGKD+C+
Sbjct: 170 RMVCAGYKEGGKDACK 185
>pdb|1H4W|A Chain A, Structure Of Human Trypsin Iv (Brain Trypsin)
Length = 224
Score = 115 bits (287), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 72/188 (38%), Positives = 104/188 (55%), Gaps = 16/188 (8%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T E N P+ V+L +G FCGG+LIS+++V++AAHC ++ + V + EHN
Sbjct: 1 IVGGYTCEENSLPYQVSL-NSGSHFCGGSLISEQWVVSAAHCYKTR-----IQVRLGEHN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + VK++ HPKYN + D+DI L+KL +P VS + LP
Sbjct: 55 -IKVLEGNEQFINAVKIIRHPKYNRD---TLDNDIMLIKLSSPAVINARVSTISLPTAPP 110
Query: 314 KFTQRTGTVVGWGRVEESGQIASD-LRATQVPVMSNQECR-QFPGFEAKLTGNMMCAGYV 371
+ GWG G D L+ PV++ EC+ +PG K+T +M C G++
Sbjct: 111 AAGTEC-LISGWGNTLSFGADYPDELKCLDAPVLTQAECKASYPG---KITNSMFCVGFL 166
Query: 372 EGGKDSCQ 379
EGGKDSCQ
Sbjct: 167 EGGKDSCQ 174
>pdb|4B4T|M Chain M, Near-Atomic Resolution Structural Model Of The Yeast 26s
Proteasome
Length = 434
Score = 115 bits (287), Expect = 1e-25, Method: Compositional matrix adjust.
Identities = 71/182 (39%), Positives = 104/182 (57%), Gaps = 10/182 (5%)
Query: 448 QPLQIHIPLPPKIDPTVTMMQVEEKPDVTYSD----IGGCKEQIEKL--REVVETPLL-- 499
Q +Q++I K+ + E+ P + + D IG + EK REV T L
Sbjct: 250 QLVQMYIGEGAKLVRDAFALAKEKAPTIIFIDELDAIGTKRFDSEKSGDREVQRTMLELL 309
Query: 500 -HLDGFDPRGNIKVLMATNRPDTLDPALMRPGRLDRKVEFGLPDLEGRTHIFKIHARSMS 558
LDGF +KVL ATNR D LDPAL+R GRLDRK+EF LP + R I +IH+R M+
Sbjct: 310 NQLDGFSSDDRVKVLAATNRVDVLDPALLRSGRLDRKIEFPLPSEDSRAQILQIHSRKMT 369
Query: 559 VERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIRARRKVASEKDFLEAVNKV-ARCTKI 617
+ DI ++ LAR GA++++V EAGM A+R + +DF+E +++V AR +K
Sbjct: 370 TDDDINWQELARSTDEFNGAQLKAVTVEAGMIALRNGQSSVKHEDFVEGISEVQARKSKS 429
Query: 618 IN 619
++
Sbjct: 430 VS 431
Score = 73.9 bits (180), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 30/58 (51%), Positives = 44/58 (75%)
Query: 116 INQPEKFVNLGIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQKYVGE 173
+ + +KF ++GI PKG L++GPPGTGKTL ARA A +T+A F+++ +LVQ Y+GE
Sbjct: 201 MKRADKFKDMGIRAPKGALMYGPPGTGKTLLARACAAQTNATFLKLAAPQLVQMYIGE 258
Score = 57.8 bits (138), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 29/69 (42%), Positives = 42/69 (60%), Gaps = 5/69 (7%)
Query: 643 DSVAPTDIEEGMRVGVDRNKYQIHIPLPPKIDPTVTMMQVEEKPDVTYSDIGGCKEQIEK 702
D + P D+ VGV+++ Y I LP + D V M+V+EKP TYSD+GG +QIE+
Sbjct: 138 DKLKPNDL-----VGVNKDSYLILDTLPSEFDSRVKAMEVDEKPTETYSDVGGLDKQIEE 192
Query: 703 LREVVETPL 711
L E + P+
Sbjct: 193 LVEAIVLPM 201
Score = 51.2 bits (121), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 26/63 (41%), Positives = 35/63 (55%)
Query: 446 NEQPLQIHIPLPPKIDPTVTMMQVEEKPDVTYSDIGGCKEQIEKLREVVETPLLHLDGFD 505
N+ I LP + D V M+V+EKP TYSD+GG +QIE+L E + P+ D F
Sbjct: 149 NKDSYLILDTLPSEFDSRVKAMEVDEKPTETYSDVGGLDKQIEELVEAIVLPMKRADKFK 208
Query: 506 PRG 508
G
Sbjct: 209 DMG 211
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/96 (31%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 27 GHKNIARGAVANRTDACFIRVIGSELVQKYVGEGAVANRTDACFIRVIGSELVQKYVGEG 86
G +AR A A +T+A F+++ +LVQ Y+GEGA R + ++ ++ E
Sbjct: 227 GKTLLAR-ACAAQTNATFLKLAAPQLVQMYIGEGAKLVRDAFALAKEKAPTII--FIDE- 282
Query: 87 ARMIXXXXXXXXXXXXXXXNEVQRTMLELINQPEKF 122
+ EVQRTMLEL+NQ + F
Sbjct: 283 ---LDAIGTKRFDSEKSGDREVQRTMLELLNQLDGF 315
>pdb|1Y59|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5A|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5B|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5U|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
Length = 223
Score = 114 bits (286), Expect = 1e-25, Method: Composition-based stats.
Identities = 69/191 (36%), Positives = 106/191 (55%), Gaps = 22/191 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E N
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGEDN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K + HP YN++ ++++DI L+KL + V+ + LP
Sbjct: 55 -INVVEGNEQFISASKSIVHPSYNSE---TYNNDIMLIKLKSAASLNSRVASISLP---- 106
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEAKLTGNMMCA 368
GT + GWG + SG D L+ + P++S+ C+ +PG ++T NM CA
Sbjct: 107 TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMFCA 163
Query: 369 GYVEGGKDSCQ 379
GY+EGGKDSCQ
Sbjct: 164 GYLEGGKDSCQ 174
>pdb|1AND|A Chain A, Anionic Trypsin Mutant With Arg 96 Replaced By His
Length = 223
Score = 114 bits (286), Expect = 1e-25, Method: Composition-based stats.
Identities = 70/191 (36%), Positives = 107/191 (56%), Gaps = 22/191 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + V + EHN
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSR-----IQVRLGEHN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K++ HP ++ K+ ++DI L+KL +P++ V+ V LP
Sbjct: 55 -INVLEGNEQFVNAAKIIKHPNFDH---KTLNNDIMLIKLSSPVKLNARVATVALPS--- 107
Query: 314 KFTQRTGT---VVGWGRVEESGQIASDL-RATQVPVMSNQECR-QFPGFEAKLTGNMMCA 368
GT + GWG SG DL + P++ +C +PG K+T NM+C
Sbjct: 108 -SCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG---KITDNMVCV 163
Query: 369 GYVEGGKDSCQ 379
G++EGGKDSCQ
Sbjct: 164 GFLEGGKDSCQ 174
>pdb|1SLX|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Zinc-Bound
pdb|1SLV|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Copper- Bound
pdb|1SLU|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin
Length = 223
Score = 114 bits (286), Expect = 1e-25, Method: Composition-based stats.
Identities = 70/191 (36%), Positives = 107/191 (56%), Gaps = 22/191 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + V + EHN
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSR-----IQVRLGEHN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K++ HP ++ K+ ++DI L+KL +P++ V+ V LP
Sbjct: 55 -INVLEGNEQFVNAAKIIKHPNFDR---KTLNNDIMLIKLSSPVKLNARVATVALPS--- 107
Query: 314 KFTQRTGT---VVGWGRVEESGQIASDL-RATQVPVMSNQECR-QFPGFEAKLTGNMMCA 368
GT + GWG SG DL + P++ +C +PG K+T NM+C
Sbjct: 108 -SCAPAGTQCLISGWGHTLSSGVNHPDLLQCLDAPLLPQADCEASYPG---KITDNMVCV 163
Query: 369 GYVEGGKDSCQ 379
G++EGGKDSCQ
Sbjct: 164 GFLEGGKDSCQ 174
>pdb|3GYL|B Chain B, Structure Of Prostasin At 1.3 Angstroms Resolution In
Complex With A Calcium Ion.
pdb|3GYM|A Chain A, Structure Of Prostasin In Complex With Aprotinin
pdb|3GYM|B Chain B, Structure Of Prostasin In Complex With Aprotinin
Length = 261
Score = 114 bits (286), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 65/195 (33%), Positives = 103/195 (52%), Gaps = 13/195 (6%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
I GG + ++PW V++ G CGG+L+S+++VL+AAHC S ++ V + H
Sbjct: 1 ITGGSSAVAGQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHCFPSEHHKEAYEVKLGAHQ 60
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
+ Y + + ++ HP Y +G++ DIALL+L P+ F + P+ LP
Sbjct: 61 LDS-YSEDAKVSTLKDIIPHPSYLQEGSQG---DIALLQLSRPITFSRYIRPISLPAAQA 116
Query: 314 KFTQRTG-TVVGWGRVEESGQIAS--DLRATQVPVMSNQECRQFPGFEAK------LTGN 364
F TV GWG V S + + L+ +VP++S + C +AK + +
Sbjct: 117 SFPNGLHCTVTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNSLYNIDAKPEEPHFVQED 176
Query: 365 MMCAGYVEGGKDSCQ 379
M+CAGYVEGGKD+CQ
Sbjct: 177 MVCAGYVEGGKDACQ 191
>pdb|3E0P|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With A
Covalent Benzoxazole Inhibitor
pdb|3E16|B Chain B, X-Ray Structure Of Human Prostasin In Complex With
Benzoxazole Warhead Peptidomimic, Lysine In P3
pdb|3E1X|B Chain B, The Crystal Structure Of Apo Prostasin At 1.7 Angstroms
Resolution
pdb|3FVF|B Chain B, The Crystal Structure Of Prostasin Complexed With Camostat
At 1.6 Angstroms Resolution
pdb|3E0N|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With
Dffr- Chloromethyl Ketone Inhibitor
Length = 271
Score = 114 bits (286), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 65/195 (33%), Positives = 103/195 (52%), Gaps = 13/195 (6%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
I GG + ++PW V++ G CGG+L+S+++VL+AAHC S ++ V + H
Sbjct: 1 ITGGSSAVAGQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHCFPSEHHKEAYEVKLGAHQ 60
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
+ Y + + ++ HP Y +G++ DIALL+L P+ F + P+ LP
Sbjct: 61 LDS-YSEDAKVSTLKDIIPHPSYLQEGSQG---DIALLQLSRPITFSRYIRPISLPAAQA 116
Query: 314 KFTQRTG-TVVGWGRVEESGQIAS--DLRATQVPVMSNQECRQFPGFEAK------LTGN 364
F TV GWG V S + + L+ +VP++S + C +AK + +
Sbjct: 117 SFPNGLHCTVTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNSLYNIDAKPEEPHFVQED 176
Query: 365 MMCAGYVEGGKDSCQ 379
M+CAGYVEGGKD+CQ
Sbjct: 177 MVCAGYVEGGKDACQ 191
>pdb|3TGI|E Chain E, Wild-Type Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
pdb|1ANE|A Chain A, Anionic Trypsin Wild Type
pdb|3FP6|E Chain E, Anionic Trypsin In Complex With Bovine Pancreatic Trypsin
Inhibitor (Bpti) Determined To The 1.49 A Resolution
Limit
Length = 223
Score = 114 bits (285), Expect = 2e-25, Method: Composition-based stats.
Identities = 70/191 (36%), Positives = 107/191 (56%), Gaps = 22/191 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + V + EHN
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSR-----IQVRLGEHN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K++ HP ++ K+ ++DI L+KL +P++ V+ V LP
Sbjct: 55 -INVLEGNEQFVNAAKIIKHPNFDR---KTLNNDIMLIKLSSPVKLNARVATVALPS--- 107
Query: 314 KFTQRTGT---VVGWGRVEESGQIASDL-RATQVPVMSNQECR-QFPGFEAKLTGNMMCA 368
GT + GWG SG DL + P++ +C +PG K+T NM+C
Sbjct: 108 -SCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG---KITDNMVCV 163
Query: 369 GYVEGGKDSCQ 379
G++EGGKDSCQ
Sbjct: 164 GFLEGGKDSCQ 174
>pdb|3DFJ|A Chain A, Crystal Structure Of Human Prostasin
pdb|3DFL|A Chain A, Crystal Structure Of Human Prostasin Complexed To 4-
Guanidinobenzoic Acid
Length = 263
Score = 114 bits (285), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 65/195 (33%), Positives = 103/195 (52%), Gaps = 13/195 (6%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
I GG + ++PW V++ G CGG+L+S+++VL+AAHC S ++ V + H
Sbjct: 1 ITGGSSAVAGQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHCFPSEHHKEAYEVKLGAHQ 60
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
+ Y + + ++ HP Y +G++ DIALL+L P+ F + P+ LP
Sbjct: 61 LDS-YSEDAKVSTLKDIIPHPSYLQEGSQG---DIALLQLSRPITFSRYIRPISLPAANA 116
Query: 314 KFTQRTG-TVVGWGRVEESGQIAS--DLRATQVPVMSNQECRQFPGFEAK------LTGN 364
F TV GWG V S + + L+ +VP++S + C +AK + +
Sbjct: 117 SFPNGLHCTVTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNALYNIDAKPEEPHFVQED 176
Query: 365 MMCAGYVEGGKDSCQ 379
M+CAGYVEGGKD+CQ
Sbjct: 177 MVCAGYVEGGKDACQ 191
>pdb|1DPO|A Chain A, Structure Of Rat Trypsin
Length = 223
Score = 114 bits (285), Expect = 2e-25, Method: Composition-based stats.
Identities = 70/191 (36%), Positives = 107/191 (56%), Gaps = 22/191 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + V + EHN
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSR-----IQVRLGEHN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K++ HP ++ K+ ++DI L+KL +P++ V+ V LP
Sbjct: 55 -INVLEGNEQFVNAAKIIKHPNFDR---KTLNNDIMLIKLSSPVKLNARVATVALPS--- 107
Query: 314 KFTQRTGT---VVGWGRVEESGQIASDL-RATQVPVMSNQECR-QFPGFEAKLTGNMMCA 368
GT + GWG SG DL + P++ +C +PG K+T NM+C
Sbjct: 108 -SCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG---KITDNMVCV 163
Query: 369 GYVEGGKDSCQ 379
G++EGGKDSCQ
Sbjct: 164 GFLEGGKDSCQ 174
>pdb|1K9O|E Chain E, Crystal Structure Of Michaelis Serpin-Trypsin Complex
pdb|1YKT|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLC|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLD|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|3FP7|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Cleaved At The
Scissile Bond (Lys15-Ala16) Determined To The 1.46 A
Resolution Limit
pdb|3FP8|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Determined To The
1.46 A Resolution Limit
Length = 223
Score = 114 bits (285), Expect = 2e-25, Method: Composition-based stats.
Identities = 70/191 (36%), Positives = 107/191 (56%), Gaps = 22/191 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + V + EHN
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSR-----IQVRLGEHN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K++ HP ++ K+ ++DI L+KL +P++ V+ V LP
Sbjct: 55 -INVLEGNEQFVNAAKIIKHPNFDR---KTLNNDIMLIKLSSPVKLNARVATVALPS--- 107
Query: 314 KFTQRTGT---VVGWGRVEESGQIASDL-RATQVPVMSNQECR-QFPGFEAKLTGNMMCA 368
GT + GWG SG DL + P++ +C +PG K+T NM+C
Sbjct: 108 -SCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG---KITDNMVCV 163
Query: 369 GYVEGGKDSCQ 379
G++EGGKDSCQ
Sbjct: 164 GFLEGGKDSCQ 174
>pdb|1ANC|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Lys
Length = 223
Score = 114 bits (285), Expect = 2e-25, Method: Composition-based stats.
Identities = 70/191 (36%), Positives = 107/191 (56%), Gaps = 22/191 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + V + EHN
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSR-----IQVRLGEHN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K++ HP ++ K+ ++DI L+KL +P++ V+ V LP
Sbjct: 55 -INVLEGNEQFVNAAKIIKHPNFDR---KTLNNDIMLIKLSSPVKLNARVATVALPS--- 107
Query: 314 KFTQRTGT---VVGWGRVEESGQIASDL-RATQVPVMSNQECR-QFPGFEAKLTGNMMCA 368
GT + GWG SG DL + P++ +C +PG K+T NM+C
Sbjct: 108 -SCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG---KITDNMVCV 163
Query: 369 GYVEGGKDSCQ 379
G++EGGKDSCQ
Sbjct: 164 GFLEGGKDSCQ 174
>pdb|1ANB|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Glu
Length = 223
Score = 114 bits (285), Expect = 2e-25, Method: Composition-based stats.
Identities = 70/191 (36%), Positives = 107/191 (56%), Gaps = 22/191 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + V + EHN
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSR-----IQVRLGEHN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K++ HP ++ K+ ++DI L+KL +P++ V+ V LP
Sbjct: 55 -INVLEGNEQFVNAAKIIKHPNFDR---KTLNNDIMLIKLSSPVKLNARVATVALPS--- 107
Query: 314 KFTQRTGT---VVGWGRVEESGQIASDL-RATQVPVMSNQECR-QFPGFEAKLTGNMMCA 368
GT + GWG SG DL + P++ +C +PG K+T NM+C
Sbjct: 108 -SCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG---KITDNMVCV 163
Query: 369 GYVEGGKDSCQ 379
G++EGGKDSCQ
Sbjct: 164 GFLEGGKDSCQ 174
>pdb|1SLW|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Nickel- Bound
Length = 223
Score = 114 bits (285), Expect = 2e-25, Method: Composition-based stats.
Identities = 69/191 (36%), Positives = 107/191 (56%), Gaps = 22/191 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + V + EHN
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSR-----IQVRLGEHN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K++ HP ++ K+ ++DI L+KL +P++ V+ + LP
Sbjct: 55 -INVLEGNEQFVNAAKIIKHPNFDR---KTLNNDIMLIKLSSPVKLNARVATIALPS--- 107
Query: 314 KFTQRTGT---VVGWGRVEESGQIASDL-RATQVPVMSNQECR-QFPGFEAKLTGNMMCA 368
GT + GWG SG DL + P++ +C +PG K+T NM+C
Sbjct: 108 -SCAPAGTQCLISGWGHTLSSGVNHPDLLQCLDAPLLPQADCEASYPG---KITDNMVCV 163
Query: 369 GYVEGGKDSCQ 379
G++EGGKDSCQ
Sbjct: 164 GFLEGGKDSCQ 174
>pdb|1KIG|H Chain H, Bovine Factor Xa
Length = 241
Score = 114 bits (285), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 77/250 (30%), Positives = 123/250 (49%), Gaps = 25/250 (10%)
Query: 194 IVGGWTTEVNEYPWVVAL-EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEH 252
IVGG E PW L + + FCGGT++++ YVLTAAHC+ +KR +
Sbjct: 1 IVGGRDCAEGECPWQALLVNEENEGFCGGTILNEFYVLTAAHCLHQAKR-----FTVRVG 55
Query: 253 NRATVYETQIETRRVVKV-LTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQL 311
+R T E E V++ + H ++ + ++D DIA+L+L TP+ F+ V+P CLP+
Sbjct: 56 DRNTEQEEGNEMAHEVEMTVKHSRFVKE---TYDFDIAVLRLKTPIRFRRNVAPACLPEK 112
Query: 312 ----GEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMC 367
TQ+TG V G+GR E G+++S L+ +VP + C+ F +T NM C
Sbjct: 113 DWAEATLMTQKTGIVSGFGRTHEKGRLSSTLKMLEVPYVDRSTCKLSSSF--TITPNMFC 170
Query: 368 AGYVEGGKDSCQVTLDEADIALLK---------SYGQGQYTKSIKAVEDDIQAVIKRVNE 418
AGY +D+CQ + K S+G+G K V + +K +++
Sbjct: 171 AGYDTQPEDACQGDSGGPHVTRFKDTYFVTGIVSWGEGCARKGKFGVYTKVSNFLKWIDK 230
Query: 419 LTGIKESDTG 428
+ + G
Sbjct: 231 IMKARAGAAG 240
>pdb|3ELA|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia Mutant In Complex With Soluble Tissue Factor
Length = 254
Score = 114 bits (284), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 72/195 (36%), Positives = 104/195 (53%), Gaps = 15/195 (7%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG E PW V L G CGGTLI+ +V++AAHC K ++LI V+ EH+
Sbjct: 1 IVGGKDCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHD 60
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
+ ++ ++RRV +V+ Y + +HDIALL+L P+ V P+CLP+
Sbjct: 61 LSE-HDGDEQSRRVAQVIIPSTYV---PGTTNHDIALLRLHQPVVLTDHVVPLCLPE--R 114
Query: 314 KFTQRT------GTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFP---GFEAKLTGN 364
F++RT V GWG++ + G A L+ VP + Q+C Q G +T
Sbjct: 115 TFSERTLAFVRFSLVSGWGQLLDRGATALVLQVLNVPRLMTQDCLQQSRKVGDSPNITEY 174
Query: 365 MMCAGYVEGGKDSCQ 379
M CAGY +G KDSC+
Sbjct: 175 MFCAGYSDGSKDSCK 189
>pdb|1VZQ|H Chain H, Complex Of Thrombin With Designed Inhibitor 7165
Length = 250
Score = 114 bits (284), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 79/206 (38%), Positives = 111/206 (53%), Gaps = 31/206 (15%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TAYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPG 356
VCLP Q G K G V GWG ++E+GQ S L+ +P++ C+
Sbjct: 118 VCLPDRETAASLLQAGYK-----GRVTGWGNLKETGQ-PSVLQVVNLPIVERPVCKD--S 169
Query: 357 FEAKLTGNMMCAGYV--EGGK-DSCQ 379
++T NM CAGY EG + D+C+
Sbjct: 170 TRIRITDNMFCAGYKPDEGKRGDACE 195
>pdb|2ANW|A Chain A, Expression, Crystallization And Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 114 bits (284), Expect = 2e-25, Method: Compositional matrix adjust.
Identities = 68/196 (34%), Positives = 110/196 (56%), Gaps = 21/196 (10%)
Query: 194 IVGGWTTEVNEYPWVVALE---QAGKFFCGGTLISDRYVLTAAHC-----VRSSKRQKDL 245
IVGG + E+PW V+L+ A + CGG+LI ++VLTAAHC ++ R
Sbjct: 1 IVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSG 60
Query: 246 IVVISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
I+ +S+ + T + ++ +++ H Y +HDIAL+KL PL + P
Sbjct: 61 ILNLSDITKDTPFS------QIKEIIIHQNYKV---SEGNHDIALIKLQAPLNYTEFQKP 111
Query: 306 VCLPQLGEKFTQRTGT-VVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEAKLTG 363
+ LP G+ T T V GWG +E G+I + L+ +P+++N+EC +++ + K+T
Sbjct: 112 ISLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDY--KITQ 169
Query: 364 NMMCAGYVEGGKDSCQ 379
M+CAGY EGGKD+C+
Sbjct: 170 RMVCAGYKEGGKDACK 185
>pdb|2R9P|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|B Chain B, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|C Chain C, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|D Chain D, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|3L33|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L3T|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3P92|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17G)
pdb|3P95|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17D)
Length = 224
Score = 114 bits (284), Expect = 3e-25, Method: Compositional matrix adjust.
Identities = 73/191 (38%), Positives = 105/191 (54%), Gaps = 22/191 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T E N P+ V+L +G FCGG+LIS+++V++AAHC ++ + V + EHN
Sbjct: 1 IVGGYTCEENSLPYQVSL-NSGSHFCGGSLISEQWVVSAAHCYKTR-----IQVRLGEHN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K++ HPKYN + D+DI L+KL +P VS + LP
Sbjct: 55 -IKVLEGNEQFINAAKIIRHPKYNRD---TLDNDIMLIKLSSPAVINARVSTISLPTA-- 108
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECR-QFPGFEAKLTGNMMCA 368
GT + GWG G D L+ PV++ EC+ +PG K+T +M C
Sbjct: 109 --PPAAGTECLISGWGNTLSFGADYPDELKCLDAPVLTQAECKASYPG---KITNSMFCV 163
Query: 369 GYVEGGKDSCQ 379
G++EGGKDSCQ
Sbjct: 164 GFLEGGKDSCQ 174
>pdb|4DG4|A Chain A, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|B Chain B, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|D Chain D, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|G Chain G, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
Length = 224
Score = 113 bits (283), Expect = 4e-25, Method: Compositional matrix adjust.
Identities = 71/188 (37%), Positives = 103/188 (54%), Gaps = 16/188 (8%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T E N P+ V+L +G FCGG+LIS+++V++AAHC ++ + V + EHN
Sbjct: 1 IVGGYTCEENSLPYQVSL-NSGYHFCGGSLISEQWVVSAAHCYKTR-----IQVRLGEHN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K++ HPKYN + D+DI L+KL +P VS + LP
Sbjct: 55 -IKVLEGNEQFINAAKIIRHPKYNRD---TLDNDIMLIKLSSPAVINARVSTISLPTAPP 110
Query: 314 KFTQRTGTVVGWGRVEESGQIASD-LRATQVPVMSNQECR-QFPGFEAKLTGNMMCAGYV 371
+ GWG G D L+ PV++ EC+ +PG K+T +M C G++
Sbjct: 111 AAGTEC-LISGWGNTLSFGADYPDELKCLDAPVLTQAECKASYPG---KITNSMFCVGFL 166
Query: 372 EGGKDSCQ 379
EGGKDSCQ
Sbjct: 167 EGGKDSCQ 174
>pdb|1TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|1TRM|B Chain B, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|2TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
Length = 223
Score = 112 bits (281), Expect = 5e-25, Method: Composition-based stats.
Identities = 69/191 (36%), Positives = 107/191 (56%), Gaps = 22/191 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + V + EHN
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSR-----IQVRLGEHN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K++ HP ++ K+ +++I L+KL +P++ V+ V LP
Sbjct: 55 -INVLEGNEQFVNAAKIIKHPNFDR---KTLNNNIMLIKLSSPVKLNARVATVALPS--- 107
Query: 314 KFTQRTGT---VVGWGRVEESGQIASDL-RATQVPVMSNQECR-QFPGFEAKLTGNMMCA 368
GT + GWG SG DL + P++ +C +PG K+T NM+C
Sbjct: 108 -SCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG---KITDNMVCV 163
Query: 369 GYVEGGKDSCQ 379
G++EGGKDSCQ
Sbjct: 164 GFLEGGKDSCQ 174
>pdb|3VEQ|B Chain B, A Binary Complex Betwwen Bovine Pancreatic Trypsin And A
Engineered Mutant Trypsin Inhibitor
Length = 223
Score = 112 bits (280), Expect = 6e-25, Method: Composition-based stats.
Identities = 70/191 (36%), Positives = 104/191 (54%), Gaps = 22/191 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E N
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGEDN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K + HP YN+ + ++DI L+KL + V+ V LP
Sbjct: 55 -INVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVASVSLP---- 106
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEAKLTGNMMCA 368
GT + GWG + SG D L+ + P++S+ C+ +PG ++T NM CA
Sbjct: 107 TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMFCA 163
Query: 369 GYVEGGKDSCQ 379
GY+EGGKDSCQ
Sbjct: 164 GYLEGGKDSCQ 174
>pdb|1EZS|C Chain C, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZS|D Chain D, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZU|C Chain C, Ecotin Y69f, D70p Bound To D102n Trypsin
pdb|1EZU|D Chain D, Ecotin Y69f, D70p Bound To D102n Trypsin
Length = 223
Score = 112 bits (280), Expect = 7e-25, Method: Composition-based stats.
Identities = 69/191 (36%), Positives = 107/191 (56%), Gaps = 22/191 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + V + EHN
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSR-----IQVRLGEHN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K++ HP ++ K+ +++I L+KL +P++ V+ V LP
Sbjct: 55 -INVLEGDEQFVNAAKIIKHPNFDR---KTLNNNIMLIKLSSPVKLNARVATVALPS--- 107
Query: 314 KFTQRTGT---VVGWGRVEESGQIASDL-RATQVPVMSNQECR-QFPGFEAKLTGNMMCA 368
GT + GWG SG DL + P++ +C +PG K+T NM+C
Sbjct: 108 -SCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG---KITDNMVCV 163
Query: 369 GYVEGGKDSCQ 379
G++EGGKDSCQ
Sbjct: 164 GFLEGGKDSCQ 174
>pdb|1H8D|H Chain H, X-Ray Structure Of The Human Alpha-Thrombin Complex With A
Tripeptide Phosphonate Inhibitor
Length = 260
Score = 112 bits (280), Expect = 7e-25, Method: Compositional matrix adjust.
Identities = 79/206 (38%), Positives = 111/206 (53%), Gaps = 31/206 (15%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPG 356
VCLP Q G K G V GWG ++E+GQ S L+ +P++ C+
Sbjct: 118 VCLPDRETAASLLQAGYK-----GRVTGWGNLKETGQ-PSVLQVVNLPIVERPVCKD--S 169
Query: 357 FEAKLTGNMMCAGYV--EGGK-DSCQ 379
++T NM CAGY EG + D+C+
Sbjct: 170 TRIRITDNMFCAGYKPDEGKRGDACE 195
>pdb|1TRN|A Chain A, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
pdb|1TRN|B Chain B, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
Length = 224
Score = 112 bits (280), Expect = 7e-25, Method: Composition-based stats.
Identities = 71/191 (37%), Positives = 104/191 (54%), Gaps = 22/191 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+ E N P+ V+L +G FCGG+LI++++V++A HC +S + V + EHN
Sbjct: 1 IVGGYNCEENSVPYQVSL-NSGYHFCGGSLINEQWVVSAGHCYKSR-----IQVRLGEHN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K++ HP+Y+ K+ ++DI L+KL + VS + LP
Sbjct: 55 -IEVLEGNEQFINAAKIIRHPQYDR---KTLNNDIMLIKLSSRAVINARVSTISLPTA-- 108
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECR-QFPGFEAKLTGNMMCA 368
TGT + GWG SG D L+ PV+S +C +PG K+T NM C
Sbjct: 109 --PPATGTKCLISGWGNTASSGADXPDELQCLDAPVLSQAKCEASYPG---KITSNMFCV 163
Query: 369 GYVEGGKDSCQ 379
G++EGGKDSCQ
Sbjct: 164 GFLEGGKDSCQ 174
>pdb|2BVR|H Chain H, Human Thrombin Complexed With Fragment-based Small
Molecules Occupying The S1 Pocket
Length = 252
Score = 112 bits (280), Expect = 8e-25, Method: Compositional matrix adjust.
Identities = 79/206 (38%), Positives = 110/206 (53%), Gaps = 31/206 (15%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPG 356
VCLP Q G K G V GWG ++E GQ S L+ +P++ C+
Sbjct: 118 VCLPDRETAASLLQAGYK-----GRVTGWGNLKEKGQ-PSVLQVVNLPIVERPVCKD--S 169
Query: 357 FEAKLTGNMMCAGYV--EGGK-DSCQ 379
++T NM CAGY EG + D+C+
Sbjct: 170 TRIRITDNMFCAGYKPDEGKRGDACE 195
>pdb|1AMH|A Chain A, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
pdb|1AMH|B Chain B, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
Length = 223
Score = 112 bits (279), Expect = 8e-25, Method: Composition-based stats.
Identities = 69/191 (36%), Positives = 106/191 (55%), Gaps = 22/191 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + V + EHN
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSR-----IQVRLGEHN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K++ HP ++ K+ ++DI L+KL +P++ V+ V LP
Sbjct: 55 -INVLEGNEQFVNAAKIIKHPNFD---RKTLNNDIMLIKLSSPVKLNARVATVALPS--- 107
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECR-QFPGFEAKLTGNMMCA 368
GT + GWG SG D L+ P++ +C +PG K+T NM+C
Sbjct: 108 -SCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG---KITDNMVCV 163
Query: 369 GYVEGGKDSCQ 379
G++EGGK SCQ
Sbjct: 164 GFLEGGKSSCQ 174
>pdb|3QK1|A Chain A, Crystal Structure Of Enterokinase-Like Trypsin Variant
Length = 229
Score = 112 bits (279), Expect = 9e-25, Method: Composition-based stats.
Identities = 69/191 (36%), Positives = 103/191 (53%), Gaps = 22/191 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E N
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGEDN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K + HP YN + ++DI L+KL + V+ + LP
Sbjct: 55 -INVVEGNEQFISASKSIVHPSYNK---RRKNNDIMLIKLKSAASLNSRVASISLP---- 106
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEAKLTGNMMCA 368
GT + GWG + SG D L+ + P++S+ C+ +PG ++T NM CA
Sbjct: 107 TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMFCA 163
Query: 369 GYVEGGKDSCQ 379
GY+EGGKDSCQ
Sbjct: 164 GYLEGGKDSCQ 174
>pdb|2RA3|A Chain A, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
pdb|2RA3|B Chain B, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
Length = 224
Score = 112 bits (279), Expect = 9e-25, Method: Composition-based stats.
Identities = 71/191 (37%), Positives = 104/191 (54%), Gaps = 22/191 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+ E N P+ V+L +G FCGG+LI++++V++A HC +S + V + EHN
Sbjct: 1 IVGGYNCEENSVPYQVSL-NSGYHFCGGSLINEQWVVSAGHCYKSR-----IQVRLGEHN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K++ HP+Y+ K+ ++DI L+KL + VS + LP
Sbjct: 55 -IEVLEGNEQFINAAKIIRHPQYDR---KTLNNDIMLIKLSSRAVINAHVSTISLPTA-- 108
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECR-QFPGFEAKLTGNMMCA 368
TGT + GWG SG D L+ PV+S +C +PG K+T NM C
Sbjct: 109 --PPATGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPG---KITSNMFCV 163
Query: 369 GYVEGGKDSCQ 379
G++EGGKDSCQ
Sbjct: 164 GFLEGGKDSCQ 174
>pdb|5PTP|A Chain A, Structure Of Hydrolase (Serine Proteinase)
Length = 223
Score = 112 bits (279), Expect = 9e-25, Method: Composition-based stats.
Identities = 69/191 (36%), Positives = 104/191 (54%), Gaps = 22/191 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E N
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGEDN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K + HP YN+ + ++DI L+KL + V+ + LP
Sbjct: 55 -INVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVASISLP---- 106
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEAKLTGNMMCA 368
GT + GWG + SG D L+ + P++S+ C+ +PG ++T NM CA
Sbjct: 107 TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMFCA 163
Query: 369 GYVEGGKDSCQ 379
GY+EGGKDSCQ
Sbjct: 164 GYLEGGKDSCQ 174
>pdb|1TAB|E Chain E, Structure Of The Trypsin-Binding Domain Of Bowman-Birk
Type Protease Inhibitor And Its Interaction With Trypsin
pdb|1TPA|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2PTC|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1PPC|E Chain E, Geometry Of Binding Of The Benzamidine-and Arginine-based
Inhibitors
N-alpha-(2-naphthyl-sulphonyl-glycyl)-dl-p-
amidinophenylalanyl- Piperidine (napap) And
(2r,4r)-4-methyl-1-[n-alpha-(3-methyl-1,2,3,4-
Tetrahydro-8-quinolinesulphonyl)-l-arginyl]-2-piperidine
Carboxylic Acid (mqpa) To Human Alpha-thrombin: X-ray
Crystallographic Determination Of The Napap-trypsin
Complex And Modeling Of Napap- Thrombin And
Mqpa-thrombin
pdb|1PPE|E Chain E, The Refined 2.0 Angstroms X-Ray Crystal Structure Of The
Complex Formed Between Bovine Beta-Trypsin And Cmti-I, A
Trypsin Inhibitor From Squash Seeds (Cucurbita Maxima):
Topological Similarity Of The Squash Seed Inhibitors
With The Carboxypeptidase A Inhibitor From Potatoes
pdb|1PPH|E Chain E, Geometry Of Binding Of The Nalpha-Tosylated Piperidides Of
M-Amidino-, P-Amidino-And P-Guanidino Phenylalanine To
Thrombin And Trypsin: X- Ray Crystal Structures Of Their
Trypsin Complexes And Modeling Of Their Thrombin
Complexes
pdb|1SMF|E Chain E, Studies On An Artificial Trypsin Inhibitor Peptide Derived
From The Mung Bean Inhibitor
pdb|1JRT|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1JRS|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1CE5|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzamidine
pdb|2BZA|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzylamine
pdb|1QCP|A Chain A, Crystal Structure Of The Rwj-51084 Bovine Pancreatic Beta-
Trypsin At 1.8 A
pdb|1SBW|A Chain A, Crystal Structure Of Mung Bean Inhibitor Lysine Active
Fragment Complex With Bovine Beta-Trypsin At 1.8a
Resolution
pdb|1YYY|1 Chain 1, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1SFI|A Chain A, High Resolution Structure Of A Potent, Cyclic Protease
Inhibitor From Sunflower Seeds
pdb|1TIO|A Chain A, High Packing Density Form Of Bovine Beta-trypsin In
Cyclohexane
pdb|2TIO|A Chain A, Low Packing Density Form Of Bovine Beta-Trypsin In
Cyclohexane
pdb|2BTC|E Chain E, Bovine Trypsin In Complex With Squash Seed Inhibitor
(Cucurbita Pepo Trypsin Inhibitor Ii)
pdb|3BTE|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta-Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTD|E Chain E, The Crystal Structures Of The Complexes Between The Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTF|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTG|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTH|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTK|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTM|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTQ|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTT|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTW|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|1QBN|A Chain A, Bovine Trypsin 2-[amino(Imino)methyl]-2-Hydroxyphenoxy]-6-
[3-(4,5-Dihydro-1h-Imidazol-2-Yl)phenoxy]pyridine-4-
Carboxylic Acid (Zk-806688) Complex
pdb|1QBO|A Chain A, Bovine Trypsin
7-[[6-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
2-Methyl-Benzimidazol-1-Yl]methyl]naphthalene-2-
Carboximidamid Zk-806711 Inhibitor Complex
pdb|1QB9|A Chain A, Bovine Trypsin
7-[[2-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
9h-Carbozol-9-Yl] Methyl]naphthalene-2-Carboximidamide
(Zk- 806450) Complex
pdb|1QB1|A Chain A, Bovine Trypsin With 1-[2-[5-[amino(imino)methyl]-2-
Hydroxyphenoxy]-6-[3-(4,
5-dihydro-1-methyl-1h-imidazol-2-
Yl)phenoxy]pyridin-4-yl]piperidine-3-carboxylic Acid
(zk- 806974)
pdb|1QB6|A Chain A, Bovine Trypsin 3,3'-[3,5-Difluoro-4-Methyl-2, 6-
Pyridinediylbis(Oxy)]bis(Benzenecarboximidamide) (Zk-
805623) Complex
pdb|1QA0|A Chain A, Bovine Trypsin 2-Aminobenzimidazole Complex
pdb|1F2S|E Chain E, Crystal Structure Of The Complex Formed Between Bovine
Beta- Trypsin And Mcti-A, A Trypsin Inhibitor Of Squash
Family At 1.8 A Resolution
pdb|1D6R|A Chain A, Crystal Structure Of Cancer Chemopreventive Bowman-Birk
Inhibitor In Ternary Complex With Bovine Trypsin At 2.3
A Resolution. Structural Basis Of Janus-Faced Serine
Protease Inhibitor Specificity
pdb|1C9T|A Chain A, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|B Chain B, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|C Chain C, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|D Chain D, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|E Chain E, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|F Chain F, Complex Of Bdellastasin With Bovine Trypsin
pdb|1QL7|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1QL8|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1G9I|E Chain E, Crystal Structure Of Beta-Trysin Complex In Cyclohexane
pdb|1EJM|A Chain A, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|C Chain C, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|E Chain E, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1JIR|A Chain A, Crystal Structure Of Trypsin Complex With Amylamine In
Cyclohexane
pdb|1J8A|A Chain A, Crystal Structure Of Benzamidine Inhibited Bovine
Pancreatic Trypsin At 105k To 1.21a Resolution From
Laboratory Source With High Number Of Waters Modelled
pdb|1G36|A Chain A, Trypsin Inhibitor Complex
pdb|1K1P|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1O|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1N|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1M|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1L|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1J|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1I|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1EB2|A Chain A, Trypsin Inhibitor Complex (Bpo)
pdb|1GJ6|A Chain A, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1N6X|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1N6Y|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1OYQ|A Chain A, Trypsin Inhibitor Complex
pdb|1O2H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O2O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2P|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Q|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2R|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2S|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2T|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2U|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2V|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2W|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2X|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Y|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Z|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O30|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O31|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O32|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O33|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O34|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O35|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O36|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O37|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O38|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O39|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3A|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3B|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3C|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3D|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3E|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3F|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3G|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O3N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1NC6|A Chain A, Potent, Small Molecule Inhibitors Of Human Mast Cell
Tryptase. Anti-Asthmatic Action Of A Dipeptide-Based
Transition State Analogue Containing Benzothiazole
Ketone
pdb|1P2I|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2J|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2K|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OX1|A Chain A, Crystal Structure Of The Bovine Trypsin Complex With A
Synthetic 11 Peptide Inhibitor
pdb|1RXP|A Chain A, Structure Of Trypsin (Orthorhombic) With 1-(4-Tert-
Butylcarbamoyl- Piperazine-1-Carbonyl)-3-(3-Guanidino-
Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid
pdb|1S0Q|A Chain A, Native Bovine Pancreatic Trypsin
pdb|1S0R|A Chain A, Bovine Pancreatic Trypsin Inhibited With Benzamidine At
Atomic Resolution
pdb|2A7H|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|1TX7|A Chain A, Bovine Trypsin Complexed With P-
Amidinophenylmethylphosphinic Acid (Ampa)
pdb|2BLV|A Chain A, Trypsin Before A High Dose X-Ray "burn"
pdb|2BLW|A Chain A, Trypsin After A High Dose X-Ray "burn"
pdb|1TX8|A Chain A, Bovine Trypsin Complexed With Amso
pdb|1Y3U|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3V|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3W|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3X|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3Y|A Chain A, Trypsin Inhibitor Complex
pdb|1YP9|A Chain A, Trypsin Inhibitor Complex
pdb|2AYW|A Chain A, Crystal Structure Of The Complex Formed Between Trypsin
And A Designed Synthetic Highly Potent Inhibitor In The
Presence Of Benzamidine At 0.97 A Resolution
pdb|2FI3|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser,
Cys38->ser) In Complex With Trypsin
pdb|2FX4|A Chain A, Bovine Trypsin Bound By 4-piperidinebutyrate To Make
Acylenzyme Complex
pdb|2FX6|A Chain A, Bovine Trypsin Complexed With 2-Aminobenzamidazole
pdb|2AGE|X Chain X, Succinyl-Aapr-Trypsin Acyl-Enzyme At 1.15 A Resolution
pdb|2AGG|X Chain X, Succinyl-Aapk-Trypsin Acyl-Enzyme At 1.28 A Resolution
pdb|2AGI|X Chain X, The Leupeptin-Trypsin Covalent Complex At 1.14 A
Resolution
pdb|2AH4|X Chain X, Guanidinobenzoyl-Trypsin Acyl-Enzyme At 1.13 A Resolution
pdb|2G5N|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G5V|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G8T|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2F3C|E Chain E, Crystal Structure Of Infestin 1, A Kazal-Type
Serineprotease Inhibitor, In Complex With Trypsin
pdb|2G81|E Chain E, Crystal Structure Of The Bowman-Birk Inhibitor From Vigna
Unguiculata Seeds In Complex With Beta-Trypsin At 1.55
Angstrons Resolution
pdb|2G55|A Chain A, Anomalous Substructure Of Trypsin (P3121)
pdb|2OTV|A Chain A, Crystal Structure Of The Complex Formed Between Bovine
Trypsin And Nicotinamide At 1.56 A Resolution
pdb|2J9N|A Chain A, Robotically Harvested Trypsin Complexed With Benzamidine
Containing Polypeptide Mediated Crystal Contacts
pdb|2OXS|A Chain A, Crytal Structure Of The Trypsin Complex With Benzamidine
At High Temperature (35 C)
pdb|2UUY|A Chain A, Structure Of A Tick Tryptase Inhibitor In Complex With
Bovine Trypsin
pdb|2ILN|A Chain A, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2ILN|B Chain B, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2CMY|A Chain A, Crystal Complex Between Bovine Trypsin And Veronica
Hederifolia Trypsin Inhibitor
pdb|1AQ7|A Chain A, Trypsin With Inhibitor Aeruginosin 98-b
pdb|1AUJ|A Chain A, Bovine Trypsin Complexed To Meta-Cyano-Benzylic Inhibitor
pdb|1AZ8|A Chain A, Bovine Trypsin Complexed To Bis-Phenylamidine Inhibitor
pdb|1BJU|A Chain A, Beta-Trypsin Complexed With Acpu
pdb|1BJV|A Chain A, Beta-Trypsin Complexed With Appu
pdb|1GBT|A Chain A, Structure Of An Acyl-Enzyme Intermediate During Catalysis:
(Guanidinobenzoyl) Trypsin
pdb|1MAX|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MAY|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MTS|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTU|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTV|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTW|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1TLD|A Chain A, Crystal Structure Of Bovine Beta-Trypsin At 1.5 Angstroms
Resolution In A Crystal Form With Low Molecular Packing
Density. Active Site Geometry, Ion Pairs And Solvent
Structure
pdb|1TPO|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPP|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPS|A Chain A, Atomic Structure Of The Trypsin-A90720a Complex: A Unified
Approach To Structure And Function
pdb|1TYN|A Chain A, Atomic Structure Of The Trypsin-cyclotheonamide A Complex:
Lessons For The Design Of Serine Protease Inhibitors
pdb|1XUF|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUG|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUH|A Chain A, Trypsin-Keto-Babim-Co+2, Ph 8.2
pdb|1XUI|A Chain A, Trypsin-Keto-Babim, Zn+2-Free, Ph 8.2
pdb|1XUJ|A Chain A, Trypsin-Keto-Babim-Zn+2, Ph 8.2
pdb|1XUK|A Chain A, Trypsin-Babim-Sulfate, Ph 5.9
pdb|2PLX|A Chain A, Trypsin Complexed To A Synthetic Peptide From Veronica
Hederifolia
pdb|2PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3PTB|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|3PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1C1N|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1O|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1P|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1Q|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1R|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1T|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2D|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2E|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2F|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2G|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2H|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2I|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2J|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2K|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2L|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2M|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5P|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Q|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5R|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5S|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5T|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5U|A Chain A, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5V|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GHZ|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI0|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI1|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI2|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI3|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI4|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI5|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI6|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2O9Q|A Chain A, The Crystal Structure Of Bovine Trypsin Complexed With A
Small Inhibition Peptide Orb2k
pdb|2QN5|T Chain T, Crystal Structure And Functional Study Of The Bowman-Birk
Inhibitor From Rice Bran In Complex With Bovine Trypsin
pdb|2QYI|A Chain A, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2QYI|C Chain C, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2ZDK|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDL|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDM|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDN|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFS|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFT|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZHD|A Chain A, Exploring Trypsin S3 Pocket
pdb|3D65|E Chain E, Crystal Structure Of Textilinin-1, A Kunitz-Type Serine
Protease Inhibitor From The Australian Common Brown
Snake Venom, In Complex With Trypsin
pdb|3E8L|A Chain A, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|3E8L|B Chain B, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|2ZQ1|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZQ2|A Chain A, Exploring Trypsin S3 Pocket
pdb|3ITI|A Chain A, Structure Of Bovine Trypsin With The Mad Triangle B3c
pdb|3GY2|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY3|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY4|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY5|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY6|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Bis-Benzamidines Diminazene And Pentamidine
pdb|3GY7|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY8|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3AAS|A Chain A, Bovine Beta-Trypsin Bound To Meta-Guanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAU|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diguanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|B Chain B, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3M35|A Chain A, Trypsin In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3MFJ|A Chain A, Bovine Trypsin At 0.8 A Resolution, Restrained Refinement
pdb|3MI4|A Chain A, Bovine Trypsin At 0.8 A Resolution, Non-Restrained
Refinemen
pdb|3I29|A Chain A, Crystal Structure Of A Binary Complex Between An Mutant
Tryp Inhibitor With Bovine Trypsin
pdb|3A7T|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide
pdb|3A7V|A Chain A, Crystal Structure Of Trypsin Complexed With
3-Formylbenzimidamide
pdb|3A7W|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((Tetrahydro-2h-
Pyran-2-Yloxyimino)methyl)benzimidamide (Soaking 4hours)
pdb|3A7X|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
45seconds)
pdb|3A7Y|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
3-Yloxyimino)methyl)benzimidamide (Soaking 2hours)
pdb|3A7Z|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
4-Yloxyimino)methyl)benzimidamide (Soaking 3hours)
pdb|3A80|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic Acid
(Soaking 40seconds)
pdb|3A81|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 8
Hours)
pdb|3A82|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid
pdb|3A83|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide
pdb|3A84|A Chain A, Crystal Structure Of Trypsin Complexed With(E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 5
Seconds)
pdb|3A85|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 15
Seconds)
pdb|3A86|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 30
Seconds)
pdb|3A87|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 5
Minutes)
pdb|3A88|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 30
Minutes)
pdb|3A89|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 4
Hours)
pdb|3A8A|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide And Aniline
pdb|3A8B|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((4-
Bromophenylimino)methyl)benzimidamide
pdb|3A8C|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
With Mixture Of
[(E)-2-(4-Carbamimidoylbenzylideneaminooxy)acetic Acid]
And [(E)-2-
(4-Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic
Acid])
pdb|3A8D|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Under
Aniline-Free Condition)
pdb|3LJJ|A Chain A, Bovine Trypsin In Complex With Ub-Thr 10
pdb|3LJO|A Chain A, Bovine Trypsin In Complex With Ub-Thr 11
pdb|2XTT|B Chain B, Bovine Trypsin In Complex With Evolutionary Enhanced
Schistocerca Gregaria Protease Inhibitor 1 (Sgpi-1-P02)
pdb|3NK8|A Chain A, Trypsin In Complex With Fluorine-Containing Fragment
pdb|3NKK|A Chain A, Trypsin In Complex With Fluorine Containing Fragment
pdb|3M7Q|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Pancreatic Trypsin
pdb|3RDZ|A Chain A, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3RDZ|B Chain B, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3ATI|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3ATK|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3ATL|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamidine
pdb|3ATM|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXA|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3RXB|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobutanoic Acid
pdb|3RXC|A Chain A, Crystal Structure Of Trypsin Complexed With
2-Aminopyridine
pdb|3RXD|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3RXE|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide
pdb|3RXF|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminopyridine
pdb|3RXG|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminocyclohexanol
pdb|3RXH|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Imidazol-4-Yl) Ethanamine
pdb|3RXI|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXJ|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobenzoic Acid
pdb|3RXK|A Chain A, Crystal Structure Of Trypsin Complexed With Methyl
4-Amino-1-Methyl- Pyrrolidine-2-Carboxylate
pdb|3RXL|A Chain A, Crystal Structure Of Trypsin Complexed With
(2,5-Dimethyl-3-Furyl) Methanamine
pdb|3RXM|A Chain A, Crystal Structure Of Trypsin Complexed With
[2-(2-Thienyl)thiazol-4- Yl]methanamine
pdb|3RXO|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Pyrrol-1-Ylphenyl) Methanamine
pdb|3RXP|A Chain A, Crystal Structure Of Trypsin Complexed With
(1,5-Dimethylpyrazol-3- Yl)methanamine
pdb|3RXQ|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F01
And F05, Cocktail Experiment)
pdb|3RXR|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine (F01 And F03, Cocktail Experiment)
pdb|3RXS|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine (F04 And A06, Cocktail
Experiment)
pdb|3RXT|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamin (F04 And F03, Cocktail
Experiment)
pdb|3RXU|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And A06, Cocktail Experiment)
pdb|3RXV|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And F03, Cocktail Experiment)
pdb|3T25|A Chain A, Tmao-Grown Orthorhombic Trypsin (Bovine)
pdb|3T26|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Sarcosine
pdb|3T27|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Betaine
pdb|3T28|A Chain A, Tmao-Grown Trypsin (Bovine)-Previously Unreported
Tetragonal Crystal Form
pdb|3T29|A Chain A, Tmao-Grown Trigonal Trypsin (Bovine)
pdb|4AB8|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4AB9|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABA|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABB|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABD|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABE|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABF|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABG|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABH|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABI|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Pta)sfti-1(1,14), That Was 1,4-
Disubstituted With A 1,2,3-Trizol To Mimic A Trans Amide
Bond
pdb|4ABJ|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Ica)sfti-1(1,14), That Was 1,5-
Disubstituted With 1,2,3-Trizol To Mimic A Cis Amide
Bond
pdb|3VPK|A Chain A, Crystal Structure Of 6-guanidinohexanoyl Trypsin
pdb|3UNR|A Chain A, Bond Length Analysis Of Asp, Glu And His Residues In
Trypsin At 1.2a Resolution
pdb|3RU4|T Chain T, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
pdb|1C1S|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|4I8G|A Chain A, Bovine Trypsin At 0.8 Resolution
pdb|4I8H|A Chain A, Bovine Trypsin At 0.75 Resolution
pdb|4I8J|A Chain A, Bovine Trypsin At 0.87 A Resolution
pdb|4I8K|A Chain A, Bovine Trypsin At 0.85 Resolution
pdb|4I8L|A Chain A, Bovine Trypsin At 0.87 Resolution
pdb|4AOQ|A Chain A, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|B Chain B, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|C Chain C, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOR|A Chain A, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|B Chain B, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|C Chain C, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
Length = 223
Score = 112 bits (279), Expect = 9e-25, Method: Composition-based stats.
Identities = 69/191 (36%), Positives = 104/191 (54%), Gaps = 22/191 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E N
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGEDN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K + HP YN+ + ++DI L+KL + V+ + LP
Sbjct: 55 -INVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVASISLP---- 106
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEAKLTGNMMCA 368
GT + GWG + SG D L+ + P++S+ C+ +PG ++T NM CA
Sbjct: 107 TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMFCA 163
Query: 369 GYVEGGKDSCQ 379
GY+EGGKDSCQ
Sbjct: 164 GYLEGGKDSCQ 174
>pdb|1QRZ|A Chain A, Catalytic Domain Of Plasminogen
pdb|1QRZ|B Chain B, Catalytic Domain Of Plasminogen
pdb|1QRZ|C Chain C, Catalytic Domain Of Plasminogen
pdb|1QRZ|D Chain D, Catalytic Domain Of Plasminogen
Length = 246
Score = 112 bits (279), Expect = 9e-25, Method: Compositional matrix adjust.
Identities = 66/190 (34%), Positives = 95/190 (50%), Gaps = 15/190 (7%)
Query: 193 RIVGGWTTEVNEYPWVVALE-QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISE 251
R+VGG + +PW V+L + G+ FCGGTLIS +VLTAAHC+ S R V++
Sbjct: 16 RVVGGCVAHPHSWPWQVSLRTRFGQHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 75
Query: 252 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQL 311
H + E ++ V ++ P DIALLKL +P V P CLP
Sbjct: 76 HQEVNL-EPHVQEIEVSRLFLEPTRK---------DIALLKLSSPAVITDKVIPACLPSP 125
Query: 312 GEKFTQRTGT-VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLTGNMMCAG 369
RT + GWG E G + L+ Q+PV+ N+ C ++ ++ +CAG
Sbjct: 126 NYMVADRTECFITGWG--ETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAG 183
Query: 370 YVEGGKDSCQ 379
++ GG DSCQ
Sbjct: 184 HLAGGTDSCQ 193
>pdb|2FI4|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser) In
Complex With Trypsin
pdb|2FTL|E Chain E, Crystal Structure Of Trypsin Complexed With Bpti At 100k
Length = 223
Score = 111 bits (278), Expect = 1e-24, Method: Composition-based stats.
Identities = 69/191 (36%), Positives = 104/191 (54%), Gaps = 22/191 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E N
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGEDN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K + HP YN+ + ++DI L+KL + V+ + LP
Sbjct: 55 -INVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLXSRVASISLP---- 106
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEAKLTGNMMCA 368
GT + GWG + SG D L+ + P++S+ C+ +PG ++T NM CA
Sbjct: 107 TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMFCA 163
Query: 369 GYVEGGKDSCQ 379
GY+EGGKDSCQ
Sbjct: 164 GYLEGGKDSCQ 174
>pdb|1BRB|E Chain E, Crystal Structures Of Rat Anionic Trypsin Complexed With
The Protein Inhibitors Appi And Bpti
pdb|1BRC|E Chain E, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
pdb|1BRA|A Chain A, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
Length = 223
Score = 111 bits (278), Expect = 1e-24, Method: Composition-based stats.
Identities = 69/191 (36%), Positives = 106/191 (55%), Gaps = 22/191 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + V + EHN
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSR-----IQVRLGEHN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K++ HP ++ K+ ++DI L+KL +P++ V+ V LP
Sbjct: 55 -INVLEGNEQFVNAAKIIKHPNFD---RKTLNNDIMLIKLSSPVKLNARVATVALPS--- 107
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECR-QFPGFEAKLTGNMMCA 368
GT + GWG SG D L+ P++ +C +PG K+T NM+C
Sbjct: 108 -SCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG---KITDNMVCV 163
Query: 369 GYVEGGKDSCQ 379
G++EGGK SCQ
Sbjct: 164 GFLEGGKGSCQ 174
>pdb|1TAW|A Chain A, Bovine Trypsin Complexed To Appi
pdb|1ZR0|A Chain A, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
pdb|1ZR0|C Chain C, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
Length = 223
Score = 111 bits (278), Expect = 1e-24, Method: Composition-based stats.
Identities = 69/191 (36%), Positives = 103/191 (53%), Gaps = 22/191 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E N
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGEDN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K + HP YN+ + ++DI L+KL + V+ + LP
Sbjct: 55 -INVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVASISLP---- 106
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEAKLTGNMMCA 368
GT + GWG + SG D L+ + P++S C+ +PG ++T NM CA
Sbjct: 107 TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSTSSCKSAYPG---QITSNMFCA 163
Query: 369 GYVEGGKDSCQ 379
GY+EGGKDSCQ
Sbjct: 164 GYLEGGKDSCQ 174
>pdb|1F5R|A Chain A, Rat Trypsinogen Mutant Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 231
Score = 111 bits (277), Expect = 1e-24, Method: Composition-based stats.
Identities = 68/189 (35%), Positives = 105/189 (55%), Gaps = 22/189 (11%)
Query: 196 GGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHNRA 255
GG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + V + EHN
Sbjct: 11 GGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSR-----IQVRLGEHN-I 63
Query: 256 TVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGEKF 315
V E + K++ HP ++ K+ ++DI L+KL +P++ V+ V LP
Sbjct: 64 NVLEGNEQFVNAAKIIKHPNFDR---KTLNNDIMLIKLSSPVKLNARVATVALPS----S 116
Query: 316 TQRTGT---VVGWGRVEESGQIASDL-RATQVPVMSNQECR-QFPGFEAKLTGNMMCAGY 370
GT + GWG SG DL + P++ +C +PG K+T NM+C G+
Sbjct: 117 CAPAGTQCLISGWGNTLSSGVNEPDLLKCLDAPLLPQADCEASYPG---KITDNMVCVGF 173
Query: 371 VEGGKDSCQ 379
+EGGKDSCQ
Sbjct: 174 LEGGKDSCQ 182
>pdb|2F83|A Chain A, Crystal Structure At 2.9 Angstroms Resolution Of Human
Plasma Coagulation Factor Xi Zymogen
Length = 625
Score = 110 bits (276), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 66/192 (34%), Positives = 109/192 (56%), Gaps = 11/192 (5%)
Query: 193 RIVGGWTTEVNEYPWVVALEQAG---KFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVI 249
RIVGG + E+PW V L + CGG++I ++++LTAAHC + K L V
Sbjct: 387 RIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYS 446
Query: 250 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLP 309
N++ + E V +++ H +Y + +DIALLKL+T + + + P+CLP
Sbjct: 447 GILNQSEIKE-DTSFFGVQEIIIHDQYKMAES---GYDIALLKLETTVNYTDSQRPICLP 502
Query: 310 QLGEKFTQRTGT-VVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEAKLTGNMMC 367
G++ T V GWG + +I + L+ ++P+++N+EC +++ G K+T M+C
Sbjct: 503 SKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGH--KITHKMIC 560
Query: 368 AGYVEGGKDSCQ 379
AGY EGGKD+C+
Sbjct: 561 AGYREGGKDACK 572
>pdb|3TGK|E Chain E, Trypsinogen Mutant D194n And Deletion Of Ile 16-Val 17
Complexed With Bovine Pancreatic Trypsin Inhibitor
(Bpti)
Length = 231
Score = 110 bits (276), Expect = 2e-24, Method: Composition-based stats.
Identities = 68/189 (35%), Positives = 105/189 (55%), Gaps = 22/189 (11%)
Query: 196 GGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHNRA 255
GG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + V + EHN
Sbjct: 11 GGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSR-----IQVRLGEHN-I 63
Query: 256 TVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGEKF 315
V E + K++ HP ++ K+ ++DI L+KL +P++ V+ V LP
Sbjct: 64 NVLEGNEQFVNAAKIIKHPNFDR---KTLNNDIMLIKLSSPVKLNARVATVALPS----S 116
Query: 316 TQRTGT---VVGWGRVEESGQIASDL-RATQVPVMSNQECR-QFPGFEAKLTGNMMCAGY 370
GT + GWG SG DL + P++ +C +PG K+T NM+C G+
Sbjct: 117 CAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG---KITDNMVCVGF 173
Query: 371 VEGGKDSCQ 379
+EGGKDSCQ
Sbjct: 174 LEGGKDSCQ 182
>pdb|1FY8|E Chain E, Crystal Structure Of The Deltaile16val17 Rat Anionic
Trypsinogen-Bpti Complex
Length = 231
Score = 110 bits (276), Expect = 2e-24, Method: Composition-based stats.
Identities = 68/189 (35%), Positives = 105/189 (55%), Gaps = 22/189 (11%)
Query: 196 GGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHNRA 255
GG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + V + EHN
Sbjct: 11 GGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSR-----IQVRLGEHN-I 63
Query: 256 TVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGEKF 315
V E + K++ HP ++ K+ ++DI L+KL +P++ V+ V LP
Sbjct: 64 NVLEGNEQFVNAAKIIKHPNFDR---KTLNNDIMLIKLSSPVKLNARVATVALPS----S 116
Query: 316 TQRTGT---VVGWGRVEESGQIASDL-RATQVPVMSNQECR-QFPGFEAKLTGNMMCAGY 370
GT + GWG SG DL + P++ +C +PG K+T NM+C G+
Sbjct: 117 CAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASYPG---KITDNMVCVGF 173
Query: 371 VEGGKDSCQ 379
+EGGKDSCQ
Sbjct: 174 LEGGKDSCQ 182
>pdb|1BUI|A Chain A, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
pdb|1BUI|B Chain B, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
Length = 250
Score = 110 bits (276), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 66/190 (34%), Positives = 94/190 (49%), Gaps = 15/190 (7%)
Query: 193 RIVGGWTTEVNEYPWVVALE-QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISE 251
R+VGG + +PW V+L + G FCGGTLIS +VLTAAHC+ S R V++
Sbjct: 20 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 79
Query: 252 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQL 311
H + E ++ V ++ P DIALLKL +P V P CLP
Sbjct: 80 HQEVNL-EPHVQEIEVSRLFLEPTRK---------DIALLKLSSPAVITDKVIPACLPSP 129
Query: 312 GEKFTQRTGT-VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLTGNMMCAG 369
RT + GWG E G + L+ Q+PV+ N+ C ++ ++ +CAG
Sbjct: 130 NYVVADRTECFITGWG--ETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAG 187
Query: 370 YVEGGKDSCQ 379
++ GG DSCQ
Sbjct: 188 HLAGGTDSCQ 197
>pdb|1H8I|H Chain H, X-Ray Crystal Structure Of Human Alpha-Thrombin With A
Tripeptide Phosphonate Inhibitor
Length = 253
Score = 110 bits (276), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 77/206 (37%), Positives = 109/206 (52%), Gaps = 30/206 (14%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPG 356
VCLP Q G K G V GWG ++E+ S L+ +P++ C+
Sbjct: 118 VCLPDRETAASLLQAGYK-----GRVTGWGNLKETWGQPSVLQVVNLPIVERPVCKD--S 170
Query: 357 FEAKLTGNMMCAGYV--EGGK-DSCQ 379
++T NM CAGY EG + D+C+
Sbjct: 171 TRIRITDNMFCAGYKPDEGKRGDACE 196
>pdb|1L4Z|A Chain A, X-Ray Crystal Structure Of The Complex Of Microplasminogen
With Alpha Domain Of Streptokinase In The Presence
Cadmium Ions
Length = 248
Score = 110 bits (276), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 66/190 (34%), Positives = 94/190 (49%), Gaps = 15/190 (7%)
Query: 193 RIVGGWTTEVNEYPWVVALE-QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISE 251
R+VGG + +PW V+L + G FCGGTLIS +VLTAAHC+ S R V++
Sbjct: 18 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 77
Query: 252 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQL 311
H + E ++ V ++ P DIALLKL +P V P CLP
Sbjct: 78 HQEVNL-EPHVQEIEVSRLFLEPTRK---------DIALLKLSSPAVITDKVIPACLPSP 127
Query: 312 GEKFTQRTGT-VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLTGNMMCAG 369
RT + GWG E G + L+ Q+PV+ N+ C ++ ++ +CAG
Sbjct: 128 NYVVADRTECFITGWG--ETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAG 185
Query: 370 YVEGGKDSCQ 379
++ GG DSCQ
Sbjct: 186 HLAGGTDSCQ 195
>pdb|3UIR|A Chain A, Crystal Structure Of The Plasmin-Textilinin-1 Complex
pdb|3UIR|B Chain B, Crystal Structure Of The Plasmin-Textilinin-1 Complex
Length = 247
Score = 110 bits (276), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 66/190 (34%), Positives = 94/190 (49%), Gaps = 15/190 (7%)
Query: 193 RIVGGWTTEVNEYPWVVALE-QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISE 251
R+VGG + +PW V+L + G FCGGTLIS +VLTAAHC+ S R V++
Sbjct: 17 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 76
Query: 252 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQL 311
H + E ++ V ++ P DIALLKL +P V P CLP
Sbjct: 77 HQEVNL-EPHVQEIEVSRLFLEPTRK---------DIALLKLSSPAVITDKVIPACLPSP 126
Query: 312 GEKFTQRTGT-VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLTGNMMCAG 369
RT + GWG E G + L+ Q+PV+ N+ C ++ ++ +CAG
Sbjct: 127 NYVVADRTECFITGWG--ETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAG 184
Query: 370 YVEGGKDSCQ 379
++ GG DSCQ
Sbjct: 185 HLAGGTDSCQ 194
>pdb|1DDJ|A Chain A, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|B Chain B, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|C Chain C, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|D Chain D, Crystal Structure Of Human Plasminogen Catalytic Domain
Length = 247
Score = 110 bits (276), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 66/190 (34%), Positives = 94/190 (49%), Gaps = 15/190 (7%)
Query: 193 RIVGGWTTEVNEYPWVVALE-QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISE 251
R+VGG + +PW V+L + G FCGGTLIS +VLTAAHC+ S R V++
Sbjct: 17 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 76
Query: 252 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQL 311
H + E ++ V ++ P DIALLKL +P V P CLP
Sbjct: 77 HQEVNL-EPHVQEIEVSRLFLEPTRK---------DIALLKLSSPAVITDKVIPACLPSP 126
Query: 312 GEKFTQRTGT-VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLTGNMMCAG 369
RT + GWG E G + L+ Q+PV+ N+ C ++ ++ +CAG
Sbjct: 127 NYVVADRTECFITGWG--ETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAG 184
Query: 370 YVEGGKDSCQ 379
++ GG DSCQ
Sbjct: 185 HLAGGTDSCQ 194
>pdb|1L4D|A Chain A, Crystal Structure Of Microplasminogen-streptokinase Alpha
Domain Complex
Length = 249
Score = 110 bits (276), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 66/190 (34%), Positives = 94/190 (49%), Gaps = 15/190 (7%)
Query: 193 RIVGGWTTEVNEYPWVVALE-QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISE 251
R+VGG + +PW V+L + G FCGGTLIS +VLTAAHC+ S R V++
Sbjct: 19 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 78
Query: 252 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQL 311
H + E ++ V ++ P DIALLKL +P V P CLP
Sbjct: 79 HQEVNL-EPHVQEIEVSRLFLEPTRK---------DIALLKLSSPAVITDKVIPACLPSP 128
Query: 312 GEKFTQRTGT-VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLTGNMMCAG 369
RT + GWG E G + L+ Q+PV+ N+ C ++ ++ +CAG
Sbjct: 129 NYVVADRTECFITGWG--ETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAG 186
Query: 370 YVEGGKDSCQ 379
++ GG DSCQ
Sbjct: 187 HLAGGTDSCQ 196
>pdb|1BML|A Chain A, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
pdb|1BML|B Chain B, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
Length = 250
Score = 110 bits (276), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 66/190 (34%), Positives = 94/190 (49%), Gaps = 15/190 (7%)
Query: 193 RIVGGWTTEVNEYPWVVALE-QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISE 251
R+VGG + +PW V+L + G FCGGTLIS +VLTAAHC+ S R V++
Sbjct: 20 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 79
Query: 252 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQL 311
H + E ++ V ++ P DIALLKL +P V P CLP
Sbjct: 80 HQEVNL-EPHVQEIEVSRLFLEPTRK---------DIALLKLSSPAVITDKVIPACLPSP 129
Query: 312 GEKFTQRTGT-VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLTGNMMCAG 369
RT + GWG E G + L+ Q+PV+ N+ C ++ ++ +CAG
Sbjct: 130 NYVVADRTECFITGWG--ETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAG 187
Query: 370 YVEGGKDSCQ 379
++ GG DSCQ
Sbjct: 188 HLAGGTDSCQ 197
>pdb|1J15|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J16|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J17|T Chain T, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99175190RT
Length = 223
Score = 110 bits (275), Expect = 2e-24, Method: Composition-based stats.
Identities = 66/190 (34%), Positives = 105/190 (55%), Gaps = 20/190 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + V + EHN
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSR-----IQVRLGEHN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K++ HP ++ + ++++DI L+KL +P++ V+ V LP
Sbjct: 55 -INVLEGNEQFVNAAKIIKHPNFDRE---TYNNDIMLIKLSSPVKLNARVATVALPS--- 107
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLTGNMMCAG 369
GT + GWG SG D L+ P++ +C F +T NM+C G
Sbjct: 108 -SCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQADCEASSSF--IITDNMVCVG 164
Query: 370 YVEGGKDSCQ 379
++EGGKD+CQ
Sbjct: 165 FLEGGKDACQ 174
>pdb|3OTJ|E Chain E, A Crystal Structure Of Trypsin Complexed With Bpti (Bovine
Pancreatic Trypsin Inhibitor) By X-RayNEUTRON JOINT
REFINEMENT
Length = 223
Score = 110 bits (275), Expect = 3e-24, Method: Composition-based stats.
Identities = 68/190 (35%), Positives = 103/190 (54%), Gaps = 22/190 (11%)
Query: 195 VGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHNR 254
VGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E N
Sbjct: 2 VGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGEDN- 54
Query: 255 ATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGEK 314
V E + K + HP YN+ + ++DI L+KL + V+ + LP
Sbjct: 55 INVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVASISLP----T 107
Query: 315 FTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEAKLTGNMMCAG 369
GT + GWG + SG D L+ + P++S+ C+ +PG ++T NM CAG
Sbjct: 108 SCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMFCAG 164
Query: 370 YVEGGKDSCQ 379
Y+EGGKDSCQ
Sbjct: 165 YLEGGKDSCQ 174
>pdb|1XXD|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXD|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXF|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
pdb|1XXF|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
Length = 238
Score = 110 bits (274), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 68/191 (35%), Positives = 110/191 (57%), Gaps = 11/191 (5%)
Query: 194 IVGGWTTEVNEYPWVVALEQAG---KFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVIS 250
IVGG + E+PW V L + CGG++I ++++LTAAHC + K L V
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 251 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQ 310
N+A + E V +++ H +Y A+S +DIALLKL+T + + + P+CLP
Sbjct: 61 ILNQAEIKE-DTSFFGVQEIIIHDQYKM--AES-GYDIALLKLETTVNYADSQRPICLPS 116
Query: 311 LGEKFTQRTGT-VVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEAKLTGNMMCA 368
G++ T V GWG + +I + L+ ++P+++N+EC +++ G K+T M+CA
Sbjct: 117 KGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGH--KITHKMICA 174
Query: 369 GYVEGGKDSCQ 379
GY EGGKD+C+
Sbjct: 175 GYREGGKDACK 185
>pdb|1ZHM|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Coagulation Factor Xia In Complex With Benzamidine
(s434a- T475a-k437 Mutant)
Length = 238
Score = 110 bits (274), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 68/191 (35%), Positives = 110/191 (57%), Gaps = 11/191 (5%)
Query: 194 IVGGWTTEVNEYPWVVALEQAG---KFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVIS 250
IVGG + E+PW V L + CGG++I ++++LTAAHC + K L V
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 251 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQ 310
N+A + E V +++ H +Y A+S +DIALLKL+T + + + P+CLP
Sbjct: 61 ILNQAEIAE-DTSFFGVQEIIIHDQYKM--AES-GYDIALLKLETTVNYADSQRPICLPS 116
Query: 311 LGEKFTQRTGT-VVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEAKLTGNMMCA 368
G++ T V GWG + +I + L+ ++P+++N+EC +++ G K+T M+CA
Sbjct: 117 KGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGH--KITHKMICA 174
Query: 369 GYVEGGKDSCQ 379
GY EGGKD+C+
Sbjct: 175 GYREGGKDACK 185
>pdb|1EAW|A Chain A, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAW|C Chain C, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAX|A Chain A, Crystal Structure Of Mtsp1 (Matriptase)
pdb|2GV6|A Chain A, Crystal Structure Of Matriptase With Inhibitor Cj-730
pdb|2GV7|A Chain A, Structure Of Matriptase In Complex With Inhibitor Cj-672
Length = 241
Score = 110 bits (274), Expect = 4e-24, Method: Compositional matrix adjust.
Identities = 71/246 (28%), Positives = 121/246 (49%), Gaps = 22/246 (8%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGK-FFCGGTLISDRYVLTAAHCVRSSK--RQKD---LIV 247
+VGG + E+PW V+L G+ CG +LIS ++++AAHC + R D
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTA 60
Query: 248 VISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVC 307
+ H+++ ++ RR+ ++++HP +N + D+DIALL+L+ P E+ V P+C
Sbjct: 61 FLGLHDQSQRSAPGVQERRLKRIISHPFFND---FTFDYDIALLELEKPAEYSSMVRPIC 117
Query: 308 LPQLGEKF-TQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMM 366
LP F + V GWG + G A L+ ++ V++ C ++T MM
Sbjct: 118 LPDASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENL--LPQQITPRMM 175
Query: 367 CAGYVEGGKDSCQ------VTLDEADIALLK----SYGQGQYTKSIKAVEDDIQAVIKRV 416
C G++ GG DSCQ ++ EAD + + S+G G ++ V + +
Sbjct: 176 CVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWI 235
Query: 417 NELTGI 422
E TG+
Sbjct: 236 KENTGV 241
>pdb|4DUR|A Chain A, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUR|B Chain B, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUU|A Chain A, The X-Ray Crystal Structure Of Full-Length Type I Human
Plasminogen
pdb|4A5T|S Chain S, Structural Basis For The Conformational Modulation
Length = 791
Score = 109 bits (272), Expect = 5e-24, Method: Compositional matrix adjust.
Identities = 66/190 (34%), Positives = 94/190 (49%), Gaps = 15/190 (7%)
Query: 193 RIVGGWTTEVNEYPWVVALE-QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISE 251
R+VGG + +PW V+L + G FCGGTLIS +VLTAAHC+ S R V++
Sbjct: 561 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 620
Query: 252 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQL 311
H + E ++ V ++ P DIALLKL +P V P CLP
Sbjct: 621 HQEVNL-EPHVQEIEVSRLFLEPTRK---------DIALLKLSSPAVITDKVIPACLPSP 670
Query: 312 GEKFTQRTGT-VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLTGNMMCAG 369
RT + GWG E G + L+ Q+PV+ N+ C ++ ++ +CAG
Sbjct: 671 NYVVADRTECFITGWG--ETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAG 728
Query: 370 YVEGGKDSCQ 379
++ GG DSCQ
Sbjct: 729 HLAGGTDSCQ 738
>pdb|3P8G|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Benzamidine
pdb|3P8F|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Sfti-1
Length = 241
Score = 109 bits (272), Expect = 5e-24, Method: Compositional matrix adjust.
Identities = 71/246 (28%), Positives = 120/246 (48%), Gaps = 22/246 (8%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGK-FFCGGTLISDRYVLTAAHCVRSSK--RQKD---LIV 247
+VGG + E+PW V+L G+ CG +LIS ++++AAHC + R D
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTA 60
Query: 248 VISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVC 307
+ H+++ ++ RR+ ++++HP +N + D+DIALL+L+ P E+ V P+C
Sbjct: 61 FLGLHDQSQRSAPGVQERRLKRIISHPFFND---FTFDYDIALLELEKPAEYSSMVRPIC 117
Query: 308 LPQLGEKF-TQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMM 366
LP F + V GWG + G A L+ ++ V+ C ++T MM
Sbjct: 118 LPDASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVIQQTTCENL--LPQQITPRMM 175
Query: 367 CAGYVEGGKDSCQ------VTLDEADIALLK----SYGQGQYTKSIKAVEDDIQAVIKRV 416
C G++ GG DSCQ ++ EAD + + S+G G ++ V + +
Sbjct: 176 CVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWI 235
Query: 417 NELTGI 422
E TG+
Sbjct: 236 KENTGV 241
>pdb|1ZHP|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine (S434a-T475a-K505
Mutant)
Length = 238
Score = 109 bits (272), Expect = 6e-24, Method: Compositional matrix adjust.
Identities = 68/191 (35%), Positives = 109/191 (57%), Gaps = 11/191 (5%)
Query: 194 IVGGWTTEVNEYPWVVALEQAG---KFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVIS 250
IVGG + E+PW V L + CGG++I ++++LTAAHC + K L V
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 251 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQ 310
N+A + E V +++ H +Y A+S +DIALLKL+T + + + P+CLP
Sbjct: 61 ILNQAEIKE-DTSFFGVQEIIIHDQYKM--AES-GYDIALLKLETTVNYADSQRPICLPS 116
Query: 311 LGEKFTQRTGT-VVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEAKLTGNMMCA 368
G++ T V GWG +I + L+ ++P+++N+EC +++ G K+T M+CA
Sbjct: 117 KGDRNVIYTDCWVTGWGYRALRDKIQNTLQKAKIPLVTNEECQKRYRGH--KITHKMICA 174
Query: 369 GYVEGGKDSCQ 379
GY EGGKD+C+
Sbjct: 175 GYREGGKDACK 185
>pdb|2D8W|A Chain A, Structure Of Hyper-Vil-Trypsin
Length = 223
Score = 109 bits (272), Expect = 6e-24, Method: Composition-based stats.
Identities = 68/191 (35%), Positives = 103/191 (53%), Gaps = 22/191 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E N
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCXKSG-----IQVRLGEDN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K + HP YN+ + ++DI L+KL + V+ + LP
Sbjct: 55 -INVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVASISLP---- 106
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEAKLTGNMMCA 368
GT + GWG + SG D L+ + P++S+ C+ +PG ++T NM CA
Sbjct: 107 TSCASAGTQCLISGWGNTKSSGTSXPDVLKCLKAPILSDSSCKSAYPG---QITSNMFCA 163
Query: 369 GYVEGGKDSCQ 379
G +EGGKDSCQ
Sbjct: 164 GXLEGGKDSCQ 174
>pdb|1MKW|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
Length = 308
Score = 109 bits (272), Expect = 7e-24, Method: Compositional matrix adjust.
Identities = 79/208 (37%), Positives = 109/208 (52%), Gaps = 26/208 (12%)
Query: 193 RIVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DL 245
RIV G EV PW V L + + CG +LISDR+VLTAAHC+ K DL
Sbjct: 49 RIVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDL 108
Query: 246 IVVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVS 304
+V I +H+R T YE ++E ++ K+ HP+YN + ++ D DIALLKL P+E +
Sbjct: 109 LVRIGKHSR-TRYERKVEKISMLDKIYIHPRYNWK--ENLDRDIALLKLKRPIELSDYIH 165
Query: 305 PVCLP--QLGEKFTQR--TGTVVGWGRVEESGQIA------SDLRATQVPVMSNQECRQF 354
PVCLP Q K G V GWG E+ + S L+ +P++ C+
Sbjct: 166 PVCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCK-- 223
Query: 355 PGFEAKLTGNMMCAGYVEG-GK--DSCQ 379
++T NM CAGY G GK D+C+
Sbjct: 224 ASTRIRITDNMFCAGYKPGEGKRGDACE 251
>pdb|1UTJ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTK|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTL|M Chain M, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTM|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
Length = 242
Score = 109 bits (272), Expect = 7e-24, Method: Compositional matrix adjust.
Identities = 69/191 (36%), Positives = 100/191 (52%), Gaps = 19/191 (9%)
Query: 192 DRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISE 251
D+IVGG+ + P V+L +G FCGG+L+++ +V++AAHC +S V + E
Sbjct: 19 DKIVGGYECKPYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHCYKSRVE-----VRLGE 72
Query: 252 HNRATV--YETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLP 309
HN E I + RV++ HP Y++ D+DI L+KL P V PV LP
Sbjct: 73 HNIKVTEGSEQFISSSRVIR---HPNYSSYNI---DNDIMLIKLSKPATLNTYVQPVALP 126
Query: 310 QLGEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQ-FPGFEAKLTGNMMCA 368
TV GWG S ++ L+ +P++S +C +PG +T M CA
Sbjct: 127 TSCAPAGTMC-TVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSYPGM---ITNAMFCA 182
Query: 369 GYVEGGKDSCQ 379
GY+EGGKDSCQ
Sbjct: 183 GYLEGGKDSCQ 193
>pdb|2ZPR|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
pdb|2ZPR|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
Length = 222
Score = 108 bits (271), Expect = 7e-24, Method: Composition-based stats.
Identities = 68/189 (35%), Positives = 97/189 (51%), Gaps = 19/189 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+ + P V+L +G FCGG+L+++ +V++AAHC +S + V + EHN
Sbjct: 1 IVGGYECKAYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHCYKSR-----VAVRLGEHN 54
Query: 254 RATV--YETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQL 311
E I + RV++ HP Y++ D+DI L+KL P V PV LP
Sbjct: 55 IKVTEGSEQFISSSRVIR---HPNYSSYNI---DNDIMLIKLSKPATLNTYVQPVALPSS 108
Query: 312 GEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQ-FPGFEAKLTGNMMCAGY 370
TV GWG S L+ +P++S +C +PG +T M CAGY
Sbjct: 109 CAP-AGTMCTVSGWGNTMSSTADGDKLQCLNIPILSYSDCNNSYPGM---ITNAMFCAGY 164
Query: 371 VEGGKDSCQ 379
+EGGKDSCQ
Sbjct: 165 LEGGKDSCQ 173
>pdb|1BIT|A Chain A, The Crystal Structure Of Anionic Salmon Trypsin In A
Second Crystal Form
Length = 237
Score = 108 bits (271), Expect = 8e-24, Method: Composition-based stats.
Identities = 69/199 (34%), Positives = 100/199 (50%), Gaps = 19/199 (9%)
Query: 184 GCGVPNRMDRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK 243
G D+IVGG+ + V+L +G FCGG+L+++ +V++AAHC +S
Sbjct: 6 GAAFATEDDKIVGGYECKAYSQAHQVSL-NSGYHFCGGSLVNENWVVSAAHCYKSRVE-- 62
Query: 244 DLIVVISEHNRATV--YETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKP 301
V + EHN E I + RV++ HP Y++ D+DI L+KL P
Sbjct: 63 ---VRLGEHNIKVTEGSEQFISSSRVIR---HPNYSSYNI---DNDIMLIKLSKPATLNT 113
Query: 302 TVSPVCLPQLGEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQ-FPGFEAK 360
V PV LP TV GWG S ++ L+ +P++S +C +PG
Sbjct: 114 YVQPVALPTSCAP-AGTMCTVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSYPGM--- 169
Query: 361 LTGNMMCAGYVEGGKDSCQ 379
+T M CAGY+EGGKDSCQ
Sbjct: 170 ITNAMFCAGYLEGGKDSCQ 188
>pdb|1XX9|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
pdb|1XX9|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
Length = 238
Score = 108 bits (271), Expect = 8e-24, Method: Compositional matrix adjust.
Identities = 67/191 (35%), Positives = 110/191 (57%), Gaps = 11/191 (5%)
Query: 194 IVGGWTTEVNEYPWVVALEQAG---KFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVIS 250
IVGG + E+PW V L + CGG++I ++++LTAAHC + K L V
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 251 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQ 310
N++ + E V +++ H +Y A+S +DIALLKL+T + + + P+CLP
Sbjct: 61 ILNQSEIKE-DTSFFGVQEIIIHDQYKM--AES-GYDIALLKLETTVNYTDSQRPICLPS 116
Query: 311 LGEKFTQRTGT-VVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEAKLTGNMMCA 368
G++ T V GWG + +I + L+ ++P+++N+EC +++ G K+T M+CA
Sbjct: 117 KGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGH--KITHKMICA 174
Query: 369 GYVEGGKDSCQ 379
GY EGGKD+C+
Sbjct: 175 GYREGGKDACK 185
>pdb|1HJ8|A Chain A, 1.00 Aa Trypsin From Atlantic Salmon
Length = 222
Score = 108 bits (271), Expect = 8e-24, Method: Composition-based stats.
Identities = 68/189 (35%), Positives = 98/189 (51%), Gaps = 19/189 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+ + P V+L +G FCGG+L+++ +V++AAHC +S V + EHN
Sbjct: 1 IVGGYECKAYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHCYKSRVE-----VRLGEHN 54
Query: 254 RATV--YETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQL 311
E I + RV++ HP Y++ D+DI L+KL P V PV LP
Sbjct: 55 IKVTEGSEQFISSSRVIR---HPNYSSYNI---DNDIMLIKLSKPATLNTYVQPVALPTS 108
Query: 312 GEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQ-FPGFEAKLTGNMMCAGY 370
TV GWG S ++ L+ +P++S +C +PG +T M CAGY
Sbjct: 109 CAP-AGTMCTVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSYPGM---ITNAMFCAGY 164
Query: 371 VEGGKDSCQ 379
+EGGKDSCQ
Sbjct: 165 LEGGKDSCQ 173
>pdb|1LV7|A Chain A, Crystal Structure Of The Aaa Domain Of Ftsh
Length = 257
Score = 108 bits (271), Expect = 9e-24, Method: Compositional matrix adjust.
Identities = 55/131 (41%), Positives = 83/131 (63%), Gaps = 4/131 (3%)
Query: 481 GGCKEQIEKLREVVETPLLHLDGFDPRGNIKVLMATNRPDTLDPALMRPGRLDRKVEFGL 540
GG E+ + L ++ L+ +DGF+ I V+ ATNRPD LDPAL+RPGR DR+V GL
Sbjct: 126 GGHDEREQTLNQM----LVEMDGFEGNEGIIVIAATNRPDVLDPALLRPGRFDRQVVVGL 181
Query: 541 PDLEGRTHIFKIHARSMSVERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIRARRKVAS 600
PD+ GR I K+H R + + DI ++AR P +GA++ ++ EA +FA R ++V S
Sbjct: 182 PDVRGREQILKVHMRRVPLAPDIDAAIIARGTPGFSGADLANLVNEAALFAARGNKRVVS 241
Query: 601 EKDFLEAVNKV 611
+F +A +K+
Sbjct: 242 MVEFEKAKDKI 252
Score = 64.3 bits (155), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 28/61 (45%), Positives = 41/61 (67%)
Query: 112 MLELINQPEKFVNLGIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQKYV 171
++E + +P +F LG + PKGVL+ GPPGTGKTL A+A+A F + GS+ V+ +V
Sbjct: 27 LVEYLREPSRFQKLGGKIPKGVLMVGPPGTGKTLLAKAIAGEAKVPFFTISGSDFVEMFV 86
Query: 172 G 172
G
Sbjct: 87 G 87
>pdb|1MH0|A Chain A, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1MH0|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
Length = 287
Score = 108 bits (270), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 80/214 (37%), Positives = 112/214 (52%), Gaps = 38/214 (17%)
Query: 193 RIVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DL 245
RIV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL
Sbjct: 30 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 89
Query: 246 IVVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVS 304
+V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F +
Sbjct: 90 LVRIGKHSR-TRYEANIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIH 146
Query: 305 PVCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSN 348
PVCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 147 PVCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVER 200
Query: 349 QECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 201 PVCKD--STRIRITDNMFCAGYKPDEGKRGDACE 232
>pdb|2CE7|A Chain A, Edta Treated
pdb|2CE7|B Chain B, Edta Treated
pdb|2CE7|C Chain C, Edta Treated
pdb|2CE7|D Chain D, Edta Treated
pdb|2CE7|E Chain E, Edta Treated
pdb|2CE7|F Chain F, Edta Treated
pdb|2CEA|A Chain A, Cell Division Protein Ftsh
pdb|2CEA|B Chain B, Cell Division Protein Ftsh
pdb|2CEA|C Chain C, Cell Division Protein Ftsh
pdb|2CEA|D Chain D, Cell Division Protein Ftsh
pdb|2CEA|E Chain E, Cell Division Protein Ftsh
pdb|2CEA|F Chain F, Cell Division Protein Ftsh
Length = 476
Score = 108 bits (270), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 78/244 (31%), Positives = 121/244 (49%), Gaps = 29/244 (11%)
Query: 481 GGCKEQIEKLREVVETPLLHLDGFDPRGNIKVLMATNRPDTLDPALMRPGRLDRKVEFGL 540
GG E+ + L ++ L+ +DGFD + I V+ ATNRPD LDPAL+RPGR D+K+
Sbjct: 130 GGHDEREQTLNQL----LVEMDGFDSKEGIIVMAATNRPDILDPALLRPGRFDKKIVVDP 185
Query: 541 PDLEGRTHIFKIHARSMSVERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIRARRKVAS 600
PD+ GR I +IH R+ + D+ E++A+ P GA++ ++ EA + A R R +
Sbjct: 186 PDMLGRKKILEIHTRNKPLAEDVNLEIIAKRTPGFVGADLENLVNEAALLAAREGRDKIT 245
Query: 601 EKDFLEAVNKV----ARCTKIINADSENPKYIINVKQFAKFVVDLADSVAPTDIEEGMRV 656
KDF EA+++V AR + +I S K II + VV +V P E R+
Sbjct: 246 MKDFEEAIDRVIAGPARKSLLI---SPAEKRIIAYHEAGHAVV---STVVPNG-EPVHRI 298
Query: 657 -----GVDRNKYQIHIPLPPK--------IDPTVTMMQVEEKPDVTYSDI-GGCKEQIEK 702
G Y +H+P K +D ++ +V + D+ G IE+
Sbjct: 299 SIIPRGYKALGYTLHLPEEDKYLVSRNELLDKLTALLGGRAAEEVVFGDVTSGAANDIER 358
Query: 703 LREV 706
E+
Sbjct: 359 ATEI 362
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 30/63 (47%), Positives = 41/63 (65%)
Query: 110 RTMLELINQPEKFVNLGIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQK 169
+ ++E + P KF +G PKG+LL GPPGTGKTL ARAVA + F + GS+ V+
Sbjct: 29 KEVVEFLKDPSKFNRIGARMPKGILLVGPPGTGKTLLARAVAGEANVPFFHISGSDFVEL 88
Query: 170 YVG 172
+VG
Sbjct: 89 FVG 91
Score = 32.7 bits (73), Expect = 0.68, Method: Compositional matrix adjust.
Identities = 15/31 (48%), Positives = 21/31 (67%)
Query: 465 TMMQVEEKPDVTYSDIGGCKEQIEKLREVVE 495
TM + VT+ D+GG +E IE+L+EVVE
Sbjct: 3 TMYKPSGNKRVTFKDVGGAEEAIEELKEVVE 33
Score = 32.7 bits (73), Expect = 0.68, Method: Compositional matrix adjust.
Identities = 15/31 (48%), Positives = 21/31 (67%)
Query: 678 TMMQVEEKPDVTYSDIGGCKEQIEKLREVVE 708
TM + VT+ D+GG +E IE+L+EVVE
Sbjct: 3 TMYKPSGNKRVTFKDVGGAEEAIEELKEVVE 33
>pdb|3KDS|E Chain E, Apo-ftsh Crystal Structure
pdb|3KDS|F Chain F, Apo-ftsh Crystal Structure
pdb|3KDS|G Chain G, Apo-ftsh Crystal Structure
Length = 465
Score = 108 bits (269), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 78/244 (31%), Positives = 121/244 (49%), Gaps = 29/244 (11%)
Query: 481 GGCKEQIEKLREVVETPLLHLDGFDPRGNIKVLMATNRPDTLDPALMRPGRLDRKVEFGL 540
GG E+ + L ++ L+ +DGFD + I V+ ATNRPD LDPAL+RPGR D+K+
Sbjct: 130 GGHDEREQTLNQL----LVEMDGFDSKEGIIVMAATNRPDILDPALLRPGRFDKKIVVDP 185
Query: 541 PDLEGRTHIFKIHARSMSVERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIRARRKVAS 600
PD+ GR I +IH R+ + D+ E++A+ P GA++ ++ EA + A R R +
Sbjct: 186 PDMLGRKKILEIHTRNKPLAEDVNLEIIAKRTPGFVGADLENLVNEAALLAAREGRDKIT 245
Query: 601 EKDFLEAVNKV----ARCTKIINADSENPKYIINVKQFAKFVVDLADSVAPTDIEEGMRV 656
KDF EA+++V AR + +I S K II + VV +V P E R+
Sbjct: 246 MKDFEEAIDRVIAGPARKSLLI---SPAEKRIIAYHEAGHAVV---STVVPNG-EPVHRI 298
Query: 657 -----GVDRNKYQIHIPLPPK--------IDPTVTMMQVEEKPDVTYSDI-GGCKEQIEK 702
G Y +H+P K +D ++ +V + D+ G IE+
Sbjct: 299 SIIPRGYKALGYTLHLPEEDKYLVSRNELLDKLTALLGGRAAEEVVFGDVTSGAANDIER 358
Query: 703 LREV 706
E+
Sbjct: 359 ATEI 362
Score = 66.2 bits (160), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 29/63 (46%), Positives = 40/63 (63%)
Query: 110 RTMLELINQPEKFVNLGIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQK 169
+ ++E + P KF +G PKG+LL GPPGTG TL ARAVA + F + GS+ V+
Sbjct: 29 KEVVEFLKDPSKFNRIGARMPKGILLVGPPGTGATLLARAVAGEANVPFFHISGSDFVEL 88
Query: 170 YVG 172
+VG
Sbjct: 89 FVG 91
Score = 32.7 bits (73), Expect = 0.69, Method: Compositional matrix adjust.
Identities = 15/31 (48%), Positives = 21/31 (67%)
Query: 465 TMMQVEEKPDVTYSDIGGCKEQIEKLREVVE 495
TM + VT+ D+GG +E IE+L+EVVE
Sbjct: 3 TMYKPSGNKRVTFKDVGGAEEAIEELKEVVE 33
Score = 32.7 bits (73), Expect = 0.69, Method: Compositional matrix adjust.
Identities = 15/31 (48%), Positives = 21/31 (67%)
Query: 678 TMMQVEEKPDVTYSDIGGCKEQIEKLREVVE 708
TM + VT+ D+GG +E IE+L+EVVE
Sbjct: 3 TMYKPSGNKRVTFKDVGGAEEAIEELKEVVE 33
>pdb|2ZPQ|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
pdb|2ZPQ|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
Length = 222
Score = 108 bits (269), Expect = 1e-23, Method: Composition-based stats.
Identities = 68/189 (35%), Positives = 97/189 (51%), Gaps = 19/189 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+ + P V+L +G FCGG+L+++ +V++AAHC +S V + EHN
Sbjct: 1 IVGGYECKAYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHCYKSRVE-----VRLGEHN 54
Query: 254 RATV--YETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQL 311
E I + RV++ HP Y++ D+DI L+KL P V PV LP
Sbjct: 55 IKVTEGSEQFISSSRVIR---HPNYSSYNI---DNDIMLIKLSKPATLNTYVQPVALPSS 108
Query: 312 GEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQ-FPGFEAKLTGNMMCAGY 370
TV GWG S + L+ +P++S +C +PG +T M CAGY
Sbjct: 109 CAP-AGTMCTVSGWGNTMSSTADKNKLQCLNIPILSYSDCNNSYPGM---ITNAMFCAGY 164
Query: 371 VEGGKDSCQ 379
+EGGKDSCQ
Sbjct: 165 LEGGKDSCQ 173
>pdb|2CGA|A Chain A, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|2CGA|B Chain B, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|1ACB|E Chain E, Crystal And Molecular Structure Of The Bovine
Alpha-Chymotrypsin-Eglin C Complex At 2.0 Angstroms
Resolution
pdb|1CGI|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1CGJ|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1EX3|A Chain A, Crystal Structure Of Bovine Chymotrypsinogen A
(Tetragonal)
pdb|1GL1|A Chain A, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|B Chain B, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|C Chain C, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL0|E Chain E, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-D2v, An Inhibitor From The Insect Locusta
Migratoria
pdb|1K2I|1 Chain 1, Crystal Structure Of Gamma-Chymotrypsin In Complex With 7-
Hydroxycoumarin
pdb|1P2M|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2M|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OXG|A Chain A, Crystal Structure Of A Complex Formed Between Organic
Solvent Treated Bovine Alpha-Chymotrypsin And Its
Autocatalytically Produced Highly Potent 14-Residue
Peptide At 2.2 Resolution
pdb|1T7C|A Chain A, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T7C|C Chain C, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|A Chain A, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|C Chain C, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|A Chain A, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|C Chain C, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|A Chain A, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|C Chain C, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|A Chain A, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|C Chain C, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1CHG|A Chain A, Chymotrypsinogen,2.5 Angstroms Crystal Structure,
Comparison With Alpha-Chymotrypsin,And Implications For
Zymogen Activation
pdb|1GCD|A Chain A, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2Y6T|A Chain A, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|B Chain B, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|C Chain C, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|D Chain D, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|3T62|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|B Chain B, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|C Chain C, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
Length = 245
Score = 108 bits (269), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 71/203 (34%), Positives = 108/203 (53%), Gaps = 21/203 (10%)
Query: 185 CGVP------NRMDRIVGGWTTEVNEYPWVVALE-QAGKFFCGGTLISDRYVLTAAHCVR 237
CGVP + + RIV G +PW V+L+ + G FCGG+LI++ +V+TAAHC
Sbjct: 1 CGVPAIQPVLSGLSRIVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGV 60
Query: 238 SSKRQKDLIVVISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPL 297
++ +VV E ++ + E +I+ ++ KV + KYN+ + ++DI LLKL T
Sbjct: 61 TTSD----VVVAGEFDQGSSSE-KIQKLKIAKVFKNSKYNSL---TINNDITLLKLSTAA 112
Query: 298 EFKPTVSPVCLPQLGEKFTQRTGTV-VGWGRVEESGQIASD-LRATQVPVMSNQECRQFP 355
F TVS VCLP + F T V GWG + D L+ +P++SN C+++
Sbjct: 113 SFSQTVSAVCLPSASDDFAAGTTCVTTGWGLTRYTNANTPDRLQQASLPLLSNTNCKKYW 172
Query: 356 GFEAKLTGNMMCAGYVEGGKDSC 378
G K+ M+CAG G SC
Sbjct: 173 G--TKIKDAMICAG--ASGVSSC 191
>pdb|1D6W|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electrophilic Inhibitors Having Cyclohexyl Moieties
At P1
pdb|1G37|A Chain A, Crystal Structure Of Human Alpha-thrombin Complexed With
Bch-10556 And Exosite-directed Peptide
Length = 287
Score = 108 bits (269), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 80/214 (37%), Positives = 112/214 (52%), Gaps = 38/214 (17%)
Query: 193 RIVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DL 245
RIV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL
Sbjct: 30 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 89
Query: 246 IVVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVS 304
+V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F +
Sbjct: 90 LVRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIH 146
Query: 305 PVCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSN 348
PVCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 147 PVCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVER 200
Query: 349 QECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 201 PVCKD--STRIRITDNMFCAGYKPDEGKRGDACE 232
>pdb|2BDY|A Chain A, Thrombin In Complex With Inhibitor
Length = 289
Score = 108 bits (269), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 80/214 (37%), Positives = 112/214 (52%), Gaps = 38/214 (17%)
Query: 193 RIVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DL 245
RIV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL
Sbjct: 30 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 89
Query: 246 IVVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVS 304
+V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F +
Sbjct: 90 LVRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIH 146
Query: 305 PVCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSN 348
PVCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 147 PVCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVER 200
Query: 349 QECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 201 PVCKD--STRIRITDNMFCAGYKPDEGKRGDACE 232
>pdb|1JWT|A Chain A, Crystal Structure Of Thrombin In Complex With A Novel
Bicyclic Lactam Inhibitor
Length = 305
Score = 108 bits (269), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 80/214 (37%), Positives = 112/214 (52%), Gaps = 38/214 (17%)
Query: 193 RIVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DL 245
RIV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL
Sbjct: 36 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 95
Query: 246 IVVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVS 304
+V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F +
Sbjct: 96 LVRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIH 152
Query: 305 PVCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSN 348
PVCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 153 PVCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVER 206
Query: 349 QECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 207 PVCKD--STRIRITDNMFCAGYKPDEGKRGDACE 238
>pdb|1D9I|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electophilic Inhibitors Having Cyclohexyl Moieties
At P1
Length = 288
Score = 108 bits (269), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 80/214 (37%), Positives = 112/214 (52%), Gaps = 38/214 (17%)
Query: 193 RIVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DL 245
RIV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL
Sbjct: 30 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 89
Query: 246 IVVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVS 304
+V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F +
Sbjct: 90 LVRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIH 146
Query: 305 PVCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSN 348
PVCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 147 PVCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVER 200
Query: 349 QECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 201 PVCKD--STRIRITDNMFCAGYKPDEGKRGDACE 232
>pdb|1NM6|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
At 1.8a
pdb|1NT1|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
pdb|1TA2|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 1
pdb|1TA6|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 14b
pdb|1SL3|A Chain A, Crystal Structue Of Thrombin In Complex With A Potent P1
Heterocycle- Aryl Based Inhibitor
pdb|1Z71|A Chain A, Thrombin And P2 Pyridine N-oxide Inhibitor Complex
Structure
pdb|1ZRB|A Chain A, Thrombin In Complex With An Azafluorenyl Inhibitor 23b
pdb|1ZGI|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 21
pdb|1ZGV|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 2
pdb|3C1K|A Chain A, Crystal Structure Of Thrombin In Complex With Inhibitor 15
Length = 287
Score = 108 bits (269), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 80/214 (37%), Positives = 112/214 (52%), Gaps = 38/214 (17%)
Query: 193 RIVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DL 245
RIV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL
Sbjct: 29 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 88
Query: 246 IVVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVS 304
+V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F +
Sbjct: 89 LVRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIH 145
Query: 305 PVCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSN 348
PVCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 146 PVCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVER 199
Query: 349 QECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 200 PVCKD--STRIRITDNMFCAGYKPDEGKRGDACE 231
>pdb|3SQE|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The
Alternative Form
pdb|3SQH|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The The
Open Form
Length = 290
Score = 108 bits (269), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 80/214 (37%), Positives = 112/214 (52%), Gaps = 38/214 (17%)
Query: 193 RIVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DL 245
RIV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL
Sbjct: 31 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 90
Query: 246 IVVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVS 304
+V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F +
Sbjct: 91 LVRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIH 147
Query: 305 PVCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSN 348
PVCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 148 PVCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVER 201
Query: 349 QECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 202 PVCKD--STRIRITDNMFCAGYKPDEGKRGDACE 233
>pdb|1NU9|A Chain A, Staphylocoagulase-prethrombin-2 Complex
pdb|1NU9|D Chain D, Staphylocoagulase-prethrombin-2 Complex
Length = 291
Score = 107 bits (268), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 80/214 (37%), Positives = 112/214 (52%), Gaps = 38/214 (17%)
Query: 193 RIVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DL 245
RIV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL
Sbjct: 32 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 91
Query: 246 IVVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVS 304
+V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F +
Sbjct: 92 LVRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIH 148
Query: 305 PVCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSN 348
PVCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 149 PVCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVER 202
Query: 349 QECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 203 PVCKD--STRIRITDNMFCAGYKPDEGKRGDACE 234
>pdb|1BZX|E Chain E, The Crystal Structure Of Anionic Salmon Trypsin In Complex
With Bovine Pancreatic Trypsin Inhibitor
pdb|2STA|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (Cucurbita Maxima Trypsin Inhibitor I)
pdb|2STB|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (cucurbita Pepo Trypsin Inhibitor Ii)
Length = 222
Score = 107 bits (268), Expect = 2e-23, Method: Composition-based stats.
Identities = 68/189 (35%), Positives = 98/189 (51%), Gaps = 19/189 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+ + P V+L +G FCGG+L+++ +V++AAHC +S V + EHN
Sbjct: 1 IVGGYECKPYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHCYKSRVE-----VRLGEHN 54
Query: 254 RATV--YETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQL 311
E I + RV++ HP Y++ D+DI L+KL P V PV LP
Sbjct: 55 IKVTEGSEQFISSSRVIR---HPNYSSYNI---DNDIMLIKLSKPATLNTYVQPVALPTS 108
Query: 312 GEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQ-FPGFEAKLTGNMMCAGY 370
TV GWG S ++ L+ +P++S +C +PG +T M CAGY
Sbjct: 109 CAP-AGTMCTVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSYPGM---ITNAMFCAGY 164
Query: 371 VEGGKDSCQ 379
+EGGKDSCQ
Sbjct: 165 LEGGKDSCQ 173
>pdb|1NTP|A Chain A, Use Of The Neutron Diffraction HD EXCHANGE TECHNIQUE TO
Determine The Conformational Dynamics Of Trypsin
Length = 223
Score = 107 bits (268), Expect = 2e-23, Method: Composition-based stats.
Identities = 67/190 (35%), Positives = 102/190 (53%), Gaps = 22/190 (11%)
Query: 195 VGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHNR 254
VGG+T N P+ V+L +G FCGG+LI ++V++AAHC +S + V + E N
Sbjct: 2 VGGYTCGANTVPYQVSL-NSGYHFCGGSLIDSQWVVSAAHCYKSG-----IQVRLGEDN- 54
Query: 255 ATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGEK 314
V E + K + HP Y++ + ++DI L+KL + V+ + LP
Sbjct: 55 INVVEGNEQFISASKSIVHPSYDSN---TLNNDIMLIKLKSAASLDSRVASISLP----T 107
Query: 315 FTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEAKLTGNMMCAG 369
GT + GWG + SG D L+ + P++S+ C+ +PG ++T NM CAG
Sbjct: 108 SCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMFCAG 164
Query: 370 YVEGGKDSCQ 379
Y+EGGKDSCQ
Sbjct: 165 YLEGGKDSCQ 174
>pdb|2FI5|E Chain E, Crystal Structure Of A Bpti Variant (Cys38->ser) In
Complex With Trypsin
pdb|2FTM|A Chain A, Crystal Structure Of Trypsin Complexed With The Bpti
Variant (Tyr35- >gly)
Length = 224
Score = 107 bits (268), Expect = 2e-23, Method: Composition-based stats.
Identities = 69/192 (35%), Positives = 105/192 (54%), Gaps = 23/192 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E N
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGEDN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPT-VSPVCLPQLG 312
V E + K + HP YN+ + ++DI L+KL + + V+ + LP
Sbjct: 55 -INVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLXDSRVASISLP--- 107
Query: 313 EKFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEAKLTGNMMC 367
GT + GWG + SG D L+ + P++S+ C+ +PG ++T NM C
Sbjct: 108 -TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMFC 163
Query: 368 AGYVEGGKDSCQ 379
AGY+EGGKDSCQ
Sbjct: 164 AGYLEGGKDSCQ 175
>pdb|1DM4|B Chain B, Ser195ala Mutant Of Human Thrombin Complexed With
Fibrinopeptide A (7- 16)
pdb|1JMO|H Chain H, Crystal Structure Of The Heparin Cofactor Ii-S195a
Thrombin Complex
Length = 260
Score = 107 bits (268), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 80/214 (37%), Positives = 112/214 (52%), Gaps = 38/214 (17%)
Query: 193 RIVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DL 245
RIV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL
Sbjct: 1 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 60
Query: 246 IVVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVS 304
+V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F +
Sbjct: 61 LVRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIH 117
Query: 305 PVCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSN 348
PVCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 118 PVCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVER 171
Query: 349 QECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 172 PVCKD--STRIRITDNMFCAGYKPDEGKRGDACE 203
>pdb|3K65|B Chain B, Crystal Structure Of Prethombin-2FRAGMENT-2 Complex
Length = 308
Score = 107 bits (268), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 80/214 (37%), Positives = 112/214 (52%), Gaps = 38/214 (17%)
Query: 193 RIVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DL 245
RIV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL
Sbjct: 49 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 108
Query: 246 IVVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVS 304
+V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F +
Sbjct: 109 LVRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIH 165
Query: 305 PVCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSN 348
PVCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 166 PVCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVER 219
Query: 349 QECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 220 PVCKD--STRIRITDNMFCAGYKPDEGKRGDACE 251
>pdb|1HAG|E Chain E, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1DOJ|A Chain A, Crystal Structure Of Human Alpha-ThrombinRwj-51438 Complex
At 1.7 A
pdb|1XM1|A Chain A, Nonbasic Thrombin Inhibitor Complex
Length = 295
Score = 107 bits (268), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 80/214 (37%), Positives = 112/214 (52%), Gaps = 38/214 (17%)
Query: 193 RIVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DL 245
RIV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL
Sbjct: 36 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 95
Query: 246 IVVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVS 304
+V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F +
Sbjct: 96 LVRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIH 152
Query: 305 PVCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSN 348
PVCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 153 PVCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVER 206
Query: 349 QECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 207 PVCKD--STRIRITDNMFCAGYKPDEGKRGDACE 238
>pdb|1EOJ|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
pdb|1EOL|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
Length = 289
Score = 107 bits (268), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 80/214 (37%), Positives = 112/214 (52%), Gaps = 38/214 (17%)
Query: 193 RIVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DL 245
RIV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL
Sbjct: 32 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 91
Query: 246 IVVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVS 304
+V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F +
Sbjct: 92 LVRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIH 148
Query: 305 PVCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSN 348
PVCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 149 PVCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVER 202
Query: 349 QECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 203 PVCKD--STRIRITDNMFCAGYKPDEGKRGDACE 234
>pdb|1ID5|H Chain H, Crystal Structure Of Bovine Thrombin Complex With Protease
Inhibitor Ecotin
Length = 256
Score = 107 bits (267), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 78/207 (37%), Positives = 108/207 (52%), Gaps = 26/207 (12%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G EV PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE ++E ++ K+ HP+YN + ++ D DIALLKL P+E + P
Sbjct: 61 VRIGKHSR-TRYERKVEKISMLDKIYIHPRYNWK--ENLDRDIALLKLKRPIELSDYIHP 117
Query: 306 VCLP--QLGEKFTQR--TGTVVGWGRVEESGQIA------SDLRATQVPVMSNQECRQFP 355
VCLP Q K G V GWG E+ + S L+ +P++ C+
Sbjct: 118 VCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKA-- 175
Query: 356 GFEAKLTGNMMCAGYVEG-GK--DSCQ 379
++T NM CAGY G GK D+C+
Sbjct: 176 STRIRITDNMFCAGYKPGEGKRGDACE 202
>pdb|1BBR|K Chain K, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1BBR|N Chain N, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1ETR|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETS|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETT|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1HRT|H Chain H, The Structure Of A Complex Of Bovine Alpha-Thrombin And
Recombinant Hirudin At 2.8 Angstroms Resolution
pdb|1TBR|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBR|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1UCY|K Chain K, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1UCY|N Chain N, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|H Chain H, Thrombin:hirudin 51-65 Complex
pdb|1MKW|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1TOC|B Chain B, Structure Of Serine Proteinase
pdb|1TOC|D Chain D, Structure Of Serine Proteinase
pdb|1TOC|F Chain F, Structure Of Serine Proteinase
pdb|1TOC|H Chain H, Structure Of Serine Proteinase
pdb|1UVT|H Chain H, Bovine Thrombin--Bm14.1248 Complex
pdb|1UVU|H Chain H, Bovine Thrombin--Bm12.1700 Complex
pdb|1YCP|H Chain H, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
pdb|1A0H|B Chain B, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1A0H|E Chain E, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1AVG|H Chain H, Thrombin Inhibitor From Triatoma Pallidipennis
pdb|2A1D|B Chain B, Staphylocoagulase Bound To Bovine Thrombin
pdb|2A1D|F Chain F, Staphylocoagulase Bound To Bovine Thrombin
pdb|2ODY|B Chain B, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|2ODY|D Chain D, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|3PMA|B Chain B, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMA|D Chain D, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMB|B Chain B, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
pdb|3PMB|D Chain D, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
Length = 259
Score = 107 bits (267), Expect = 2e-23, Method: Compositional matrix adjust.
Identities = 78/207 (37%), Positives = 108/207 (52%), Gaps = 26/207 (12%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G EV PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE ++E ++ K+ HP+YN + ++ D DIALLKL P+E + P
Sbjct: 61 VRIGKHSR-TRYERKVEKISMLDKIYIHPRYNWK--ENLDRDIALLKLKRPIELSDYIHP 117
Query: 306 VCLP--QLGEKFTQR--TGTVVGWGRVEESGQIA------SDLRATQVPVMSNQECRQFP 355
VCLP Q K G V GWG E+ + S L+ +P++ C+
Sbjct: 118 VCLPDKQTAAKLLHAGFKGRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKA-- 175
Query: 356 GFEAKLTGNMMCAGYVEG-GK--DSCQ 379
++T NM CAGY G GK D+C+
Sbjct: 176 STRIRITDNMFCAGYKPGEGKRGDACE 202
>pdb|2ZPS|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 3 From Chum
Salmon
Length = 222
Score = 107 bits (267), Expect = 3e-23, Method: Composition-based stats.
Identities = 67/189 (35%), Positives = 97/189 (51%), Gaps = 19/189 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+ + P V+L +G FCGG+L+++ +V++AAHC ++ V + EHN
Sbjct: 1 IVGGYECKAYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHCYKTRVE-----VRLGEHN 54
Query: 254 RATV--YETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQL 311
E I + RV++ HP Y++ D+DI L+KL P V PV LP
Sbjct: 55 IKVTEGSEQFISSSRVIR---HPNYSSYNI---DNDIMLIKLSKPATLNTYVQPVALPSS 108
Query: 312 GEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQ-FPGFEAKLTGNMMCAGY 370
TV GWG S + L+ +P++S +C +PG +T M CAGY
Sbjct: 109 CAP-AGTMCTVSGWGNTMSSTADKNKLQCLNIPILSYSDCNNSYPGM---ITNAMFCAGY 164
Query: 371 VEGGKDSCQ 379
+EGGKDSCQ
Sbjct: 165 LEGGKDSCQ 173
>pdb|1BTH|H Chain H, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
pdb|1BTH|K Chain K, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 259
Score = 107 bits (266), Expect = 3e-23, Method: Compositional matrix adjust.
Identities = 80/213 (37%), Positives = 111/213 (52%), Gaps = 38/213 (17%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSNQ 349
VCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 118 VCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTTNVGKGQ-PSVLQVVNLPIVERP 171
Query: 350 ECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+CQ
Sbjct: 172 VCKD--STRIRITDNMFCAGYKPDEGKRGDACQ 202
>pdb|3NXP|A Chain A, Crystal Structure Of Human Prethrombin-1
Length = 424
Score = 106 bits (265), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 80/214 (37%), Positives = 112/214 (52%), Gaps = 38/214 (17%)
Query: 193 RIVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DL 245
RIV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL
Sbjct: 165 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 224
Query: 246 IVVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVS 304
+V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F +
Sbjct: 225 LVRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIH 281
Query: 305 PVCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSN 348
PVCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 282 PVCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVER 335
Query: 349 QECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 336 PVCKD--STRIRITDNMFCAGYKPDEGKRGDACE 367
>pdb|1RJX|B Chain B, Human Plasminogen Catalytic Domain, K698m Mutant
Length = 247
Score = 106 bits (264), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 65/189 (34%), Positives = 92/189 (48%), Gaps = 15/189 (7%)
Query: 194 IVGGWTTEVNEYPWVVALE-QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEH 252
+VGG + +PW V+L + G FCGGTLIS +VLTAAHC+ S R V++ H
Sbjct: 18 VVGGCVAYPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAH 77
Query: 253 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLG 312
+ E ++ V ++ P DIALLKL +P V P CLP
Sbjct: 78 QEVNL-EPHVQEIEVSRLFLEPTRK---------DIALLKLSSPAVITDKVIPACLPSPN 127
Query: 313 EKFTQRTGT-VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLTGNMMCAGY 370
RT + GWG E G + L Q+PV+ N+ C ++ ++ +CAG+
Sbjct: 128 YVVADRTECFITGWG--ETQGTFGAGLLMEAQLPVIENKVCNRYEFLNGRVQSTELCAGH 185
Query: 371 VEGGKDSCQ 379
+ GG DSCQ
Sbjct: 186 LAGGTDSCQ 194
>pdb|1ZHR|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine
(S434a-T475a-C482s-K437a Mutant)
pdb|1ZPB|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 4-Methyl-Pentanoic Acid {1-[4-
Guanidino-1-(Thiazole-2-Carbonyl)-Butylcarbamoyl]-2-
Methyl- Propyl}-Amide
pdb|1ZPC|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
2-[2-(3-Chloro-Phenyl)-2-Hydroxy-
Acetylamino]-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]- 3-Methyl-Butyramide
pdb|2FDA|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Coagulation Factor Xia In Complex With
Alpha-Ketothiazole Arginine Derived Ligand
pdb|1ZMJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With 4-(Guanidinomethyl)-Phenylboronic Acid
pdb|1ZML|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With (R)-1-(4-(4-(Hydroxymethyl)-1,3,2-
Dioxaborolan-2-Yl)phenethyl)guanidine
pdb|1ZMN|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
(R)-1-(4-(4-(Hydroxymethyl)-1,3,
2-Dioxaborolan-2-Yl)phenyl)guanidine
pdb|1ZOM|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With A Peptidomimetic Inhibitor
pdb|1ZSJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
N-(7-Carbamimidoyl-Naphthalen-1-
Yl)-3-Hydroxy-2-Methyl-Benzamide
pdb|1ZSK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
6-Carbamimidoyl-4-(3-Hydroxy-2-
Methyl-Benzoylamino)-Naphthalene-2-Carboxylic Acid
Methyl Ester
pdb|1ZTJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Benzylamino-2-
Methylsulfanyl-6-Oxo-6h-Pyrimidin-1-Yl)-N-[4-Guanidino-
1- (Thiazole-2-Carbonyl)-Butyl]-Acetamide
pdb|1ZTK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Amino-6-Oxo-2-M-Tolyl-6h-
Pyrimidin-1-Yl)-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]-Acetamide
pdb|1ZTL|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With N-[4-Guanidino-1-(Thiazole-2-
Carbonyl)-Butyl]-2-{6-Oxo-5-[(Quinolin-8-Ylmethyl)-
Amino]- 2-M-Tolyl-6h-Pyrimidin-1-Yl}-Acetamide
Length = 238
Score = 106 bits (264), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 67/191 (35%), Positives = 109/191 (57%), Gaps = 11/191 (5%)
Query: 194 IVGGWTTEVNEYPWVVALEQAG---KFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVIS 250
IVGG + E+PW V L + CGG++I ++++LTAAHC + K L V
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 251 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQ 310
N+A + E V +++ H +Y A+S +DIALLKL+T + + + P+ LP
Sbjct: 61 ILNQAEIAE-DTSFFGVQEIIIHDQYKM--AES-GYDIALLKLETTVNYADSQRPISLPS 116
Query: 311 LGEKFTQRTGT-VVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEAKLTGNMMCA 368
G++ T V GWG + +I + L+ ++P+++N+EC +++ G K+T M+CA
Sbjct: 117 KGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGH--KITHKMICA 174
Query: 369 GYVEGGKDSCQ 379
GY EGGKD+C+
Sbjct: 175 GYREGGKDACK 185
>pdb|3BG8|A Chain A, Crystal Structure Of Factor Xia In Complex With
Clavatadine A
Length = 238
Score = 106 bits (264), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 67/191 (35%), Positives = 109/191 (57%), Gaps = 11/191 (5%)
Query: 194 IVGGWTTEVNEYPWVVALEQAG---KFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVIS 250
IVGG + E+PW V L + CGG++I ++++LTAAHC + K L V
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 251 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQ 310
N++ + E V +++ H +Y A+S +DIALLKL+T + + + P+ LP
Sbjct: 61 ILNQSEIKE-DTSFFGVQEIIIHDQYKM--AES-GYDIALLKLETTVNYTDSQRPISLPS 116
Query: 311 LGEKFTQRTGT-VVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEAKLTGNMMCA 368
GE+ T V GWG + +I + L+ ++P+++N+EC +++ G K+T M+CA
Sbjct: 117 KGERNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGH--KITHKMICA 174
Query: 369 GYVEGGKDSCQ 379
GY EGGKD+C+
Sbjct: 175 GYREGGKDACK 185
>pdb|1ZLR|A Chain A, Factor Xi Catalytic Domain Complexed With
2-Guanidino-1-(4-(4,4,5,5-
Tetramethyl-1,3,2-Dioxaborolan-2-Yl)phenyl)ethyl
Nicotinate
Length = 237
Score = 106 bits (264), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 67/191 (35%), Positives = 109/191 (57%), Gaps = 11/191 (5%)
Query: 194 IVGGWTTEVNEYPWVVALEQAG---KFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVIS 250
IVGG + E+PW V L + CGG++I ++++LTAAHC + K L V
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 251 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQ 310
N+A + E V +++ H +Y A+S +DIALLKL+T + + + P+ LP
Sbjct: 61 ILNQAEIAE-DTSFFGVQEIIIHDQYKM--AES-GYDIALLKLETTVNYADSQRPISLPS 116
Query: 311 LGEKFTQRTGT-VVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEAKLTGNMMCA 368
G++ T V GWG + +I + L+ ++P+++N+EC +++ G K+T M+CA
Sbjct: 117 KGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGH--KITHKMICA 174
Query: 369 GYVEGGKDSCQ 379
GY EGGKD+C+
Sbjct: 175 GYREGGKDACK 185
>pdb|1SFQ|B Chain B, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SFQ|E Chain E, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SG8|B Chain B, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SG8|E Chain E, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SGI|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SGI|E Chain E, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SHH|B Chain B, Slow Form Of Thrombin Bound With Ppack
pdb|1SHH|E Chain E, Slow Form Of Thrombin Bound With Ppack
pdb|2HWL|B Chain B, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|2HWL|D Chain D, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|3BV9|B Chain B, Structure Of Thrombin Bound To The Inhibitor Fm19
Length = 259
Score = 106 bits (264), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 79/213 (37%), Positives = 111/213 (52%), Gaps = 38/213 (17%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYEANIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSNQ 349
VCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 118 VCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERP 171
Query: 350 ECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 172 VCKD--STRIRITDNMFCAGYKPDEGKRGDACE 202
>pdb|2A0Q|B Chain B, Structure Of Thrombin In 400 Mm Potassium Chloride
pdb|2A0Q|D Chain D, Structure Of Thrombin In 400 Mm Potassium Chloride
Length = 257
Score = 106 bits (264), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 79/213 (37%), Positives = 111/213 (52%), Gaps = 38/213 (17%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYEANIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSNQ 349
VCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 118 VCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERP 171
Query: 350 ECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 172 VCKD--STRIRITDNMFCAGYKPDEGKRGDACE 202
>pdb|1ZJD|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Kunitz Protease Inhibitor
Domain Of Protease Nexin Ii
Length = 237
Score = 106 bits (264), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 67/191 (35%), Positives = 109/191 (57%), Gaps = 11/191 (5%)
Query: 194 IVGGWTTEVNEYPWVVALEQAG---KFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVIS 250
IVGG + E+PW V L + CGG++I ++++LTAAHC + K L V
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 251 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQ 310
N+A + E V +++ H +Y A+S +DIALLKL+T + + + P+ LP
Sbjct: 61 ILNQAEIKE-DTSFFGVQEIIIHDQYKM--AES-GYDIALLKLETTVNYADSQRPISLPS 116
Query: 311 LGEKFTQRTGT-VVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEAKLTGNMMCA 368
G++ T V GWG + +I + L+ ++P+++N+EC +++ G K+T M+CA
Sbjct: 117 KGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGH--KITHKMICA 174
Query: 369 GYVEGGKDSCQ 379
GY EGGKD+C+
Sbjct: 175 GYREGGKDACK 185
>pdb|1TQ0|B Chain B, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ0|D Chain D, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ7|B Chain B, Crystal Structure Of The Anticoagulant Thrombin Mutant
W215aE217A Bound To Ppack
Length = 257
Score = 106 bits (264), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 79/213 (37%), Positives = 111/213 (52%), Gaps = 38/213 (17%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSNQ 349
VCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 118 VCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERP 171
Query: 350 ECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 172 VCKD--STRIRITDNMFCAGYKPDEGKRGDACE 202
>pdb|3BN9|B Chain B, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3BN9|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3NCL|A Chain A, Crystal Structure Of Mt-Sp1 Bound To Benzamidine
Phosphonate Inhibitor
pdb|3NPS|A Chain A, Crystal Structure Of Membrane-Type Serine Protease 1
(Mt-Sp1) In Complex With The Fab Inhibitor S4
pdb|3SO3|A Chain A, Structures Of Fab-Protease Complexes Reveal A Highly
Specific Non- Canonical Mechanism Of Inhibition
Length = 241
Score = 105 bits (263), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 70/246 (28%), Positives = 120/246 (48%), Gaps = 22/246 (8%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGK-FFCGGTLISDRYVLTAAHCVRSSK--RQKD---LIV 247
+VGG + E+PW V+L G+ CG +LIS ++++AAHC + R D
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTA 60
Query: 248 VISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVC 307
+ H+++ ++ RR+ ++++HP +N + D+DIALL+L+ P E+ V P+
Sbjct: 61 FLGLHDQSQRSAPGVQERRLKRIISHPFFND---FTFDYDIALLELEKPAEYSSMVRPIS 117
Query: 308 LPQLGEKF-TQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMM 366
LP F + V GWG + G A L+ ++ V++ C ++T MM
Sbjct: 118 LPDASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENL--LPQQITPRMM 175
Query: 367 CAGYVEGGKDSCQ------VTLDEADIALLK----SYGQGQYTKSIKAVEDDIQAVIKRV 416
C G++ GG DSCQ ++ EAD + + S+G G ++ V + +
Sbjct: 176 CVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWI 235
Query: 417 NELTGI 422
E TG+
Sbjct: 236 KENTGV 241
>pdb|1Z8J|B Chain B, Crystal Structure Of The Thrombin Mutant G193p Bound To
Ppack
Length = 259
Score = 105 bits (263), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 79/213 (37%), Positives = 111/213 (52%), Gaps = 38/213 (17%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSNQ 349
VCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 118 VCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERP 171
Query: 350 ECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 172 VCKD--STRIRITDNMFCAGYKPDEGKRGDACE 202
>pdb|3EE0|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF HUMAN
Thrombin (Space Group P2(1)2(1)2(1))
pdb|3HKJ|B Chain B, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
pdb|3HKJ|E Chain E, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
Length = 259
Score = 105 bits (263), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 79/213 (37%), Positives = 111/213 (52%), Gaps = 38/213 (17%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSNQ 349
VCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 118 VCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERP 171
Query: 350 ECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 172 VCKD--STRIRITDNMFCAGYKPDEGKRGDACE 202
>pdb|1QUR|H Chain H, Human Alpha-Thrombin In Complex With Bivalent,
Benzamidine-Based Synthetic Inhibitor
pdb|1D3D|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzothiophene Inhibitor 4
pdb|1EB1|H Chain H, Complex Structure Of Human Thrombin With N-Methyl-Arginine
Inhibitor
pdb|1GHV|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1YPE|H Chain H, Thrombin Inhibitor Complex
pdb|1YPG|H Chain H, Thrombin Inhibitor Complex
pdb|1YPJ|H Chain H, Thrombin Inhibitor Complex
pdb|1YPK|H Chain H, Thrombin Inhibitor Complex
pdb|1YPL|H Chain H, X-Ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1008
pdb|1YPM|H Chain H, X-ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1014
pdb|2ANM|H Chain H, Ternary Complex Of An Orally Active Thrombin Inhibitor
With Human Thrombin And A C-Terminal Hirudin Derived
Exo-Sit Inhibitor
pdb|2CF9|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|1GHX|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GHY|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2CF8|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|2CN0|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Inhibitor
pdb|3BIU|H Chain H, Human Thrombin-In Complex With Ub-Thr10
pdb|3BIV|H Chain H, Human Thrombin-In Complex With Ub-Thr11
pdb|2V3H|H Chain H, Thrombin With 3-Cycle No F
pdb|2V3O|H Chain H, Thrombin With 3-Cycle With F
pdb|4AX9|H Chain H, Human Thrombin Complexed With Napsagatran, Ro0466240
pdb|4AYV|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AYY|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AZ2|B Chain B, Human Thrombin - Inhibitor Complex
pdb|1GHW|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-centered Short Hydrogen Bonding Network At The
Active Site
Length = 257
Score = 105 bits (263), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 79/213 (37%), Positives = 111/213 (52%), Gaps = 38/213 (17%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSNQ 349
VCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 118 VCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERP 171
Query: 350 ECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 172 VCKD--STRIRITDNMFCAGYKPDEGKRGDACE 202
>pdb|1B7X|B Chain B, Structure Of Human Alpha-Thrombin Y225i Mutant Bound To D-
Phe-Pro-Arg-Chloromethylketone
Length = 259
Score = 105 bits (263), Expect = 6e-23, Method: Compositional matrix adjust.
Identities = 79/213 (37%), Positives = 111/213 (52%), Gaps = 38/213 (17%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSNQ 349
VCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 118 VCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERP 171
Query: 350 ECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 172 VCKD--STRIRITDNMFCAGYKPDEGKRGDACE 202
>pdb|1DX5|M Chain M, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|N Chain N, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|O Chain O, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|P Chain P, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1E0F|D Chain D, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|F Chain F, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|E Chain E, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
Length = 259
Score = 105 bits (263), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 79/213 (37%), Positives = 111/213 (52%), Gaps = 38/213 (17%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFIENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSNQ 349
VCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 118 VCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERP 171
Query: 350 ECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 172 VCKD--STRIRITDNMFCAGYKPDEGKRGDACE 202
>pdb|1JOU|B Chain B, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|D Chain D, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|F Chain F, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1TB6|H Chain H, 2.5a Crystal Structure Of The
Antithrombin-Thrombin-Heparin Ternary Complex
pdb|2B5T|B Chain B, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|2B5T|D Chain D, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|3B9F|H Chain H, 1.6 A Structure Of The Pci-Thrombin-Heparin Complex
pdb|3GIS|B Chain B, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|D Chain D, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|F Chain F, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3LU9|B Chain B, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|3LU9|E Chain E, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|4DT7|B Chain B, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DT7|D Chain D, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DY7|B Chain B, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
pdb|4DY7|E Chain E, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
Length = 259
Score = 105 bits (263), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 79/213 (37%), Positives = 111/213 (52%), Gaps = 38/213 (17%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSNQ 349
VCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 118 VCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERP 171
Query: 350 ECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 172 VCKD--STRIRITDNMFCAGYKPDEGKRGDACE 202
>pdb|3EDX|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|D Chain D, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|F Chain F, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3HK3|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(ONE Molecule In The Asymmetric Unit)
pdb|3HK6|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HK6|D Chain D, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HKI|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
pdb|3HKI|E Chain E, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
Length = 258
Score = 105 bits (263), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 72/200 (36%), Positives = 101/200 (50%), Gaps = 33/200 (16%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV GW E PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILYPPWDKNFTENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE +E ++ K+ HP+YN + ++ D DIALLKL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNVEKISMLEKIYVHPRYNWR--ENLDRDIALLKLKKPVPFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEESGQI------ASDLRATQVPVMSNQE 350
VCLP + G K G V GWG + E+ S L+ +P++
Sbjct: 118 VCLPDKQTVTSLLRAGYK-----GRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPV 172
Query: 351 CRQFPGFEAKLTGNMMCAGY 370
C+ ++T NM CAG+
Sbjct: 173 CKA--STRIRITDNMFCAGF 190
>pdb|1THP|B Chain B, Structure Of Human Alpha-Thrombin Y225p Mutant Bound To
D-Phe-Pro-Arg- Chloromethylketone
pdb|3S7H|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|D Chain D, Structure Of Thrombin Mutant Y225p In The E Form
Length = 259
Score = 105 bits (263), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 79/213 (37%), Positives = 111/213 (52%), Gaps = 38/213 (17%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSNQ 349
VCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 118 VCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERP 171
Query: 350 ECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 172 VCKD--STRIRITDNMFCAGYKPDEGKRGDACE 202
>pdb|1Z8I|B Chain B, Crystal Structure Of The Thrombin Mutant G193a Bound To
Ppack
Length = 259
Score = 105 bits (263), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 79/214 (36%), Positives = 111/214 (51%), Gaps = 38/214 (17%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSNQ 349
VCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 118 VCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERP 171
Query: 350 ECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQV 380
C+ ++T NM CAGY EG + D+C+
Sbjct: 172 VCKD--STRIRITDNMFCAGYKPDEGKRGDACEA 203
>pdb|2THF|B Chain B, Structure Of Human Alpha-thrombin Y225f Mutant Bound To
D-phe-pro-arg- Chloromethylketone
Length = 259
Score = 105 bits (263), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 79/213 (37%), Positives = 111/213 (52%), Gaps = 38/213 (17%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSNQ 349
VCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 118 VCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERP 171
Query: 350 ECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 172 VCKD--STRIRITDNMFCAGYKPDEGKRGDACE 202
>pdb|1GJ5|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190ALA190 PROTEASE, Structure-Based Drug Design
pdb|1SB1|H Chain H, Novel Non-Covalent Thrombin Inhibitors Incorporating P1
4,5,6,7- Tetrahydrobenzothiazole Arginine Side Chain
Mimetics
pdb|2PW8|H Chain H, Crystal Structure Of Sulfo-Hirudin Complexed To Thrombin
pdb|3DD2|H Chain H, Crystal Structure Of An Rna Aptamer Bound To Human
Thrombin
pdb|1GJ4|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190/ala190 Protease, Structure-based Drug Design
Length = 258
Score = 105 bits (263), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 79/213 (37%), Positives = 111/213 (52%), Gaps = 38/213 (17%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSNQ 349
VCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 118 VCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERP 171
Query: 350 ECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 172 VCKD--STRIRITDNMFCAGYKPDEGKRGDACE 202
>pdb|1ABI|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1ABJ|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1DWB|H Chain H, Crystallographic Analysis At 3.0-angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-directed Inhibitors
pdb|1DWC|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWD|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWE|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1FPH|H Chain H, The Interaction Of Thrombin With Fibrinogen: A Structural
Basis For Its Specificity
pdb|1HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of Alpha-
Thrombin
pdb|1IHS|H Chain H, Crystal Structure Of The Complex Of Human Alpha-thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1IHT|H Chain H, Crystal Structure Of The Complex Of Human Alpha-Thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1PPB|H Chain H, The Refined 1.9 Angstroms Crystal Structure Of Human
Alpha-Thrombin: Interaction With D-Phe-Pro-Arg
Chloromethylketone And Significance Of The
Tyr-Pro-Pro-Trp Insertion Segment
pdb|1THR|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1THS|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1TMB|H Chain H, Molecular Basis For The Inhibition Of Human Alpha-thrombin
By The Macrocyclic Peptide Cyclotheonamide A
pdb|2HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of
Alpha-Thrombin
pdb|2HPP|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-Thrombin
pdb|2HPQ|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-thrombin
pdb|3HTC|H Chain H, The Structure Of A Complex Of Recombinant Hirudin And
Human Alpha-Thrombin
pdb|4HTC|H Chain H, The Refined Structure Of The Hirudin-Thrombin Complex
pdb|1HUT|H Chain H, The Structure Of Alpha-Thrombin Inhibited By A 15-Mer
Single-Stranded Dna Aptamer
pdb|1NRN|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRO|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRP|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRQ|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRR|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRS|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1TMT|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1TMU|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1HLT|H Chain H, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HLT|K Chain K, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HAH|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1HAI|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|3HAT|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1FPC|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1HBT|H Chain H, Human Alpha-Thrombin Complexed With A Peptidyl Pyridinium
Methyl Ketone Containing Bivalent Inhibitor
pdb|1HDT|H Chain H, Structure Of A Retro-Binding Peptide Inhibitor Complexed
With Human Alpha-Thrombin
pdb|1HAO|H Chain H, Complex Of Human Alpha-thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (based On Nmr Model Of
Dna)
pdb|1HAP|H Chain H, Complex Of Human Alpha-Thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (Based On X-Ray Model Of
Dna)
pdb|1AHT|H Chain H, Crystal Structure Of Human Alpha-Thrombin Complexed With
Hirugen And P-Amidinophenylpyruvate At 1.6 Angstroms
Resolution
pdb|1DIT|H Chain H, Complex Of A Divalent Inhibitor With Thrombin
pdb|1TOM|H Chain H, Alpha-Thrombin Complexed With Hirugen
pdb|1HXF|H Chain H, Human Thrombin Complex With Hirudin Variant
pdb|1BMM|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-4-[(Aminoiminomethyl)
Amino]-N-[[1-[3-Hydroxy-2-[(2-
Naphthalenylsulfonyl)amino]-1-
Oxopropyl]-2-Pyrrolidinyl] Methyl]butanamide
(Bms-186282)
pdb|1BMN|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-1-(Aminoiminomethyl)-
N-[[1-[n-[(2-Naphthalenylsulfonyl)-L-Seryl]-
Pyrrolidinyl]methyl]-3- Piperidenecarboxamide
(Bms-189090)
pdb|1UMA|H Chain H, Alpha-Thrombin (Hirugen) Complexed With
Na-(N,N-Dimethylcarbamoyl)- Alpha-Azalysine
pdb|1LHD|H Chain H, Human Alpha-thrombin Complexed With
Ac-(d)phe-pro-borolys-oh
pdb|1LHE|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-N-
Butyl-Amidino-Glycine-Oh
pdb|1LHF|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-
Homolys-Oh
pdb|1LHG|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-
Boroornithine-Oh
pdb|1LHC|H Chain H, Human Alpha-Thrombin Complexed With
Ac-(D)phe-Pro-Boroarg-Oh
pdb|1AD8|H Chain H, Complex Of Thrombin With And Inhibitor Containing A Novel
P1 Moiety
pdb|1AI8|H Chain H, Human Alpha-Thrombin Ternary Complex With The Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Borompg
pdb|1AIX|H Chain H, Human Alpha-Thrombin Ternary Complex With Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Boroval
pdb|1AE8|H Chain H, Human Alpha-Thrombin Inhibition By
Eoc-D-Phe-Pro-Azalys-Onp
pdb|1AFE|H Chain H, Human Alpha-Thrombin Inhibition By Cbz-Pro-Azalys-Onp
pdb|1UVS|H Chain H, Bovine Thrombin--Bm51.1011 Complex
pdb|5GDS|H Chain H, Hirunorms Are True Hirudin Mimetics. The Crystal Structure
Of Human Alpha-Thrombin:hirunorm V Complex
pdb|1AY6|H Chain H, Thrombin Inhibitor From Theonalla, Cyclotheanamide-Based
Macrocyclic Tripeptide Motif
pdb|1A46|H Chain H, Thrombin Complexed With Hirugen And A Beta-Strand Mimetic
Inhibitor
pdb|1A4W|H Chain H, Crystal Structures Of Thrombin With Thiazole-Containing
Inhibitors: Probes Of The S1' Binding Site
pdb|1A5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1B5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1TBZ|H Chain H, Human Thrombin With Active Site N-Methyl-D
Phenylalanyl-N-[5-
(Aminoiminomethyl)amino]-1-{{benzothiazolyl)carbonyl]
Butyl]-L- Prolinamide Trifluroacetate And
Exosite-Hirugen
pdb|1A2C|H Chain H, Structure Of Thrombin Inhibited By Aeruginosin298-A From A
Blue-Green Alga
pdb|1A61|H Chain H, Thrombin Complexed With A Beta-Mimetic Thiazole-Containing
Inhibitor
pdb|1A3B|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog1
pdb|1A3E|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog2
pdb|1AWF|H Chain H, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|B Chain B, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|D Chain D, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1BCU|H Chain H, Alpha-Thrombin Complexed With Hirugen And Proflavin
pdb|8KME|2 Chain 2, Crystal Structure Of Human Alpha-thrombin Inhibited With
Sel2770.
pdb|1BA8|B Chain B, Thrombin Inhibitor With A Rigid Tripeptidyl Aldehydes
pdb|1BB0|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1CA8|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|4THN|H Chain H, The Crystal Structure Of Alpha-Thrombin-Hirunorm Iv
Complex Reveals A Novel Specificity Site Recognition
Mode.
pdb|1QBV|H Chain H, Crystal Structure Of Thrombin Complexed With An
Guanidine-Mimetic Inhibitor
pdb|1D4P|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
5- Amidinoindole-4-benzylpiperidine Inhibitor
pdb|7KME|H Chain H, Crystal Structure Of Human Alpha-Thrombin Inhibited With
Sel2711.
pdb|1QHR|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ1|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ6|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ7|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1D3P|B Chain B, Crystal Structure Of Human Aplha-Thrombin In Complex With
Benzo[b]thiophene Inhibitor 3
pdb|1D3Q|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 2
pdb|1D3T|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 1
pdb|1C4U|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4V|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4Y|2 Chain 2, Selective Non-Electrophilic Thrombin Inhibitors
pdb|1DE7|H Chain H, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1DE7|K Chain K, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1G30|B Chain B, Thrombin Inhibitor Complex
pdb|1G32|B Chain B, Thrombin Inhibitor Complex
pdb|1KTS|B Chain B, Thrombin Inhibitor Complex
pdb|1KTT|B Chain B, Thrombin Inhibitor Complex
pdb|1K21|H Chain H, Human Thrombin-Inhibitor Complex
pdb|1K22|H Chain H, Human Thrombin-inhibitor Complex
pdb|1NY2|2 Chain 2, Human Alpha Thrombin Inhibited By Rppgf And Hirugen
pdb|1O2G|H Chain H, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1OYT|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Fluorinated Inhibitor
pdb|1NO9|H Chain H, Design Of Weakly Basic Thrombin Inhibitors Incorporating
Novel P1 Binding Functions: Molecular And X-Ray
Crystallographic Studies.
pdb|1OOK|B Chain B, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Human Alpha-thrombin
pdb|1P8V|C Chain C, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Alpha-thrombin At 2.6a
pdb|1NU7|B Chain B, Staphylocoagulase-Thrombin Complex
pdb|1NU7|F Chain F, Staphylocoagulase-Thrombin Complex
pdb|1NZQ|H Chain H, D-Phe-Pro-Arg-Type Thrombin Inhibitor
pdb|1O0D|H Chain H, Human Thrombin Complexed With A D-Phe-Pro-Arg-Type
Inhibitor And A C- Terminal Hirudin Derived Exo-Site
Inhibitor
pdb|1MU6|B Chain B, Crystal Structure Of Thrombin In Complex With L-378,622
pdb|1MU8|B Chain B, Thrombin-Hirugen_l-378,650
pdb|1MUE|B Chain B, Thrombin-Hirugen-L405,426
pdb|1SR5|C Chain C, Antithrombin-Anhydrothrombin-Heparin Ternary Complex
Structure
pdb|1O5G|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1XMN|B Chain B, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|D Chain D, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|F Chain F, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|H Chain H, Crystal Structure Of Thrombin Bound To Heparin
pdb|1WAY|B Chain B, Active Site Thrombin Inhibitors
pdb|1T4U|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|1T4V|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|2AFQ|B Chain B, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2AFQ|D Chain D, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2A45|B Chain B, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|2A45|E Chain E, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|1W7G|H Chain H, Alpha-Thrombin Complex With Sulfated Hirudin (Residues
54-65) And L- Arginine Template Inhibitor Cs107
pdb|2FES|H Chain H, Orally Active Thrombin Inhibitors
pdb|2C8W|B Chain B, Thrombin Inhibitors
pdb|2C8X|B Chain B, Thrombin Inhibitors
pdb|2C8Y|B Chain B, Thrombin Inhibitors
pdb|2C8Z|B Chain B, Thrombin Inhibitors
pdb|2C90|B Chain B, Thrombin Inhibitors
pdb|2C93|B Chain B, Thrombin Inhibitors
pdb|2FEQ|H Chain H, Orally Active Thrombin Inhibitors
pdb|2BVS|H Chain H, Human Thrombin Complexed With Fragment-Based Small
Molecules Occupying The S1 Pocket
pdb|2BVX|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-P2-Linker
pdb|2BXT|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2BXU|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2A2X|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
Inh12
pdb|2ANK|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
And An Exosite Decapeptide
pdb|2GDE|H Chain H, Thrombin In Complex With Inhibitor
pdb|2H9T|H Chain H, Crystal Structure Of Human Alpha-Thrombin In Complex With
Suramin
pdb|2JH0|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH5|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH6|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|1C1U|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1V|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1W|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5L|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5N|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5O|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1HXE|H Chain H, Serine Protease
pdb|2UUF|B Chain B, Thrombin-Hirugen Binary Complex At 1.26a Resolution
pdb|2UUJ|B Chain B, Thrombin-Hirugen-Gw473178 Ternary Complex At 1.32a
Resolution
pdb|2UUK|B Chain B, Thrombin-Hirugen-Gw420128 Ternary Complex At 1.39a
Resolution
pdb|3BF6|H Chain H, Thrombin:suramin Complex
pdb|2R2M|B Chain B, 2-(2-chloro-6-fluorophenyl)acetamides As Potent Thrombin
Inhibitors
pdb|3EGK|H Chain H, Knoble Inhibitor
pdb|2ZC9|H Chain H, Thrombin In Complex With Inhibitor
pdb|2ZDA|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZDV|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZF0|H Chain H, Exploring Thrombin S1 Pocket
pdb|3E6P|H Chain H, Crystal Structure Of Human Meizothrombin Desf1
pdb|2ZFF|H Chain H, Exploring Thrombin S1-Pocket
pdb|2ZFP|H Chain H, Thrombin Inibition
pdb|2ZGB|H Chain H, Thrombin Inhibition
pdb|2ZGX|H Chain H, Thrombin Inhibition
pdb|2ZFQ|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZFR|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHQ|H Chain H, Thrombin Inhibition
pdb|2ZI2|H Chain H, Thrombin Inhibition
pdb|2ZIQ|H Chain H, Thrombin Inhibition
pdb|2ZG0|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHE|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHF|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHW|H Chain H, Exploring Thrombin S3 Pocket
pdb|3C27|B Chain B, Cyanofluorophenylacetamides As Orally Efficacious Thrombin
Inhibitors
pdb|2ZNK|H Chain H, Thrombin Inhibition
pdb|2ZO3|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3D49|H Chain H, Thrombin Inhibition
pdb|3DA9|B Chain B, Crystal Structure Of Thrombin In Complex With Inhibitor
pdb|3DHK|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3DT0|H Chain H, Understanding Thrombin Inhibition
pdb|3DUX|H Chain H, Understanding Thrombin Inhibition
pdb|3EQ0|H Chain H, Thrombin Inhibitor
pdb|3F68|H Chain H, Thrombin Inhibition
pdb|3PMH|B Chain B, Mechanism Of Sulfotyrosine-Mediated Glycoprotein Ib
Interaction With Two Distinct Alpha-Thrombin Sites
pdb|3P6Z|B Chain B, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P6Z|H Chain H, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3LDX|H Chain H, Discovery And Clinical Evaluation Of Rwj-671818, A
Thrombin Inhibitor With An Oxyguanidine P1 Motif
pdb|3P70|B Chain B, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|D Chain D, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|F Chain F, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|H Chain H, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3TU7|H Chain H, Human Alpha-Thrombin Complexed With
N-(Methylsulfonyl)-D-Phenylalanyl-
N-((1-Carbamimidoyl-4-Piperidinyl)methyl)-L-Prolinamide
(Bms-189664)
pdb|3QLP|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And A Modified Thrombin Binding Aptamer (Mtba)
pdb|3P17|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3B23|B Chain B, Crystal Structure Of Thrombin-Variegin Complex: Insights
Of A Novel Mechanism Of Inhibition And Design Of Tunable
Thrombin Inhibitors
pdb|3QTO|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QTV|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QX5|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QWC|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3U69|H Chain H, Unliganded Wild-Type Human Thrombin
pdb|3U8T|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Cys
pdb|3RLW|H Chain H, Human Thrombin In Complex With Mi328
pdb|3RLY|H Chain H, Human Thrombin In Complex With Mi329
pdb|3RM0|H Chain H, Human Thrombin In Complex With Mi354
pdb|3RM2|H Chain H, Human Thrombin In Complex With Mi003
pdb|3RML|H Chain H, Human Thrombin In Complex With Mi331
pdb|3RMM|H Chain H, Human Thrombin In Complex With Mi332
pdb|3RMN|H Chain H, Human Thrombin In Complex With Mi341
pdb|3RMO|H Chain H, Human Thrombin In Complex With Mi004
pdb|3U8O|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-D-Thr
pdb|3U8R|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Ile
pdb|3SHA|H Chain H, Human Thrombin In Complex With Ubthr97
pdb|3SHC|H Chain H, Human Thrombin In Complex With Ubthr101
pdb|3SI3|H Chain H, Human Thrombin In Complex With Ubthr103
pdb|3SI4|H Chain H, Human Thrombin In Complex With Ubthr104
pdb|3SV2|H Chain H, Human Thrombin In Complex With Ubthr105
pdb|4E7R|H Chain H, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4E7R|G Chain G, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4DIH|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Sodium Ions
pdb|4DII|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Potassium Ions
pdb|3T5F|H Chain H, Human Thrombin In Complex With Mi340
pdb|3UTU|H Chain H, High Affinity Inhibitor Of Human Thrombin
pdb|3U98|H Chain H, Human Thrombin In Complex With Mi001
pdb|3U9A|H Chain H, Human Thrombin In Complex With Mi330
pdb|4E05|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|4E06|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|3UWJ|H Chain H, Human Thrombin In Complex With Mi353
pdb|4BAH|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAK|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAM|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAN|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAO|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAQ|B Chain B, Thrombin In Complex With Inhibitor
Length = 259
Score = 105 bits (263), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 79/213 (37%), Positives = 111/213 (52%), Gaps = 38/213 (17%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSNQ 349
VCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 118 VCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERP 171
Query: 350 ECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 172 VCKD--STRIRITDNMFCAGYKPDEGKRGDACE 202
>pdb|1WBG|B Chain B, Active Site Thrombin Inhibitors
Length = 259
Score = 105 bits (263), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 79/213 (37%), Positives = 111/213 (52%), Gaps = 38/213 (17%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSNQ 349
VCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 118 VCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERP 171
Query: 350 ECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 172 VCKD--STRIRITDNMFCAGYKPDEGKRGDACE 202
>pdb|1RD3|B Chain B, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
pdb|1RD3|D Chain D, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
Length = 259
Score = 105 bits (263), Expect = 7e-23, Method: Compositional matrix adjust.
Identities = 79/213 (37%), Positives = 111/213 (52%), Gaps = 38/213 (17%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSNQ 349
VCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 118 VCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERP 171
Query: 350 ECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 172 VCKD--STRIRITDNMFCAGYKPDEGKRGDACE 202
>pdb|1TWX|B Chain B, Crystal Structure Of The Thrombin Mutant D221aD222K
Length = 259
Score = 105 bits (262), Expect = 8e-23, Method: Compositional matrix adjust.
Identities = 79/213 (37%), Positives = 111/213 (52%), Gaps = 38/213 (17%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSNQ 349
VCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 118 VCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERP 171
Query: 350 ECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 172 VCKD--STRIRITDNMFCAGYKPDEGKRGDACE 202
>pdb|2OCV|B Chain B, Structural Basis Of Na+ Activation Mimicry In Murine
Thrombin
Length = 259
Score = 105 bits (262), Expect = 8e-23, Method: Compositional matrix adjust.
Identities = 72/200 (36%), Positives = 101/200 (50%), Gaps = 33/200 (16%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV GW E PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILYPPWDKNFTENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE +E ++ K+ HP+YN + ++ D DIALLKL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNVEKISMLEKIYVHPRYNWR--ENLDRDIALLKLKKPVPFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEESGQI------ASDLRATQVPVMSNQE 350
VCLP + G K G V GWG + E+ S L+ +P++
Sbjct: 118 VCLPDKQTVTSLLRAGYK-----GRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPV 172
Query: 351 CRQFPGFEAKLTGNMMCAGY 370
C+ ++T NM CAG+
Sbjct: 173 CKA--STRIRITDNMFCAGF 190
>pdb|3R3G|B Chain B, Structure Of Human Thrombin With Residues 145-150 Of
Murine Thrombin
Length = 259
Score = 105 bits (262), Expect = 8e-23, Method: Compositional matrix adjust.
Identities = 77/212 (36%), Positives = 108/212 (50%), Gaps = 36/212 (16%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEESGQI------ASDLRATQVPVMSNQE 350
VCLP Q G K G V GWG + E+ S L+ +P++
Sbjct: 118 VCLPDRETAASLLQAGYK-----GRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPV 172
Query: 351 CRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 173 CKD--STRIRITDNMFCAGYKPDEGKRGDACE 202
>pdb|3GIC|B Chain B, Structure Of Thrombin Mutant Delta(146-149e) In The Free
Form
Length = 250
Score = 105 bits (262), Expect = 9e-23, Method: Compositional matrix adjust.
Identities = 78/206 (37%), Positives = 109/206 (52%), Gaps = 33/206 (16%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPG 356
VCLP Q G K G V GWG ++ GQ S L+ +P++ C+
Sbjct: 118 VCLPDRETAASLLQAGYK-----GRVTGWGNLK--GQ-PSVLQVVNLPIVERPVCKD--S 167
Query: 357 FEAKLTGNMMCAGYV--EGGK-DSCQ 379
++T NM CAGY EG + D+C+
Sbjct: 168 TRIRITDNMFCAGYKPDEGKRGDACE 193
>pdb|2PUX|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par3
pdb|2PV9|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par4
Length = 258
Score = 105 bits (262), Expect = 9e-23, Method: Compositional matrix adjust.
Identities = 72/200 (36%), Positives = 101/200 (50%), Gaps = 33/200 (16%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV GW E PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILYPPWDKNFTENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE +E ++ K+ HP+YN + ++ D DIALLKL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNVEKISMLEKIYVHPRYNWR--ENLDRDIALLKLKKPVPFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEESGQI------ASDLRATQVPVMSNQE 350
VCLP + G K G V GWG + E+ S L+ +P++
Sbjct: 118 VCLPDKQTVTSLLRAGYK-----GRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPV 172
Query: 351 CRQFPGFEAKLTGNMMCAGY 370
C+ ++T NM CAG+
Sbjct: 173 CKA--STRIRITDNMFCAGF 190
>pdb|2PGB|B Chain B, Inhibitor-Free Human Thrombin Mutant C191a-C220a
pdb|2PGQ|B Chain B, Human Thrombin Mutant C191a-C220a In Complex With The
Inhibitor Ppack
Length = 259
Score = 105 bits (262), Expect = 9e-23, Method: Compositional matrix adjust.
Identities = 75/201 (37%), Positives = 104/201 (51%), Gaps = 35/201 (17%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSNQ 349
VCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 118 VCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERP 171
Query: 350 ECRQFPGFEAKLTGNMMCAGY 370
C+ ++T NM CAGY
Sbjct: 172 VCKD--STRIRITDNMFCAGY 190
>pdb|1ZPZ|A Chain A, Factor Xi Catalytic Domain Complexed With N-((R)-1-(4-
Bromophenyl)ethyl)urea-Asn-Val-Arg-Alpha-Ketothiazole
pdb|1ZRK|A Chain A, Factor Xi Complexed With 3-Hydroxypropyl 3-(7-
Amidinonaphthalene-1-Carboxamido)benzenesulfonate
pdb|1ZSL|A Chain A, Factor Xi Complexed With A Pyrimidinone Inhibitor
Length = 238
Score = 105 bits (261), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 66/191 (34%), Positives = 109/191 (57%), Gaps = 11/191 (5%)
Query: 194 IVGGWTTEVNEYPWVVALEQAG---KFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVIS 250
IVGG + E+PW V L + CGG++I ++++LTAAHC + K L V
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 251 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQ 310
N++ + E V +++ H +Y A+S +DIALLKL+T + + + P+ LP
Sbjct: 61 ILNQSEIAE-DTSFFGVQEIIIHDQYKM--AES-GYDIALLKLETTVNYTDSQRPISLPS 116
Query: 311 LGEKFTQRTGT-VVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEAKLTGNMMCA 368
G++ T V GWG + +I + L+ ++P+++N+EC +++ G K+T M+CA
Sbjct: 117 KGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGH--KITHKMICA 174
Query: 369 GYVEGGKDSCQ 379
GY EGGKD+C+
Sbjct: 175 GYREGGKDACK 185
>pdb|3SOR|A Chain A, Factor Xia In Complex With A Clorophenyl-tetrazole
Inhibitor
pdb|3SOS|A Chain A, Benzothiazinone Inhibitor In Complex With Fxia
Length = 238
Score = 105 bits (261), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 66/191 (34%), Positives = 109/191 (57%), Gaps = 11/191 (5%)
Query: 194 IVGGWTTEVNEYPWVVALEQAG---KFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVIS 250
IVGG + E+PW V L + CGG++I ++++LTAAHC + K L V
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 251 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQ 310
N++ + E V +++ H +Y A+S +DIALLKL+T + + + P+ LP
Sbjct: 61 ILNQSEIKE-DTSFFGVQEIIIHDQYKM--AES-GYDIALLKLETTVNYTDSQRPISLPS 116
Query: 311 LGEKFTQRTGT-VVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEAKLTGNMMCA 368
G++ T V GWG + +I + L+ ++P+++N+EC +++ G K+T M+CA
Sbjct: 117 KGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGH--KITHKMICA 174
Query: 369 GYVEGGKDSCQ 379
GY EGGKD+C+
Sbjct: 175 GYREGGKDACK 185
>pdb|2TBS|A Chain A, Cold-Adaption Of Enzymes: Structural Comparison Between
Salmon And Bovine Trypsins
Length = 222
Score = 105 bits (261), Expect = 1e-22, Method: Composition-based stats.
Identities = 67/189 (35%), Positives = 96/189 (50%), Gaps = 19/189 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+ + V+L +G FCGG+L+++ +V++AAHC +S V + EHN
Sbjct: 1 IVGGYECKAYSQAHQVSL-NSGYHFCGGSLVNENWVVSAAHCYKSRVE-----VRLGEHN 54
Query: 254 RATV--YETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQL 311
E I + RV++ HP Y++ D+DI L+KL P V PV LP
Sbjct: 55 IKVTEGSEQFISSSRVIR---HPNYSSYNI---DNDIMLIKLSKPATLNTYVQPVALPTS 108
Query: 312 GEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECR-QFPGFEAKLTGNMMCAGY 370
TV GWG S + L+ +P++S +C +PG +T M CAGY
Sbjct: 109 CAP-AGTMCTVSGWGNTMSSTADSDKLQCLNIPILSYSDCNDSYPGM---ITNAMFCAGY 164
Query: 371 VEGGKDSCQ 379
+EGGKDSCQ
Sbjct: 165 LEGGKDSCQ 173
>pdb|3JZ1|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E:na+
Form
pdb|3JZ2|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E Form
pdb|3QGN|B Chain B, The Allosteric E-E Equilibrium Is A Key Property Of The
Trypsin Fold
Length = 259
Score = 105 bits (261), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 79/213 (37%), Positives = 111/213 (52%), Gaps = 38/213 (17%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSNQ 349
VCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 118 VCLPDRETAASLLQAGYK-----GRVTGWGPLKETWTANVGKGQ-PSVLQVVNLPIVERP 171
Query: 350 ECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 172 VCKD--STRIRITDNMFCAGYKPDEGKRGDACE 202
>pdb|1MBQ|A Chain A, Anionic Trypsin From Pacific Chum Salmon
Length = 220
Score = 104 bits (260), Expect = 1e-22, Method: Composition-based stats.
Identities = 67/189 (35%), Positives = 96/189 (50%), Gaps = 19/189 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+ + P V+L +G FCGG+L+++ +V++AAHC +S V + EHN
Sbjct: 1 IVGGYECKAYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHCYKSRVE-----VRLGEHN 54
Query: 254 RATV--YETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQL 311
E I + RV++ HP Y++ D+DI L+KL V PV LP
Sbjct: 55 IKVTEGSEQFISSSRVIR---HPNYSSYNI---DNDIMLIKLSKSATLNTYVQPVALPSS 108
Query: 312 GEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQ-FPGFEAKLTGNMMCAGY 370
TV GWG S + L+ +P++S +C +PG +T M CAGY
Sbjct: 109 CAP-AGTMCTVSGWGNTMSSTADKNKLQCLNIPILSYSDCNNSYPGM---ITNAMFCAGY 164
Query: 371 VEGGKDSCQ 379
+EGGKDSCQ
Sbjct: 165 LEGGKDSCQ 173
>pdb|2OLG|A Chain A, Crystal Structure Of The Serine Protease Domain Of
Prophenoloxidase Activating Factor-I In A Zymogen Form
Length = 278
Score = 103 bits (258), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 76/217 (35%), Positives = 112/217 (51%), Gaps = 29/217 (13%)
Query: 185 CGVPNRMDRIVGGWTTEVNEYPWVVALEQAG-----KFFCGGTLISDRYVLTAAHCVRSS 239
CG D+I+ G T E+PW + +F CGG+LI++RY++TAAHCV +
Sbjct: 14 CGYQVEADKILNGDDTVPEEFPWTAMIGYKNSSNFEQFACGGSLINNRYIVTAAHCV--A 71
Query: 240 KRQKDLI-----VVISEHNRATVYETQIETRRVV----------KVLTHPKYNAQGAKSH 284
R ++ V + E N AT + R V + + HP Y G+K
Sbjct: 72 GRVLRVVGALNKVRLGEWNTATDPDCYGAVRVCVPDKPIDLGIEETIQHPDY-VDGSKDR 130
Query: 285 DHDIALLKLDTPLEFKPTVSPVCLPQLGE--KFTQRTGTVVGWGRVEESGQIASDLRATQ 342
HDIAL++L+ +EF + PVCLPQ E + QR TVVGWGR E+GQ ++ +
Sbjct: 131 YHDIALIRLNRQVEFTNYIRPVCLPQPNEEVQVGQRL-TVVGWGRT-ETGQYSTIKQKLA 188
Query: 343 VPVMSNQEC-RQFPGFEAKLTGNMMCAGYVEGGKDSC 378
VPV+ ++C + F ++ + +CAG E KDSC
Sbjct: 189 VPVVHAEQCAKTFGAAGVRVRSSQLCAG-GEKAKDSC 224
>pdb|2GP9|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A Self-
Inhibited Conformation
pdb|3BEI|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A
Self_inhibited Conformation
pdb|3BEF|B Chain B, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3BEF|E Chain E, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3QDZ|B Chain B, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4.
pdb|3QDZ|D Chain D, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4
Length = 259
Score = 103 bits (258), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 78/213 (36%), Positives = 111/213 (52%), Gaps = 38/213 (17%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE IE ++ K+ HP+YN + ++ D +IAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRNIALMKLKKPVAFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSNQ 349
VCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 118 VCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERP 171
Query: 350 ECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
C+ ++T NM CAGY EG + D+C+
Sbjct: 172 VCKD--STRIRITDNMFCAGYKPDEGKRGDACE 202
>pdb|2OD3|B Chain B, Human Thrombin Chimera With Human Residues 184a, 186,
186a, 186b, 186c And 222 Replaced By Murine Thrombin
Equivalents
Length = 259
Score = 103 bits (258), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 74/201 (36%), Positives = 104/201 (51%), Gaps = 35/201 (17%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPVMSNQ 349
VCLP Q G K G V GWG ++E+ GQ S L+ +P++
Sbjct: 118 VCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERP 171
Query: 350 ECRQFPGFEAKLTGNMMCAGY 370
C+ ++T NM CAG+
Sbjct: 172 VCKD--STRIRITDNMFCAGF 190
>pdb|1VR1|H Chain H, Specifity For Plasminogen Activator Inhibitor-1
Length = 261
Score = 103 bits (257), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 79/217 (36%), Positives = 110/217 (50%), Gaps = 42/217 (19%)
Query: 194 IVGGWTTEVNEYPWVVAL------EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK---- 243
IV G E+ PW V L +F CG +LISDR+VLTAAHC+ K
Sbjct: 1 IVEGSDAEIGMSPWQVMLFAKHRRSPGERFLCGASLISDRWVLTAAHCLLYPPWDKNFTE 60
Query: 244 -DLIVVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKP 301
DL+V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F
Sbjct: 61 NDLLVRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSD 117
Query: 302 TVSPVCLP---------QLGEKFTQRTGTVVGWGRVEES-------GQIASDLRATQVPV 345
+ PVCLP Q G K G V GWG ++E+ GQ S L+ +P+
Sbjct: 118 YIHPVCLPDRETAASLLQAGYK-----GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPI 171
Query: 346 MSNQECRQFPGFEAKLTGNMMCAGYV--EGGK-DSCQ 379
+ C+ ++T NM CA Y EG + D+C+
Sbjct: 172 VERPVCKD--STRIRITDNMFCAYYKPDEGKRGDACE 206
>pdb|2F91|A Chain A, 1.2a Resolution Structure Of A Crayfish Trypsin Complexed
With A Peptide Inhibitor, Sgti
Length = 237
Score = 103 bits (256), Expect = 5e-22, Method: Composition-based stats.
Identities = 63/192 (32%), Positives = 100/192 (52%), Gaps = 12/192 (6%)
Query: 194 IVGGWTTEVNEYPWVVALEQA----GKFFCGGTLISDRYVLTAAHCVRSSKRQK--DLIV 247
IVGG + E+P+ ++ ++ FCG ++ ++ Y +TA HCV + L +
Sbjct: 1 IVGGTDATLGEFPYQLSFQETFIGFSFHFCGASIYNENYAITAGHCVYGDDYENPSGLQI 60
Query: 248 VISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVC 307
V E + +V E + V K++ H ++ D+DI+LLKL L F V+P+
Sbjct: 61 VAGELD-MSVNEGSEQIITVSKIILHENFDYNLL---DNDISLLKLSGSLTFNDNVAPIA 116
Query: 308 LPQLGEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMC 367
LP+ G T V GWG E G L+ VP++S+++CR G + ++ +M+C
Sbjct: 117 LPEQGHTATGDV-IVTGWGTTSEGGNTPDVLQKVTVPLVSDEDCRADYGAD-EILDSMIC 174
Query: 368 AGYVEGGKDSCQ 379
AG EGGKDSCQ
Sbjct: 175 AGVPEGGKDSCQ 186
>pdb|3UQV|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 103 bits (256), Expect = 5e-22, Method: Composition-based stats.
Identities = 68/190 (35%), Positives = 103/190 (54%), Gaps = 20/190 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E N
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGEDN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K + HP YN++ ++++DI L+KL + V+ + LP
Sbjct: 55 -INVVEGNEQFISASKSIVHPSYNSE---TYNNDIMLIKLKSAASLNSRVASISLP---- 106
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLTGNMMCAG 369
GT + GWG + SG D L+ + P++S+ C+ F +T NM CAG
Sbjct: 107 TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAG 164
Query: 370 YVEGGKDSCQ 379
Y+EGGKDSCQ
Sbjct: 165 YLEGGKDSCQ 174
>pdb|1R7R|A Chain A, The Crystal Structure Of Murine P97VCP AT 3.6A
Length = 816
Score = 102 bits (255), Expect = 6e-22, Method: Compositional matrix adjust.
Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 45/223 (20%)
Query: 491 REVVETPLLHLDGFDPRGNIKVLMATNRPDTLDPALMRPGRLDRKVEFGLPDLEGRTHIF 550
R +V L +DG R ++ V+ ATNRP+++DPAL R GR DR+V+ G+PD GR I
Sbjct: 322 RRIVSQLLTLMDGLKQRAHVIVMAATNRPNSIDPALRRFGRFDREVDIGIPDATGRLEIL 381
Query: 551 KIHARSMSVERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIRARRKVASEKDFLEAVNK 610
+IH ++M + D+ E +A GA++ ++C+EA + AIR +
Sbjct: 382 QIHTKNMKLADDVDLEQVANETHGHVGADLAALCSEAALQAIRKKMD------------- 428
Query: 611 VARCTKIINADSENPKYIINVKQFAKFVVDLADSVAPTDIEEGMRVGVDRNKYQIHIPLP 670
++DL D ++ + V +D ++ + P
Sbjct: 429 ---------------------------LIDLEDETIDAEVMNSLAVTMDDFRWALSQSNP 461
Query: 671 PKIDPTVTMMQVEEKPDVTYSDIGGCKEQIEKLREVVETPLLH 713
+ TV E P VT+ DIGG ++ +L+E+V+ P+ H
Sbjct: 462 SALRETVV-----EVPQVTWEDIGGLEDVKRELQELVQYPVEH 499
Score = 80.5 bits (197), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 37/99 (37%), Positives = 58/99 (58%)
Query: 493 VVETPLLHLDGFDPRGNIKVLMATNRPDTLDPALMRPGRLDRKVEFGLPDLEGRTHIFKI 552
V+ L +DG + N+ ++ ATNRPD +DPA++RPGRLD+ + LPD + R I K
Sbjct: 600 VINQILTEMDGMSTKKNVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEKSRVAILKA 659
Query: 553 HARSMSVERDIRFELLARLCPNSTGAEIRSVCTEAGMFA 591
+ R V +D+ E LA++ +GA++ +C A A
Sbjct: 660 NLRKSPVAKDVDLEFLAKMTNGFSGADLTEICQRACKLA 698
Score = 73.2 bits (178), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 34/65 (52%), Positives = 46/65 (70%), Gaps = 1/65 (1%)
Query: 110 RTMLEL-INQPEKFVNLGIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQ 168
+ M+EL + P F +G++PP+G+LL+GPPGTGKTL ARAVAN T A F + G E++
Sbjct: 217 KEMVELPLRHPALFKAIGVKPPRGILLYGPPGTGKTLIARAVANETGAFFFLINGPEIMS 276
Query: 169 KYVGE 173
K GE
Sbjct: 277 KLAGE 281
Score = 70.9 bits (172), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 33/71 (46%), Positives = 46/71 (64%), Gaps = 4/71 (5%)
Query: 107 EVQRTMLELIN----QPEKFVNLGIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVI 162
+V+R + EL+ P+KF+ G+ P KGVL +GPPG GKTL A+A+AN A FI +
Sbjct: 484 DVKRELQELVQYPVEHPDKFLKFGMTPSKGVLFYGPPGCGKTLLAKAIANECQANFISIK 543
Query: 163 GSELVQKYVGE 173
G EL+ + GE
Sbjct: 544 GPELLTMWFGE 554
Score = 37.7 bits (86), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 13/27 (48%), Positives = 22/27 (81%)
Query: 474 DVTYSDIGGCKEQIEKLREVVETPLLH 500
+V Y D+GGC++Q+ +++E+VE PL H
Sbjct: 200 EVGYDDVGGCRKQLAQIKEMVELPLRH 226
Score = 37.7 bits (86), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 13/27 (48%), Positives = 22/27 (81%)
Query: 687 DVTYSDIGGCKEQIEKLREVVETPLLH 713
+V Y D+GGC++Q+ +++E+VE PL H
Sbjct: 200 EVGYDDVGGCRKQLAQIKEMVELPLRH 226
Score = 35.4 bits (80), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 17/44 (38%), Positives = 27/44 (61%)
Query: 461 DPTVTMMQVEEKPDVTYSDIGGCKEQIEKLREVVETPLLHLDGF 504
+P+ V E P VT+ DIGG ++ +L+E+V+ P+ H D F
Sbjct: 460 NPSALRETVVEVPQVTWEDIGGLEDVKRELQELVQYPVEHPDKF 503
>pdb|3CF1|A Chain A, Structure Of P97VCP IN COMPLEX WITH ADPADP.ALFX
pdb|3CF1|B Chain B, Structure Of P97VCP IN COMPLEX WITH ADPADP.ALFX
pdb|3CF1|C Chain C, Structure Of P97VCP IN COMPLEX WITH ADPADP.ALFX
pdb|3CF2|A Chain A, Structure Of P97VCP IN COMPLEX WITH ADPAMP-Pnp
pdb|3CF2|B Chain B, Structure Of P97VCP IN COMPLEX WITH ADPAMP-Pnp
pdb|3CF2|C Chain C, Structure Of P97VCP IN COMPLEX WITH ADPAMP-Pnp
pdb|3CF2|D Chain D, Structure Of P97VCP IN COMPLEX WITH ADPAMP-Pnp
pdb|3CF3|A Chain A, Structure Of P97VCP IN COMPLEX WITH ADP
pdb|3CF3|B Chain B, Structure Of P97VCP IN COMPLEX WITH ADP
pdb|3CF3|C Chain C, Structure Of P97VCP IN COMPLEX WITH ADP
Length = 806
Score = 102 bits (255), Expect = 6e-22, Method: Compositional matrix adjust.
Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 45/223 (20%)
Query: 491 REVVETPLLHLDGFDPRGNIKVLMATNRPDTLDPALMRPGRLDRKVEFGLPDLEGRTHIF 550
R +V L +DG R ++ V+ ATNRP+++DPAL R GR DR+V+ G+PD GR I
Sbjct: 322 RRIVSQLLTLMDGLKQRAHVIVMAATNRPNSIDPALRRFGRFDREVDIGIPDATGRLEIL 381
Query: 551 KIHARSMSVERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIRARRKVASEKDFLEAVNK 610
+IH ++M + D+ E +A GA++ ++C+EA + AIR +
Sbjct: 382 QIHTKNMKLADDVDLEQVANETHGHVGADLAALCSEAALQAIRKKMD------------- 428
Query: 611 VARCTKIINADSENPKYIINVKQFAKFVVDLADSVAPTDIEEGMRVGVDRNKYQIHIPLP 670
++DL D ++ + V +D ++ + P
Sbjct: 429 ---------------------------LIDLEDETIDAEVMNSLAVTMDDFRWALSQSNP 461
Query: 671 PKIDPTVTMMQVEEKPDVTYSDIGGCKEQIEKLREVVETPLLH 713
+ TV E P VT+ DIGG ++ +L+E+V+ P+ H
Sbjct: 462 SALRETVV-----EVPQVTWEDIGGLEDVKRELQELVQYPVEH 499
Score = 80.5 bits (197), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 37/99 (37%), Positives = 58/99 (58%)
Query: 493 VVETPLLHLDGFDPRGNIKVLMATNRPDTLDPALMRPGRLDRKVEFGLPDLEGRTHIFKI 552
V+ L +DG + N+ ++ ATNRPD +DPA++RPGRLD+ + LPD + R I K
Sbjct: 600 VINQILTEMDGMSTKKNVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEKSRVAILKA 659
Query: 553 HARSMSVERDIRFELLARLCPNSTGAEIRSVCTEAGMFA 591
+ R V +D+ E LA++ +GA++ +C A A
Sbjct: 660 NLRKSPVAKDVDLEFLAKMTNGFSGADLTEICQRACKLA 698
Score = 73.2 bits (178), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 34/65 (52%), Positives = 46/65 (70%), Gaps = 1/65 (1%)
Query: 110 RTMLEL-INQPEKFVNLGIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQ 168
+ M+EL + P F +G++PP+G+LL+GPPGTGKTL ARAVAN T A F + G E++
Sbjct: 217 KEMVELPLRHPALFKAIGVKPPRGILLYGPPGTGKTLIARAVANETGAFFFLINGPEIMS 276
Query: 169 KYVGE 173
K GE
Sbjct: 277 KLAGE 281
Score = 70.9 bits (172), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 33/71 (46%), Positives = 46/71 (64%), Gaps = 4/71 (5%)
Query: 107 EVQRTMLELIN----QPEKFVNLGIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVI 162
+V+R + EL+ P+KF+ G+ P KGVL +GPPG GKTL A+A+AN A FI +
Sbjct: 484 DVKRELQELVQYPVEHPDKFLKFGMTPSKGVLFYGPPGCGKTLLAKAIANECQANFISIK 543
Query: 163 GSELVQKYVGE 173
G EL+ + GE
Sbjct: 544 GPELLTMWFGE 554
Score = 38.1 bits (87), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 14/27 (51%), Positives = 22/27 (81%)
Query: 474 DVTYSDIGGCKEQIEKLREVVETPLLH 500
+V Y DIGGC++Q+ +++E+VE PL H
Sbjct: 200 EVGYDDIGGCRKQLAQIKEMVELPLRH 226
Score = 38.1 bits (87), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 14/27 (51%), Positives = 22/27 (81%)
Query: 687 DVTYSDIGGCKEQIEKLREVVETPLLH 713
+V Y DIGGC++Q+ +++E+VE PL H
Sbjct: 200 EVGYDDIGGCRKQLAQIKEMVELPLRH 226
Score = 35.4 bits (80), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 17/44 (38%), Positives = 27/44 (61%)
Query: 461 DPTVTMMQVEEKPDVTYSDIGGCKEQIEKLREVVETPLLHLDGF 504
+P+ V E P VT+ DIGG ++ +L+E+V+ P+ H D F
Sbjct: 460 NPSALRETVVEVPQVTWEDIGGLEDVKRELQELVQYPVEHPDKF 503
>pdb|1DLK|B Chain B, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
pdb|1DLK|D Chain D, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
Length = 230
Score = 102 bits (254), Expect = 7e-22, Method: Composition-based stats.
Identities = 66/188 (35%), Positives = 101/188 (53%), Gaps = 15/188 (7%)
Query: 194 IVGGWTTEVNEYPWVVALE-QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEH 252
IV G +PW V+L+ + G FCGG+LI++ +V+TAAHC ++ +VV E
Sbjct: 1 IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEF 56
Query: 253 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLG 312
++ + E +I+ ++ KV + KYN+ + ++DI LLKL T F TVS VCLP
Sbjct: 57 DQGSSSE-KIQKLKIAKVFKNSKYNSL---TINNDITLLKLSTAASFSQTVSAVCLPSAS 112
Query: 313 EKFTQRTGTV-VGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLTGNMMCAGY 370
+ F T V GWG + D L+ +P++SN C+++ G K+ M+CAG
Sbjct: 113 DDFAAGTTCVTTGWGLTRYTNANTPDRLQQASLPLLSNTNCKKYWG--TKIKDAMICAG- 169
Query: 371 VEGGKDSC 378
G SC
Sbjct: 170 -ASGVSSC 176
>pdb|1SGF|G Chain G, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|Z Chain Z, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 237
Score = 102 bits (253), Expect = 1e-21, Method: Composition-based stats.
Identities = 62/195 (31%), Positives = 94/195 (48%), Gaps = 18/195 (9%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+ E N PW VA+ + ++ CGG L+ +VLTAAHC + + V N
Sbjct: 1 IVGGFKCEKNSQPWHVAVYRYTQYLCGGVLLDPNWVLTAAHCYDDNYK------VWLGKN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSH--------DHDIALLKLDTPLEFKPTVSP 305
E + R V K + HP +N + H +D+ LL+L P + TV P
Sbjct: 55 NLFKDEPSAQHRFVSKAIPHPGFNMSLMRKHIRFLEYDYSNDLMLLRLSKPADITDTVKP 114
Query: 306 VCLPQLGEKFTQRTGTVVGWGRVEESG-QIASDLRATQVPVMSNQECRQFPGFEAKLTGN 364
+ LP K T GWG + + Q DL + ++ N++C + K+T
Sbjct: 115 ITLPTEEPKLGS-TCLASGWGSITPTKFQFTDDLYCVNLKLLPNEDCAK--AHIEKVTDA 171
Query: 365 MMCAGYVEGGKDSCQ 379
M+CAG ++GGKD+C+
Sbjct: 172 MLCAGEMDGGKDTCK 186
>pdb|1L2E|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor
pdb|1LO6|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor At 1.56 A Resolution
Length = 223
Score = 102 bits (253), Expect = 1e-21, Method: Composition-based stats.
Identities = 63/187 (33%), Positives = 99/187 (52%), Gaps = 15/187 (8%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
+V G + +P+ AL +G CGG LI +VLTAAHC ++ +L V + +HN
Sbjct: 1 LVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHC-----KKPNLQVFLGKHN 55
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
+Q E VV+ + HP Y+ A SHD DI LL+L P + + P+ L +
Sbjct: 56 LRQRESSQ-EQSSVVRAVIHPDYD---AASHDQDIMLLRLARPAKLSELIQPLPLERDCS 111
Query: 314 KFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQ-FPGFEAKLTGNMMCAGYVE 372
T + ++GWG+ + G ++ + ++S +EC +PG ++T NM+CAG +
Sbjct: 112 ANTT-SCHILGWGKTAD-GDFPDTIQCAYIHLVSREECEHAYPG---QITQNMLCAGDEK 166
Query: 373 GGKDSCQ 379
GKDSCQ
Sbjct: 167 YGKDSCQ 173
>pdb|3UNS|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UOP|A Chain A, Bovine Trypsin Variant X(triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UQO|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 101 bits (252), Expect = 1e-21, Method: Composition-based stats.
Identities = 67/190 (35%), Positives = 103/190 (54%), Gaps = 20/190 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E N
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGEDN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K + HP YN++ ++++DI L+KL + V+ + LP
Sbjct: 55 -INVVEGNEQFISASKSIVHPSYNSE---TYNNDIMLIKLKSAASLNSRVASISLP---- 106
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLTGNMMCAG 369
GT + GWG + SG D L+ + P++S+ C+ F +T NM CAG
Sbjct: 107 TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAG 164
Query: 370 YVEGGKDSCQ 379
Y+EGGKD+CQ
Sbjct: 165 YLEGGKDACQ 174
>pdb|3UNQ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UPE|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|B Chain B, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 101 bits (252), Expect = 1e-21, Method: Composition-based stats.
Identities = 67/190 (35%), Positives = 103/190 (54%), Gaps = 20/190 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E N
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGEDN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K + HP YN++ ++++DI L+KL + V+ + LP
Sbjct: 55 -INVVEGNEQFISASKSIVHPSYNSE---TYNNDIMLIKLKSAASLNSRVASISLP---- 106
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLTGNMMCAG 369
GT + GWG + SG D L+ + P++S+ C+ F +T NM CAG
Sbjct: 107 TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAG 164
Query: 370 YVEGGKDSCQ 379
Y+EGGKD+CQ
Sbjct: 165 YLEGGKDACQ 174
>pdb|1V2N|T Chain T, Potent Factor Xa Inhibitor In Complex With Bovine Trypsin
Variant X(99175190)BT
Length = 223
Score = 101 bits (252), Expect = 1e-21, Method: Composition-based stats.
Identities = 67/190 (35%), Positives = 103/190 (54%), Gaps = 20/190 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E N
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGEDN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K + HP YN++ ++++DI L+KL + V+ + LP
Sbjct: 55 -INVVEGNEQFISASKSIVHPSYNSE---TYNNDIMLIKLKSAASLNSRVASISLP---- 106
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLTGNMMCAG 369
GT + GWG + SG D L+ + P++S+ C+ F +T NM CAG
Sbjct: 107 TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAG 164
Query: 370 YVEGGKDSCQ 379
Y+EGGKD+CQ
Sbjct: 165 YLEGGKDACQ 174
>pdb|1V2K|T Chain T, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin Variant X(Triple.Glu)bt.D2
pdb|1V2L|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.D1
pdb|1V2M|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.A1
Length = 223
Score = 101 bits (252), Expect = 1e-21, Method: Composition-based stats.
Identities = 67/190 (35%), Positives = 103/190 (54%), Gaps = 20/190 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E N
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGEDN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K + HP YN++ ++++DI L+KL + V+ + LP
Sbjct: 55 -INVVEGNEQFISASKSIVHPSYNSE---TYNNDIMLIKLKSAASLNSRVASISLP---- 106
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLTGNMMCAG 369
GT + GWG + SG D L+ + P++S+ C+ F +T NM CAG
Sbjct: 107 TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAG 164
Query: 370 YVEGGKDSCQ 379
Y+EGGKD+CQ
Sbjct: 165 YLEGGKDACQ 174
>pdb|3PWB|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PWC|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PYH|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3Q00|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Comlex
With Small Molecule Inhibitor
Length = 223
Score = 101 bits (252), Expect = 1e-21, Method: Composition-based stats.
Identities = 67/190 (35%), Positives = 103/190 (54%), Gaps = 20/190 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E N
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGEDN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K + HP YN++ ++++DI L+KL + V+ + LP
Sbjct: 55 -INVVEGNEQFISASKSIVHPSYNSE---TYNNDIMLIKLKSAASLNSRVASISLP---- 106
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLTGNMMCAG 369
GT + GWG + SG D L+ + P++S+ C+ F +T NM CAG
Sbjct: 107 TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAG 164
Query: 370 YVEGGKDSCQ 379
Y+EGGKD+CQ
Sbjct: 165 YLEGGKDACQ 174
>pdb|4B2A|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
pdb|4B2A|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
Length = 223
Score = 101 bits (252), Expect = 1e-21, Method: Composition-based stats.
Identities = 67/190 (35%), Positives = 103/190 (54%), Gaps = 20/190 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E N
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGEDN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K + HP YN++ ++++DI L+KL + V+ + LP
Sbjct: 55 -INVVEGNEQFISASKSIVHPSYNSE---TYNNDIMLIKLKSAASLNSRVASISLP---- 106
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLTGNMMCAG 369
GT + GWG + SG D L+ + P++S+ C+ F +T NM CAG
Sbjct: 107 TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAG 164
Query: 370 YVEGGKDSCQ 379
Y+EGGKD+CQ
Sbjct: 165 YLEGGKDACQ 174
>pdb|3PMJ|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLB|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLP|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PM3|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 101 bits (252), Expect = 1e-21, Method: Composition-based stats.
Identities = 67/190 (35%), Positives = 103/190 (54%), Gaps = 20/190 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E N
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGEDN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K + HP YN++ ++++DI L+KL + V+ + LP
Sbjct: 55 -INVVEGNEQFISASKSIVHPSYNSE---TYNNDIMLIKLKSAASLNSRVASISLP---- 106
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLTGNMMCAG 369
GT + GWG + SG D L+ + P++S+ C+ F +T NM CAG
Sbjct: 107 TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAG 164
Query: 370 YVEGGKDSCQ 379
Y+EGGKD+CQ
Sbjct: 165 YLEGGKDACQ 174
>pdb|4B2B|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
pdb|4B2B|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
Length = 223
Score = 101 bits (252), Expect = 1e-21, Method: Composition-based stats.
Identities = 67/190 (35%), Positives = 103/190 (54%), Gaps = 20/190 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E N
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGEDN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K + HP YN++ ++++DI L+KL + V+ + LP
Sbjct: 55 -INVVEGNEQFISASKSIVHPSYNSE---TYNNDIMLIKLKSAASLNSRVASISLP---- 106
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLTGNMMCAG 369
GT + GWG + SG D L+ + P++S+ C+ F +T NM CAG
Sbjct: 107 TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAG 164
Query: 370 YVEGGKDSCQ 379
Y+EGGKD+CQ
Sbjct: 165 YLEGGKDACQ 174
>pdb|4B2C|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
pdb|4B2C|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
Length = 223
Score = 101 bits (252), Expect = 1e-21, Method: Composition-based stats.
Identities = 67/190 (35%), Positives = 103/190 (54%), Gaps = 20/190 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E N
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGEDN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K + HP YN++ ++++DI L+KL + V+ + LP
Sbjct: 55 -INVVEGNEQFISASKSIVHPSYNSE---TYNNDIMLIKLKSAASLNSRVASISLP---- 106
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLTGNMMCAG 369
GT + GWG + SG D L+ + P++S+ C+ F +T NM CAG
Sbjct: 107 TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAG 164
Query: 370 YVEGGKDSCQ 379
Y+EGGKD+CQ
Sbjct: 165 YLEGGKDACQ 174
>pdb|4B1T|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
pdb|4B1T|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
Length = 223
Score = 101 bits (252), Expect = 1e-21, Method: Composition-based stats.
Identities = 67/190 (35%), Positives = 103/190 (54%), Gaps = 20/190 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E N
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGEDN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K + HP YN++ ++++DI L+KL + V+ + LP
Sbjct: 55 -INVVEGNEQFISASKSIVHPSYNSE---TYNNDIMLIKLKSAASLNSRVASISLP---- 106
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLTGNMMCAG 369
GT + GWG + SG D L+ + P++S+ C+ F +T NM CAG
Sbjct: 107 TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAG 164
Query: 370 YVEGGKDSCQ 379
Y+EGGKD+CQ
Sbjct: 165 YLEGGKDACQ 174
>pdb|2OQ5|A Chain A, Crystal Structure Of Desc1, A New Member Of The Type Ii
Transmembrane Serine Proteinases Family
Length = 232
Score = 101 bits (251), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 71/244 (29%), Positives = 114/244 (46%), Gaps = 20/244 (8%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG E E+PW +L+ G CG TLI+ ++++AAHC + K
Sbjct: 1 IVGGTEVEEGEWPWQASLQWDGSHRCGATLINATWLVSAAHCFTTYKNPARWTASFG--- 57
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
T+ ++++ R + +++ H KY SHD+DI+L +L +P+ + V VCLP
Sbjct: 58 -VTIKPSKMK-RGLRRIIVHEKYK---HPSHDYDISLAELSSPVPYTNAVHRVCLPDASY 112
Query: 314 KFT-QRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCAGYVE 372
+F V G+G ++ G + LR QV ++ C + + +T M+CAG +E
Sbjct: 113 EFQPGDVMFVTGFGALKNDGYSQNHLRQAQVTLIDATTCNEPQAYNDAITPRMLCAGSLE 172
Query: 373 GGKDSCQ-------VTLDEADIALLKSYGQGQYTKSIKAVEDDIQAVIKRVNELTGIKES 425
G D+CQ V+ D DI L G + + + + V RV L S
Sbjct: 173 GKTDACQGDSGGPLVSSDARDIWYLA----GIVSWGDECAKPNKPGVYTRVTALRDWITS 228
Query: 426 DTGL 429
TG+
Sbjct: 229 KTGI 232
>pdb|3PLK|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 100 bits (250), Expect = 2e-21, Method: Composition-based stats.
Identities = 66/190 (34%), Positives = 103/190 (54%), Gaps = 20/190 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+L++ ++V++AAHC +S + V + E N
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLLNSQWVVSAAHCYKSG-----IQVRLGEDN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K + HP YN++ ++++DI L+KL + V+ + LP
Sbjct: 55 -INVVEGNEQFISASKSIVHPSYNSE---TYNNDIMLIKLKSAASLNSRVASISLP---- 106
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLTGNMMCAG 369
GT + GWG + SG D L+ + P++S+ C+ F +T NM CAG
Sbjct: 107 TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAG 164
Query: 370 YVEGGKDSCQ 379
Y+EGGKD+CQ
Sbjct: 165 YLEGGKDACQ 174
>pdb|1YBW|A Chain A, Protease Domain Of Hgfa With No Inhibitor
pdb|1YBW|B Chain B, Protease Domain Of Hgfa With No Inhibitor
pdb|1YC0|A Chain A, Short Form Hgfa With First Kunitz Domain From Hai-1
pdb|2R0K|A Chain A, Protease Domain Of Hgfa With Inhibitor Fab58
Length = 283
Score = 100 bits (249), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 58/195 (29%), Positives = 98/195 (50%), Gaps = 14/195 (7%)
Query: 193 RIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEH 252
RI+GG ++ +PW+ A+ G FC G+L+ +V++AAHC S + + VV+ +H
Sbjct: 35 RIIGGSSSLPGSHPWLAAI-YIGDSFCAGSLVHTCWVVSAAHCFSHSPPRDSVSVVLGQH 93
Query: 253 --NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKL----DTPLEFKPTVSPV 306
NR T + + + +N DHD+ L++L D V P+
Sbjct: 94 FFNRTTDVTQTFGIEKYIPYTLYSVFNPS-----DHDLVLIRLKKKGDRCATRSQFVQPI 148
Query: 307 CLPQLGEKF-TQRTGTVVGWGRVEES-GQIASDLRATQVPVMSNQECRQFPGFEAKLTGN 364
CLP+ G F + GWG ++E+ +S LR VP++++ +C + A ++ N
Sbjct: 149 CLPEPGSTFPAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCSSPEVYGADISPN 208
Query: 365 MMCAGYVEGGKDSCQ 379
M+CAGY + D+CQ
Sbjct: 209 MLCAGYFDCKSDACQ 223
>pdb|1V2S|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Ssfi.Glu)bt.D1
pdb|1V2T|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(ssfi.glu)bt.b4
Length = 223
Score = 100 bits (249), Expect = 3e-21, Method: Composition-based stats.
Identities = 68/190 (35%), Positives = 101/190 (53%), Gaps = 20/190 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E N
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGEDN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K + HP YN+ + ++DI L+KL + V+ + LP
Sbjct: 55 -INVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVASISLP---- 106
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLTGNMMCAG 369
GT + GWG + SG D L+ + P++S+ C+ F +T NM CAG
Sbjct: 107 TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAG 164
Query: 370 YVEGGKDSCQ 379
Y+EGGKDSCQ
Sbjct: 165 YLEGGKDSCQ 174
>pdb|1ELV|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Complement C1s Protease
Length = 333
Score = 100 bits (248), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 72/223 (32%), Positives = 111/223 (49%), Gaps = 46/223 (20%)
Query: 185 CGVP----NRMDRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSK 240
CGVP RI+GG ++ +PW V + + GG LI++ +VLTAAH V ++
Sbjct: 70 CGVPREPFEEKQRIIGGSDADIKNFPWQVFFDNP---WAGGALINEYWVLTAAHVVEGNR 126
Query: 241 RQKDLIVVISEHNRATVY--ETQIETRRVVK--------VLTHPKYN----AQGAKSHDH 286
T+Y T ++T R+ K V HP + +G + D+
Sbjct: 127 E-------------PTMYVGSTSVQTSRLAKSKMLTPEHVFIHPGWKLLAVPEGRTNFDN 173
Query: 287 DIALLKLDTPLEFKPTVSPVCLPQLGEKFT---QRTGTVVGWGRVEESGQIASDLRATQV 343
DIAL++L P++ PTVSP+CLP + G + GWGR E+ + A L+A ++
Sbjct: 174 DIALVRLKDPVKMGPTVSPICLPGTSSDYNLMDGDLGLISGWGRTEKRDR-AVRLKAARL 232
Query: 344 PVMSNQECRQF----PGFEAK---LTGNMMCAGYVEGGKDSCQ 379
PV ++C++ P +A+ T NM+CAG E G DSC+
Sbjct: 233 PVAPLRKCKEVKVEKPTADAEAYVFTPNMICAG-GEKGMDSCK 274
>pdb|3UWI|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|B Chain B, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|C Chain C, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|D Chain D, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|E Chain E, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|F Chain F, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|G Chain G, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|H Chain H, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|I Chain I, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|J Chain J, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|K Chain K, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|L Chain L, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|M Chain M, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|N Chain N, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|O Chain O, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|P Chain P, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V12|A Chain A, Bovine Trypsin Variant X(tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V13|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 100 bits (248), Expect = 4e-21, Method: Composition-based stats.
Identities = 66/190 (34%), Positives = 102/190 (53%), Gaps = 20/190 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E N
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGEDN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K + HP YN++ ++++DI L+KL + V+ + LP
Sbjct: 55 -INVVEGNEQFISASKSIVHPSYNSE---TYNNDIMLIKLKSAASLNSRVASISLP---- 106
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLTGNMMCAG 369
GT + GWG + SG D L+ + P++S+ C+ F +T NM C G
Sbjct: 107 TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF--IITSNMFCVG 164
Query: 370 YVEGGKDSCQ 379
Y+EGGKD+CQ
Sbjct: 165 YLEGGKDACQ 174
>pdb|3V0X|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 99.8 bits (247), Expect = 5e-21, Method: Composition-based stats.
Identities = 66/190 (34%), Positives = 102/190 (53%), Gaps = 20/190 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E N
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGEDN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K + HP YN++ ++++DI L+KL + V+ + LP
Sbjct: 55 -INVVEGNEQFISASKSIVHPSYNSE---TYNNDIMLIKLKSAASLXSRVASISLP---- 106
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLTGNMMCAG 369
GT + GWG + SG D L+ + P++S+ C+ F +T NM C G
Sbjct: 107 TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF--IITSNMFCVG 164
Query: 370 YVEGGKDSCQ 379
Y+EGGKD+CQ
Sbjct: 165 YLEGGKDACQ 174
>pdb|1V2U|T Chain T, Benzamidine In Complex With Bovine Trypsin Varinat X(Ssai)
Bt.D1
pdb|1V2V|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssai)
Bt.C1
pdb|1V2W|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssai)bt.B4
Length = 223
Score = 99.8 bits (247), Expect = 5e-21, Method: Composition-based stats.
Identities = 68/190 (35%), Positives = 101/190 (53%), Gaps = 20/190 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E N
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGEDN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K + HP YN+ + ++DI L+KL + V+ + LP
Sbjct: 55 -INVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVASISLP---- 106
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLTGNMMCAG 369
GT + GWG + SG D L+ + P++S+ C+ A +T NM CAG
Sbjct: 107 TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKS--ASSAIITSNMFCAG 164
Query: 370 YVEGGKDSCQ 379
Y+EGGKDSCQ
Sbjct: 165 YLEGGKDSCQ 174
>pdb|1V2O|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.B4
pdb|1V2P|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.A4
Length = 223
Score = 99.0 bits (245), Expect = 8e-21, Method: Composition-based stats.
Identities = 67/190 (35%), Positives = 101/190 (53%), Gaps = 20/190 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E N
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGEDN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K + HP YN+ + ++DI L+KL + V+ + LP
Sbjct: 55 -INVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVASISLP---- 106
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLTGNMMCAG 369
GT + GWG + SG D L+ + P++S+ C+ + +T NM CAG
Sbjct: 107 TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSY--IITSNMFCAG 164
Query: 370 YVEGGKDSCQ 379
Y+EGGKDSCQ
Sbjct: 165 YLEGGKDSCQ 174
>pdb|1HJ9|A Chain A, Atomic Resolution Structures Of Trypsin Provide Insight
Into Structural Radiation Damage
Length = 223
Score = 99.0 bits (245), Expect = 8e-21, Method: Composition-based stats.
Identities = 65/189 (34%), Positives = 100/189 (52%), Gaps = 18/189 (9%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E N
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGEDN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLP-QLG 312
V E + K + HP YN+ + ++DI L+KL + V+ + LP
Sbjct: 55 -INVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVASISLPTSCA 110
Query: 313 EKFTQRTGTVVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEAKLTGNMMCAGY 370
TQ + GWG + SG D L+ + P++S+ C+ +PG ++T NM CA
Sbjct: 111 SAGTQ--CLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMFCAYG 165
Query: 371 VEGGKDSCQ 379
+EG DSCQ
Sbjct: 166 LEGKGDSCQ 174
>pdb|1GVL|A Chain A, Human Prokallikrein 6 (Hk6) PROZYME PROPROTEASE M
Proneurosin
Length = 223
Score = 99.0 bits (245), Expect = 8e-21, Method: Composition-based stats.
Identities = 65/189 (34%), Positives = 100/189 (52%), Gaps = 17/189 (8%)
Query: 193 RIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEH 252
++V G + +P+ AL +G CGG LI +VLTAAHC ++ +L V + +H
Sbjct: 1 KLVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHC-----KKPNLQVFLGKH 55
Query: 253 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLG 312
N E+ E VV+ + HP Y+ A SHD DI LL+L P + + P LP
Sbjct: 56 N-LRQQESSQEQSSVVRAVIHPDYD---AASHDQDIMLLRLARPAKLSELIQP--LPLER 109
Query: 313 EKFTQRTGT-VVGWGRVEESGQIASDLRATQVPVMSNQECRQ-FPGFEAKLTGNMMCAGY 370
+ Q T ++GWG+ + G ++ + ++S +EC +PG ++T NM+CAG
Sbjct: 110 DCSAQTTSCHILGWGKTAD-GDFPDTIQCAYIHLVSREECEHAYPG---QITQNMLCAGD 165
Query: 371 VEGGKDSCQ 379
+ GKDSCQ
Sbjct: 166 EKYGKDSCQ 174
>pdb|4D8N|A Chain A, Human Kallikrein 6 Inhibitors With A
Para-Amidobenzylanmine P1 Group Carry A High Binding
Efficiency
pdb|3VFE|A Chain A, Virtual Screening And X-Ray Crystallography For Human
Kallikrein 6 Inhibitors With An Amidinothiophene P1
Group
Length = 223
Score = 99.0 bits (245), Expect = 9e-21, Method: Composition-based stats.
Identities = 65/188 (34%), Positives = 99/188 (52%), Gaps = 17/188 (9%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
+V G + +P+ AL +G CGG LI +VLTAAHC ++ +L V + +HN
Sbjct: 1 LVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHC-----KKPNLQVFLGKHN 55
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
+Q E VV+ + HP Y+ A SHD DI LL+L P + + P LP +
Sbjct: 56 LGQQESSQ-EQSSVVRAVIHPDYD---AASHDQDIMLLRLARPAKLSELIQP--LPLERD 109
Query: 314 KFTQRTGT-VVGWGRVEESGQIASDLRATQVPVMSNQECRQ-FPGFEAKLTGNMMCAGYV 371
Q T ++GWG+ + G ++ + ++S +EC +PG ++T NM+CAG
Sbjct: 110 CSAQTTSCHILGWGKTAD-GDFPDTIQCAYIHLVSREECEHAYPG---QITQNMLCAGDE 165
Query: 372 EGGKDSCQ 379
+ GKDSCQ
Sbjct: 166 KYGKDSCQ 173
>pdb|2TLD|E Chain E, Crystal Structure Of An Engineered Subtilisin Inhibitor
Complexed With Bovine Trypsin
Length = 220
Score = 98.2 bits (243), Expect = 1e-20, Method: Composition-based stats.
Identities = 67/189 (35%), Positives = 102/189 (53%), Gaps = 20/189 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E N
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGEDN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLP-QLG 312
V E + K + HP YN+ + ++DI L+KL + V+ + LP
Sbjct: 55 -INVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVASISLPTSCA 110
Query: 313 EKFTQRTGTVVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEAKLTGNMMCAGY 370
TQ + GWG + SG D L+ + P++S+ C+ +PG ++T NM CAG
Sbjct: 111 SAGTQ--CLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMFCAG- 164
Query: 371 VEGGKDSCQ 379
+EGG DSCQ
Sbjct: 165 LEGG-DSCQ 172
>pdb|1V2Q|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Sswi)bt.B4
Length = 223
Score = 98.2 bits (243), Expect = 1e-20, Method: Composition-based stats.
Identities = 67/190 (35%), Positives = 101/190 (53%), Gaps = 20/190 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E N
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGEDN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K + HP YN+ + ++DI L+KL + V+ + LP
Sbjct: 55 -INVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVASISLP---- 106
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLTGNMMCAG 369
GT + GWG + SG D L+ + P++S+ C+ + +T NM CAG
Sbjct: 107 TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSW--IITSNMFCAG 164
Query: 370 YVEGGKDSCQ 379
Y+EGGKDSCQ
Sbjct: 165 YLEGGKDSCQ 174
>pdb|2WUB|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUB|C Chain C, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUC|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non- Inhibitory Antibody Fab40.Deltatrp And
Ac-Kqlr-Chloromethylketone
pdb|3K2U|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Inhibitory Antibody Fab40
Length = 257
Score = 97.8 bits (242), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 57/194 (29%), Positives = 97/194 (50%), Gaps = 14/194 (7%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEH- 252
I+GG ++ +PW+ A+ G FC G+L+ +V++AAHC S + + VV+ +H
Sbjct: 1 IIGGSSSLPGSHPWLAAI-YIGDSFCAGSLVHTCWVVSAAHCFSHSPPRDSVSVVLGQHF 59
Query: 253 -NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKL----DTPLEFKPTVSPVC 307
NR T + + + +N DHD+ L++L D V P+C
Sbjct: 60 FNRTTDVTQTFGIEKYIPYTLYSVFNPS-----DHDLVLIRLKKKGDRCATRSQFVQPIC 114
Query: 308 LPQLGEKF-TQRTGTVVGWGRVEES-GQIASDLRATQVPVMSNQECRQFPGFEAKLTGNM 365
LP+ G F + GWG ++E+ +S LR VP++++ +C + A ++ NM
Sbjct: 115 LPEPGSTFPAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCSSPEVYGADISPNM 174
Query: 366 MCAGYVEGGKDSCQ 379
+CAGY + D+CQ
Sbjct: 175 LCAGYFDCKSDACQ 188
>pdb|2R0L|A Chain A, Short Form Hgfa With Inhibitory Fab75
Length = 248
Score = 97.8 bits (242), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 57/194 (29%), Positives = 97/194 (50%), Gaps = 14/194 (7%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEH- 252
I+GG ++ +PW+ A+ G FC G+L+ +V++AAHC S + + VV+ +H
Sbjct: 1 IIGGSSSLPGSHPWLAAI-YIGDSFCAGSLVHTCWVVSAAHCFSHSPPRDSVSVVLGQHF 59
Query: 253 -NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKL----DTPLEFKPTVSPVC 307
NR T + + + +N DHD+ L++L D V P+C
Sbjct: 60 FNRTTDVTQTFGIEKYIPYTLYSVFNPS-----DHDLVLIRLKKKGDRCATRSQFVQPIC 114
Query: 308 LPQLGEKF-TQRTGTVVGWGRVEES-GQIASDLRATQVPVMSNQECRQFPGFEAKLTGNM 365
LP+ G F + GWG ++E+ +S LR VP++++ +C + A ++ NM
Sbjct: 115 LPEPGSTFPAGHKCQIAGWGHLDENVSGYSSSLREALVPLVADHKCSSPEVYGADISPNM 174
Query: 366 MCAGYVEGGKDSCQ 379
+CAGY + D+CQ
Sbjct: 175 LCAGYFDCKSDACQ 188
>pdb|1V2J|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssri)
Bt.C1
pdb|1V2R|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssri)bt.B4
Length = 223
Score = 97.4 bits (241), Expect = 2e-20, Method: Composition-based stats.
Identities = 67/190 (35%), Positives = 100/190 (52%), Gaps = 20/190 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + E N
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG-----IQVRLGEDN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K + HP YN+ + ++DI L+KL + V+ + LP
Sbjct: 55 -INVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVASISLP---- 106
Query: 314 KFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLTGNMMCAG 369
GT + GWG + SG D L+ + P++S+ C+ +T NM CAG
Sbjct: 107 TSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKS--ASSRIITSNMFCAG 164
Query: 370 YVEGGKDSCQ 379
Y+EGGKDSCQ
Sbjct: 165 YLEGGKDSCQ 174
>pdb|2EEK|A Chain A, Crystal Structure Of Atlantic Cod Trypsin Complexed With
Benzamidine
Length = 220
Score = 97.1 bits (240), Expect = 3e-20, Method: Composition-based stats.
Identities = 78/234 (33%), Positives = 111/234 (47%), Gaps = 27/234 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEH- 252
IVGG+ + V+L +G FCGG+L+S +V++AAHC +S R V + EH
Sbjct: 1 IVGGYECTKHSQAHQVSL-NSGYHFCGGSLVSKDWVVSAAHCYKSVLR-----VRLGEHH 54
Query: 253 ---NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLP 309
N T E I + V++ HP Y++ ++DI L+KL P V V LP
Sbjct: 55 IRVNEGT--EQYISSSSVIR---HPNYSSYNI---NNDIMLIKLTKPATLNQYVHAVALP 106
Query: 310 QLGEKFTQRT-GTVVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEAKLTGNMMC 367
E T TV GWG S L+ +P++S+ +C +PG +T +M C
Sbjct: 107 T--ECAADATMCTVSGWGNTMSSVADGDKLQCLSLPILSHADCANSYPGM---ITQSMFC 161
Query: 368 AGYVEGGKDSCQVTLDEADIALLKSYGQGQYTKSIKAVEDDIQAVIKRVNELTG 421
AGY+EGGKDSCQ D + QG + E D V +V L+G
Sbjct: 162 AGYLEGGKDSCQG--DSGGPVVCNGVLQGVVSWGYGCAERDHPGVYAKVCVLSG 213
>pdb|1NPM|A Chain A, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
pdb|1NPM|B Chain B, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
Length = 225
Score = 96.7 bits (239), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 63/176 (35%), Positives = 90/176 (51%), Gaps = 13/176 (7%)
Query: 206 PWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHNRATVYETQIETR 265
PW AL Q + CGG L+ DR+VLTAAHC K+QK V + +H+ + + + E
Sbjct: 13 PWQAALFQGERLICGGVLVGDRWVLTAAHC----KKQK-YSVRLGDHSLQSRDQPEQEI- 66
Query: 266 RVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGEKFTQRTGTVVGW 325
+V + + HP YN + H HDI L++L V PV L L K Q+ + GW
Sbjct: 67 QVAQSIQHPCYNNSNPEDHSHDIMLIRLQNSANLGDKVKPVQLANLCPKVGQKC-IISGW 125
Query: 326 GRVEESGQ-IASDLRATQVPVMSNQEC-RQFPGFEAKLTGNMMCAGYVEGGKDSCQ 379
G V + + L +V + S +C R +PG K+T M+CAG G D+CQ
Sbjct: 126 GTVTSPQENFPNTLNCAEVKIYSQNKCERAYPG---KITEGMVCAG-SSNGADTCQ 177
>pdb|1SPJ|A Chain A, Structure Of Mature Human Tissue Kallikrein (Human
Kallikrein 1 Or Klk1) At 1.70 Angstrom Resolution With
Vacant Active Site
Length = 238
Score = 95.9 bits (237), Expect = 7e-20, Method: Compositional matrix adjust.
Identities = 63/195 (32%), Positives = 93/195 (47%), Gaps = 19/195 (9%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGGW E + PW AL F CGG L+ ++VLTAAHC+ + + + + HN
Sbjct: 1 IVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQ-----LWLGRHN 55
Query: 254 RATVYETQIETRRVVKVLTHPKYNA--------QGAKSHDHDIALLKLDTPLE-FKPTVS 304
E + V + HP +N Q + + HD+ LL+L P + V
Sbjct: 56 LFDD-ENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVK 114
Query: 305 PVCLPQLGEKFTQRTGTVVGWGRVE-ESGQIASDLRATQVPVMSNQECRQFPGFEAKLTG 363
V LP E T GWG +E E+ DL+ + ++ N EC++ K+T
Sbjct: 115 VVELPT-EEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKK--AHVQKVTD 171
Query: 364 NMMCAGYVEGGKDSC 378
M+C G++EGGKD+C
Sbjct: 172 FMLCVGHLEGGKDTC 186
>pdb|1Q3X|A Chain A, Crystal Structure Of The Catalytic Region Of Human Masp-2
pdb|1Q3X|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-2
Length = 328
Score = 95.1 bits (235), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 67/205 (32%), Positives = 100/205 (48%), Gaps = 18/205 (8%)
Query: 185 CGVPNRM--DRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQ 242
CG+ R RI GG + ++PW V + G G L+ D +VLTAAH V K
Sbjct: 76 CGLSARTTGGRIYGGQKAKPGDFPWQVLI--LGGTTAAGALLYDNWVLTAAHAVYEQKHD 133
Query: 243 KD-LIVVISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKP 301
L + + R + + TQ + V H Y D+DIAL+KL+ +
Sbjct: 134 ASALDIRMGTLKRLSPHYTQAWSE---AVFIHEGYTHDAG--FDNDIALIKLNNKVVINS 188
Query: 302 TVSPVCLPQL-GEKF--TQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQEC----RQF 354
++P+CLP+ E F T GT GWG + + G +A +L +P++ +Q+C +
Sbjct: 189 NITPICLPRKEAESFMRTDDIGTASGWG-LTQRGFLARNLMYVDIPIVDHQKCTAAYEKP 247
Query: 355 PGFEAKLTGNMMCAGYVEGGKDSCQ 379
P +T NM+CAG GGKDSC+
Sbjct: 248 PYPRGSVTANMLCAGLESGGKDSCR 272
>pdb|2XXL|A Chain A, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
pdb|2XXL|B Chain B, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
Length = 408
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 71/209 (33%), Positives = 107/209 (51%), Gaps = 33/209 (15%)
Query: 193 RIVGGWTTEVNEYPWVVAL--EQAG--KFFCGGTLISDRYVLTAAHCVRSSKRQKDLI-V 247
R+ G+ +++ PW+ L +Q G +F CGG +IS+RY+LTAAHCV Q DL +
Sbjct: 118 RVSNGYEVKLSSRPWMALLRYQQFGESRFLCGGAMISERYILTAAHCVHG--LQNDLYEI 175
Query: 248 VISEHNRATVYETQIETRR-----------VVKVLTHPKYNAQGAKSHDHDIALLKLDTP 296
+ EH +T + + + R+ + K L H KY+A+ HDIALLKL+
Sbjct: 176 RLGEHRISTEEDCRQQGRKKKCAPPVVNVGIEKHLIHEKYDARHIM---HDIALLKLNRS 232
Query: 297 LEFKPTVSPVCLP---QLGEKFTQ-RTGTVVGWGRVEESGQIASDLRATQVPVMSNQECR 352
+ F+ + P+CLP +L EK Q T V GWG E+G + L VP+ C
Sbjct: 233 VPFQKHIKPICLPITDELKEKAEQISTYFVTGWG-TTENGSSSDVLLQANVPLQPRSACS 291
Query: 353 QFPGFEAKLTGNMMCAGYVEGG--KDSCQ 379
Q + + + +C G GG +DSC+
Sbjct: 292 Q--AYRRAVPLSQLCVG---GGDLQDSCK 315
>pdb|1BHX|B Chain B, X-Ray Structure Of The Complex Of Human Alpha Thrombin
With The Inhibitor Sdz 229-357
pdb|1RIW|B Chain B, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
pdb|2PKS|B Chain B, Thrombin In Complex With Inhibitor
pdb|3PO1|B Chain B, Thrombin In Complex With Benzothiazole Guanidine
Length = 147
Score = 94.0 bits (232), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 62/155 (40%), Positives = 84/155 (54%), Gaps = 25/155 (16%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 306 VCLP---------QLGEKFTQRTGTVVGWGRVEES 331
VCLP Q G K G V GWG ++E+
Sbjct: 118 VCLPDRETAASLLQAGYK-----GRVTGWGNLKET 147
>pdb|2DHR|A Chain A, Whole Cytosolic Region Of Atp-Dependent Metalloprotease
Ftsh (G399l)
pdb|2DHR|B Chain B, Whole Cytosolic Region Of Atp-Dependent Metalloprotease
Ftsh (G399l)
pdb|2DHR|C Chain C, Whole Cytosolic Region Of Atp-Dependent Metalloprotease
Ftsh (G399l)
pdb|2DHR|D Chain D, Whole Cytosolic Region Of Atp-Dependent Metalloprotease
Ftsh (G399l)
pdb|2DHR|E Chain E, Whole Cytosolic Region Of Atp-Dependent Metalloprotease
Ftsh (G399l)
pdb|2DHR|F Chain F, Whole Cytosolic Region Of Atp-Dependent Metalloprotease
Ftsh (G399l)
Length = 499
Score = 93.6 bits (231), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 53/134 (39%), Positives = 80/134 (59%), Gaps = 3/134 (2%)
Query: 478 SDIGGCKEQIEKLREVVETPLLHLDGFDPRGNIKVLMATNRPDTLDPALMRPGRLDRKVE 537
S +GG ++ E + + L+ +DGF+ I V+ ATNRPD LDPAL+RPGR DR++
Sbjct: 141 SGVGGGNDERE---QTLNQLLVEMDGFEKDTAIVVMAATNRPDILDPALLRPGRFDRQIA 197
Query: 538 FGLPDLEGRTHIFKIHARSMSVERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIRARRK 597
PD++GR I +IHAR + D+ LLA+ P GA++ ++ EA + A R R+
Sbjct: 198 IDAPDVKGREQILRIHARGKPLAEDVDLALLAKRTPGFVGADLENLLNEAALLAAREGRR 257
Query: 598 VASEKDFLEAVNKV 611
+ KD EA ++V
Sbjct: 258 KITMKDLEEAADRV 271
Score = 62.8 bits (151), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 29/61 (47%), Positives = 37/61 (60%)
Query: 112 MLELINQPEKFVNLGIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQKYV 171
++E + P +F +G PKGVLL GPPG GKT ARAVA FI GS+ V+ +V
Sbjct: 46 IVEFLKNPSRFHEMGARIPKGVLLVGPPGVGKTHLARAVAGEARVPFITASGSDFVEMFV 105
Query: 172 G 172
G
Sbjct: 106 G 106
>pdb|4EIW|A Chain A, Whole Cytosolic Region Of Atp-Dependent Metalloprotease
Ftsh (G399l)
pdb|4EIW|B Chain B, Whole Cytosolic Region Of Atp-Dependent Metalloprotease
Ftsh (G399l)
pdb|4EIW|C Chain C, Whole Cytosolic Region Of Atp-Dependent Metalloprotease
Ftsh (G399l)
pdb|4EIW|D Chain D, Whole Cytosolic Region Of Atp-Dependent Metalloprotease
Ftsh (G399l)
pdb|4EIW|E Chain E, Whole Cytosolic Region Of Atp-Dependent Metalloprotease
Ftsh (G399l)
pdb|4EIW|F Chain F, Whole Cytosolic Region Of Atp-Dependent Metalloprotease
Ftsh (G399l)
Length = 508
Score = 93.6 bits (231), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 53/134 (39%), Positives = 80/134 (59%), Gaps = 3/134 (2%)
Query: 478 SDIGGCKEQIEKLREVVETPLLHLDGFDPRGNIKVLMATNRPDTLDPALMRPGRLDRKVE 537
S +GG ++ E + + L+ +DGF+ I V+ ATNRPD LDPAL+RPGR DR++
Sbjct: 150 SGVGGGNDERE---QTLNQLLVEMDGFEKDTAIVVMAATNRPDILDPALLRPGRFDRQIA 206
Query: 538 FGLPDLEGRTHIFKIHARSMSVERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIRARRK 597
PD++GR I +IHAR + D+ LLA+ P GA++ ++ EA + A R R+
Sbjct: 207 IDAPDVKGREQILRIHARGKPLAEDVDLALLAKRTPGFVGADLENLLNEAALLAAREGRR 266
Query: 598 VASEKDFLEAVNKV 611
+ KD EA ++V
Sbjct: 267 KITMKDLEEAADRV 280
Score = 62.8 bits (151), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 29/61 (47%), Positives = 37/61 (60%)
Query: 112 MLELINQPEKFVNLGIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQKYV 171
++E + P +F +G PKGVLL GPPG GKT ARAVA FI GS+ V+ +V
Sbjct: 55 IVEFLKNPSRFHEMGARIPKGVLLVGPPGVGKTHLARAVAGEARVPFITASGSDFVEMFV 114
Query: 172 G 172
G
Sbjct: 115 G 115
>pdb|3HU3|A Chain A, Structure Of P97 N-D1 R155h Mutant In Complex With Atpgs
pdb|3HU3|B Chain B, Structure Of P97 N-D1 R155h Mutant In Complex With Atpgs
Length = 489
Score = 93.2 bits (230), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 45/205 (21%)
Query: 491 REVVETPLLHLDGFDPRGNIKVLMATNRPDTLDPALMRPGRLDRKVEFGLPDLEGRTHIF 550
R +V L +DG R ++ V+ ATNRP+++DPAL R GR DR+V+ G+PD GR I
Sbjct: 322 RRIVSQLLTLMDGLKQRAHVIVMAATNRPNSIDPALRRFGRFDREVDIGIPDATGRLEIL 381
Query: 551 KIHARSMSVERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIRARRKVASEKDFLEAVNK 610
+IH ++M + D+ E +A GA++ ++C+EA + AIR +
Sbjct: 382 QIHTKNMKLADDVDLEQVANETHGHVGADLAALCSEAALQAIRKKMD------------- 428
Query: 611 VARCTKIINADSENPKYIINVKQFAKFVVDLADSVAPTDIEEGMRVGVDRNKYQIHIPLP 670
++DL D ++ + V +D ++ + P
Sbjct: 429 ---------------------------LIDLEDETIDAEVMNSLAVTMDDFRWALSQSNP 461
Query: 671 PKIDPTVTMMQVEEKPDVTYSDIGG 695
+ TV E P VT+ DIGG
Sbjct: 462 SALRETVV-----EVPQVTWEDIGG 481
Score = 73.6 bits (179), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 34/65 (52%), Positives = 46/65 (70%), Gaps = 1/65 (1%)
Query: 110 RTMLEL-INQPEKFVNLGIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQ 168
+ M+EL + P F +G++PP+G+LL+GPPGTGKTL ARAVAN T A F + G E++
Sbjct: 217 KEMVELPLRHPALFKAIGVKPPRGILLYGPPGTGKTLIARAVANETGAFFFLINGPEIMS 276
Query: 169 KYVGE 173
K GE
Sbjct: 277 KLAGE 281
Score = 38.1 bits (87), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 14/27 (51%), Positives = 22/27 (81%)
Query: 474 DVTYSDIGGCKEQIEKLREVVETPLLH 500
+V Y DIGGC++Q+ +++E+VE PL H
Sbjct: 200 EVGYDDIGGCRKQLAQIKEMVELPLRH 226
Score = 38.1 bits (87), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 14/27 (51%), Positives = 22/27 (81%)
Query: 687 DVTYSDIGGCKEQIEKLREVVETPLLH 713
+V Y DIGGC++Q+ +++E+VE PL H
Sbjct: 200 EVGYDDIGGCRKQLAQIKEMVELPLRH 226
>pdb|3HU1|A Chain A, Structure Of P97 N-D1 R95g Mutant In Complex With Atpgs
pdb|3HU1|B Chain B, Structure Of P97 N-D1 R95g Mutant In Complex With Atpgs
pdb|3HU1|C Chain C, Structure Of P97 N-D1 R95g Mutant In Complex With Atpgs
pdb|3HU1|D Chain D, Structure Of P97 N-D1 R95g Mutant In Complex With Atpgs
pdb|3HU1|E Chain E, Structure Of P97 N-D1 R95g Mutant In Complex With Atpgs
pdb|3HU1|F Chain F, Structure Of P97 N-D1 R95g Mutant In Complex With Atpgs
Length = 489
Score = 93.2 bits (230), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 45/205 (21%)
Query: 491 REVVETPLLHLDGFDPRGNIKVLMATNRPDTLDPALMRPGRLDRKVEFGLPDLEGRTHIF 550
R +V L +DG R ++ V+ ATNRP+++DPAL R GR DR+V+ G+PD GR I
Sbjct: 322 RRIVSQLLTLMDGLKQRAHVIVMAATNRPNSIDPALRRFGRFDREVDIGIPDATGRLEIL 381
Query: 551 KIHARSMSVERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIRARRKVASEKDFLEAVNK 610
+IH ++M + D+ E +A GA++ ++C+EA + AIR +
Sbjct: 382 QIHTKNMKLADDVDLEQVANETHGHVGADLAALCSEAALQAIRKKMD------------- 428
Query: 611 VARCTKIINADSENPKYIINVKQFAKFVVDLADSVAPTDIEEGMRVGVDRNKYQIHIPLP 670
++DL D ++ + V +D ++ + P
Sbjct: 429 ---------------------------LIDLEDETIDAEVMNSLAVTMDDFRWALSQSNP 461
Query: 671 PKIDPTVTMMQVEEKPDVTYSDIGG 695
+ TV E P VT+ DIGG
Sbjct: 462 SALRETVV-----EVPQVTWEDIGG 481
Score = 73.2 bits (178), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 34/65 (52%), Positives = 46/65 (70%), Gaps = 1/65 (1%)
Query: 110 RTMLEL-INQPEKFVNLGIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQ 168
+ M+EL + P F +G++PP+G+LL+GPPGTGKTL ARAVAN T A F + G E++
Sbjct: 217 KEMVELPLRHPALFKAIGVKPPRGILLYGPPGTGKTLIARAVANETGAFFFLINGPEIMS 276
Query: 169 KYVGE 173
K GE
Sbjct: 277 KLAGE 281
Score = 38.1 bits (87), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 14/27 (51%), Positives = 22/27 (81%)
Query: 474 DVTYSDIGGCKEQIEKLREVVETPLLH 500
+V Y DIGGC++Q+ +++E+VE PL H
Sbjct: 200 EVGYDDIGGCRKQLAQIKEMVELPLRH 226
Score = 38.1 bits (87), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 14/27 (51%), Positives = 22/27 (81%)
Query: 687 DVTYSDIGGCKEQIEKLREVVETPLLH 713
+V Y DIGGC++Q+ +++E+VE PL H
Sbjct: 200 EVGYDDIGGCRKQLAQIKEMVELPLRH 226
>pdb|1PYT|D Chain D, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 251
Score = 93.2 bits (230), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 72/247 (29%), Positives = 114/247 (46%), Gaps = 23/247 (9%)
Query: 188 PNRMDRIVGGWTTEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHCVRSSKRQK 243
PN R+VGG + +PW ++L+ + CGGTLI+ +VLTAAHC+ ++ +
Sbjct: 8 PNLSARVVGGEDAIPHSWPWQISLQYLRDNTWRHTCGGTLITPNHVLTAAHCISNTLTYR 67
Query: 244 DLIVVISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTV 303
V + ++N E V + H K+N+ + +DIAL+KL +E T+
Sbjct: 68 ---VALGKNNLEVEDEAGSLYVGVDTIFVHEKWNSFLVR---NDIALIKLAETVELGDTI 121
Query: 304 SPVCLPQLGEKFTQRTGT-VVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLT 362
CLP G Q V GWGR+ +G IA++L+ PV+ C Q + +
Sbjct: 122 QVACLPSEGSLLPQDYPCFVTGWGRLYTNGPIAAELQQGLQPVVDYATCSQRDWWGTTVK 181
Query: 363 GNMMCAG---------YVEGGKDSCQVTLDEADIALLKSYGQGQYTKSIK--AVEDDIQA 411
M+CAG GG +CQ + D+ + S+G G + K V + A
Sbjct: 182 ETMVCAGGDGVISACNGDSGGPLNCQAD-GQWDVRGIVSFGSGLSCNTFKKPTVFTRVSA 240
Query: 412 VIKRVNE 418
I +N+
Sbjct: 241 YIDWINQ 247
>pdb|3HU2|A Chain A, Structure Of P97 N-D1 R86a Mutant In Complex With Atpgs
pdb|3HU2|B Chain B, Structure Of P97 N-D1 R86a Mutant In Complex With Atpgs
pdb|3HU2|C Chain C, Structure Of P97 N-D1 R86a Mutant In Complex With Atpgs
pdb|3HU2|D Chain D, Structure Of P97 N-D1 R86a Mutant In Complex With Atpgs
pdb|3HU2|E Chain E, Structure Of P97 N-D1 R86a Mutant In Complex With Atpgs
pdb|3HU2|F Chain F, Structure Of P97 N-D1 R86a Mutant In Complex With Atpgs
Length = 489
Score = 93.2 bits (230), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 45/205 (21%)
Query: 491 REVVETPLLHLDGFDPRGNIKVLMATNRPDTLDPALMRPGRLDRKVEFGLPDLEGRTHIF 550
R +V L +DG R ++ V+ ATNRP+++DPAL R GR DR+V+ G+PD GR I
Sbjct: 322 RRIVSQLLTLMDGLKQRAHVIVMAATNRPNSIDPALRRFGRFDREVDIGIPDATGRLEIL 381
Query: 551 KIHARSMSVERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIRARRKVASEKDFLEAVNK 610
+IH ++M + D+ E +A GA++ ++C+EA + AIR +
Sbjct: 382 QIHTKNMKLADDVDLEQVANETHGHVGADLAALCSEAALQAIRKKMD------------- 428
Query: 611 VARCTKIINADSENPKYIINVKQFAKFVVDLADSVAPTDIEEGMRVGVDRNKYQIHIPLP 670
++DL D ++ + V +D ++ + P
Sbjct: 429 ---------------------------LIDLEDETIDAEVMNSLAVTMDDFRWALSQSNP 461
Query: 671 PKIDPTVTMMQVEEKPDVTYSDIGG 695
+ TV E P VT+ DIGG
Sbjct: 462 SALRETVV-----EVPQVTWEDIGG 481
Score = 73.6 bits (179), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 34/65 (52%), Positives = 46/65 (70%), Gaps = 1/65 (1%)
Query: 110 RTMLEL-INQPEKFVNLGIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQ 168
+ M+EL + P F +G++PP+G+LL+GPPGTGKTL ARAVAN T A F + G E++
Sbjct: 217 KEMVELPLRHPALFKAIGVKPPRGILLYGPPGTGKTLIARAVANETGAFFFLINGPEIMS 276
Query: 169 KYVGE 173
K GE
Sbjct: 277 KLAGE 281
Score = 38.1 bits (87), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 14/27 (51%), Positives = 22/27 (81%)
Query: 474 DVTYSDIGGCKEQIEKLREVVETPLLH 500
+V Y DIGGC++Q+ +++E+VE PL H
Sbjct: 200 EVGYDDIGGCRKQLAQIKEMVELPLRH 226
Score = 38.1 bits (87), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 14/27 (51%), Positives = 22/27 (81%)
Query: 687 DVTYSDIGGCKEQIEKLREVVETPLLH 713
+V Y DIGGC++Q+ +++E+VE PL H
Sbjct: 200 EVGYDDIGGCRKQLAQIKEMVELPLRH 226
>pdb|1PPZ|A Chain A, Trypsin Complexes At Atomic And Ultra-High Resolution
pdb|1PQA|A Chain A, Trypsin With Pmsf At Atomic Resolution
Length = 224
Score = 93.2 bits (230), Expect = 4e-19, Method: Composition-based stats.
Identities = 61/188 (32%), Positives = 92/188 (48%), Gaps = 13/188 (6%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG + ++P++V++ + G +CGG+L++ VLTAAHCV + I S
Sbjct: 1 IVGGTSASAGDFPFIVSISRNGGPWCGGSLLNANTVLTAAHCVSGYAQSGFQIRAGSLSR 60
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLG- 312
+ + + + RV HP Y+ +++D+A+LKL T + + L G
Sbjct: 61 TSGGITSSLSSVRV-----HPSYSG-----NNNDLAILKLSTSIPSGGNIGYARLAASGS 110
Query: 313 EKFTQRTGTVVGWGRVEESG-QIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCAGYV 371
+ + TV GWG E G +L VP++S CR G A +T M CAG
Sbjct: 111 DPVAGSSATVAGWGATSEGGSSTPVNLLKVTVPIVSRATCRAQYGTSA-ITNQMFCAGVS 169
Query: 372 EGGKDSCQ 379
GGKDSCQ
Sbjct: 170 SGGKDSCQ 177
>pdb|1GDU|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1PQ5|A Chain A, Trypsin At Ph 5, 0.85 A
pdb|1PQ7|A Chain A, Trypsin At 0.8 A, Ph5 BORAX
pdb|1PQ8|A Chain A, Trypsin At Ph 4 At Atomic Resolution
pdb|2G51|A Chain A, Anomalous Substructure Of Trypsin (P1)
pdb|2G52|A Chain A, Anomalous Substructure Of Trypsin (P21)
pdb|1TRY|A Chain A, Structure Of Inhibited Trypsin From Fusarium Oxysporum At
1.55 Angstroms
pdb|2VU8|E Chain E, Crystal Structure Of An Insect Inhibitor With A Fungal
Trypsin
Length = 224
Score = 93.2 bits (230), Expect = 4e-19, Method: Composition-based stats.
Identities = 61/188 (32%), Positives = 92/188 (48%), Gaps = 13/188 (6%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG + ++P++V++ + G +CGG+L++ VLTAAHCV + I S
Sbjct: 1 IVGGTSASAGDFPFIVSISRNGGPWCGGSLLNANTVLTAAHCVSGYAQSGFQIRAGSLSR 60
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLG- 312
+ + + + RV HP Y+ +++D+A+LKL T + + L G
Sbjct: 61 TSGGITSSLSSVRV-----HPSYSG-----NNNDLAILKLSTSIPSGGNIGYARLAASGS 110
Query: 313 EKFTQRTGTVVGWGRVEESG-QIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCAGYV 371
+ + TV GWG E G +L VP++S CR G A +T M CAG
Sbjct: 111 DPVAGSSATVAGWGATSEGGSSTPVNLLKVTVPIVSRATCRAQYGTSA-ITNQMFCAGVS 169
Query: 372 EGGKDSCQ 379
GGKDSCQ
Sbjct: 170 SGGKDSCQ 177
>pdb|1BRU|P Chain P, Structure Of Porcine Pancreatic Elastase Complexed With
The Elastase Inhibitor Gr143783
Length = 241
Score = 93.2 bits (230), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 59/181 (32%), Positives = 96/181 (53%), Gaps = 10/181 (5%)
Query: 194 IVGGWTTEVNEYPWVVALE--QAGKF--FCGGTLISDRYVLTAAHCVRSSKRQKDLIVVI 249
+VGG N +PW V+L+ +G++ CGGTL+ +VLTAAHC+ SS+ + VV+
Sbjct: 1 VVGGEDARPNSWPWQVSLQYDSSGQWRHTCGGTLVDQSWVLTAAHCISSSRTYR---VVL 57
Query: 250 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLP 309
H+ +T + +V K++ H +N+ S+ +DIALLKL +P+ + CLP
Sbjct: 58 GRHSLSTNEPGSLAV-KVSKLVVHQDWNSN-QLSNGNDIALLKLASPVSLTDKIQLGCLP 115
Query: 310 QLGEKF-TQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCA 368
G V GWGR++ +G L+ Q+ V+ C + + + + NM+CA
Sbjct: 116 AAGTILPNNYVCYVTGWGRLQTNGASPDILQQGQLLVVDYATCSKPGWWGSTVKTNMICA 175
Query: 369 G 369
G
Sbjct: 176 G 176
>pdb|1BBR|H Chain H, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1UCY|H Chain H, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|F Chain F, Thrombin:hirudin 51-65 Complex
pdb|1YCP|K Chain K, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 150
Score = 93.2 bits (230), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 62/150 (41%), Positives = 82/150 (54%), Gaps = 15/150 (10%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G EV PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLL 60
Query: 247 VVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
V I +H+R T YE ++E ++ K+ HP+YN + ++ D DIALLKL P+E + P
Sbjct: 61 VRIGKHSR-TRYERKVEKISMLDKIYIHPRYNWK--ENLDRDIALLKLKRPIELSDYIHP 117
Query: 306 VCLP--QLGEKFTQR--TGTVVGWGRVEES 331
VCLP Q K G V GWG E+
Sbjct: 118 VCLPDKQTAAKLLHAGFKGRVTGWGNRRET 147
>pdb|1FIW|A Chain A, Three-Dimensional Structure Of Beta-Acrosin From Ram
Spermatozoa
Length = 290
Score = 93.2 bits (230), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 16/199 (8%)
Query: 194 IVGGWTTEVNEYPWVVALE------QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIV 247
I+GG +PW+V+L+ CGG+L++ +++LTAAHC R K+ D +
Sbjct: 1 IIGGQDAAHGAWPWMVSLQIFTYHNNRRYHVCGGSLLNSQWLLTAAHCFRIKKKVTDWRL 60
Query: 248 VIS----EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTV 303
+ E + ++ R V K++ H KY+ A S +DIAL+K+ P+ +
Sbjct: 61 IFGAKEVEWGTNKPVKPPLQERYVEKIIIHEKYS---ASSEANDIALMKITPPVTCGHFI 117
Query: 304 SPVCLPQL--GEKFTQRTGTVVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAK 360
P CLPQ G +T V GWG ++E+ + S L+ +V ++ C + +
Sbjct: 118 GPGCLPQFRAGPPRVPQTCWVAGWGFLQENARRTSPMLQEARVDLIDLGLCNSTRWYNGR 177
Query: 361 LTGNMMCAGYVEGGKDSCQ 379
+ +CAGY EG D+CQ
Sbjct: 178 IRSTNVCAGYPEGKIDTCQ 196
>pdb|4B4T|K Chain K, Near-Atomic Resolution Structural Model Of The Yeast 26s
Proteasome
Length = 428
Score = 92.8 bits (229), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 52/111 (46%), Positives = 67/111 (60%), Gaps = 1/111 (0%)
Query: 498 LLHLDGFDPRGNIKVLMATNRPDTLDPALMRPGRLDRKVEF-GLPDLEGRTHIFKIHARS 556
L +DGFD N+KV+MATNR DTLDPAL+RPGRLDRK+EF L D R IF A
Sbjct: 300 LTQMDGFDQSTNVKVIMATNRADTLDPALLRPGRLDRKIEFPSLRDRRERRLIFGTIASK 359
Query: 557 MSVERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIRARRKVASEKDFLEA 607
MS+ + + L + +GA I ++ EAG+ A+R R V + D EA
Sbjct: 360 MSLAPEADLDSLIIRNDSLSGAVIAAIMQEAGLRAVRKNRYVILQSDLEEA 410
Score = 82.4 bits (202), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 35/56 (62%), Positives = 44/56 (78%)
Query: 118 QPEKFVNLGIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQKYVGE 173
Q + + +GI+PP+GVLL+GPPGTGKT+ +AVAN T A FIRV GSE V KY+GE
Sbjct: 194 QADLYEQIGIDPPRGVLLYGPPGTGKTMLVKAVANSTKAAFIRVNGSEFVHKYLGE 249
Score = 62.8 bits (151), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 40/122 (32%), Positives = 66/122 (54%), Gaps = 13/122 (10%)
Query: 400 KSIKAVEDDIQAVIKRVNELTGIKESDTGLAPPALWDLTADKQTLQNEQPLQIHIP---- 455
K I++V I ++ +++ TGI S TG++ T D++ L+ + +H
Sbjct: 87 KRIQSVPLVIGQFLEPIDQNTGIVSSTTGMSYVVRILSTLDRELLKPSMSVALHRHSNAL 146
Query: 456 ---LPPKIDPTVTMMQVEEKPDVTYSDIGGCKEQIEKLREVVETPLLHLDGFD------P 506
LPP D ++++M EKPDVTY+D+GG Q +++RE VE PL+ D ++ P
Sbjct: 147 VDILPPDSDSSISVMGENEKPDVTYADVGGLDMQKQEIREAVELPLVQADLYEQIGIDPP 206
Query: 507 RG 508
RG
Sbjct: 207 RG 208
Score = 55.1 bits (131), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 27/77 (35%), Positives = 46/77 (59%)
Query: 637 FVVDLADSVAPTDIEEGMRVGVDRNKYQIHIPLPPKIDPTVTMMQVEEKPDVTYSDIGGC 696
+VV + ++ ++ M V + R+ + LPP D ++++M EKPDVTY+D+GG
Sbjct: 118 YVVRILSTLDRELLKPSMSVALHRHSNALVDILPPDSDSSISVMGENEKPDVTYADVGGL 177
Query: 697 KEQIEKLREVVETPLLH 713
Q +++RE VE PL+
Sbjct: 178 DMQKQEIREAVELPLVQ 194
Score = 47.0 bits (110), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 21/30 (70%), Positives = 23/30 (76%)
Query: 61 AVANRTDACFIRVIGSELVQKYVGEGARMI 90
AVAN T A FIRV GSE V KY+GEG RM+
Sbjct: 225 AVANSTKAAFIRVNGSEFVHKYLGEGPRMV 254
Score = 43.9 bits (102), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 32/98 (32%), Positives = 42/98 (42%), Gaps = 26/98 (26%)
Query: 35 AVANRTDACFIRVIGSELVQKYVGEG----------AVANRTDACFIRVIGSELVQKYVG 84
AVAN T A FIRV GSE V KY+GEG A N FI + S +++
Sbjct: 225 AVANSTKAAFIRVNGSEFVHKYLGEGPRMVRDVFRLARENAPSIIFIDEVDSIATKRFDA 284
Query: 85 EGARMIXXXXXXXXXXXXXXXNEVQRTMLELINQPEKF 122
+ EVQR ++EL+ Q + F
Sbjct: 285 QTG----------------SDREVQRILIELLTQMDGF 306
>pdb|1ZJK|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-2
Length = 403
Score = 92.4 bits (228), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 66/205 (32%), Positives = 100/205 (48%), Gaps = 18/205 (8%)
Query: 185 CGVPNRM--DRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQ 242
CG+ R +I GG + ++PW V + G G L+ D +VLTAAH V K
Sbjct: 151 CGLSARTTGGQIYGGQKAKPGDFPWQVLI--LGGTTAAGALLYDNWVLTAAHAVYEQKHD 208
Query: 243 KD-LIVVISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKP 301
L + + R + + TQ + V H Y D+DIAL+KL+ +
Sbjct: 209 ASALDIRMGTLKRLSPHYTQAWSE---AVFIHEGYTHDAG--FDNDIALIKLNNKVVINS 263
Query: 302 TVSPVCLPQL-GEKF--TQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQEC----RQF 354
++P+CLP+ E F T GT GWG + + G +A +L +P++ +Q+C +
Sbjct: 264 NITPICLPRKEAESFMRTDDIGTASGWG-LTQRGFLARNLMYVDIPIVDHQKCTAAYEKP 322
Query: 355 PGFEAKLTGNMMCAGYVEGGKDSCQ 379
P +T NM+CAG GGKDSC+
Sbjct: 323 PYPRGSVTANMLCAGLESGGKDSCR 347
>pdb|1FIZ|A Chain A, Three Dimensional Structure Of Beta-Acrosin From Boar
Spermatozoa
Length = 263
Score = 92.4 bits (228), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 58/201 (28%), Positives = 101/201 (50%), Gaps = 20/201 (9%)
Query: 194 IVGGWTTEVNEYPWVVALE------QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIV 247
+VGG + E +PW+V+L+ CGG L++ +VLTAAHC ++ K+ D +
Sbjct: 1 VVGGMSAEPGAWPWMVSLQIFMYHNNRRYHTCGGILLNSHWVLTAAHCFKNKKKVTDWRL 60
Query: 248 VISEHNRATVYETQ------IETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKP 301
+ + V+ + ++ R V +++ H KY + +DIAL+K+ P+ P
Sbjct: 61 IFGANE--VVWGSNKPVKPPLQERFVEEIIIHEKYV---SGLEINDIALIKITPPVPCGP 115
Query: 302 TVSPVCLPQL--GEKFTQRTGTVVGWGRVEESG-QIASDLRATQVPVMSNQECRQFPGFE 358
+ P CLPQ G +T V GWG ++E G + + L+ +V ++ + C +
Sbjct: 116 FIGPGCLPQFKAGPPRAPQTCWVTGWGYLKEKGPRTSPTLQEARVALIDLELCNSTRWYN 175
Query: 359 AKLTGNMMCAGYVEGGKDSCQ 379
++ +CAGY G D+CQ
Sbjct: 176 GRIRSTNVCAGYPRGKIDTCQ 196
>pdb|1E32|A Chain A, Structure Of The N-Terminal Domain And The D1 Aaa Domain
Of Membrane Fusion Atpase P97
pdb|1S3S|A Chain A, Crystal Structure Of Aaa Atpase P97VCP ND1 IN COMPLEX WITH
P47 C
pdb|1S3S|B Chain B, Crystal Structure Of Aaa Atpase P97VCP ND1 IN COMPLEX WITH
P47 C
pdb|1S3S|C Chain C, Crystal Structure Of Aaa Atpase P97VCP ND1 IN COMPLEX WITH
P47 C
pdb|1S3S|D Chain D, Crystal Structure Of Aaa Atpase P97VCP ND1 IN COMPLEX WITH
P47 C
pdb|1S3S|E Chain E, Crystal Structure Of Aaa Atpase P97VCP ND1 IN COMPLEX WITH
P47 C
pdb|1S3S|F Chain F, Crystal Structure Of Aaa Atpase P97VCP ND1 IN COMPLEX WITH
P47 C
Length = 458
Score = 91.7 bits (226), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 43/113 (38%), Positives = 69/113 (61%)
Query: 491 REVVETPLLHLDGFDPRGNIKVLMATNRPDTLDPALMRPGRLDRKVEFGLPDLEGRTHIF 550
R +V L +DG R ++ V+ ATNRP+++DPAL R GR DR+V+ G+PD GR I
Sbjct: 322 RRIVSQLLTLMDGLKQRAHVIVMAATNRPNSIDPALRRFGRFDREVDIGIPDATGRLEIL 381
Query: 551 KIHARSMSVERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIRARRKVASEKD 603
+IH ++M + D+ E +A GA++ ++C+EA + AIR + + +D
Sbjct: 382 QIHTKNMKLADDVDLEQVANETHGHVGADLAALCSEAALQAIRKKMDLIDLED 434
Score = 73.2 bits (178), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 34/65 (52%), Positives = 46/65 (70%), Gaps = 1/65 (1%)
Query: 110 RTMLEL-INQPEKFVNLGIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQ 168
+ M+EL + P F +G++PP+G+LL+GPPGTGKTL ARAVAN T A F + G E++
Sbjct: 217 KEMVELPLRHPALFKAIGVKPPRGILLYGPPGTGKTLIARAVANETGAFFFLINGPEIMS 276
Query: 169 KYVGE 173
K GE
Sbjct: 277 KLAGE 281
Score = 37.7 bits (86), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 13/27 (48%), Positives = 22/27 (81%)
Query: 474 DVTYSDIGGCKEQIEKLREVVETPLLH 500
+V Y D+GGC++Q+ +++E+VE PL H
Sbjct: 200 EVGYDDVGGCRKQLAQIKEMVELPLRH 226
Score = 37.7 bits (86), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 13/27 (48%), Positives = 22/27 (81%)
Query: 687 DVTYSDIGGCKEQIEKLREVVETPLLH 713
+V Y D+GGC++Q+ +++E+VE PL H
Sbjct: 200 EVGYDDVGGCRKQLAQIKEMVELPLRH 226
>pdb|1XVM|A Chain A, Trypsin From Fusarium Oxysporum- Room Temperature To
Atomic Resolution
pdb|1XVO|A Chain A, Trypsin From Fusarium Oxysporum At Ph 6
pdb|1FY5|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDN|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FY4|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FN8|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDQ|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
Length = 224
Score = 91.7 bits (226), Expect = 1e-18, Method: Composition-based stats.
Identities = 60/187 (32%), Positives = 91/187 (48%), Gaps = 13/187 (6%)
Query: 195 VGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHNR 254
VGG + ++P++V++ + G +CGG+L++ VLTAAHCV + I S
Sbjct: 2 VGGTSASAGDFPFIVSISRNGGPWCGGSLLNANTVLTAAHCVSGYAQSGFQIRAGSLSRT 61
Query: 255 ATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLG-E 313
+ + + + RV HP Y+ +++D+A+LKL T + + L G +
Sbjct: 62 SGGITSSLSSVRV-----HPSYSG-----NNNDLAILKLSTSIPSGGNIGYARLAASGSD 111
Query: 314 KFTQRTGTVVGWGRVEESG-QIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCAGYVE 372
+ TV GWG E G +L VP++S CR G A +T M CAG
Sbjct: 112 PVAGSSATVAGWGATSEGGSSTPVNLLKVTVPIVSRATCRAQYGTSA-ITNQMFCAGVSS 170
Query: 373 GGKDSCQ 379
GGKDSCQ
Sbjct: 171 GGKDSCQ 177
>pdb|4FXG|H Chain H, Complement C4 In Complex With Masp-2
pdb|4FXG|J Chain J, Complement C4 In Complex With Masp-2
Length = 242
Score = 91.7 bits (226), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 63/194 (32%), Positives = 95/194 (48%), Gaps = 16/194 (8%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKD-LIVVISEH 252
I GG + ++PW V + G G L+ D +VLTAAH V K L + +
Sbjct: 1 IYGGQKAKPGDFPWQVLI--LGGTTAAGALLYDNWVLTAAHAVYEQKHDASALDIRMGTL 58
Query: 253 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQL- 311
R + + TQ + V H Y D+DIAL+KL+ + ++P+CLP+
Sbjct: 59 KRLSPHYTQAWSE---AVFIHEGYTHDAG--FDNDIALIKLNNKVVINSNITPICLPRKE 113
Query: 312 GEKF--TQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQEC----RQFPGFEAKLTGNM 365
E F T GT GWG + + G +A +L +P++ +Q+C + P +T NM
Sbjct: 114 AESFMRTDDIGTASGWG-LTQRGFLARNLMYVDIPIVDHQKCTAAYEKPPYPRGSVTANM 172
Query: 366 MCAGYVEGGKDSCQ 379
+CAG GGKDSC+
Sbjct: 173 LCAGLESGGKDSCR 186
>pdb|3TVJ|B Chain B, Catalytic Fragment Of Masp-2 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 242
Score = 91.7 bits (226), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 63/194 (32%), Positives = 95/194 (48%), Gaps = 16/194 (8%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKD-LIVVISEH 252
I GG + ++PW V + G G L+ D +VLTAAH V K L + +
Sbjct: 1 IYGGQKAKPGDFPWQVLI--LGGTTAAGALLYDNWVLTAAHAVYEQKHDASALDIRMGTL 58
Query: 253 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQL- 311
R + + TQ + V H Y D+DIAL+KL+ + ++P+CLP+
Sbjct: 59 KRLSPHYTQAWSE---AVFIHEGYTHDAG--FDNDIALIKLNNKVVINSNITPICLPRKE 113
Query: 312 GEKF--TQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQEC----RQFPGFEAKLTGNM 365
E F T GT GWG + + G +A +L +P++ +Q+C + P +T NM
Sbjct: 114 AESFMRTDDIGTASGWG-LTQRGFLARNLMYVDIPIVDHQKCTAAYEKPPYPRGSVTANM 172
Query: 366 MCAGYVEGGKDSCQ 379
+CAG GGKDSC+
Sbjct: 173 LCAGLESGGKDSCR 186
>pdb|1IXZ|A Chain A, Crystal Structure Of The Ftsh Atpase Domain From Thermus
Thermophilus
pdb|1IY0|A Chain A, Crystal Structure Of The Ftsh Atpase Domain With Amp-Pnp
From Thermus Thermophilus
pdb|1IY1|A Chain A, Crystal Structure Of The Ftsh Atpase Domain With Adp From
Thermus Thermophilus
Length = 254
Score = 90.9 bits (224), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 52/132 (39%), Positives = 78/132 (59%), Gaps = 3/132 (2%)
Query: 478 SDIGGCKEQIEKLREVVETPLLHLDGFDPRGNIKVLMATNRPDTLDPALMRPGRLDRKVE 537
S +GG ++ E + + L+ +DGF+ I V+ ATNRPD LDPAL+RPGR DR++
Sbjct: 126 SGVGGGNDERE---QTLNQLLVEMDGFEKDTAIVVMAATNRPDILDPALLRPGRFDRQIA 182
Query: 538 FGLPDLEGRTHIFKIHARSMSVERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIRARRK 597
PD++GR I +IHAR + D+ LLA+ P GA++ ++ EA + A R R+
Sbjct: 183 IDAPDVKGREQILRIHARGKPLAEDVDLALLAKRTPGFVGADLENLLNEAALLAAREGRR 242
Query: 598 VASEKDFLEAVN 609
+ KD EA +
Sbjct: 243 KITMKDLEEAAS 254
Score = 62.0 bits (149), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 29/61 (47%), Positives = 37/61 (60%)
Query: 112 MLELINQPEKFVNLGIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQKYV 171
++E + P +F +G PKGVLL GPPG GKT ARAVA FI GS+ V+ +V
Sbjct: 31 IVEFLKNPSRFHEMGARIPKGVLLVGPPGVGKTHLARAVAGEARVPFITASGSDFVEMFV 90
Query: 172 G 172
G
Sbjct: 91 G 91
>pdb|1MD8|A Chain A, Monomeric Structure Of The Active Catalytic Domain Of
Complement Protease C1r
Length = 329
Score = 90.9 bits (224), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 18/207 (8%)
Query: 185 CGVP----NRMDRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCV---- 236
CG P + RI+GG ++ +PW V G+ GG L+ DR++LTAAH +
Sbjct: 77 CGKPVNPVEQRQRIIGGQKAKMGNFPWQVFTNIHGR--GGGALLGDRWILTAAHTLYPKE 134
Query: 237 RSSKRQKDLIVVISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTP 296
++ L V + N + ++ + +V HP Y + + + DIALL+L+
Sbjct: 135 HEAQSNASLDVFLGHTNVEEL--MKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENS 192
Query: 297 LEFKPTVSPVCLPQLGEKFT-QRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFP 355
+ P + P+CLP + G V G+G +EE +IA DLR ++PV + Q C +
Sbjct: 193 VTLGPNLLPICLPDNDTFYDLGLMGYVSGFGVMEE--KIAHDLRFVRLPVANPQACENWL 250
Query: 356 GFEAKL---TGNMMCAGYVEGGKDSCQ 379
+ ++ + NM CAG+ +D+CQ
Sbjct: 251 RGKNRMDVFSQNMFCAGHPSLKQDACQ 277
>pdb|1MD7|A Chain A, Monomeric Structure Of The Zymogen Of Complement Protease
C1r
Length = 328
Score = 90.5 bits (223), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 18/207 (8%)
Query: 185 CGVP----NRMDRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCV---- 236
CG P + RI+GG ++ +PW V G+ GG L+ DR++LTAAH +
Sbjct: 77 CGKPVNPVEQRQRIIGGQKAKMGNFPWQVFTNIHGR--GGGALLGDRWILTAAHTLYPKE 134
Query: 237 RSSKRQKDLIVVISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTP 296
++ L V + N + ++ + +V HP Y + + + DIALL+L+
Sbjct: 135 HEAQSNASLDVFLGHTNVEEL--MKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENS 192
Query: 297 LEFKPTVSPVCLPQLGEKFT-QRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFP 355
+ P + P+CLP + G V G+G +EE +IA DLR ++PV + Q C +
Sbjct: 193 VTLGPNLLPICLPDNDTFYDLGLMGYVSGFGVMEE--KIAHDLRFVRLPVANPQACENWL 250
Query: 356 GFEAKL---TGNMMCAGYVEGGKDSCQ 379
+ ++ + NM CAG+ +D+CQ
Sbjct: 251 RGKNRMDVFSQNMFCAGHPSLKQDACQ 277
>pdb|1TON|A Chain A, Rat Submaxillary Gland Serine Protease, Tonin. Structure
Solution And Refinement At 1.8 Angstroms Resolution
Length = 235
Score = 90.5 bits (223), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 62/194 (31%), Positives = 92/194 (47%), Gaps = 20/194 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+ E N PW VA+ ++ CGG LI +V+TAAHC ++ + V+ N
Sbjct: 1 IVGGYKCEKNSQPWQVAV--INEYLCGGVLIDPSWVITAAHCYSNNYQ------VLLGRN 52
Query: 254 RATVYETQIETRRVVKVLTHPKY--------NAQGAKSHDHDIALLKLDTPLEFKPTVSP 305
E + R V + HP Y Q H +D+ LL L P + V
Sbjct: 53 NLFKDEPFAQRRLVRQSFRHPDYIPLIVTNDTEQPVHDHSNDLMLLHLSEPADITGGVKV 112
Query: 306 VCLPQLGEKFTQRTGTVVGWGRVEESGQIAS-DLRATQVPVMSNQECRQFPGFEAKLTGN 364
+ LP E T GWG S + S DL+ + ++SN++C + ++ +T
Sbjct: 113 IDLPT-KEPKVGSTCLASGWGSTNPSEMVVSHDLQCVNIHLLSNEKCIET--YKDNVTDV 169
Query: 365 MMCAGYVEGGKDSC 378
M+CAG +EGGKD+C
Sbjct: 170 MLCAGEMEGGKDTC 183
>pdb|1IY2|A Chain A, Crystal Structure Of The Ftsh Atpase Domain From Thermus
Thermophilus
Length = 278
Score = 90.5 bits (223), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 52/132 (39%), Positives = 78/132 (59%), Gaps = 3/132 (2%)
Query: 478 SDIGGCKEQIEKLREVVETPLLHLDGFDPRGNIKVLMATNRPDTLDPALMRPGRLDRKVE 537
S +GG ++ E + + L+ +DGF+ I V+ ATNRPD LDPAL+RPGR DR++
Sbjct: 150 SGVGGGNDERE---QTLNQLLVEMDGFEKDTAIVVMAATNRPDILDPALLRPGRFDRQIA 206
Query: 538 FGLPDLEGRTHIFKIHARSMSVERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIRARRK 597
PD++GR I +IHAR + D+ LLA+ P GA++ ++ EA + A R R+
Sbjct: 207 IDAPDVKGREQILRIHARGKPLAEDVDLALLAKRTPGFVGADLENLLNEAALLAAREGRR 266
Query: 598 VASEKDFLEAVN 609
+ KD EA +
Sbjct: 267 KITMKDLEEAAS 278
Score = 62.0 bits (149), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 29/61 (47%), Positives = 37/61 (60%)
Query: 112 MLELINQPEKFVNLGIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQKYV 171
++E + P +F +G PKGVLL GPPG GKT ARAVA FI GS+ V+ +V
Sbjct: 55 IVEFLKNPSRFHEMGARIPKGVLLVGPPGVGKTHLARAVAGEARVPFITASGSDFVEMFV 114
Query: 172 G 172
G
Sbjct: 115 G 115
>pdb|2ZCH|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|2ZCK|P Chain P, Crystal Structure Of A Ternary Complex Between Psa, A
Substrat-Acyl Intermediate And An Activating Antibody
pdb|2ZCL|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|3QUM|P Chain P, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
pdb|3QUM|Q Chain Q, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
Length = 237
Score = 89.7 bits (221), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 62/195 (31%), Positives = 90/195 (46%), Gaps = 18/195 (9%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGGW E + PW V + G+ CGG L+ ++VLTAAHC+R+ ++++ H+
Sbjct: 1 IVGGWECEKHSQPWQVLVASRGRAVCGGVLVHPQWVLTAAHCIRNKS-----VILLGRHS 55
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSH--------DHDIALLKLDTPLEFKPTVSP 305
+T + +V HP Y+ K+ HD+ LL+L P E V
Sbjct: 56 LFHPEDTG-QVFQVSHSFPHPLYDMSLLKNRFLRPGDDSSHDLMLLRLSEPAELTDAVKV 114
Query: 306 VCLPQLGEKFTQRTGTVVGWGRVE-ESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGN 364
+ LP E T GWG +E E L+ + V+SN C Q K+T
Sbjct: 115 MDLPT-QEPALGTTCYASGWGSIEPEEFLTPKKLQCVDLHVISNDVCAQV--HPQKVTKF 171
Query: 365 MMCAGYVEGGKDSCQ 379
M+CAG GGK +C
Sbjct: 172 MLCAGRWTGGKSTCS 186
>pdb|1AO5|A Chain A, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
pdb|1AO5|B Chain B, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
Length = 237
Score = 89.7 bits (221), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 62/196 (31%), Positives = 90/196 (45%), Gaps = 20/196 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
+VGG+ E N PW VA+ + CGG L+ +VLTAAHC D V N
Sbjct: 1 VVGGFNCEKNSQPWQVAVYYQKEHICGGVLLDRNWVLTAAHCYV------DQYEVWLGKN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQ---------GAKSHDHDIALLKLDTPLEFKPTVS 304
+ E + R V K HP +N GA D D+ LL+L P + V
Sbjct: 55 KLFQEEPSAQHRLVSKSFPHPGFNMSLLMLQTIPPGADFSD-DLMLLRLSKPADITDVVK 113
Query: 305 PVCLPQLGEKFTQRTGTVVGWGRVEES-GQIASDLRATQVPVMSNQECRQFPGFEAKLTG 363
P+ LP K + GWG + + Q DL+ + ++ N+ C + + K+T
Sbjct: 114 PIALPTKEPKPGSKC-LASGWGSITPTRWQKPDDLQCVFITLLPNENCAKV--YLQKVTD 170
Query: 364 NMMCAGYVEGGKDSCQ 379
M+CAG + GGKD+C+
Sbjct: 171 VMLCAGEMGGGKDTCR 186
>pdb|2XRC|A Chain A, Human Complement Factor I
pdb|2XRC|B Chain B, Human Complement Factor I
pdb|2XRC|C Chain C, Human Complement Factor I
pdb|2XRC|D Chain D, Human Complement Factor I
Length = 565
Score = 89.4 bits (220), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 70/211 (33%), Positives = 106/211 (50%), Gaps = 31/211 (14%)
Query: 185 CGVPNRMD----RIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSK 240
CGV NRM RIVGG ++ + PW VA++ A CGG I ++LTAAHC+R+SK
Sbjct: 309 CGVKNRMHIRRKRIVGGKRAQLGDLPWQVAIKDASGITCGGIYIGGCWILTAAHCLRASK 368
Query: 241 RQKDLIVVISEHNRATVYETQIETRRVV-----KVLTHPKYNAQGAKSHDHDIALLKLDT 295
+ I V + +R+V +++ H YN A ++ +DIAL+++
Sbjct: 369 THRYQIWT------TVVDWIHPDLKRIVIEYVDRIIFHENYN---AGTYQNDIALIEMKK 419
Query: 296 PLEFK----PTVSPVCLPQLGEKFT-QRTGTVVGWGRVEESGQIASDLRATQVPVMSNQE 350
K P P C+P F T V GWGR +++ ++ S L+ +V ++SN
Sbjct: 420 DGNKKDCELPRSIPACVPWSPYLFQPNDTCIVSGWGREKDNERVFS-LQWGEVKLISN-- 476
Query: 351 CRQFPG--FEAKLTGNMMCAGYVEGGKDSCQ 379
C +F G F K M CAG +G D+C+
Sbjct: 477 CSKFYGNRFYEK---EMECAGTYDGSIDACK 504
>pdb|2QY0|B Chain B, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
pdb|2QY0|D Chain D, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
Length = 242
Score = 89.0 bits (219), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 16/195 (8%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCV----RSSKRQKDLIVVI 249
I+GG ++ +PW V G+ GG L+ DR++LTAAH + ++ L V +
Sbjct: 1 IIGGQKAKMGNFPWQVFTNIHGR--GGGALLGDRWILTAAHTLYPKEHEAQSNASLDVFL 58
Query: 250 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLP 309
N + ++ + +V HP Y + + + DIALL+L+ + P + P+CLP
Sbjct: 59 GHTNVEEL--MKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLPICLP 116
Query: 310 QLGEKFTQ--RTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKL---TGN 364
+ F G V G+G +EE +IA DLR ++PV + Q C + + ++ + N
Sbjct: 117 D-NDTFYDLGLMGYVSGFGVMEE--KIAHDLRFVRLPVANPQACENWLRGKNRMDVFSQN 173
Query: 365 MMCAGYVEGGKDSCQ 379
M CAG+ +D+CQ
Sbjct: 174 MFCAGHPSLKQDACQ 188
>pdb|1GPZ|A Chain A, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
pdb|1GPZ|B Chain B, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
Length = 399
Score = 89.0 bits (219), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 18/207 (8%)
Query: 185 CGVP----NRMDRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCV---- 236
CG P + +I+GG ++ +PW V G+ GG L+ DR++LTAAH +
Sbjct: 145 CGKPVNPVEQRQQIIGGQKAKMGNFPWQVFTNIHGR--GGGALLGDRWILTAAHTLYPKE 202
Query: 237 RSSKRQKDLIVVISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTP 296
++ L V + N + ++ + +V HP Y + + + DIALL+L+
Sbjct: 203 HEAQSNASLDVFLGHTNVEEL--MKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENS 260
Query: 297 LEFKPTVSPVCLPQLGEKFT-QRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFP 355
+ P + P+CLP + G V G+G +EE +IA DLR ++PV + Q C +
Sbjct: 261 VTLGPNLLPICLPDNDTFYDLGLMGYVSGFGVMEE--KIAHDLRFVRLPVANPQACENWL 318
Query: 356 GFEAKL---TGNMMCAGYVEGGKDSCQ 379
+ ++ + NM CAG+ +D+CQ
Sbjct: 319 RGKNRMDVFSQNMFCAGHPSLKQDACQ 345
>pdb|2R62|A Chain A, Crystal Structure Of Helicobacter Pylori Atp Dependent
Protease, Ftsh
pdb|2R62|B Chain B, Crystal Structure Of Helicobacter Pylori Atp Dependent
Protease, Ftsh
pdb|2R65|A Chain A, Crystal Structure Of Helicobacter Pylori Atp Dependent
Protease, Ftsh Adp Complex
pdb|2R65|B Chain B, Crystal Structure Of Helicobacter Pylori Atp Dependent
Protease, Ftsh Adp Complex
pdb|2R65|C Chain C, Crystal Structure Of Helicobacter Pylori Atp Dependent
Protease, Ftsh Adp Complex
pdb|2R65|D Chain D, Crystal Structure Of Helicobacter Pylori Atp Dependent
Protease, Ftsh Adp Complex
pdb|2R65|E Chain E, Crystal Structure Of Helicobacter Pylori Atp Dependent
Protease, Ftsh Adp Complex
Length = 268
Score = 89.0 bits (219), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 46/131 (35%), Positives = 71/131 (54%), Gaps = 1/131 (0%)
Query: 481 GGCKEQIEKLREVVETPLLHLDGFDPRGN-IKVLMATNRPDTLDPALMRPGRLDRKVEFG 539
GG ++ + + L +DGF + VL ATNRP+ LDPALMRPGR DR+V
Sbjct: 122 GGVVSGNDEREQTLNQLLAEMDGFGSENAPVIVLAATNRPEILDPALMRPGRFDRQVLVD 181
Query: 540 LPDLEGRTHIFKIHARSMSVERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIRARRKVA 599
PD GR I K+H + + + D+ + +A+L GA++ ++ EA + A R +K
Sbjct: 182 KPDFNGRVEILKVHIKGVKLANDVNLQEVAKLTAGLAGADLANIINEAALLAGRNNQKEV 241
Query: 600 SEKDFLEAVNK 610
++ EAV +
Sbjct: 242 RQQHLKEAVER 252
Score = 66.6 bits (161), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 29/61 (47%), Positives = 41/61 (67%)
Query: 112 MLELINQPEKFVNLGIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQKYV 171
+++ + PE++ NLG + PKGVLL GPPGTGKTL A+AVA F + GS ++ +V
Sbjct: 26 IVDFLKYPERYANLGAKIPKGVLLVGPPGTGKTLLAKAVAGEAHVPFFSMGGSSFIEMFV 85
Query: 172 G 172
G
Sbjct: 86 G 86
>pdb|1AUT|C Chain C, Human Activated Protein C
Length = 250
Score = 88.2 bits (217), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 63/199 (31%), Positives = 99/199 (49%), Gaps = 24/199 (12%)
Query: 194 IVGGWTTEVNEYPW-VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEH 252
++ G T + PW VV L+ K CG LI +VLTAAHC+ SK+ L+V + E+
Sbjct: 1 LIDGKMTRRGDSPWQVVLLDSKKKLACGAVLIHPSWVLTAAHCMDESKK---LLVRLGEY 57
Query: 253 N--RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQ 310
+ R +E ++ + +V HP Y+ + D+DIALL L P T+ P+CLP
Sbjct: 58 DLRRWEKWELDLDIK---EVFVHPNYSKS---TTDNDIALLHLAQPATLSQTIVPICLPD 111
Query: 311 --LGEKFTQRTGT---VVGWGRVEESGQIASD-----LRATQVPVMSNQECRQFPGFEAK 360
L E+ + G V GWG + A L ++PV+ + EC +
Sbjct: 112 SGLAERELNQAGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSEV--MSNM 169
Query: 361 LTGNMMCAGYVEGGKDSCQ 379
++ NM+CAG + +D+C+
Sbjct: 170 VSENMLCAGILGDRQDACE 188
>pdb|3F6U|H Chain H, Crystal Structure Of Human Activated Protein C (Apc)
Complexed With Ppack
Length = 240
Score = 87.8 bits (216), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 63/199 (31%), Positives = 99/199 (49%), Gaps = 24/199 (12%)
Query: 194 IVGGWTTEVNEYPW-VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEH 252
++ G T + PW VV L+ K CG LI +VLTAAHC+ SK+ L+V + E+
Sbjct: 1 LIDGKMTRRGDSPWQVVLLDSKKKLACGAVLIHPSWVLTAAHCMDESKK---LLVRLGEY 57
Query: 253 N--RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQ 310
+ R +E ++ + +V HP Y+ + D+DIALL L P T+ P+CLP
Sbjct: 58 DLRRWEKWELDLDIK---EVFVHPNYSKS---TTDNDIALLHLAQPATLSQTIVPICLPD 111
Query: 311 --LGEKFTQRTGT---VVGWGRVEESGQIASD-----LRATQVPVMSNQECRQFPGFEAK 360
L E+ + G V GWG + A L ++PV+ + EC +
Sbjct: 112 SGLAERELNQAGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSEV--MSNM 169
Query: 361 LTGNMMCAGYVEGGKDSCQ 379
++ NM+CAG + +D+C+
Sbjct: 170 VSENMLCAGILGDRQDACE 188
>pdb|2JET|B Chain B, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 128
Score = 87.4 bits (215), Expect = 2e-17, Method: Composition-based stats.
Identities = 56/143 (39%), Positives = 82/143 (57%), Gaps = 23/143 (16%)
Query: 192 DRIVGGWTTEVNEYPWVVALE-QAGKFFCGGTLISDRYVLTAAHC-VRSSKRQKDLIVVI 249
D I G W PW V+L+ + G FCGG+LIS+ +V+TAAHC V++S +VV
Sbjct: 3 DAIPGSW-------PWQVSLQDKTGFHFCGGSLISEDWVVTAAHCGVKTSD-----VVVA 50
Query: 250 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLP 309
E ++ + E I+ ++ +V +PK+N ++ DI LLKL TP +F TVS VCLP
Sbjct: 51 GEFDQGS-DEENIQVLKIAQVFKNPKFNMFTVRN---DITLLKLATPAQFSETVSAVCLP 106
Query: 310 QLGEKFTQRTGTV---VGWGRVE 329
+ + F GTV GWG+ +
Sbjct: 107 NVDDDFP--PGTVCATTGWGKTK 127
>pdb|4H4F|A Chain A, Crystal Structure Of Human Chymotrypsin C (ctrc) Bound To
Inhibitor Eglin C From Hirudo Medicinalis
Length = 249
Score = 87.4 bits (215), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 66/241 (27%), Positives = 113/241 (46%), Gaps = 22/241 (9%)
Query: 194 IVGGWTTEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVI 249
+VGG + +PW ++L+ + CGGTLI+ +VLTAAHC+ +++ + V +
Sbjct: 1 VVGGEDARPHSWPWQISLQYLKNDTWRHTCGGTLIASNFVLTAAHCISNTRTYR---VAV 57
Query: 250 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLP 309
++N E V + H ++NA ++ DIAL+KL +E T+ CLP
Sbjct: 58 GKNNLEVEDEEGSLFVGVDTIHVHKRWNALLLRN---DIALIKLAEHVELSDTIQVACLP 114
Query: 310 QLGEKFTQRT-GTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCA 368
+ + V GWGR+ +G IA L+ PV+ + C + + ++ M+CA
Sbjct: 115 EKDSLLPKDYPCYVTGWGRLWTNGPIADKLQQGLQPVVDHATCSRIDWWGFRVKKTMVCA 174
Query: 369 G---------YVEGGKDSCQVTLDEADIALLKSYG--QGQYTKSIKAVEDDIQAVIKRVN 417
G GG +CQ+ ++ + S+G +G T+ V + A I +N
Sbjct: 175 GGDGVISACNGDSGGPLNCQLENGSWEVFGIVSFGSRRGCNTRKKPVVYTRVSAYIDWIN 234
Query: 418 E 418
E
Sbjct: 235 E 235
>pdb|2B9L|A Chain A, Crystal Structure Of Prophenoloxidase Activating Factor-Ii
From The Beetle Holotrichia Diomphalia
Length = 394
Score = 87.0 bits (214), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 68/220 (30%), Positives = 105/220 (47%), Gaps = 35/220 (15%)
Query: 185 CGVPNR--MDRIVGGWTTEV--NEYPWVVALEQAG--------KFFCGGTLISDRYVLTA 232
CG+ N +D + G T E E+PW+VA+ +A + CGG+LI+ VLT
Sbjct: 118 CGIRNERGLDFKITGQTNEAEYGEFPWMVAVLKANVIPGSGEEQLVCGGSLIAPSVVLTG 177
Query: 233 AHCVRSSKRQKDLIVVISEHNRATVYETQIET-------RRVVKVLTHPKYNAQGAKSHD 285
AHCV S + D I + RA ++T E R++ +V+ H +N K+
Sbjct: 178 AHCVNSYQSNLDAIKI-----RAGEWDTLTEKERLPYQERKIRQVIIHSNFNP---KTVV 229
Query: 286 HDIALLKLDTPLEFKPTVSPVCLPQLGEKFTQRTGTVVGWGRVEESG--QIASDLRATQV 343
+D+ALL LD PL + +CLPQ + F GWG+ E + ++ L+ Q+
Sbjct: 230 NDVALLLLDRPLVQADNIGTICLPQQSQIFDSTECFASGWGKKEFGSRHRYSNILKKIQL 289
Query: 344 PVMSNQECRQ-----FPGFEAKLTGNMMCAGYVEGGKDSC 378
P + +C+ G + L +CAG E GKD+C
Sbjct: 290 PTVDRDKCQADLRNTRLGLKFVLDQTFVCAGG-EQGKDTC 328
>pdb|4IGD|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-1
Length = 406
Score = 86.7 bits (213), Expect = 4e-17, Method: Compositional matrix adjust.
Identities = 64/242 (26%), Positives = 114/242 (47%), Gaps = 25/242 (10%)
Query: 185 CGVPN----RMDRIVGGWTTEVNEYPWVVALEQA-GKFFCGGTLISDRYVLTAAHCVRSS 239
CG+P M +I G + PW+ L G+ FCGG+L+ +++TAAHC+ S
Sbjct: 143 CGLPKFSRKLMAQIFNGRPAQKGTTPWIAMLSHLNGQPFCGGSLLGSSWIVTAAHCLHQS 202
Query: 240 -------KRQKDLI------VVISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDH 286
R DL+ +++ +H R E + + V HP+Y+ + ++
Sbjct: 203 LDPEDPTLRDSDLLSPSDFKIILGKHWRLRSDENE-QHLGVKHTTLHPQYDPN---TFEN 258
Query: 287 DIALLKLDTPLEFKPTVSPVCLPQLGEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVM 346
D+AL++L V P+CLP+ G + V GWG+ + + L ++P++
Sbjct: 259 DVALVELLESPVLNAFVMPICLPE-GPQQEGAMVIVSGWGK-QFLQRFPETLMEIEIPIV 316
Query: 347 SNQECRQ-FPGFEAKLTGNMMCAGYVEGGKDSCQVTLDEADIALLKSYGQGQYTKSIKAV 405
+ C++ + + K+T +M+CAG EGGKD+C + L + GQ ++
Sbjct: 317 DHSTCQKAYAPLKKKVTRDMICAGEKEGGKDACAGDSGGPMVTLNRERGQWYLVGTVSWG 376
Query: 406 ED 407
+D
Sbjct: 377 DD 378
>pdb|1ELT|A Chain A, Structure Of Native Pancreatic Elastase From North
Atlantic Salmon At 1.61 Angstroms Resolution
Length = 236
Score = 86.7 bits (213), Expect = 5e-17, Method: Composition-based stats.
Identities = 56/189 (29%), Positives = 94/189 (49%), Gaps = 13/189 (6%)
Query: 194 IVGGWTTEVNEYPWVVALE-QAGKFF---CGGTLISDRYVLTAAHCVRSSKRQKDLIVVI 249
+VGG + N +PW ++L+ ++G + CGG+LI +V+TAAHCV S++ + VV+
Sbjct: 1 VVGGRVAQPNSWPWQISLQYKSGSSYYHTCGGSLIRQGWVMTAAHCVDSARTWR---VVL 57
Query: 250 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLP 309
EHN T E + + V V H +N+ + +DIALL+L+T V LP
Sbjct: 58 GEHNLNT-NEGKEQIMTVNSVFIHSGWNSDDV-AGGYDIALLRLNTQASLNSAVQLAALP 115
Query: 310 QLGEKFTQRTGT-VVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCA 368
+ + GWG+ G ++ L+ +P + + C + + + M+CA
Sbjct: 116 PSNQILPNNNPCYITGWGKTSTGGPLSDSLKQAWLPSVDHATCSSSGWWGSTVKTTMVCA 175
Query: 369 GYVEGGKDS 377
G GG +S
Sbjct: 176 G---GGANS 181
>pdb|2QZ4|A Chain A, Human Paraplegin, Aaa Domain In Complex With Adp
Length = 262
Score = 85.9 bits (211), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 55/157 (35%), Positives = 83/157 (52%), Gaps = 11/157 (7%)
Query: 469 VEEKPDVTYSDIGGCKEQIEKLREVVETPLLHLDGFDPRGNIKVLMATNRPDTLDPALMR 528
V +K T S +E+ + + L+ +DG ++ VL +TNR D LD ALMR
Sbjct: 110 VGKKRSTTMSGFSNTEEE-----QTLNQLLVEMDGMGTTDHVIVLASTNRADILDGALMR 164
Query: 529 PGRLDRKVEFGLPDLEGRTHIFKIHARSMSVERDIRF--ELLARLCPNSTGAEIRSVCTE 586
PGRLDR V LP L+ R IF+ H +S+ + + F + LA L P +GA+I ++C E
Sbjct: 165 PGRLDRHVFIDLPTLQERREIFEQHLKSLKLTQSSTFYSQRLAELTPGFSGADIANICNE 224
Query: 587 AGMFAIRARRKVASEKDFLEAVNKV----ARCTKIIN 619
A + A R +F AV +V A+ +KI++
Sbjct: 225 AALHAAREGHTSVHTLNFEYAVERVLAGTAKKSKILS 261
Score = 62.8 bits (151), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 27/59 (45%), Positives = 38/59 (64%)
Query: 110 RTMLELINQPEKFVNLGIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQ 168
R ++ + PE+F+ LG + PKG LL GPPG GKTL A+AVA F+ + G+E V+
Sbjct: 19 REFVDYLKSPERFLQLGAKVPKGALLLGPPGCGKTLLAKAVATEAQVPFLAMAGAEFVE 77
>pdb|2BM2|A Chain A, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|B Chain B, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|C Chain C, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|D Chain D, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2FWW|A Chain A, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|B Chain B, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|C Chain C, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|D Chain D, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FXR|A Chain A, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|B Chain B, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|C Chain C, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|D Chain D, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FPZ|A Chain A, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|B Chain B, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|C Chain C, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|D Chain D, Human Tryptase With 2-Amino Benzimidazole
pdb|2FS8|A Chain A, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|B Chain B, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|C Chain C, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|D Chain D, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS9|A Chain A, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|B Chain B, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|C Chain C, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|D Chain D, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2GDD|A Chain A, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|B Chain B, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|C Chain C, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|D Chain D, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2ZA5|A Chain A, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|B Chain B, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|C Chain C, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|D Chain D, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|4A6L|A Chain A, Beta-Tryptase Inhibitor
pdb|4A6L|B Chain B, Beta-Tryptase Inhibitor
pdb|4A6L|C Chain C, Beta-Tryptase Inhibitor
pdb|4A6L|D Chain D, Beta-Tryptase Inhibitor
pdb|3V7T|A Chain A, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|B Chain B, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|C Chain C, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|D Chain D, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
Length = 245
Score = 85.5 bits (210), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 69/201 (34%), Positives = 102/201 (50%), Gaps = 25/201 (12%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKF---FCGGTLISDRYVLTAAHCVRSSKRQKDLIVVIS 250
IVGG +++PW V+L G + FCGG+LI ++VLTAAHCV KDL +
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCV--GPDVKDLAALRV 58
Query: 251 EHNRATVYETQIETRRVVKVLTHPK-YNAQ-GAKSHDHDIALLKLDTPLEFKPTVSPVCL 308
+ +Y Q + V +++ HP+ Y AQ GA DIALL+L+ P++ V V L
Sbjct: 59 QLREQHLY-YQDQLLPVSRIIVHPQFYTAQIGA-----DIALLELEEPVKVSSHVHTVTL 112
Query: 309 PQLGEKFTQ-RTGTVVGWGRVEESGQIAS--DLRATQVPVMSNQECR------QFPGFEA 359
P E F V GWG V+ ++ L+ +VP+M N C + G +
Sbjct: 113 PPASETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDV 172
Query: 360 KLT-GNMMCAGYVEGGKDSCQ 379
++ +M+CAG +DSCQ
Sbjct: 173 RIVRDDMLCAGNTR--RDSCQ 191
>pdb|2ZEB|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
Length = 243
Score = 85.5 bits (210), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 69/201 (34%), Positives = 102/201 (50%), Gaps = 25/201 (12%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKF---FCGGTLISDRYVLTAAHCVRSSKRQKDLIVVIS 250
IVGG +++PW V+L G + FCGG+LI ++VLTAAHCV KDL +
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCV--GPDVKDLAALRV 58
Query: 251 EHNRATVYETQIETRRVVKVLTHPK-YNAQ-GAKSHDHDIALLKLDTPLEFKPTVSPVCL 308
+ +Y Q + V +++ HP+ Y AQ GA DIALL+L+ P++ V V L
Sbjct: 59 QLREQHLY-YQDQLLPVSRIIVHPQFYTAQIGA-----DIALLELEEPVKVSSHVHTVTL 112
Query: 309 PQLGEKFTQ-RTGTVVGWGRVEESGQIAS--DLRATQVPVMSNQECR------QFPGFEA 359
P E F V GWG V+ ++ L+ +VP+M N C + G +
Sbjct: 113 PPASETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDV 172
Query: 360 KLT-GNMMCAGYVEGGKDSCQ 379
++ +M+CAG +DSCQ
Sbjct: 173 RIVRDDMLCAGNTR--RDSCQ 191
>pdb|1SGF|A Chain A, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|X Chain X, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 240
Score = 85.5 bits (210), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 56/186 (30%), Positives = 84/186 (45%), Gaps = 18/186 (9%)
Query: 203 NEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHNRATVYETQI 262
N PW VA+ + K+ CGG L+ +VLTAAHC D V N E
Sbjct: 13 NSQPWHVAVYRFNKYQCGGVLLDRNWVLTAAHCYN------DKYQVWLGKNNFLEDEPSD 66
Query: 263 ETRRVVKVLTHPKYN--------AQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGEK 314
+ R V K + HP +N Q + +D+ LL+L P + V P+ LP K
Sbjct: 67 QHRLVSKAIPHPDFNMSLLNEHTPQPEDDYSNDLMLLRLSKPADITDVVKPITLPTEEPK 126
Query: 315 FTQRTGTVVGWGRVEE-SGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCAGYVEG 373
T GWG + DL+ + ++ N++C + E K+T M+CAG ++G
Sbjct: 127 LGS-TCLASGWGSTTPIKFKYPDDLQCVNLKLLPNEDCDK--AHEMKVTDAMLCAGEMDG 183
Query: 374 GKDSCQ 379
G +C+
Sbjct: 184 GSYTCE 189
>pdb|1A0L|A Chain A, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|B Chain B, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|C Chain C, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|D Chain D, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
Length = 244
Score = 85.5 bits (210), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 69/201 (34%), Positives = 102/201 (50%), Gaps = 25/201 (12%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKF---FCGGTLISDRYVLTAAHCVRSSKRQKDLIVVIS 250
IVGG +++PW V+L G + FCGG+LI ++VLTAAHCV KDL +
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCV--GPDVKDLAALRV 58
Query: 251 EHNRATVYETQIETRRVVKVLTHPK-YNAQ-GAKSHDHDIALLKLDTPLEFKPTVSPVCL 308
+ +Y Q + V +++ HP+ Y AQ GA DIALL+L+ P++ V V L
Sbjct: 59 QLREQHLY-YQDQLLPVSRIIVHPQFYTAQIGA-----DIALLELEEPVKVSSHVHTVTL 112
Query: 309 PQLGEKFTQ-RTGTVVGWGRVEESGQIAS--DLRATQVPVMSNQECR------QFPGFEA 359
P E F V GWG V+ ++ L+ +VP+M N C + G +
Sbjct: 113 PPASETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDV 172
Query: 360 KLT-GNMMCAGYVEGGKDSCQ 379
++ +M+CAG +DSCQ
Sbjct: 173 RIVRDDMLCAGNTR--RDSCQ 191
>pdb|2FMJ|A Chain A, 220-Loop Mutant Of Streptomyces Griseus Trypsin
Length = 222
Score = 85.1 bits (209), Expect = 1e-16, Method: Composition-based stats.
Identities = 62/186 (33%), Positives = 82/186 (44%), Gaps = 18/186 (9%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
+VGG E+P++V L CGG L + VLTAAHCV S + +
Sbjct: 1 VVGGTRAAQGEFPFMVRLSMG----CGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVD 56
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
+ ++ R KVL P YN G D AL+KL P+ +PT+
Sbjct: 57 LQSSSAVKV---RSTKVLQAPGYNGTG-----KDWALIKLAQPIN-QPTLKIATT----T 103
Query: 314 KFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCAGYVEG 373
+ Q T TV GWG E G L VP +S+ CR G E + +CAGY G
Sbjct: 104 AYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSAYGNEL-VANEEICAGYDTG 162
Query: 374 GKDSCQ 379
G D+CQ
Sbjct: 163 GVDTCQ 168
>pdb|1KDQ|A Chain A, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 131
Score = 84.0 bits (206), Expect = 2e-16, Method: Composition-based stats.
Identities = 56/148 (37%), Positives = 83/148 (56%), Gaps = 23/148 (15%)
Query: 187 VPNRMDRIVGGWTTEVNEYPWVVALE-QAGKFFCGGTLISDRYVLTAAHC-VRSSKRQKD 244
+ N D I G W PW V+L+ + G FCGG+LIS+ +V+TAAHC V++S
Sbjct: 1 IVNGEDAIPGSW-------PWQVSLQDKTGFHFCGGSLISEDWVVTAAHCGVKTSD---- 49
Query: 245 LIVVISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVS 304
+VV E ++ + E I+ ++ +V +PK+N ++ DI LLKL TP +F TVS
Sbjct: 50 -VVVAGEFDQGS-DEENIQVLKIAQVFKNPKFNMFTVRN---DITLLKLATPAQFSETVS 104
Query: 305 PVCLPQLGEKFTQRTGTV---VGWGRVE 329
V LP + + F GTV GWG+ +
Sbjct: 105 AVSLPNVDDDFP--PGTVCATTGWGKTK 130
>pdb|1MTN|B Chain B, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|F Chain F, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|B Chain B, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|G Chain G, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|B Chain B, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|G Chain G, Bovine Chymotrypsin Complexed To Bpti
pdb|1AFQ|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|1VGC|B Chain B, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|B Chain B, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|B Chain B, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid
Acid Inhibitor Complex
pdb|4VGC|B Chain B, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|B Chain B, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With
N-Acetyl-Leucil- Phenylalanine Aldehyde Bound At The
Active Site
pdb|1N8O|B Chain B, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|C Chain C, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|D Chain D, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|B Chain B, Crystal Structure Of A Benzohydroxamic AcidVANADATE
Complex Bound To Chymotrypsin A
pdb|1GMH|F Chain F, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|B Chain B, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|F Chain F, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|F Chain F, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|F Chain F, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|F Chain F, Chemistry Of Caged Enzymes II. Photoactivation Of
Inhibited Chymotrypsin
pdb|6GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|7GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|1CHO|F Chain F, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|F Chain F, The X-Ray Crystal Structure Of The Tetrahedral
Intermediate Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|F Chain F, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|F Chain F, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|B Chain B, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|F Chain F, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|B Chain B, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|F Chain F, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|B Chain B, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|F Chain F, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|F Chain F, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|B Chain B, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|B Chain B, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|B Chain B, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|B Chain B, Three-Dimensional Structure Of Chymotrypsin Inactivated
With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation
Of Serine Proteases By Chloroketones
pdb|3GCH|B Chain B, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
pdb|3RU4|D Chain D, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 131
Score = 84.0 bits (206), Expect = 3e-16, Method: Composition-based stats.
Identities = 51/135 (37%), Positives = 76/135 (56%), Gaps = 10/135 (7%)
Query: 194 IVGGWTTEVNEYPWVVALE-QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEH 252
IV G +PW V+L+ + G FCGG+LI++ +V+TAAHC ++ +VV E
Sbjct: 1 IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEF 56
Query: 253 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLG 312
++ + E +I+ ++ KV + KYN+ + ++DI LLKL T F TVS VCLP
Sbjct: 57 DQGSSSE-KIQKLKIAKVFKNSKYNSL---TINNDITLLKLSTAASFSQTVSAVCLPSAS 112
Query: 313 EKFTQRTGTV-VGWG 326
+ F T V GWG
Sbjct: 113 DDFAAGTTCVTTGWG 127
>pdb|4E7N|A Chain A, Crystal Structure Of Ahv_tl-I, A Glycosylated Snake-Venom
Thrombin- Like Enzyme From Agkistrodon Halys
Length = 238
Score = 83.2 bits (204), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 61/193 (31%), Positives = 99/193 (51%), Gaps = 19/193 (9%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISE 251
I+GG +NE+ ++VAL ++ FCGGTLI+ +VLTAAHC R + R K +
Sbjct: 1 IIGGDECNINEHRFLVALYTSRSRTLFCGGTLINQEWVLTAAHCDRKNFRIK-----LGM 55
Query: 252 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSH---DHDIALLKLDTPLEFKPTVSPVCL 308
H++ E E RV K K+ +K++ D DI L++LD+P++ ++P
Sbjct: 56 HSKKVPNED--EQTRVPK----EKFFCLSSKNYTLWDKDIMLIRLDSPVKNSKHIAPF-S 108
Query: 309 PQLGEKFTQRTGTVVGWGRVEESGQIASDL-RATQVPVMSNQECRQ-FPGFEAKLTGNMM 366
++GWGR+ + D+ + ++ + CR +P FE T +
Sbjct: 109 LPSSPPSVGSVCRIMGWGRISPTEGTYPDVPHCVNINLLEYEMCRAPYPEFELPATSRTL 168
Query: 367 CAGYVEGGKDSCQ 379
CAG +EGGKD+C+
Sbjct: 169 CAGILEGGKDTCK 181
>pdb|3GOV|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-1
pdb|4DJZ|B Chain B, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
pdb|4DJZ|D Chain D, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 251
Score = 82.8 bits (203), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 58/217 (26%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 206 PWVVALEQA-GKFFCGGTLISDRYVLTAAHCVRSS-------KRQKDLI------VVISE 251
PW+ L G+ FCGG+L+ +++TAAHC+ S R DL+ +++ +
Sbjct: 13 PWIAMLSHLNGQPFCGGSLLGSSWIVTAAHCLHQSLDPKDPTLRDSDLLSPSDFKIILGK 72
Query: 252 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQL 311
H R E + + V HP+Y+ + ++D+AL++L V P+CLP+
Sbjct: 73 HWRLRSDENE-QHLGVKHTTLHPQYD---PNTFENDVALVELLESPVLNAFVMPICLPE- 127
Query: 312 GEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQ-FPGFEAKLTGNMMCAGY 370
G + V GWG+ + + L ++P++ + C++ + + K+T +M+CAG
Sbjct: 128 GPQQEGAMVIVSGWGK-QFLQRFPETLMEIEIPIVDHSTCQKAYAPLKKKVTRDMICAGE 186
Query: 371 VEGGKDSCQVTLDEADIALLKSYGQGQYTKSIKAVED 407
EGGKD+C + L + GQ ++ +D
Sbjct: 187 KEGGKDACAGDSGGPMVTLNRERGQWYLVGTVSWGDD 223
>pdb|2EST|E Chain E, Crystallographic Study Of The Binding Of A Trifluoroacetyl
Dipeptide Anilide Inhibitor With Elastase
pdb|4EST|E Chain E, Crystal Structure Of The Covalent Complex Formed By A
Peptidyl Alpha, Alpha-Difluoro-Beta-Keto Amide With
Porcine Pancreatic Elastase At 1.78-Angstroms Resolution
pdb|5EST|E Chain E, Crystallographic Analysis Of The Inhibition Of Porcine
Pancreatic Elastase By A Peptidyl Boronic Acid:
Structure Of A Reaction Intermediate
pdb|7EST|E Chain E, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|8EST|E Chain E, Reaction Of Porcine Pancreatic Elastase With 7-substituted
3-alkoxy-4-chloroisocoumarins: Design Of Potent
Inhibitors Using The Crystal Structure Of The Complex
Formed With 4- Chloro-3-ethoxy-7-guanidino-isocoumarin
pdb|1ELA|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELC|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELB|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELD|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1ELE|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1NES|E Chain E, Structure Of The Product Complex Of Acetyl-ala-pro-ala
With Porcine Pancreatic Elastase At 1.65 Angstroms
Resolution
pdb|1BMA|A Chain A, Benzyl Methyl Aminimide Inhibitor Complexed To Porcine
Pancreatic Elastase
pdb|1FLE|E Chain E, Crystal Structure Of Elafin Complexed With Porcine
Pancreatic Elastase
pdb|1B0E|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With Mdl
101,146
pdb|1QGF|A Chain A, Porcine Pancreatic Elastase Complexed With (3r, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One
pdb|1QIX|B Chain B, Porcine Pancreatic Elastase Complexed With Human
Beta-casomorphin-7
pdb|1QR3|E Chain E, Structure Of Porcine Pancreatic Elastase In Complex With
Fr901277, A Novel Macrocyclic Inhibitor Of Elastases At
1.6 Angstrom Resolution
pdb|1E34|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2- One Soaked In Ph 9 Buffer For One Minute
pdb|1E35|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One Soaked In Ph 9 Buffer For Two
Minutes
pdb|1E36|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One
pdb|1E37|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 1 Minute
pdb|1E38|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 2 Minutes
pdb|1HAZ|B Chain B, Snapshots Of Serine Protease Catalysis: (c) Acyl-enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-casomorphin-7 Jumped To Ph 9 For 1 Minute
pdb|1H9L|B Chain B, Porcine Pancreatic Elastase Complexed With
Acetyl-Val-Glu-Pro-Ile-Cooh
pdb|1OKX|A Chain A, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|1OKX|B Chain B, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|2FO9|A Chain A, Structure Of Porcine Pancreatic Elastase In 95% Acetone
pdb|2FOA|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010 %
BENZENE
pdb|2FOB|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010
CYCLOHEXANE
pdb|2FOC|A Chain A, Structure Of Porcine Pancreatic Elastase In 55%
Dimethylformamide
pdb|2FOD|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Ethanol
pdb|2FOE|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Hexane
pdb|2FOF|A Chain A, Structure Of Porcine Pancreatic Elastase In 80%
Isopropanol
pdb|2FOG|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2FOH|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2BD4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin- 7 And Lys-Ser At Ph 5.0
pdb|2BD5|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Lys- Ser At Ph 5 And Immersed In
Ph 9 Buffer For 30 Seconds
pdb|2BD9|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 28 Seconds (2nd Ph Jump)
pdb|2BDC|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile At
Ph 5.0
pdb|2H1U|A Chain A, Porcine Pancreatic Elastase Complexed With Metpheleuglu At
Ph 5.0
pdb|1BTU|A Chain A, Porcine Pancreatic Elastase Complexed With (3s, 4r)-1-
Toluenesulphonyl-3-Ethyl-Azetidin-2-One-4-Carboxylic
Acid
pdb|1EAS|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 3.
Design, Synthesis, X-Ray Crystallographic Analysis, And
Structure-Activity Relationships For A Series Of Orally
Active 3-Amino-6-Phenylpyridin- 2-One Trifluoromethyl
Ketones
pdb|1EAT|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 5.
Design, Synthesis, And X-Ray Crystallography Of A Series
Of Orally Active 5- Amino-Pyrimidin-6-One-Containing
Trifluoromethylketones
pdb|1EAU|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 6.
Design Of A Potent, Intratracheally Active,
Pyridone-Based Trifluoromethyl Ketone
pdb|1ELF|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ELG|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ESA|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|1EST|A Chain A, The Atomic Structure Of Crystalline Porcine Pancreatic
Elastase At 2.5 Angstroms Resolution. Comparisons With
The Structure Of Alpha- Chymotrypsin
pdb|1INC|A Chain A, Crystal Structures Of The Complex Of Porcine Pancreatic
Elastase With Two Valine-Derived Benzoxazinone
Inhibitors
pdb|1JIM|A Chain A, Stereospecific Reaction Of 3-Methoxy-4-Chloro-7-
Aminoisocoumarin With Crystalline Porcine Pancreatic
Elastase
pdb|1LVY|A Chain A, Porcine Elastase
pdb|3EST|A Chain A, Structure Of Native Porcine Pancreatic Elastase At 1.65
Angstroms Resolution
pdb|6EST|A Chain A, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|9EST|A Chain A, Structural Study Of Porcine Pancreatic Elastase Complexed
With 7- Amino-3-(2-Bromoethoxy)-4-Chloroisocoumarin As A
Nonreactivatable Doubly Covalent Enzyme-Inhibitor
Complex
pdb|1GVK|B Chain B, Porcine Pancreatic Elastase Acyl Enzyme At 0.95 A
Resolution
pdb|3E3T|A Chain A, Structure Of Porcine Pancreatic Elastase With The Magic
Triangle I3c
pdb|3MNB|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. First Stage Of
Radiation Damage
pdb|3MNC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Second Stage Of
Radiation Damage
pdb|3MNS|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Third Stage Of
Radiation Damage
pdb|3MNX|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fourth Stage Of
Radiation Damage
pdb|3MO3|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fifth Stage Of
Radiation Damage
pdb|3MO6|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Sixth Stage Of
Radiation Damage
pdb|3MO9|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Seventh Stage Of
Radiation Damage
pdb|3MOC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Eighth Stage Of
Radiation Damage
pdb|3MTY|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. First Step Of Radiation
Damage
pdb|3MU0|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU1|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3MU4|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. First Step Of Radiation
Damage
pdb|3MU5|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU8|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3ODD|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Second Step Of Radiation
Damage
pdb|3ODF|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Second Step Of Radiation
Damage
pdb|2BB4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Asp- Phe At Ph 5.0
pdb|2BD2|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0
pdb|2BD3|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Lys- Ala-nh2 At Ph 5.0
pdb|2BD7|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
pdb|2BD8|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 30 Seconds
pdb|2BDA|A Chain A, Porcine Pancreatic Elastase Complexed With N-Acetyl-Npi
And Ala-Ala At Ph 5.0
pdb|2BDB|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile And
Ala-ala At Ph 5.0
pdb|1ESB|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|4GVU|A Chain A, Lyngbyastatin 7-porcine Pancreatic Elastase Co-crystal
Structure
Length = 240
Score = 82.8 bits (203), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 58/191 (30%), Positives = 95/191 (49%), Gaps = 11/191 (5%)
Query: 194 IVGGWTTEVNEYPWVVALE-QAGKFF---CGGTLISDRYVLTAAHCVRSSKRQKDLIVVI 249
+VGG + N +P ++L+ ++G + CGGTLI +V+TAAHCV R+ VV+
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCV---DRELTFRVVV 57
Query: 250 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLP 309
EHN T+ + V K++ HP +N + +DIALL+L + V LP
Sbjct: 58 GEHNLNQNNGTE-QYVGVQKIVVHPYWNTDDVAA-GYDIALLRLAQSVTLNSYVQLGVLP 115
Query: 310 QLGEKFTQRT-GTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCA 368
+ G + + GWG +GQ+A L+ +P + C + + + +M+CA
Sbjct: 116 RAGTILANNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGSTVKNSMVCA 175
Query: 369 GYVEGGKDSCQ 379
G +G + CQ
Sbjct: 176 G-GDGVRSGCQ 185
>pdb|3I77|A Chain A, 3599170-Loops Of Fxa In Sgt
Length = 230
Score = 82.8 bits (203), Expect = 7e-16, Method: Composition-based stats.
Identities = 60/188 (31%), Positives = 87/188 (46%), Gaps = 14/188 (7%)
Query: 194 IVGGWTTEVNEYPWVVAL-EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEH 252
+VGG E+P++V L + + FCGG L + VLTAAHCV S +
Sbjct: 1 VVGGTRAAQGEFPFMVRLINEENEGFCGGALYAQDIVLTAAHCVSGSGNNTSITATGGVV 60
Query: 253 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLG 312
+ + ++ R KVL P + + ++ D AL+KL P+ +PT+
Sbjct: 61 DLQSSSAVKV---RSTKVLQAPGFTKE---TYGKDWALIKLAQPIN-QPTLKIATT---- 109
Query: 313 EKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCAGYVE 372
+ Q T TV GWG E G L VP +S+ CR F + M+CAGY +
Sbjct: 110 TAYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSSSSF-ILVANEMICAGYPD 168
Query: 373 -GGKDSCQ 379
GG D+CQ
Sbjct: 169 TGGVDTCQ 176
>pdb|1A5I|A Chain A, Catalytic Domain Of Vampire Bat (Desmodus Rotundus) Saliva
Plasminogen Activator In Complex With Egr-Cmk
(Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 82.4 bits (202), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 70/252 (27%), Positives = 116/252 (46%), Gaps = 34/252 (13%)
Query: 195 VGGWTTEVNEYPWVVAL------EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVV 248
GG T++ +PW A+ +F CGG LIS +VLTAAHC + S L VV
Sbjct: 15 TGGLFTDITSHPWQAAIFAQNRRSSGERFLCGGILISSCWVLTAAHCFQESYLPDQLKVV 74
Query: 249 ISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKL--DTP--LEFKPTVS 304
+ R E + +T +V K + H +++ ++++DIALL+L D+P + +V
Sbjct: 75 LGRTYRVKPGEEE-QTFKVKKYIVHKEFDDD---TYNNDIALLQLKSDSPQCAQESDSVR 130
Query: 305 PVCLPQLGEKFTQRTGT-VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLT 362
+CLP+ + T + G+G+ + S S+ L+ V + + C F +T
Sbjct: 131 AICLPEANLQLPDWTECELSGYGKHKSSSPFYSEQLKEGHVRLYPSSRCAPKFLFNKTVT 190
Query: 363 GNMMCAGYVEGGK------DSCQ-------VTLDEADIALLKSYGQGQYTKSIKAVEDDI 409
NM+CAG G+ D+CQ V +++ + LL G + + E D+
Sbjct: 191 NNMLCAGDTRSGEIYPNVHDACQGDSGGPLVCMNDNHMTLL-----GIISWGVGCGEKDV 245
Query: 410 QAVIKRVNELTG 421
V +V G
Sbjct: 246 PGVYTKVTNYLG 257
>pdb|1ORF|A Chain A, The Oligomeric Structure Of Human Granzyme A Reveals The
Molecular Determinants Of Substrate Specificity
Length = 234
Score = 82.4 bits (202), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 57/189 (30%), Positives = 90/189 (47%), Gaps = 11/189 (5%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
I+GG + P++V L K C G LI+ +VLTAAHC + + Q V++ H+
Sbjct: 1 IIGGNEVTPHSRPYMVLLSLDRKTICAGALIAKDWVLTAAHCNLNKRSQ----VILGAHS 56
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
T E + V K +P Y+ + + D+ LL+L + V+ + LP+ G+
Sbjct: 57 -ITREEPTKQIMLVKKEFPYPCYDPA---TREGDLKLLQLTEKAKINKYVTILHLPKKGD 112
Query: 314 KFTQRT-GTVVGWGRVEESGQIASDLRATQVPVMSNQEC--RQFPGFEAKLTGNMMCAGY 370
T V GWGR S + LR ++ ++ + C R F + NM+CAG
Sbjct: 113 DVKPGTMCQVAGWGRTHNSASWSDTLREVEITIIDRKVCNDRNHYNFNPVIGMNMVCAGS 172
Query: 371 VEGGKDSCQ 379
+ GG+DSC
Sbjct: 173 LRGGRDSCN 181
>pdb|1EAI|A Chain A, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1EAI|B Chain B, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1C1M|A Chain A, Porcine Elastase Under Xenon Pressure (8 Bar)
pdb|1HV7|A Chain A, Porcine Pancreatic Elastase Complexed With Gw311616a
pdb|1FZZ|A Chain A, The Crystal Structure Of The Complex Of Non-Peptidic
Inhibitor Ono-6818 And Porcine Pancreatic Elastase.
pdb|1GWA|A Chain A, Triiodide Derivative Of Porcine Pancreas Elastase
pdb|1L0Z|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Dry Paraffin
Oil
pdb|1L1G|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Glycerol
pdb|1LKA|A Chain A, Porcine Pancreatic ElastaseCA-Complex
pdb|1LKB|A Chain A, Porcine Pancreatic Elastase/na-complex
pdb|1MMJ|N Chain N, Porcine Pancreatic Elastase Complexed With A Potent
Peptidyl Inhibitor, Fr136706
pdb|1MCV|A Chain A, Crystal Structure Analysis Of A Hybrid Squash Inhibitor In
Complex With Porcine Pancreatic Elastase
pdb|1UO6|A Chain A, Porcine Pancreatic ElastaseXE-Complex
pdb|1UVO|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(crystal A)
pdb|1UVP|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(Crystal B)
pdb|2A7C|A Chain A, On The Routine Use Of Soft X-rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2A7J|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2BLO|A Chain A, Elastase Before A High Dose X-Ray "burn"
pdb|2BLQ|A Chain A, Elastase After A High Dose X-Ray "burn"
pdb|2D26|C Chain C, Active Site Distortion Is Sufficient For Proteinase
Inhibit Second Crystal Structure Of Covalent
Serpin-Proteinase Complex
pdb|2CV3|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With A Macroclyclic Peptide Inhibitor
pdb|2DE8|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With A
Unique Conformation Induced By Tris
pdb|2DE9|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With Tris After Soaking A Tris-Free Solution
pdb|2G4T|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastase (na)
pdb|2G4U|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastaase
(ca)
pdb|2OQU|A Chain A, High Pressure Cryocooling Of Capillary Sample
Cryoprotection And Diffraction Phasing At Long
Wavelengths
pdb|1QNJ|A Chain A, The Structure Of Native Porcine Pancreatic Elastase At
Atomic Resolution (1.1 A)
pdb|2IOT|A Chain A, Clavulanic Acid Bound To Elastase
pdb|2V0B|A Chain A, Sad Structure Solution Porcine Pancreatic Elastase From A
Selenate Derivative
pdb|2V35|A Chain A, Porcine Pancreatic Elastase In Complex With Inhibitor Jm54
pdb|3HGP|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By High
Resolution Crystallography
pdb|3HGN|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By Neutron
Crystallography
pdb|3UOU|A Chain A, Crystal Structure Of The Kunitz-Type Protease Inhibitor
Shpi-1 Lys13leu Mutant In Complex With Pancreatic
Elastase
Length = 240
Score = 82.4 bits (202), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 58/191 (30%), Positives = 95/191 (49%), Gaps = 11/191 (5%)
Query: 194 IVGGWTTEVNEYPWVVALE-QAGKFF---CGGTLISDRYVLTAAHCVRSSKRQKDLIVVI 249
+VGG + N +P ++L+ ++G + CGGTLI +V+TAAHCV R+ VV+
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCV---DRELTFRVVV 57
Query: 250 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLP 309
EHN T+ + V K++ HP +N + +DIALL+L + V LP
Sbjct: 58 GEHNLNQNDGTE-QYVGVQKIVVHPYWNTDDVAA-GYDIALLRLAQSVTLNSYVQLGVLP 115
Query: 310 QLGEKFTQRT-GTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCA 368
+ G + + GWG +GQ+A L+ +P + C + + + +M+CA
Sbjct: 116 RAGTILANNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGSTVKNSMVCA 175
Query: 369 GYVEGGKDSCQ 379
G +G + CQ
Sbjct: 176 G-GDGVRSGCQ 185
>pdb|1HAX|B Chain B, Snapshots Of Serine Protease Catalysis: (A) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 At Ph 5
pdb|1HAY|B Chain B, Snapshots Of Serine Protease Catalysis: (B) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 10 Seconds
pdb|1HB0|B Chain B, Snapshots Of Serine Protease Catalysis: (D) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 2 Minutes
Length = 240
Score = 82.4 bits (202), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 58/191 (30%), Positives = 95/191 (49%), Gaps = 11/191 (5%)
Query: 194 IVGGWTTEVNEYPWVVALE-QAGKFF---CGGTLISDRYVLTAAHCVRSSKRQKDLIVVI 249
+VGG + N +P ++L+ ++G + CGGTLI +V+TAAHCV R+ VV+
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCV---DRELTFRVVV 57
Query: 250 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLP 309
EHN T+ + V K++ HP +N + +DIALL+L + V LP
Sbjct: 58 GEHNLNQNNGTE-QYVGVQKIVVHPYWNTDDVAA-GYDIALLRLAQSVTLNSYVQLGVLP 115
Query: 310 QLGEKFTQRT-GTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCA 368
+ G + + GWG +GQ+A L+ +P + C + + + +M+CA
Sbjct: 116 RAGTILRNNSPCYITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGSTVKNSMVCA 175
Query: 369 GYVEGGKDSCQ 379
G +G + CQ
Sbjct: 176 G-GDGVRSGCQ 185
>pdb|1SGT|A Chain A, Refined Crystal Structure Of Streptomyces Griseus Trypsin
At 1.7 Angstroms Resolution
Length = 223
Score = 82.0 bits (201), Expect = 1e-15, Method: Composition-based stats.
Identities = 65/190 (34%), Positives = 84/190 (44%), Gaps = 25/190 (13%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIV---VIS 250
+VGG E+P++V L CGG L + VLTAAHCV S + V+
Sbjct: 1 VVGGTRAAQGEFPFMVRLSMG----CGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVD 56
Query: 251 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQ 310
+ A V R KVL P YN G D AL+KL P+ +PT+
Sbjct: 57 LQSGAAV------KVRSTKVLQAPGYNGTG-----KDWALIKLAQPIN-QPTLKIATT-- 102
Query: 311 LGEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCAGY 370
+ Q T TV GWG E G L VP +S+ CR G E + +CAGY
Sbjct: 103 --TAYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSAYGNEL-VANEEICAGY 159
Query: 371 VE-GGKDSCQ 379
+ GG D+CQ
Sbjct: 160 PDTGGVDTCQ 169
>pdb|1OP8|A Chain A, Crystal Structure Of Human Granzyme A
pdb|1OP8|B Chain B, Crystal Structure Of Human Granzyme A
pdb|1OP8|C Chain C, Crystal Structure Of Human Granzyme A
pdb|1OP8|D Chain D, Crystal Structure Of Human Granzyme A
pdb|1OP8|E Chain E, Crystal Structure Of Human Granzyme A
pdb|1OP8|F Chain F, Crystal Structure Of Human Granzyme A
Length = 234
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 57/189 (30%), Positives = 89/189 (47%), Gaps = 11/189 (5%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
I+GG + P++V L K C G LI+ +VLTAAHC + + Q V++ H+
Sbjct: 1 IIGGNEVTPHSRPYMVLLSLDRKTICAGALIAKDWVLTAAHCNLNKRSQ----VILGAHS 56
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
T E + V K +P Y+ + + D+ LL+L + V+ + LP+ G+
Sbjct: 57 -ITREEPTKQIMLVKKEFPYPCYDPA---TREGDLKLLQLTEKAKINKYVTILHLPKKGD 112
Query: 314 KFTQRTGT-VVGWGRVEESGQIASDLRATQVPVMSNQEC--RQFPGFEAKLTGNMMCAGY 370
T V GWGR S + LR + ++ + C R F + NM+CAG
Sbjct: 113 DVKPGTMCQVAGWGRTHNSASWSDTLREVNITIIDRKVCNDRNHYNFNPVIGMNMVCAGS 172
Query: 371 VEGGKDSCQ 379
+ GG+DSC
Sbjct: 173 LRGGRDSCN 181
>pdb|3BSQ|A Chain A, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|B Chain B, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|C Chain C, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
Length = 227
Score = 81.6 bits (200), Expect = 1e-15, Method: Composition-based stats.
Identities = 56/186 (30%), Positives = 89/186 (47%), Gaps = 15/186 (8%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
I+ G +PW VAL + CGG L+++R+VLTAAHC + + V +
Sbjct: 1 IIDGAPCARGSHPWQVALLSGNQLHCGGVLVNERWVLTAAHC-----KMNEYTVHLGSD- 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
T+ + + + + K HP Y+ Q +H +D+ L+KL++ V V LP E
Sbjct: 55 --TLGDRRAQRIKASKSFRHPGYSTQ---THVNDLMLVKLNSQARLSSMVKKVRLPSRCE 109
Query: 314 KFTQRTGTVVGWGRVEESG-QIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCAGYVE 372
T TV GWG SDL V ++S Q+C + ++ L +M+CAG +
Sbjct: 110 P-PGTTCTVSGWGTTTSPDVTFPSDLMCVDVKLISPQDCTKV--YKDLLENSMLCAGIPD 166
Query: 373 GGKDSC 378
K++C
Sbjct: 167 SKKNAC 172
>pdb|2QXG|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXG|B Chain B, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXH|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXI|A Chain A, High Resolution Structure Of Human Kallikrein 7 In Complex
With Suc-Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXJ|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-ala-pro-phe-chloromethylketone And Copper
Length = 224
Score = 81.6 bits (200), Expect = 1e-15, Method: Composition-based stats.
Identities = 56/186 (30%), Positives = 89/186 (47%), Gaps = 15/186 (8%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
I+ G +PW VAL + CGG L+++R+VLTAAHC + + V +
Sbjct: 1 IIDGAPCARGSHPWQVALLSGNQLHCGGVLVNERWVLTAAHC-----KMNEYTVHLGSD- 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
T+ + + + + K HP Y+ Q +H +D+ L+KL++ V V LP E
Sbjct: 55 --TLGDRRAQRIKASKSFRHPGYSTQ---THVNDLMLVKLNSQARLSSMVKKVRLPSRCE 109
Query: 314 KFTQRTGTVVGWGRVEESG-QIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCAGYVE 372
T TV GWG SDL V ++S Q+C + ++ L +M+CAG +
Sbjct: 110 P-PGTTCTVSGWGTTTSPDVTFPSDLMCVDVKLISPQDCTKV--YKDLLENSMLCAGIPD 166
Query: 373 GGKDSC 378
K++C
Sbjct: 167 SKKNAC 172
>pdb|1OS8|A Chain A, Recombinant Streptomyces Griseus Trypsin
Length = 223
Score = 81.6 bits (200), Expect = 1e-15, Method: Composition-based stats.
Identities = 62/187 (33%), Positives = 83/187 (44%), Gaps = 19/187 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
+VGG E+P++V L CGG L + VLTAAHCV S + +
Sbjct: 1 VVGGTRAAQGEFPFMVRLSMG----CGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVD 56
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
+ ++ R KVL P YN G D AL+KL P+ +PT+
Sbjct: 57 LQSSSAVKV---RSTKVLQAPGYNGTG-----KDWALIKLAQPIN-QPTLKIATT----T 103
Query: 314 KFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCAGYVE- 372
+ Q T TV GWG E G L VP +S+ CR G E + +CAGY +
Sbjct: 104 AYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSAYGNEL-VANEEICAGYPDT 162
Query: 373 GGKDSCQ 379
GG D+CQ
Sbjct: 163 GGVDTCQ 169
>pdb|2F9N|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
Length = 245
Score = 81.3 bits (199), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 21/199 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKF---FCGGTLISDRYVLTAAHCVRSSKRQKDLIVVIS 250
IVGG +++PW V+L ++ FCGG+LI ++VLTAAHCV KDL +
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCV--GPDVKDLATLRV 58
Query: 251 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQ 310
+ +Y Q + V +++ HP++ + DIALL+L+ P+ V V LP
Sbjct: 59 QLREQHLY-YQDQLLPVSRIIVHPQFYIIQTGA---DIALLELEEPVNISSRVHTVMLPP 114
Query: 311 LGEKFTQ-RTGTVVGWGRVEESGQIAS--DLRATQVPVMSNQECR------QFPGFEAKL 361
E F V GWG V+ + L+ +VP+M N C + G + ++
Sbjct: 115 ASETFPPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRI 174
Query: 362 T-GNMMCAGYVEGGKDSCQ 379
+M+CAG + +DSCQ
Sbjct: 175 IRDDMLCAGNSQ--RDSCQ 191
>pdb|1DST|A Chain A, Mutant Of Factor D With Enhanced Catalytic Activity
Length = 228
Score = 80.9 bits (198), Expect = 2e-15, Method: Composition-based stats.
Identities = 51/187 (27%), Positives = 91/187 (48%), Gaps = 8/187 (4%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
I+GG E + P++ +++ G CGG L+++++VL+AAHC+ + K + V++ H+
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGK-VQVLLGAHS 59
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
+ E V++ + HP Y + DHD+ LL+L P V P+ ++
Sbjct: 60 LSQP-EPSKRLYDVLRAVPHPDYQPD---TIDHDLLLLQLSEKATLGPAVRPLPWQRVDR 115
Query: 314 KFTQRT-GTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCAGYVE 372
T V GWG V +G+ L+ +PV+ C + + +T +MCA
Sbjct: 116 DVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAE--S 173
Query: 373 GGKDSCQ 379
+DSC+
Sbjct: 174 NRRDSCK 180
>pdb|3CF0|A Chain A, Structure Of D2 Subdomain Of P97VCP IN COMPLEX WITH ADP
pdb|3CF0|B Chain B, Structure Of D2 Subdomain Of P97VCP IN COMPLEX WITH ADP
pdb|3CF0|C Chain C, Structure Of D2 Subdomain Of P97VCP IN COMPLEX WITH ADP
pdb|3CF0|D Chain D, Structure Of D2 Subdomain Of P97VCP IN COMPLEX WITH ADP
pdb|3CF0|E Chain E, Structure Of D2 Subdomain Of P97VCP IN COMPLEX WITH ADP
pdb|3CF0|F Chain F, Structure Of D2 Subdomain Of P97VCP IN COMPLEX WITH ADP
pdb|3CF0|G Chain G, Structure Of D2 Subdomain Of P97VCP IN COMPLEX WITH ADP
pdb|3CF0|H Chain H, Structure Of D2 Subdomain Of P97VCP IN COMPLEX WITH ADP
pdb|3CF0|I Chain I, Structure Of D2 Subdomain Of P97VCP IN COMPLEX WITH ADP
pdb|3CF0|J Chain J, Structure Of D2 Subdomain Of P97VCP IN COMPLEX WITH ADP
pdb|3CF0|K Chain K, Structure Of D2 Subdomain Of P97VCP IN COMPLEX WITH ADP
pdb|3CF0|L Chain L, Structure Of D2 Subdomain Of P97VCP IN COMPLEX WITH ADP
pdb|3CF0|M Chain M, Structure Of D2 Subdomain Of P97VCP IN COMPLEX WITH ADP
pdb|3CF0|N Chain N, Structure Of D2 Subdomain Of P97VCP IN COMPLEX WITH ADP
Length = 301
Score = 80.5 bits (197), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 37/99 (37%), Positives = 58/99 (58%)
Query: 493 VVETPLLHLDGFDPRGNIKVLMATNRPDTLDPALMRPGRLDRKVEFGLPDLEGRTHIFKI 552
V+ L +DG + N+ ++ ATNRPD +DPA++RPGRLD+ + LPD + R I K
Sbjct: 138 VINQILTEMDGMSTKKNVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEKSRVAILKA 197
Query: 553 HARSMSVERDIRFELLARLCPNSTGAEIRSVCTEAGMFA 591
+ R V +D+ E LA++ +GA++ +C A A
Sbjct: 198 NLRKSPVAKDVDLEFLAKMTNGFSGADLTEICQRACKLA 236
Score = 70.9 bits (172), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 33/71 (46%), Positives = 46/71 (64%), Gaps = 4/71 (5%)
Query: 107 EVQRTMLELIN----QPEKFVNLGIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVI 162
+V+R + EL+ P+KF+ G+ P KGVL +GPPG GKTL A+A+AN A FI +
Sbjct: 22 DVKRELQELVQYPVEHPDKFLKFGMTPSKGVLFYGPPGCGKTLLAKAIANECQANFISIK 81
Query: 163 GSELVQKYVGE 173
G EL+ + GE
Sbjct: 82 GPELLTMWFGE 92
Score = 34.3 bits (77), Expect = 0.26, Method: Compositional matrix adjust.
Identities = 16/36 (44%), Positives = 24/36 (66%)
Query: 469 VEEKPDVTYSDIGGCKEQIEKLREVVETPLLHLDGF 504
V E P VT+ DIGG ++ +L+E+V+ P+ H D F
Sbjct: 6 VVEVPQVTWEDIGGLEDVKRELQELVQYPVEHPDKF 41
Score = 30.8 bits (68), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 14/32 (43%), Positives = 22/32 (68%)
Query: 682 VEEKPDVTYSDIGGCKEQIEKLREVVETPLLH 713
V E P VT+ DIGG ++ +L+E+V+ P+ H
Sbjct: 6 VVEVPQVTWEDIGGLEDVKRELQELVQYPVEH 37
>pdb|1OSS|A Chain A, T190p Streptomyces Griseus Trypsin In Complex With
Benzamidine
Length = 223
Score = 80.5 bits (197), Expect = 3e-15, Method: Composition-based stats.
Identities = 62/187 (33%), Positives = 82/187 (43%), Gaps = 19/187 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
+VGG E+P++V L CGG L + VLTAAHCV S + +
Sbjct: 1 VVGGTRAAQGEFPFMVRLSMG----CGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVD 56
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
+ ++ R KVL P YN G D AL+KL P+ +PT+
Sbjct: 57 LQSSSAVKV---RSTKVLQAPGYNGTG-----KDWALIKLAQPIN-QPTLKIATT----T 103
Query: 314 KFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCAGYVE- 372
+ Q T TV GWG E G L VP +S+ CR G E + +CAGY +
Sbjct: 104 AYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSAYGNEL-VANEEICAGYPDT 162
Query: 373 GGKDSCQ 379
GG D CQ
Sbjct: 163 GGVDPCQ 169
>pdb|4GSO|A Chain A, Structure Of Jararacussin-I
Length = 232
Score = 80.1 bits (196), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 58/187 (31%), Positives = 97/187 (51%), Gaps = 15/187 (8%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
++GG ++NE+P++ L G +FCG TLI+ +V+TAAHC S+ Q L V H+
Sbjct: 1 VLGGDECDINEHPFLAFLYSHG-YFCGLTLINQEWVVTAAHC-DSTNFQMQLGV----HS 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
+ + E + +TR + P N ++ D DI L+KLD P+ ++P+ LP
Sbjct: 55 KKVLNEDE-QTRNPKEKFICPNKNM--SEVLDKDIMLIKLDKPISNSKHIAPLSLPS-NP 110
Query: 314 KFTQRTGTVVGWGRVEESGQIASDL-RATQVPVMSNQECR-QFPGFEAKLTGNMMCAGYV 371
++GWG + + D+ + ++ + C+ + G AK T +CAG +
Sbjct: 111 PSVGSVCRIMGWGSITIPNETYPDVPYCANINLVDYEVCQGAYNGLPAKTT---LCAGVL 167
Query: 372 EGGKDSC 378
EGGKD+C
Sbjct: 168 EGGKDTC 174
>pdb|2ZGC|A Chain A, Crystal Structure Of Active Human Granzyme M
pdb|2ZGH|A Chain A, Crystal Structure Of Active Granzyme M Bound To Its
Product
pdb|2ZKS|A Chain A, Structural Insights Into The Proteolytic Machinery Of
Apoptosis- Inducing Granzyme M
Length = 240
Score = 79.7 bits (195), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 48/175 (27%), Positives = 90/175 (51%), Gaps = 9/175 (5%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
I+GG + P++ +L++ G CGG L+ ++VLTAAHC+ ++R L +V+ H
Sbjct: 1 IIGGREVIPHSRPYMASLQRNGSHLCGGVLVHPKWVLTAAHCL--AQRMAQLRLVLGLHT 58
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
++ T + + HP+Y A ++D+ALL+LD ++ T+ P+ LP +
Sbjct: 59 ----LDSPGLTFHIKAAIQHPRYKPVPAL--ENDLALLQLDGKVKPSRTIRPLALPSKRQ 112
Query: 314 KFTQRT-GTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMC 367
T ++ GWG + G+++ LR + V+ + C + L+ +M+C
Sbjct: 113 VVAAGTRCSMAGWGLTHQGGRLSRVLRELDLQVLDTRMCNNSRFWNGSLSPSMVC 167
>pdb|2F9O|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9P|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
Length = 245
Score = 79.7 bits (195), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 21/199 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKF---FCGGTLISDRYVLTAAHCVRSSKRQKDLIVVIS 250
IVGG +++PW V+L ++ FCGG+LI ++VLTAAHCV KDL +
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCV--GPDVKDLATLRV 58
Query: 251 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQ 310
+ +Y Q + V +++ HP++ + DIALL+L+ P+ V V LP
Sbjct: 59 QLREQHLY-YQDQLLPVSRIIVHPQFYIIQTGA---DIALLELEEPVNISSRVHTVMLPP 114
Query: 311 LGEKFTQ-RTGTVVGWGRVEESGQIAS--DLRATQVPVMSNQECR------QFPGFEAKL 361
E F V GWG V+ + L+ +VP+M N C + G + ++
Sbjct: 115 ASETFPPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRI 174
Query: 362 T-GNMMCAGYVEGGKDSCQ 379
+M+CAG + +DSC+
Sbjct: 175 IRDDMLCAGNSQ--RDSCK 191
>pdb|1AKS|A Chain A, Crystal Structure Of The First Active Autolysate Form Of
The Porcine Alpha Trypsin
pdb|1UHB|A Chain A, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A
Resolution
Length = 125
Score = 79.0 bits (193), Expect = 8e-15, Method: Composition-based stats.
Identities = 49/139 (35%), Positives = 74/139 (53%), Gaps = 17/139 (12%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + V + EHN
Sbjct: 1 IVGGYTCAANSIPYQVSL-NSGSHFCGGSLINSQWVVSAAHCYKSR-----IQVRLGEHN 54
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
V E + K++THP +N + D+DI L+KL +P V+ V LP
Sbjct: 55 -IDVLEGNEQFINAAKIITHPNFNGN---TLDNDIMLIKLSSPATLNSRVATVSLP---- 106
Query: 314 KFTQRTGT---VVGWGRVE 329
+ GT + GWG +
Sbjct: 107 RSCAAAGTECLISGWGNTK 125
>pdb|1FDP|A Chain A, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|B Chain B, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|C Chain C, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|D Chain D, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
Length = 235
Score = 79.0 bits (193), Expect = 8e-15, Method: Composition-based stats.
Identities = 51/188 (27%), Positives = 91/188 (48%), Gaps = 8/188 (4%)
Query: 193 RIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEH 252
RI+GG E + P++ +++ G CGG L+++++VL+AAHC+ + K + V++ H
Sbjct: 7 RILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGK-VQVLLGAH 65
Query: 253 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLG 312
+ + E V++ + HP + DHD+ LL+L P V P+ ++
Sbjct: 66 SLSQP-EPSKRLYDVLRAVPHPDSQPD---TIDHDLLLLQLSEKATLGPAVRPLPWQRVD 121
Query: 313 EKFTQRT-GTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCAGYV 371
T V GWG V +G+ L+ +PV+ C + + +T +MCA
Sbjct: 122 RDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAE-- 179
Query: 372 EGGKDSCQ 379
+DSC+
Sbjct: 180 SNRRDSCK 187
>pdb|1AZZ|A Chain A, Fiddler Crab Collagenase Complexed To Ecotin
pdb|1AZZ|B Chain B, Fiddler Crab Collagenase Complexed To Ecotin
Length = 226
Score = 79.0 bits (193), Expect = 9e-15, Method: Composition-based stats.
Identities = 64/189 (33%), Positives = 89/189 (47%), Gaps = 19/189 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG N +P AL +FCGG+LIS ++LTAAHC+ + + VV+ HN
Sbjct: 1 IVGGVEAVPNSWPHQAALFIDDMYFCGGSLISPEWILTAAHCMDGAGF---VDVVLGAHN 57
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
TQ+ T + H YN+ + DIA+++L P+ ++ V LP
Sbjct: 58 IREDEATQV-TIQSTDFTVHENYNSFVISN---DIAVIRLPVPVTLTAAIATVGLPSTDV 113
Query: 314 KFTQRTGTVV---GWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKLTGNMMCAG 369
GTVV GWG +S SD LR VP+MSN +C G +T +C
Sbjct: 114 G----VGTVVTPTGWGLPSDSALGISDVLRQVDVPIMSNADCDAVYGI---VTDGNICID 166
Query: 370 YVEGGKDSC 378
GGK +C
Sbjct: 167 ST-GGKGTC 174
>pdb|1LTO|A Chain A, Human Alpha1-Tryptase
pdb|1LTO|B Chain B, Human Alpha1-Tryptase
pdb|1LTO|C Chain C, Human Alpha1-Tryptase
pdb|1LTO|D Chain D, Human Alpha1-Tryptase
Length = 245
Score = 78.6 bits (192), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 61/199 (30%), Positives = 97/199 (48%), Gaps = 21/199 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKF---FCGGTLISDRYVLTAAHCVRSSKRQKDLIVVIS 250
IVGG +++PW V+L ++ FCGG+LI ++VLTAAHC+ KDL +
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCL--GPDVKDLATLRV 58
Query: 251 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQ 310
+ +Y Q + V +++ HP++ + DIALL+L+ P+ V V LP
Sbjct: 59 QLREQHLY-YQDQLLPVSRIIVHPQFYIIQTGA---DIALLELEEPVNISSRVHTVMLPP 114
Query: 311 LGEKFTQ-RTGTVVGWGRVEESGQIAS--DLRATQVPVMSNQECR------QFPGFEAKL 361
E F V GWG V+ + L+ +VP+M N C + G + ++
Sbjct: 115 ASETFPPGMPCWVTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRI 174
Query: 362 T-GNMMCAGYVEGGKDSCQ 379
+M+CAG +DSC+
Sbjct: 175 IRDDMLCAG--NSQRDSCK 191
>pdb|3I78|A Chain A, 3599170186220-Loops Of Fxa In Sgt
Length = 229
Score = 78.6 bits (192), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 58/187 (31%), Positives = 85/187 (45%), Gaps = 13/187 (6%)
Query: 194 IVGGWTTEVNEYPWVVAL-EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEH 252
+VGG E+P++V L + + FCGG L + VLTAAHCV S +
Sbjct: 1 VVGGTRAAQGEFPFMVRLINEENEGFCGGALYAQDIVLTAAHCVSGSGNNTSITATGGVV 60
Query: 253 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLG 312
+ + ++ R KVL P + + ++ D AL+KL P+ +PT+
Sbjct: 61 DLQSSSAVKV---RSTKVLQAPGFTKE---TYGKDWALIKLAQPIN-QPTLKIATTT--- 110
Query: 313 EKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCAGYVE 372
+ Q T TV GWG E G L VP +S+ CR F + M+CAGY
Sbjct: 111 -AYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSSSSF-ILVANEMICAGYDT 168
Query: 373 GGKDSCQ 379
+D+CQ
Sbjct: 169 KQEDTCQ 175
>pdb|3BEU|A Chain A, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
pdb|3BEU|B Chain B, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
Length = 224
Score = 78.2 bits (191), Expect = 1e-14, Method: Composition-based stats.
Identities = 57/186 (30%), Positives = 82/186 (44%), Gaps = 16/186 (8%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
+VGG E+P++V L CGG L + VLTAAHCV S + +
Sbjct: 1 VVGGTRAAQGEFPFMVRLSMG----CGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVD 56
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
+ ++ R KVL P + + ++ D AL+KL P+ +PT+
Sbjct: 57 LQSSSAVKV---RSTKVLQAPGFTKE---TYGKDWALIKLAQPIN-QPTLKIATT----T 105
Query: 314 KFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCAGYVEG 373
+ Q T TV GWG E G L VP +S+ CR F + M+CAGY
Sbjct: 106 AYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSSSSF-ILVANEMICAGYDTK 164
Query: 374 GKDSCQ 379
+D+CQ
Sbjct: 165 QEDTCQ 170
>pdb|2VNT|A Chain A, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|B Chain B, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|C Chain C, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|D Chain D, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|E Chain E, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|F Chain F, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
Length = 276
Score = 78.2 bits (191), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 57/200 (28%), Positives = 103/200 (51%), Gaps = 17/200 (8%)
Query: 193 RIVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRQKDLIV 247
+I+GG T + PW A+ + + + CGG+L+S +V++A HC +++D IV
Sbjct: 23 KIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIV 82
Query: 248 VI--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTP----LEFKP 301
+ S N T E + E V ++ H Y+A +H +DIALLK+ + +
Sbjct: 83 YLGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKIRSKEGRCAQPSR 138
Query: 302 TVSPVCLPQLGEKFTQRTGT-VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEA 359
T+ +CLP + T + G+G+ + + + L+ T V ++S++EC+Q + +
Sbjct: 139 TIQTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGS 198
Query: 360 KLTGNMMCAGYVEGGKDSCQ 379
++T M+CA + DSCQ
Sbjct: 199 EVTTKMLCAADPQWKTDSCQ 218
>pdb|3IG6|B Chain B, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
pdb|3IG6|D Chain D, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
Length = 253
Score = 78.2 bits (191), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 58/199 (29%), Positives = 102/199 (51%), Gaps = 17/199 (8%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRQKDLIVV 248
I+GG T + PW A+ + + + CGG+LIS +V++A HC +++D IV
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 249 I--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTP----LEFKPT 302
+ S N T E + E V ++ H Y+A +H +DIALLK+ + + T
Sbjct: 61 LGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 303 VSPVCLPQLGEKFTQRTGT-VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAK 360
+ +CLP + T + G+G+ + + + L+ T V ++S++EC+Q + ++
Sbjct: 117 IQTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSE 176
Query: 361 LTGNMMCAGYVEGGKDSCQ 379
+T M+CA + DSCQ
Sbjct: 177 VTTKMLCAADPQWKTDSCQ 195
>pdb|2ZGJ|A Chain A, Crystal Structure Of D86n-gzmm Complexed With Its Optimal
Synthesized Substrate
Length = 240
Score = 78.2 bits (191), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 47/175 (26%), Positives = 90/175 (51%), Gaps = 9/175 (5%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
I+GG + P++ +L++ G CGG L+ ++VLTAAHC+ ++R L +V+ H
Sbjct: 1 IIGGREVIPHSRPYMASLQRNGSHLCGGVLVHPKWVLTAAHCL--AQRMAQLRLVLGLHT 58
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
++ T + + HP+Y A ++++ALL+LD ++ T+ P+ LP +
Sbjct: 59 ----LDSPGLTFHIKAAIQHPRYKPVPAL--ENNLALLQLDGKVKPSRTIRPLALPSKRQ 112
Query: 314 KFTQRT-GTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMC 367
T ++ GWG + G+++ LR + V+ + C + L+ +M+C
Sbjct: 113 VVAAGTRCSMAGWGLTHQGGRLSRVLRELDLQVLDTRMCNNSRFWNGSLSPSMVC 167
>pdb|1PYT|C Chain C, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 253
Score = 77.8 bits (190), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 52/183 (28%), Positives = 90/183 (49%), Gaps = 10/183 (5%)
Query: 193 RIVGGWTTEVNEYPWVVAL--EQAGKFF--CGGTLISDRYVLTAAHCVRSSKRQKDLIVV 248
R+V G + W V+L E+ G F CGG+LI+ +V+TA HC+ +S+ + VV
Sbjct: 11 RVVNGEDAVPYSWSWQVSLQYEKDGAFHHTCGGSLIAPDWVVTAGHCISTSRTYQ---VV 67
Query: 249 ISEHNRATVYET-QIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVC 307
+ E++R+ + + Q+ + HP +N+ + +DIAL+KL + V
Sbjct: 68 LGEYDRSVLQGSEQVIPINAGDLFVHPLWNSN-CVACGNDIALVKLSRSAQLGDKVQLAN 126
Query: 308 LPQLGEKFTQRTGTVV-GWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMM 366
LP G+ + GWGR+ G + L+ +PV+ + C Q+ + + M+
Sbjct: 127 LPPAGDILPNEAPCYISGWGRLYTGGPLPDKLQEALLPVVDYEHCSQYDWWGITVKKTMV 186
Query: 367 CAG 369
CAG
Sbjct: 187 CAG 189
>pdb|1YM0|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component B: A Novel, Glycosylated Two-chained Trypsin
Length = 238
Score = 77.8 bits (190), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 51/191 (26%), Positives = 93/191 (48%), Gaps = 11/191 (5%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISE 251
IVGG E+PW V++ + + FCGG++I+DR+V+ AAHC++ + + +V+ E
Sbjct: 1 IVGGIEARPYEFPWQVSVRRKSSDSHFCGGSIINDRWVVCAAHCMQ-GEAPALVSLVVGE 59
Query: 252 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQL 311
H+ + T +T V + + Y+ + ++D++++K + F V P+C P
Sbjct: 60 HDSSAA-STVRQTHDVDSIFVNENYD---PATLENDVSVIKTAVAITFDINVGPICAPDP 115
Query: 312 GEKFTQRTGTVVGWGRVEESGQIA-SDLRATQVPVMSNQECRQFPGFEAKLTGNMMCAGY 370
+ R GWG + G + LR + + +N C + + +M+CA
Sbjct: 116 ANDYVYRKSQCSGWGTINSGGVCCPAVLRYVTLNITTNAFCDAVYTSD-TIYDDMICATD 174
Query: 371 VEG--GKDSCQ 379
G +DSCQ
Sbjct: 175 NTGMTDRDSCQ 185
>pdb|4D9Q|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9Q|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 77.8 bits (190), Expect = 2e-14, Method: Composition-based stats.
Identities = 54/189 (28%), Positives = 91/189 (48%), Gaps = 12/189 (6%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
I+GG E + P++ +++ G+ CGG L+++++VL+AAHC+ + K + V++ H+
Sbjct: 1 ILGGREAEAHARPYMASVQVNGEHLCGGVLVAEQWVLSAAHCLEDAADGK-VQVLLGAHS 59
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
+ E V++ + HP + DHD+ LL+L P V P LP
Sbjct: 60 LSQP-EPSKRLYDVLRAVPHPDSRPD---TIDHDLLLLQLSEKATLGPAVRP--LPWQRV 113
Query: 314 KFTQRTGT---VVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCAGY 370
GT V GWG V +G+ L+ +PV+ C + + +T MMCA
Sbjct: 114 DRDVEPGTLCDVAGWGIVSHAGRRPDRLQHVLLPVLDRATCNRRTHHDGAITQRMMCAE- 172
Query: 371 VEGGKDSCQ 379
+DSC+
Sbjct: 173 -SNRRDSCK 180
>pdb|1OWE|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWH|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQA|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQO|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
Length = 245
Score = 77.4 bits (189), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 57/199 (28%), Positives = 103/199 (51%), Gaps = 17/199 (8%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRQKDLIVV 248
I+GG T + PW A+ + + + CGG+L+S +V++A HC +++D IV
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 249 I--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTP----LEFKPT 302
+ S N T E + E V ++ H Y+A +H +DIALLK+ + + T
Sbjct: 61 LGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 303 VSPVCLPQLGEKFTQRTGT-VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAK 360
+ +CLP + T + G+G+ + + + + L+ T V ++S++EC+Q + ++
Sbjct: 117 IQTICLPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSE 176
Query: 361 LTGNMMCAGYVEGGKDSCQ 379
+T M+CA + DSCQ
Sbjct: 177 VTTKMLCAADPQWKTDSCQ 195
>pdb|1LMW|B Chain B, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
pdb|1LMW|D Chain D, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
Length = 253
Score = 77.4 bits (189), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 57/199 (28%), Positives = 102/199 (51%), Gaps = 17/199 (8%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRQKDLIVV 248
I+GG T + PW A+ + + + CGG+L+S +V++A HC +++D IV
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 249 I--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTP----LEFKPT 302
+ S N T E + E V ++ H Y+A +H +DIALLK+ + + T
Sbjct: 61 LGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 303 VSPVCLPQLGEKFTQRTGT-VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAK 360
+ +CLP + T + G+G+ + + + L+ T V ++S++EC+Q + ++
Sbjct: 117 IQTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSE 176
Query: 361 LTGNMMCAGYVEGGKDSCQ 379
+T M+CA + DSCQ
Sbjct: 177 VTTKMLCAADPQWKTDSCQ 195
>pdb|2XWA|A Chain A, Crystal Structure Of Complement Factor D Mutant R202a
pdb|2XWA|B Chain B, Crystal Structure Of Complement Factor D Mutant R202a
Length = 228
Score = 77.0 bits (188), Expect = 3e-14, Method: Composition-based stats.
Identities = 50/187 (26%), Positives = 90/187 (48%), Gaps = 8/187 (4%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
I+GG E + P++ +++ G CGG L+++++VL+AAHC+ + K + V++ H+
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGK-VQVLLGAHS 59
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
+ E V++ + HP + DHD+ LL+L P V P+ ++
Sbjct: 60 LSQP-EPSKRLYDVLRAVPHPDSQPD---TIDHDLLLLQLSEKATLGPAVRPLPWQRVDR 115
Query: 314 KFTQRT-GTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCAGYVE 372
T V GWG V +G+ L+ +PV+ C + + +T +MCA
Sbjct: 116 DVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAE--S 173
Query: 373 GGKDSCQ 379
+DSC+
Sbjct: 174 NRRDSCK 180
>pdb|1DSU|A Chain A, Human Factor D, Complement Activating Enzyme
pdb|1DSU|B Chain B, Human Factor D, Complement Activating Enzyme
pdb|1DFP|A Chain A, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DFP|B Chain B, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DIC|A Chain A, Structure Of 3,4-Dichloroisocoumarin-Inhibited Factor D
pdb|1BIO|A Chain A, Human Complement Factor D In Complex With Isatoic
Anhydride Inhibitor
pdb|1HFD|A Chain A, Human Complement Factor D In A P21 Crystal Form
pdb|4D9R|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9R|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 77.0 bits (188), Expect = 3e-14, Method: Composition-based stats.
Identities = 50/187 (26%), Positives = 90/187 (48%), Gaps = 8/187 (4%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
I+GG E + P++ +++ G CGG L+++++VL+AAHC+ + K + V++ H+
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGK-VQVLLGAHS 59
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
+ E V++ + HP + DHD+ LL+L P V P+ ++
Sbjct: 60 LSQP-EPSKRLYDVLRAVPHPDSQPD---TIDHDLLLLQLSEKATLGPAVRPLPWQRVDR 115
Query: 314 KFTQRT-GTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCAGYVE 372
T V GWG V +G+ L+ +PV+ C + + +T +MCA
Sbjct: 116 DVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAE--S 173
Query: 373 GGKDSCQ 379
+DSC+
Sbjct: 174 NRRDSCK 180
>pdb|2XW9|A Chain A, Crystal Structure Of Complement Factor D Mutant S183a
pdb|2XWB|I Chain I, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|J Chain J, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 228
Score = 77.0 bits (188), Expect = 3e-14, Method: Composition-based stats.
Identities = 50/187 (26%), Positives = 90/187 (48%), Gaps = 8/187 (4%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
I+GG E + P++ +++ G CGG L+++++VL+AAHC+ + K + V++ H+
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGK-VQVLLGAHS 59
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
+ E V++ + HP + DHD+ LL+L P V P+ ++
Sbjct: 60 LSQP-EPSKRLYDVLRAVPHPDSQPD---TIDHDLLLLQLSEKATLGPAVRPLPWQRVDR 115
Query: 314 KFTQRT-GTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCAGYVE 372
T V GWG V +G+ L+ +PV+ C + + +T +MCA
Sbjct: 116 DVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAE--S 173
Query: 373 GGKDSCQ 379
+DSC+
Sbjct: 174 NRRDSCK 180
>pdb|1GJ7|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJ8|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJA|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJB|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1O3P|B Chain B, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1C5W|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5X|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Y|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Z|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GJ9|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJD|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJC|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
Length = 253
Score = 76.6 bits (187), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 57/199 (28%), Positives = 102/199 (51%), Gaps = 17/199 (8%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRQKDLIVV 248
I+GG T + PW A+ + + + CGG+L+S +V++A HC +++D IV
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 249 I--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTP----LEFKPT 302
+ S N T E + E V ++ H Y+A +H +DIALLK+ + + T
Sbjct: 61 LGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 303 VSPVCLPQLGEKFTQRTGT-VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAK 360
+ +CLP + T + G+G+ + + + L+ T V ++S++EC+Q + ++
Sbjct: 117 IQTICLPSMYNDPQFGTSCEITGFGKEASTDYLYPEQLKMTVVKLISHRECQQPHYYGSE 176
Query: 361 LTGNMMCAGYVEGGKDSCQ 379
+T M+CA + DSCQ
Sbjct: 177 VTTKMLCAADPQWKTDSCQ 195
>pdb|1OWD|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWI|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWJ|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWK|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQT|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1U6Q|A Chain A, Substituted 2-naphthamadine Inhibitors Of Urokinase
Length = 245
Score = 76.6 bits (187), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 57/199 (28%), Positives = 102/199 (51%), Gaps = 17/199 (8%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRQKDLIVV 248
I+GG T + PW A+ + + + CGG+L+S +V++A HC +++D IV
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 249 I--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTP----LEFKPT 302
+ S N T E + E V ++ H Y+A +H +DIALLK+ + + T
Sbjct: 61 LGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 303 VSPVCLPQLGEKFTQRTGT-VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAK 360
+ +CLP + T + G+G+ + + + L+ T V ++S++EC+Q + ++
Sbjct: 117 IQTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSE 176
Query: 361 LTGNMMCAGYVEGGKDSCQ 379
+T M+CA + DSCQ
Sbjct: 177 VTTKMLCAADPQWKTDSCQ 195
>pdb|1MZA|A Chain A, Crystal Structure Of Human Pro-Granzyme K
pdb|1MZD|A Chain A, Crystal Structure Of Human Pro-Granzyme K
Length = 240
Score = 76.6 bits (187), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 57/197 (28%), Positives = 96/197 (48%), Gaps = 23/197 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEH- 252
I+GG + P++ +++ G CGG LI ++VLTAAHC + + VV+ H
Sbjct: 3 IIGGKEVSPHSRPFMASIQYGGHHVCGGVLIDPQWVLTAAHCQYRFTKGQSPTVVLGAHS 62
Query: 253 -NRATVYETQIETRRVV---KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCL 308
++ + +E ++ + +V + P+ N DI L+KL T + V +
Sbjct: 63 LSKNEASKQTLEIKKFIPFSRVTSDPQSN---------DIMLVKLQTAAKLNKHVK---M 110
Query: 309 PQLGEKFTQRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQEC--RQFPGFEAKLT 362
+ K + R+GT V GWG + SD LR V V+S + C + + + +T
Sbjct: 111 LHIRSKTSLRSGTKCKVTGWGATDPDSLRPSDTLREVTVTVLSRKLCNSQSYYNGDPFIT 170
Query: 363 GNMMCAGYVEGGKDSCQ 379
+M+CAG +G KDSC+
Sbjct: 171 KDMVCAGDAKGQKDSCK 187
>pdb|1GI8|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI7|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI9|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
Length = 245
Score = 76.6 bits (187), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 57/199 (28%), Positives = 102/199 (51%), Gaps = 17/199 (8%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRQKDLIVV 248
I+GG T + PW A+ + + + CGG+L+S +V++A HC +++D IV
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 249 I--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTP----LEFKPT 302
+ S N T E + E V ++ H Y+A +H +DIALLK+ + + T
Sbjct: 61 LGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 303 VSPVCLPQLGEKFTQRTGT-VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAK 360
+ +CLP + T + G+G+ + + + L+ T V ++S++EC+Q + ++
Sbjct: 117 IQTICLPSMYNDPQFGTSCEITGFGKEASTDYLYPEQLKMTVVKLISHRECQQPHYYGSE 176
Query: 361 LTGNMMCAGYVEGGKDSCQ 379
+T M+CA + DSCQ
Sbjct: 177 VTTKMLCAADPQWKTDSCQ 195
>pdb|1FUJ|A Chain A, Pr3 (Myeloblastin)
pdb|1FUJ|B Chain B, Pr3 (Myeloblastin)
pdb|1FUJ|C Chain C, Pr3 (Myeloblastin)
pdb|1FUJ|D Chain D, Pr3 (Myeloblastin)
Length = 221
Score = 75.9 bits (185), Expect = 8e-14, Method: Composition-based stats.
Identities = 61/194 (31%), Positives = 94/194 (48%), Gaps = 20/194 (10%)
Query: 194 IVGGWTTEVNEYPWVVALE---QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVIS 250
IVGG + + P++ +L+ G FCGGTLI +VLTAAHC+R Q+ + VV+
Sbjct: 1 IVGGHEAQPHSRPYMASLQMRGNPGSHFCGGTLIHPSFVLTAAHCLRDIP-QRLVNVVLG 59
Query: 251 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQ 310
HN T TQ + V +V N A++ +DI L++L +P +V+ V LPQ
Sbjct: 60 AHNVRTQEPTQ-QHFSVAQVF----LNNYDAENKLNDILLIQLSSPANLSASVATVQLPQ 114
Query: 311 LGEKFTQRTGTV-VGWGRV---EESGQIASDLRATQVPVMSNQE--CRQFPGFEAKLT-- 362
+ T + +GWGRV + Q+ +L T V C P +A +
Sbjct: 115 QDQPVPHGTQCLAMGWGRVGAHDPPAQVLQELNVTVVTFFCRPHNICTFVPRRKAGICFG 174
Query: 363 ---GNMMCAGYVEG 373
G ++C G ++G
Sbjct: 175 DSGGPLICDGIIQG 188
>pdb|1O5A|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1O5B|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5C|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
Length = 253
Score = 75.5 bits (184), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 56/199 (28%), Positives = 102/199 (51%), Gaps = 17/199 (8%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRQKDLIVV 248
I+GG T + PW A+ + + + CGG+L+S +V++A HC +++D IV
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 249 I--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTP----LEFKPT 302
+ S N T E + E V ++ H Y+A +H +DIALLK+ + + T
Sbjct: 61 LGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 303 VSPVCLPQLGEKFTQRTGT-VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAK 360
+ +CLP + T + G+G+ + + + L+ T V ++S++EC+Q + ++
Sbjct: 117 IQTICLPSMYNDPQFGTSCEITGFGKEASTDYLYPEQLKMTVVKLISHRECQQPHYYGSE 176
Query: 361 LTGNMMCAGYVEGGKDSCQ 379
+T M+CA + D+CQ
Sbjct: 177 VTTKMLCAADPQWKTDACQ 195
>pdb|1GVZ|A Chain A, Prostate Specific Antigen (Psa) From Stallion Seminal
Plasma
Length = 237
Score = 75.5 bits (184), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
I+GGW E + PW VA+ G F CGG L+ ++VLTAAHC+ D + + HN
Sbjct: 1 IIGGWECEKHSKPWQVAVYHQGHFQCGGVLVHPQWVLTAAHCMSD-----DYQIWLGRHN 55
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSH--------DHDIALLKLDTPLEFKPTVSP 305
+ +T + +V P+++ K HD+ LL+L P V
Sbjct: 56 LSKDEDT-AQFHQVSDSFLDPQFDLSLLKKKYLRPYDDISHDLMLLRLAQPARITDAVKI 114
Query: 306 VCLPQLGEKFTQRTGTVVGWGRVEE-SGQIASDLRATQVPVMSNQEC-RQFPGFEAKLTG 363
+ LP K T GWG + + + + L+ ++ + SN++C R +P K+T
Sbjct: 115 LDLPTQEPKLGS-TCYTSGWGLISTFTNRGSGTLQCVELRLQSNEKCARAYP---EKMTE 170
Query: 364 NMMCAGYVEGGKDSCQVTLDEADIALL 390
++CA + + DS + L ++ AL+
Sbjct: 171 FVLCATHRD---DSGSICLGDSGGALI 194
>pdb|2PSX|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin
pdb|2PSY|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin And Zinc
Length = 227
Score = 75.5 bits (184), Expect = 1e-13, Method: Composition-based stats.
Identities = 56/193 (29%), Positives = 95/193 (49%), Gaps = 24/193 (12%)
Query: 194 IVGGWTTEVNEYPWVVALE-QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEH 252
I+ G +++ PW AL + + +CG L+ +++LTAAHC R+K V + +
Sbjct: 1 IINGSDCDMHTQPWQAALLLRPNQLYCGAVLVHPQWLLTAAHC-----RKKVFRVRLGHY 55
Query: 253 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCL---- 308
+ + VYE+ + + VK + HP Y+ G H +D+ L+KL+ + V P+ +
Sbjct: 56 SLSPVYESGQQMFQGVKSIPHPGYSHPG---HSNDLMLIKLNRRIRPTKDVRPINVSSHC 112
Query: 309 PQLGEKFTQRTGTVVGWGRVEESGQI--ASDLRATQVPVMSNQECRQFPGFEAKLTGNMM 366
P G K V GWG +S Q+ L+ + V+S + C + ++ M
Sbjct: 113 PSAGTKC-----LVSGWG-TTKSPQVHFPKVLQCLNISVLSQKRCED--AYPRQIDDTMF 164
Query: 367 CAGYVEGGKDSCQ 379
CAG + G+DSCQ
Sbjct: 165 CAGD-KAGRDSCQ 176
>pdb|1FI8|A Chain A, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
pdb|1FI8|B Chain B, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
Length = 228
Score = 75.1 bits (183), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 17/182 (9%)
Query: 194 IVGGWTTEVNEYPWVVAL----EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVI 249
I+GG + + P++ L E +G CGG LI + +VLTAAHC S + V +
Sbjct: 1 IIGGHEAKPHSRPYMAYLQIMDEYSGSKKCGGFLIREDFVLTAAHCSGSK-----IQVTL 55
Query: 250 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLP 309
HN + Q + VVK++ HP YN +K+ +DI LLKL + + V P+ LP
Sbjct: 56 GAHNIKEQEKMQ-QIIPVVKIIPHPAYN---SKTISNDIMLLKLKSKAKRSSAVKPLNLP 111
Query: 310 QLGEKFT-QRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQF-PGFEAKLTGNMMC 367
+ K V GWG++ G+ + L+ ++ V +Q+C + + K N +C
Sbjct: 112 RRNVKVKPGDVCYVAGWGKLGPMGKYSDTLQEVELTVQEDQKCESYLKNYFDK--ANEIC 169
Query: 368 AG 369
AG
Sbjct: 170 AG 171
>pdb|2NWN|A Chain A, New Pharmacophore For Serine Protease Inhibition Revealed
By Crystal Structure Of Human Urokinase-Type Plasminogen
Activator Complexed With A Cyclic Peptidyl Inhibitor,
Upain-1
pdb|2O8T|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145Q) IN COMPLEX WITH
Inhibitors
pdb|3KGP|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KHV|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KID|U Chain U, The Crystal Structures Of 2-Aminobenzothiazole-Based
Inhibitors In Complexes With Urokinase-Type Plasminogen
Activator
pdb|3M61|U Chain U, Crystal Structure Of Complex Of Urokinase And A Upain-1
Variant(W3a) In Ph4.6 Condition
pdb|3OX7|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph4.6
pdb|3OY5|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph7.4
pdb|3OY6|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh036 At Ph4.6
pdb|3QN7|A Chain A, Potent And Selective Bicyclic Peptide Inhibitor (Uk18) Of
Human Urokinase-Type Plasminogen Activator(Upa)
Length = 253
Score = 75.1 bits (183), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 57/199 (28%), Positives = 102/199 (51%), Gaps = 17/199 (8%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRQKDLIVV 248
I+GG T + PW A+ + + + CGG+LIS +V++A HC +++D IV
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 249 I--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTP----LEFKPT 302
+ S N T E + E V ++ H Y+A +H +DIALLK+ + + T
Sbjct: 61 LGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 303 VSPVCLPQLGEKFTQRTGT-VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAK 360
+ + LP + T + G+G+ + + + + L+ T V ++S++EC+Q + ++
Sbjct: 117 IQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSE 176
Query: 361 LTGNMMCAGYVEGGKDSCQ 379
+T M+CA + DSCQ
Sbjct: 177 VTTKMLCAADPQWKTDSCQ 195
>pdb|1SC8|U Chain U, Urokinase Plasminogen Activator B-Chain-J435 Complex
pdb|1VJ9|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt464 Complex
pdb|1VJA|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt463 Complex
Length = 262
Score = 75.1 bits (183), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 57/200 (28%), Positives = 102/200 (51%), Gaps = 17/200 (8%)
Query: 193 RIVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRQKDLIV 247
+I+GG T + PW A+ + + + CGG+LIS +V++A HC +++D IV
Sbjct: 15 KIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIV 74
Query: 248 VI--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTP----LEFKP 301
+ S N T E + E V ++ H Y+A +H +DIALLK+ + +
Sbjct: 75 YLGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKIRSKEGRCAQPSR 130
Query: 302 TVSPVCLPQLGEKFTQRTGT-VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEA 359
T+ + LP + T + G+G+ + + + L+ T V ++S++EC+Q + +
Sbjct: 131 TIQTISLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGS 190
Query: 360 KLTGNMMCAGYVEGGKDSCQ 379
++T M+CA + DSCQ
Sbjct: 191 EVTTKMLCAADPQWKTDSCQ 210
>pdb|2O8U|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|2O8W|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|3PB1|E Chain E, Crystal Structure Of A Michaelis Complex Between
Plasminogen Activator Inhibitor-1 And Urokinase-Type
Plasminogen Activator
Length = 253
Score = 75.1 bits (183), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 57/199 (28%), Positives = 102/199 (51%), Gaps = 17/199 (8%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRQKDLIVV 248
I+GG T + PW A+ + + + CGG+LIS +V++A HC +++D IV
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 249 I--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTP----LEFKPT 302
+ S N T E + E V ++ H Y+A +H +DIALLK+ + + T
Sbjct: 61 LGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 303 VSPVCLPQLGEKFTQRTGT-VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAK 360
+ + LP + T + G+G+ + + + + L+ T V ++S++EC+Q + ++
Sbjct: 117 IQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSE 176
Query: 361 LTGNMMCAGYVEGGKDSCQ 379
+T M+CA + DSCQ
Sbjct: 177 VTTKMLCAADPQWKTDSCQ 195
>pdb|4FU7|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU8|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU9|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUB|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUC|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUD|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUE|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUF|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUG|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUH|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUI|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUJ|A Chain A, Crystal Structure Of The Urokinase
pdb|4DVA|U Chain U, The Crystal Structure Of Human Urokinase-type Plasminogen
Activator Catalytic Domain
pdb|4DW2|U Chain U, The Crystal Structure Of Upa In Complex With The Fab
Fragment Of Mab- 112
Length = 246
Score = 75.1 bits (183), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 57/199 (28%), Positives = 102/199 (51%), Gaps = 17/199 (8%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRQKDLIVV 248
I+GG T + PW A+ + + + CGG+LIS +V++A HC +++D IV
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 249 I--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTP----LEFKPT 302
+ S N T E + E V ++ H Y+A +H +DIALLK+ + + T
Sbjct: 61 LGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 303 VSPVCLPQLGEKFTQRTGT-VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAK 360
+ + LP + T + G+G+ + + + + L+ T V ++S++EC+Q + ++
Sbjct: 117 IQTIALPSMYNDPQFGTSCEITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSE 176
Query: 361 LTGNMMCAGYVEGGKDSCQ 379
+T M+CA + DSCQ
Sbjct: 177 VTTKMLCAADPQWKTDSCQ 195
>pdb|1FON|A Chain A, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
pdb|1FON|B Chain B, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
Length = 240
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 48/172 (27%), Positives = 85/172 (49%), Gaps = 10/172 (5%)
Query: 204 EYPWVVAL--EQAGKFF--CGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHNRATVYE 259
+ W V+L E+ G F CGG+LI+ +V+TA HC+ +S+ + VV+ E++R+ +
Sbjct: 9 SWSWQVSLQYEKDGAFHHTCGGSLIAPDWVVTAGHCISTSRTYQ---VVLGEYDRSVLEG 65
Query: 260 T-QIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGEKFTQR 318
+ Q+ + HP +N+ + +DIAL+KL + V LP G+
Sbjct: 66 SEQVIPINAGDLFVHPLWNSN-CVACGNDIALVKLSRSAQLGDKVQLANLPPAGDILPNE 124
Query: 319 TGTVV-GWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCAG 369
+ GWGR+ G + L+ +P + + C Q+ + + M+CAG
Sbjct: 125 APCYISGWGRLYTGGPLPDKLQQALLPTVDYEHCSQWDWWGITVKKTMVCAG 176
>pdb|1EJN|A Chain A, Urokinase Plasminogen Activator B-Chain Inhibitor Complex
pdb|1F5K|U Chain U, Urokinase Plasminogen Activator B-Chain-Benzamidine
Complex
pdb|1F5L|A Chain A, Urokinase Plasminogen Activator B-Chain-Amiloride Complex
pdb|1F92|A Chain A, Urokinase Plasminogen Activator B Chain-Uki-1d Complex
pdb|2R2W|U Chain U, Urokinase Plasminogen Activator B-Chain-Gppe Complex
pdb|2VIN|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIO|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIP|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIQ|A Chain A, Fragment-based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-type
Plasminogen Activator
pdb|2VIV|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIW|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
Length = 253
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 17/199 (8%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRQKDLIVV 248
I+GG T + PW A+ + + + CGG+LIS +V++A HC +++D IV
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 249 I--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTP----LEFKPT 302
+ S N T E + E V ++ H Y+A +H +DIALLK+ + + T
Sbjct: 61 LGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 303 VSPVCLPQLGEKFTQRTGT-VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAK 360
+ + LP + T + G+G+ + + + L+ T V ++S++EC+Q + ++
Sbjct: 117 IQTISLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSE 176
Query: 361 LTGNMMCAGYVEGGKDSCQ 379
+T M+CA + DSCQ
Sbjct: 177 VTTKMLCAADPQWKTDSCQ 195
>pdb|3MWI|U Chain U, The Complex Crystal Structure Of Urokianse And
5-Nitro-1h-Indole-2- Amidine
Length = 246
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 17/199 (8%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRQKDLIVV 248
I+GG T + PW A+ + + + CGG+LIS +V++A HC +++D IV
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 249 I--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTP----LEFKPT 302
+ S N T E + E V ++ H Y+A +H +DIALLK+ + + T
Sbjct: 61 LGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 303 VSPVCLPQLGEKFTQRTGT-VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAK 360
+ + LP + T + G+G+ + + + L+ T V ++S++EC+Q + ++
Sbjct: 117 IQTIALPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSE 176
Query: 361 LTGNMMCAGYVEGGKDSCQ 379
+T M+CA + DSCQ
Sbjct: 177 VTTKMLCAADPQWKTDSCQ 195
>pdb|1W0Z|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W10|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W11|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W12|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W13|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W14|U Chain U, Urokinase Type Plasminogen Activator
pdb|3MHW|U Chain U, The Complex Crystal Structure Of Urokianse And 2-
Aminobenzothiazole
Length = 247
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 17/199 (8%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRQKDLIVV 248
I+GG T + PW A+ + + + CGG+LIS +V++A HC +++D IV
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 249 I--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTP----LEFKPT 302
+ S N T E + E V ++ H Y+A +H +DIALLK+ + + T
Sbjct: 61 LGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 303 VSPVCLPQLGEKFTQRTGT-VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAK 360
+ + LP + T + G+G+ + + + L+ T V ++S++EC+Q + ++
Sbjct: 117 IQTISLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSE 176
Query: 361 LTGNMMCAGYVEGGKDSCQ 379
+T M+CA + DSCQ
Sbjct: 177 VTTKMLCAADPQWKTDSCQ 195
>pdb|3S9A|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Closed-Form)
pdb|3S9B|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V (Open-Form)
pdb|3S9C|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V In Complex
With The Fragment (Residues 1533-1546) Of Human Factor V
pdb|3SBK|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Ppack-Bound Form)
Length = 234
Score = 73.6 bits (179), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 56/191 (29%), Positives = 92/191 (48%), Gaps = 19/191 (9%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISE 251
+VGG +NE+P++VAL + C G LI+ +VLTAAHC R + R K +
Sbjct: 1 VVGGDECNINEHPFLVALYTSASSTIHCAGALINREWVLTAAHCDRRNIRIK-----LGM 55
Query: 252 HNRATVYET-QIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQ 310
H++ E QI R + K+ D DI L++L P+ + ++PV LP
Sbjct: 56 HSKNIRNEDEQIRVPRGKYFCLNTKF----PNGLDKDIMLIRLRRPVTYSTHIAPVSLPS 111
Query: 311 LGEKFTQRTGTVVGWGRVEESGQIASDL-RATQVPVMSNQECRQ-FPGFEAKLTGNMMCA 368
R ++GWG++ S D+ T + ++ ++ C +P A +CA
Sbjct: 112 RSRGVGSRC-RIMGWGKI--STTTYPDVPHCTNIFIVKHKWCEPLYPWVPAD--SRTLCA 166
Query: 369 GYVEGGKDSCQ 379
G ++GG+D+C
Sbjct: 167 GILKGGRDTCH 177
>pdb|2X8A|A Chain A, Human Nuclear Valosin Containing Protein Like (Nvl), C-
Terminal Aaa-Atpase Domain
Length = 274
Score = 73.2 bits (178), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 45/126 (35%), Positives = 72/126 (57%), Gaps = 8/126 (6%)
Query: 493 VVETPLLHLDGFDPRGNIKVLMATNRPDTLDPALMRPGRLDRKVEFGLPDLEGRTHIFKI 552
VV L +DG + R + ++ ATNRPD +DPA++RPGRLD+ + GLP R I K
Sbjct: 130 VVNQLLTEMDGLEARQQVFIMAATNRPDIIDPAILRPGRLDKTLFVGLPPPADRLAILKT 189
Query: 553 HARSMS---VERDIRFELLA--RLCPNSTGAEIRSVCTEAGMFAIR---ARRKVASEKDF 604
++ + ++ D+ E +A C TGA++ ++ EA + A+R AR+K +EK
Sbjct: 190 ITKNGTKPPLDADVNLEAIAGDLRCDCYTGADLSALVREASICALRQEMARQKSGNEKGE 249
Query: 605 LEAVNK 610
L+ +K
Sbjct: 250 LKVSHK 255
Score = 70.9 bits (172), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 44/114 (38%), Positives = 57/114 (50%), Gaps = 15/114 (13%)
Query: 107 EVQRTMLELINQPEKFVNLGIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSEL 166
E+ +L + P++F LG+ P GVLL GPPG GKTL A+AVAN + FI V G EL
Sbjct: 21 ELTMAILAPVRNPDQFKALGLVTPAGVLLAGPPGCGKTLLAKAVANESGLNFISVKGPEL 80
Query: 167 VQKYVGE------RVLMEGCNNEGCGV---------PNRMDRIVGGWTTEVNEY 205
+ YVGE +V N+ C + P R DR G VN+
Sbjct: 81 LNMYVGESERAVRQVFQRAKNSAPCVIFFDEVDALCPRRSDRETGASVRVVNQL 134
Score = 30.8 bits (68), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 15/30 (50%), Positives = 18/30 (60%)
Query: 61 AVANRTDACFIRVIGSELVQKYVGEGARMI 90
AVAN + FI V G EL+ YVGE R +
Sbjct: 63 AVANESGLNFISVKGPELLNMYVGESERAV 92
Score = 30.0 bits (66), Expect = 5.0, Method: Compositional matrix adjust.
Identities = 17/37 (45%), Positives = 20/37 (54%)
Query: 29 KNIARGAVANRTDACFIRVIGSELVQKYVGEGAVANR 65
K + AVAN + FI V G EL+ YVGE A R
Sbjct: 57 KTLLAKAVANESGLNFISVKGPELLNMYVGESERAVR 93
>pdb|1FV9|A Chain A, Crystal Structure Of Human Microurokinase In Complex With
2- Amino-5-Hydroxy-Benzimidazole
Length = 245
Score = 73.2 bits (178), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 56/199 (28%), Positives = 101/199 (50%), Gaps = 17/199 (8%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRQKDLIVV 248
I+GG T + PW A+ + + + CGG+L+S +V++A HC +++D IV
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 249 I--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTP----LEFKPT 302
+ S N T E + E V ++ H Y+A +H +DIALLK+ + + T
Sbjct: 61 LGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 303 VSPVCLPQLGEKFTQRTGT-VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAK 360
+ + LP + T + G+G+ + + + L+ T V ++S++EC+Q + ++
Sbjct: 117 IQTIALPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSE 176
Query: 361 LTGNMMCAGYVEGGKDSCQ 379
+T M+CA + DSCQ
Sbjct: 177 VTTKMLCAADPQWKTDSCQ 195
>pdb|2KRK|A Chain A, Solution Nmr Structure Of 26s Protease Regulatory Subunit
8 From H.Sapiens, Northeast Structural Genomics
Consortium Target Target Hr3102a
Length = 86
Score = 72.8 bits (177), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 34/71 (47%), Positives = 48/71 (67%)
Query: 541 PDLEGRTHIFKIHARSMSVERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIRARRKVAS 600
P+ E R I KIH+R M++ R I +A L P ++GAE++ VCTEAGM+A+R RR +
Sbjct: 11 PNEEARLDILKIHSRKMNLTRGINLRKIAELMPGASGAEVKGVCTEAGMYALRERRVHVT 70
Query: 601 EKDFLEAVNKV 611
++DF AV KV
Sbjct: 71 QEDFEMAVAKV 81
>pdb|3FZZ|A Chain A, Structure Of Grc
pdb|3FZZ|B Chain B, Structure Of Grc
Length = 227
Score = 72.4 bits (176), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 55/182 (30%), Positives = 80/182 (43%), Gaps = 17/182 (9%)
Query: 194 IVGGWTTEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVI 249
I+GG + P++ E K FCGG L+ D++VLTAAHC + + + V +
Sbjct: 1 IIGGNEISPHSRPYMAYYEFLKVGGKKMFCGGFLVRDKFVLTAAHC-----KGRSMTVTL 55
Query: 250 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLP 309
HN ETQ + V K + HP YN +DI LLKL + V P+ LP
Sbjct: 56 GAHNIKAKEETQ-QIIPVAKAIPHPDYNPD---DRSNDIMLLKLVRNAKRTRAVRPLNLP 111
Query: 310 QLGEKFTQ-RTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLT-GNMMC 367
+ V GWG+V G+ L ++ V +Q C F++ N +C
Sbjct: 112 RRNAHVKPGDECYVAGWGKVTPDGEFPKTLHEVKLTVQKDQVCES--QFQSSYNRANEIC 169
Query: 368 AG 369
G
Sbjct: 170 VG 171
>pdb|3G01|A Chain A, Structure Of Grc Mutant E192rE193G
pdb|3G01|B Chain B, Structure Of Grc Mutant E192rE193G
Length = 227
Score = 72.4 bits (176), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 55/182 (30%), Positives = 80/182 (43%), Gaps = 17/182 (9%)
Query: 194 IVGGWTTEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVI 249
I+GG + P++ E K FCGG L+ D++VLTAAHC + + + V +
Sbjct: 1 IIGGNEISPHSRPYMAYYEFLKVGGKKMFCGGFLVRDKFVLTAAHC-----KGRSMTVTL 55
Query: 250 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLP 309
HN ETQ + V K + HP YN +DI LLKL + V P+ LP
Sbjct: 56 GAHNIKAKEETQ-QIIPVAKAIPHPDYNPD---DRSNDIMLLKLVRNAKRTRAVRPLNLP 111
Query: 310 QLGEKFT-QRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLT-GNMMC 367
+ V GWG+V G+ L ++ V +Q C F++ N +C
Sbjct: 112 RRNAHVKPGDECYVAGWGKVTPDGEFPKTLHEVKLTVQKDQVCES--QFQSSYNRANEIC 169
Query: 368 AG 369
G
Sbjct: 170 VG 171
>pdb|1KLT|A Chain A, Crystal Structure Of Pmsf-Treated Human Chymase At 1.9
Angstroms Resolution
Length = 226
Score = 72.0 bits (175), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 59/203 (29%), Positives = 82/203 (40%), Gaps = 32/203 (15%)
Query: 194 IVGGWTTEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVI 249
I+GG ++ + P++ LE FCGG LI +VLTAAHC + + V +
Sbjct: 1 IIGGTESKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCA-----GRSITVTL 55
Query: 250 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLP 309
HN T E + V+K HPKYN + HDI LLKL V + P
Sbjct: 56 GAHN-ITEEEDTWQKLEVIKQFRHPKYNTS---TLHHDIMLLKLKEKASLTLAVGTLPFP 111
Query: 310 -QLGEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLT------ 362
Q R V GWGR + L+ ++ +M Q C F F+ L
Sbjct: 112 SQFNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNLQLCVGNP 171
Query: 363 ------------GNMMCAGYVEG 373
G ++CAG +G
Sbjct: 172 RKTKSAFKGDSGGPLLCAGVAQG 194
>pdb|1OP0|A Chain A, Crystal Structure Of Aav-sp-i, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 71.6 bits (174), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 52/187 (27%), Positives = 91/187 (48%), Gaps = 13/187 (6%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
++GG ++NE+ ++VA FFCGGTLI+ +V+TAAHC D + + H+
Sbjct: 1 VIGGNECDINEHRFLVAFFNTTGFFCGGTLINPEWVVTAAHC-----DSTDFQMQLGVHS 55
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
+ + E + +TR + P N + D DI L+KLD P+ ++P+
Sbjct: 56 KKVLNEDE-QTRNPKEKFICP--NKNNNEVLDKDIMLIKLDKPISNSKHIAPL-SLPSSP 111
Query: 314 KFTQRTGTVVGWGRVEESGQIASDL-RATQVPVMSNQECRQ-FPGFEAKLTGNMMCAGYV 371
++GWG + + D+ + ++ + C+ +P A+ +CAG V
Sbjct: 112 PSVGSVCRIMGWGSITPVKETFPDVPYCANINLLDHAVCQAGYPELLAEY--RTLCAGIV 169
Query: 372 EGGKDSC 378
+GGKD+C
Sbjct: 170 QGGKDTC 176
>pdb|1OP2|A Chain A, Crystal Structure Of Aav-Sp-Ii, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 71.6 bits (174), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 13/187 (6%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
++GG ++NE+ ++VA FFCGGTLI+ +V+TAAHC S+ Q L V H+
Sbjct: 1 VIGGNECDINEHRFLVAFFNTTGFFCGGTLINPEWVVTAAHC-DSTNFQMQLGV----HS 55
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
+ + E + +TR + P N + D DI L+KLD P+ ++P+
Sbjct: 56 KKVLNEDE-QTRNPKEKFICP--NKNNNEVLDKDIMLIKLDKPISNSKHIAPL-SLPSSP 111
Query: 314 KFTQRTGTVVGWGRVEESGQIASDL-RATQVPVMSNQECRQ-FPGFEAKLTGNMMCAGYV 371
++GWG + + D+ + ++ + C+ +P A+ +CAG V
Sbjct: 112 PSVGSVCRIMGWGSITPVKETFPDVPYCANINLLDHAVCQAGYPELLAEY--RTLCAGIV 169
Query: 372 EGGKDSC 378
+GGKD+C
Sbjct: 170 QGGKDTC 176
>pdb|2AIP|A Chain A, Crystal Structure Of Native Protein C Activator From The
Venom Of Copperhead Snake Agkistrodon Contortrix
Contortrix
pdb|2AIQ|A Chain A, Crystal Structure Of Benzamidine-Inhibited Protein C
Activator From The Venom Of Copperhead Snake Agkistrodon
Contortrix Contortrix
Length = 231
Score = 71.6 bits (174), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 22/191 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
++GG +NE+ ++ AL A CGGTLI+ +VLTA HC R + R + + HN
Sbjct: 1 VIGGDECNINEHRFL-ALVYANGSLCGGTLINQEWVLTARHCDRGNMR-----IYLGMHN 54
Query: 254 RATVYETQIETRRVVKVLTHPKY---NAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQ 310
++ + ++ KY N + D DI L++L+ P+ ++P+ LP
Sbjct: 55 ------LKVLNKDALRRFPKEKYFCLNTRNDTIWDKDIMLIRLNRPVRNSAHIAPLSLPS 108
Query: 311 LGEKFTQRTGTVVGWGRVEESGQIASDL-RATQVPVMSNQECR-QFPGFEAKLTGNMMCA 368
++GWG + D+ + ++ C+ + G A +CA
Sbjct: 109 -NPPSVGSVCRIMGWGTITSPNATLPDVPHCANINILDYAVCQAAYKGLAAT----TLCA 163
Query: 369 GYVEGGKDSCQ 379
G +EGGKD+C+
Sbjct: 164 GILEGGKDTCK 174
>pdb|4AFQ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFQ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFS|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFZ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFZ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AG1|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|B Chain B, Human Chymase - Fynomer Complex
Length = 226
Score = 71.2 bits (173), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 59/203 (29%), Positives = 81/203 (39%), Gaps = 32/203 (15%)
Query: 194 IVGGWTTEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVI 249
I+GG + + P++ LE FCGG LI +VLTAAHC + + V +
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCA-----GRSITVTL 55
Query: 250 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLP 309
HN T E + V+K HPKYN + HDI LLKL V + P
Sbjct: 56 GAHN-ITEEEDTWQKLEVIKQFRHPKYNTS---TLHHDIMLLKLKEKASLTLAVGTLPFP 111
Query: 310 -QLGEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLT------ 362
Q R V GWGR + L+ ++ +M Q C F F+ L
Sbjct: 112 SQFNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNLQLCVGNP 171
Query: 363 ------------GNMMCAGYVEG 373
G ++CAG +G
Sbjct: 172 RKTKSAFKGDSGGPLLCAGVAQG 194
>pdb|1NN6|A Chain A, Human Pro-Chymase
Length = 228
Score = 71.2 bits (173), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 59/203 (29%), Positives = 81/203 (39%), Gaps = 32/203 (15%)
Query: 194 IVGGWTTEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVI 249
I+GG + + P++ LE FCGG LI +VLTAAHC + + V +
Sbjct: 3 IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCA-----GRSITVTL 57
Query: 250 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLP 309
HN T E + V+K HPKYN + HDI LLKL V + P
Sbjct: 58 GAHN-ITEEEDTWQKLEVIKQFRHPKYNTS---TLHHDIMLLKLKEKASLTLAVGTLPFP 113
Query: 310 -QLGEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLT------ 362
Q R V GWGR + L+ ++ +M Q C F F+ L
Sbjct: 114 SQFNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNLQLCVGNP 173
Query: 363 ------------GNMMCAGYVEG 373
G ++CAG +G
Sbjct: 174 RKTKSAFKGDSGGPLLCAGVAQG 196
>pdb|3N7O|A Chain A, X-Ray Structure Of Human Chymase In Complex With Small
Molecule Inhibitor
Length = 226
Score = 71.2 bits (173), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 60/203 (29%), Positives = 81/203 (39%), Gaps = 32/203 (15%)
Query: 194 IVGGWTTEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVI 249
I+GG + + P++ LE FCGG LI +VLTAAHC S + V +
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGRS-----ITVTL 55
Query: 250 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLP 309
HN T E + V+K HPKYN + HDI LLKL V + P
Sbjct: 56 GAHN-ITEEEDTWQKLEVIKQFRHPKYNTS---TLHHDIMLLKLKEKASLTLAVGTLPFP 111
Query: 310 -QLGEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLT------ 362
Q R V GWGR + L+ ++ +M Q C F F+ L
Sbjct: 112 SQFNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNLQLCVGNP 171
Query: 363 ------------GNMMCAGYVEG 373
G ++CAG +G
Sbjct: 172 RKTKSAFKGDSGGPLLCAGAAQG 194
>pdb|1PJP|A Chain A, The 2.2 A Crystal Structure Of Human Chymase In Complex
With Succinyl- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|1T31|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|2HVX|A Chain A, Discovery Of Potent, Orally Active, Nonpeptide Inhibitors
Of Human Mast Cell Chymase By Using Structure-Based Drug
Design
pdb|3S0N|A Chain A, Crystal Structure Of Human Chymase With Benzimidazolone
Inhibitor
Length = 226
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 82/204 (40%), Gaps = 34/204 (16%)
Query: 194 IVGGWTTEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVI 249
I+GG + + P++ LE FCGG LI +VLTAAHC S + V +
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGRS-----ITVTL 55
Query: 250 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLP 309
HN T E + V+K HPKYN + HDI LLKL V + P
Sbjct: 56 GAHN-ITEEEDTWQKLEVIKQFRHPKYNTS---TLHHDIMLLKLKEKASLTLAVGTLPFP 111
Query: 310 QLGEKFTQ--RTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLT----- 362
+ F R V GWGR + L+ ++ +M Q C F F+ L
Sbjct: 112 SQ-KNFVPPGRMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNLQLCVGN 170
Query: 363 -------------GNMMCAGYVEG 373
G ++CAG +G
Sbjct: 171 PRKTKSAFKGDSGGPLLCAGAAQG 194
>pdb|1BDA|A Chain A, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
pdb|1BDA|B Chain B, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 64/253 (25%), Positives = 108/253 (42%), Gaps = 31/253 (12%)
Query: 193 RIVGGWTTEVNEYPWVVAL------EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLI 246
RI GG ++ +PW A+ +F CGG LIS ++L+AAHC + L
Sbjct: 13 RIKGGLFADIASHPWQAAIFAKHRRSPGERFLCGGILISSCWILSAAHCFQERFPPHHLT 72
Query: 247 VVISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTP----LEFKPT 302
V++ R E + + V K + H +++ ++D+DIALL+L + +
Sbjct: 73 VILGRTYRVVPGEEE-QKFEVEKYIVHKEFDDD---TYDNDIALLQLKSDSSRCAQESSV 128
Query: 303 VSPVCLPQLGEKFTQRTGT-VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAK 360
V VCLP + T + G+G+ E S+ L+ V + + C
Sbjct: 129 VRTVCLPPADLQLPDWTECELSGYGKHEALSPFYSERLKEAHVRLYPSSRCTSQHLLNRT 188
Query: 361 LTGNMMCAGYVEGG------KDSCQ-------VTLDEADIALLK--SYGQGQYTKSIKAV 405
+T NM+CAG G D+CQ V L++ + L+ S+G G K + V
Sbjct: 189 VTDNMLCAGDTRSGGPQANLHDACQGDSGGPLVCLNDGRMTLVGIISWGLGCGQKDVPGV 248
Query: 406 EDDIQAVIKRVNE 418
+ + + +
Sbjct: 249 YTKVTNYLDWIRD 261
>pdb|3RP2|A Chain A, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
pdb|3RP2|B Chain B, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
Length = 224
Score = 69.3 bits (168), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 34/204 (16%)
Query: 194 IVGGWTTEVNEYPWVVAL----EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVI 249
I+GG + + P++ L E+ + CGG LIS ++VLTAAHC + +++ V++
Sbjct: 1 IIGGVESIPHSRPYMAHLDIVTEKGLRVICGGFLISRQFVLTAAHC-----KGREITVIL 55
Query: 250 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLP 309
H+ TQ + +V K + H YN+ + HDI LLKL+ +E P V+ V LP
Sbjct: 56 GAHDVRKRESTQ-QKIKVEKQIIHESYNSV---PNLHDIMLLKLEKKVELTPAVNVVPLP 111
Query: 310 QLGEKFTQRTGT--VVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLT----- 362
+ F GWG+ + LR ++ +M + C + +E K
Sbjct: 112 SPSD-FIHPGAMCWAAGWGKTGVRDPTSYTLREVELRIMDEKACVDYRYYEYKFQVCVGS 170
Query: 363 -------------GNMMCAGYVEG 373
G ++CAG G
Sbjct: 171 PTTLRAAFMGDSGGPLLCAGVAHG 194
>pdb|1SI5|H Chain H, Protease-Like Domain From 2-Chain Hepatocyte Growth Factor
Length = 240
Score = 68.6 bits (166), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 53/176 (30%), Positives = 83/176 (47%), Gaps = 15/176 (8%)
Query: 207 WVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHNRATVYETQIETRR 266
W+V+L K CGG+LI + +VLTA C S+ KD + H+ V+ E +
Sbjct: 13 WMVSLRYRNKHICGGSLIKESWVLTARQCF-PSRDLKDYEAWLGIHD---VHGRGDEKCK 68
Query: 267 VVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGEKFTQRTG-TVVGW 325
V ++ Y +G+ D+ L+KL P VS + LP G ++T +V GW
Sbjct: 69 QVLNVSQLVYGPEGS-----DLVLMKLARPAVLDDFVSTIDLPNYGSTIPEKTSCSVYGW 123
Query: 326 GRVEESGQIASD--LRATQVPVMSNQECRQFPGFEAKLTGNMMCAGYVEGGKDSCQ 379
G +G I D LR + +M N++C Q + L + +CAG + G C+
Sbjct: 124 GY---TGLINYDGLLRVAHLYIMGNEKCSQHHRGKVTLNESEICAGAEKIGSGPCE 176
>pdb|1SHY|A Chain A, The Crystal Structure Of Hgf Beta-Chain In Complex With
The Sema Domain Of The Met Receptor
Length = 234
Score = 68.6 bits (166), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 53/176 (30%), Positives = 83/176 (47%), Gaps = 15/176 (8%)
Query: 207 WVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHNRATVYETQIETRR 266
W+V+L K CGG+LI + +VLTA C S+ KD + H+ V+ E +
Sbjct: 13 WMVSLRYRNKHICGGSLIKESWVLTARQCF-PSRDLKDYEAWLGIHD---VHGRGDEKCK 68
Query: 267 VVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGEKFTQRTG-TVVGW 325
V ++ Y +G+ D+ L+KL P VS + LP G ++T +V GW
Sbjct: 69 QVLNVSQLVYGPEGS-----DLVLMKLARPAVLDDFVSTIDLPNYGSTIPEKTSCSVYGW 123
Query: 326 GRVEESGQIASD--LRATQVPVMSNQECRQFPGFEAKLTGNMMCAGYVEGGKDSCQ 379
G +G I D LR + +M N++C Q + L + +CAG + G C+
Sbjct: 124 GY---TGLINYDGLLRVAHLYIMGNEKCSQHHRGKVTLNESEICAGAEKIGSGPCE 176
>pdb|1RTF|B Chain B, Complex Of Benzamidine With The Catalytic Domain Of Human
Two Chain Tissue Plasminogen Activator [(Tc)-T-Pa]
pdb|1A5H|A Chain A, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
pdb|1A5H|B Chain B, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
Length = 252
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 63/252 (25%), Positives = 107/252 (42%), Gaps = 31/252 (12%)
Query: 194 IVGGWTTEVNEYPWVVAL------EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIV 247
I GG ++ +PW A+ +F CGG LIS ++L+AAHC + L V
Sbjct: 1 IKGGLFADIASHPWQAAIFAKHRRSPGERFLCGGILISSCWILSAAHCFQERFPPHHLTV 60
Query: 248 VISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTP----LEFKPTV 303
++ R E + + V K + H +++ ++D+DIALL+L + + V
Sbjct: 61 ILGRTYRVVPGEEE-QKFEVEKYIVHKEFDDD---TYDNDIALLQLKSDSSRCAQESSVV 116
Query: 304 SPVCLPQLGEKFTQRTGT-VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEAKL 361
VCLP + T + G+G+ E S+ L+ V + + C +
Sbjct: 117 RTVCLPPADLQLPDWTECELSGYGKHEALSPFYSERLKEAHVRLYPSSRCTSQHLLNRTV 176
Query: 362 TGNMMCAGYVEGG------KDSCQ-------VTLDEADIALLK--SYGQGQYTKSIKAVE 406
T NM+CAG G D+CQ V L++ + L+ S+G G K + V
Sbjct: 177 TDNMLCAGDTRSGGPQANLHDACQGDSGGPLVCLNDGRMTLVGIISWGLGCGQKDVPGVY 236
Query: 407 DDIQAVIKRVNE 418
+ + + +
Sbjct: 237 TKVTNYLDWIRD 248
>pdb|1EUF|A Chain A, Bovine Duodenase(New Serine Protease), Crystal Structure
Length = 227
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 58/182 (31%), Positives = 88/182 (48%), Gaps = 19/182 (10%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGK-FFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVIS 250
I+GG + + P++ L + +GK CGG L+ + +VLTAAHC+ SS + V +
Sbjct: 1 IIGGHEAKPHSRPYMAFLLFKTSGKSHICGGFLVREDFVLTAAHCLGSS-----INVTLG 55
Query: 251 EHNRATVYETQ--IETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCL 308
HN TQ I RR + HP YN + + +DI LLKL + VSP+ L
Sbjct: 56 AHNIMERERTQQVIPVRRPIP---HPDYNDE---TLANDIMLLKLTRKADITDKVSPINL 109
Query: 309 PQ-LGEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMC 367
P+ L E +V GWGR+ + L+ + V S ++C F+ + +C
Sbjct: 110 PRSLAEVKPGMMCSVAGWGRLGVNMPSTDKLQEVDLEVQSEEKC--IARFKNYIPFTQIC 167
Query: 368 AG 369
AG
Sbjct: 168 AG 169
>pdb|3KW6|A Chain A, Crystal Structure Of A Domain Of 26s Proteasome Regulatory
Subunit 8 From Homo Sapiens. Northeast Structural
Genomics Consortium Target Id Hr3102a
Length = 78
Score = 67.8 bits (164), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 32/71 (45%), Positives = 46/71 (64%)
Query: 541 PDLEGRTHIFKIHARSMSVERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIRARRKVAS 600
P+ E R I KIH+R ++ R I +A L P ++GAE++ VCTEAG +A+R RR +
Sbjct: 3 PNEEARLDILKIHSRKXNLTRGINLRKIAELXPGASGAEVKGVCTEAGXYALRERRVHVT 62
Query: 601 EKDFLEAVNKV 611
++DF AV KV
Sbjct: 63 QEDFEXAVAKV 73
>pdb|2WIN|I Chain I, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|J Chain J, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|K Chain K, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|L Chain L, C3 Convertase (C3bbb) Stabilized By Scin
Length = 507
Score = 66.2 bits (160), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 38/120 (31%), Positives = 60/120 (50%), Gaps = 19/120 (15%)
Query: 200 TEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHNRA 255
T+ ++ PW + G C G ++S+ +VLTAAHC ++ + V + R
Sbjct: 229 TDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKR- 287
Query: 256 TVYETQIETRRVVKVLTHPKYNAQGAKS------HDHDIALLKLDTPLEFKPTVSPVCLP 309
+ +IE VL HP YN G K +D+D+AL+KL L++ T+ P+CLP
Sbjct: 288 ---DLEIEV-----VLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLP 339
>pdb|1RRK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
pdb|1RS0|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With Di-Isopropyl-Phosphate (Dip)
pdb|1RTK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With 4-Guanidinobenzoic Acid
Length = 497
Score = 66.2 bits (160), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 38/120 (31%), Positives = 60/120 (50%), Gaps = 19/120 (15%)
Query: 200 TEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHNRA 255
T+ ++ PW + G C G ++S+ +VLTAAHC ++ + V + R
Sbjct: 221 TDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKR- 279
Query: 256 TVYETQIETRRVVKVLTHPKYNAQGAKS------HDHDIALLKLDTPLEFKPTVSPVCLP 309
+ +IE VL HP YN G K +D+D+AL+KL L++ T+ P+CLP
Sbjct: 280 ---DLEIEV-----VLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLP 331
>pdb|2XWB|F Chain F, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|H Chain H, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 732
Score = 66.2 bits (160), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 38/120 (31%), Positives = 60/120 (50%), Gaps = 19/120 (15%)
Query: 200 TEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHNRA 255
T+ ++ PW + G C G ++S+ +VLTAAHC ++ + V + R
Sbjct: 454 TDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKR- 512
Query: 256 TVYETQIETRRVVKVLTHPKYNAQGAKS------HDHDIALLKLDTPLEFKPTVSPVCLP 309
+ +IE VL HP YN G K +D+D+AL+KL L++ T+ P+CLP
Sbjct: 513 ---DLEIEV-----VLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLP 564
>pdb|2OK5|A Chain A, Human Complement Factor B
Length = 752
Score = 65.9 bits (159), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 38/120 (31%), Positives = 60/120 (50%), Gaps = 19/120 (15%)
Query: 200 TEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHNRA 255
T+ ++ PW + G C G ++S+ +VLTAAHC ++ + V + R
Sbjct: 473 TDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKR- 531
Query: 256 TVYETQIETRRVVKVLTHPKYNAQGAKS------HDHDIALLKLDTPLEFKPTVSPVCLP 309
+ +IE VL HP YN G K +D+D+AL+KL L++ T+ P+CLP
Sbjct: 532 ---DLEIEV-----VLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLP 583
>pdb|1KYN|B Chain B, Cathepsin-G
pdb|1KYN|A Chain A, Cathepsin-G
Length = 235
Score = 65.9 bits (159), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 60/184 (32%), Positives = 94/184 (51%), Gaps = 24/184 (13%)
Query: 194 IVGGWTTEVNEYPWVVALE---QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVIS 250
I+GG + + P++ L+ AG+ CGG L+ + +VLTAAHC S ++ V +
Sbjct: 1 IIGGRESRPHSRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHCWGS-----NINVTLG 55
Query: 251 EHN--RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCL 308
HN R + I RR ++ HP+YN ++ +DI LL+L + V+PV L
Sbjct: 56 AHNIQRRENTQQHITARRAIR---HPQYN---QRTIQNDIMLLQLSRRVRRNRNVNPVAL 109
Query: 309 PQLGEKFTQRT-GTVVGWGRVEESGQIASD-LRATQVPVMSNQEC-RQFPGFEAKLTGNM 365
P+ E T TV GWGRV S + +D LR Q+ V +++C R F ++ +
Sbjct: 110 PRAQEGLRPGTLCTVAGWGRV--SMRRGTDTLREVQLRVQRDRQCLRIFGSYDPR---RQ 164
Query: 366 MCAG 369
+C G
Sbjct: 165 ICVG 168
>pdb|1A7S|A Chain A, Atomic Resolution Structure Of Hbp
pdb|1AE5|A Chain A, Human Heparin Binding Protein
Length = 225
Score = 65.9 bits (159), Expect = 8e-11, Method: Composition-based stats.
Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 10/162 (6%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG ++P++ +++ G+ FCGG LI R+V+TAA C +S +V+ +
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGRHFCGGALIHARFVMTAASCFQSQNPGVSTVVLGAYDL 60
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
R E Q + ++ Y+ Q + +D+ LL+LD +V+ + LP +
Sbjct: 61 RRR--ERQSRQTFSISSMSENGYDPQ---QNLNDLMLLQLDREANLTSSVTILPLPL--Q 113
Query: 314 KFTQRTGT---VVGWGRVEESGQIASDLRATQVPVMSNQECR 352
T GT V GWG G+++ R V V +CR
Sbjct: 114 NATVEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCR 155
>pdb|1EQ9|A Chain A, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
pdb|1EQ9|B Chain B, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
Length = 222
Score = 65.9 bits (159), Expect = 8e-11, Method: Composition-based stats.
Identities = 47/168 (27%), Positives = 79/168 (47%), Gaps = 23/168 (13%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG V +YP+ V+L +G CG +++ + VLTAAHCV +S N
Sbjct: 1 IVGGKDAPVGKYPYQVSLRLSGSHRCGASILDNNNVLTAAHCVDG----------LSNLN 50
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGA---KSHD-----HDIALLKLDTPLEFKPTVSP 305
R V+ + T + + + Y+ + A K++D +D+AL+ L P++F V P
Sbjct: 51 RLKVH---VGTNYLSE--SGDVYDVEDAVVNKNYDDFLLRNDVALVHLTNPIKFNDLVQP 105
Query: 306 VCLPQLGEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQ 353
+ L E T+ GWG G + L+ ++ V ++C +
Sbjct: 106 IKLSTNDEDLESNPCTLTGWGSTRLGGNTPNALQEIELIVHPQKQCER 153
>pdb|3HRZ|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|I Chain I, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|2XWJ|I Chain I, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|J Chain J, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|K Chain K, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|L Chain L, Crystal Structure Of Complement C3b In Complex With Factor
B
Length = 741
Score = 65.9 bits (159), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 38/120 (31%), Positives = 60/120 (50%), Gaps = 19/120 (15%)
Query: 200 TEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHNRA 255
T+ ++ PW + G C G ++S+ +VLTAAHC ++ + V + R
Sbjct: 463 TDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKR- 521
Query: 256 TVYETQIETRRVVKVLTHPKYNAQGAKS------HDHDIALLKLDTPLEFKPTVSPVCLP 309
+ +IE VL HP YN G K +D+D+AL+KL L++ T+ P+CLP
Sbjct: 522 ---DLEIEV-----VLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLP 573
>pdb|1FY3|A Chain A, [g175q]hbp, A Mutant Of Human Heparin Binding Protein
(cap37)
Length = 225
Score = 65.9 bits (159), Expect = 8e-11, Method: Composition-based stats.
Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 10/162 (6%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG ++P++ +++ G+ FCGG LI R+V+TAA C +S +V+ +
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGRHFCGGALIHARFVMTAASCFQSQNPGVSTVVLGAYDL 60
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
R E Q + ++ Y+ Q + +D+ LL+LD +V+ + LP +
Sbjct: 61 RRR--ERQSRQTFSISSMSENGYDPQ---QNLNDLMLLQLDREANLTSSVTILPLPL--Q 113
Query: 314 KFTQRTGT---VVGWGRVEESGQIASDLRATQVPVMSNQECR 352
T GT V GWG G+++ R V V +CR
Sbjct: 114 NATVEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCR 155
>pdb|1DLE|A Chain A, Factor B Serine Protease Domain
pdb|1DLE|B Chain B, Factor B Serine Protease Domain
Length = 298
Score = 65.5 bits (158), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 38/120 (31%), Positives = 60/120 (50%), Gaps = 19/120 (15%)
Query: 200 TEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHNRA 255
T+ ++ PW + G C G ++S+ +VLTAAHC ++ + V + R
Sbjct: 22 TDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKR- 80
Query: 256 TVYETQIETRRVVKVLTHPKYNAQGAKS------HDHDIALLKLDTPLEFKPTVSPVCLP 309
+ +IE VL HP YN G K +D+D+AL+KL L++ T+ P+CLP
Sbjct: 81 ---DLEIEV-----VLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRPICLP 132
>pdb|1BQY|A Chain A, Plasminogen Activator (tsv-pa) From Snake Venom
pdb|1BQY|B Chain B, Plasminogen Activator (tsv-pa) From Snake Venom
Length = 234
Score = 65.1 bits (157), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 47/187 (25%), Positives = 89/187 (47%), Gaps = 11/187 (5%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
+ GG +NE+ +V L + F CGGTLI+ +V+TAAHC + ++ H+
Sbjct: 1 VFGGDECNINEHRSLVVLFNSNGFLCGGTLINQDWVVTAAHC-----DSNNFQLLFGVHS 55
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
+ + E + +TR + P N + D DI L+KLD+ + ++P+
Sbjct: 56 KKILNEDE-QTRDPKEKFFCP--NRKKDDEVDKDIMLIKLDSSVSNSEHIAPL-SLPSSP 111
Query: 314 KFTQRTGTVVGWGRVEESGQIASDL-RATQVPVMSNQECRQFPGFEAKLTGNMMCAGYVE 372
++GWG+ + +I D+ + ++ + CR + ++ +CAG ++
Sbjct: 112 PSVGSVCRIMGWGKTIPTKEIYPDVPHCANINILDHAVCRTAYSWR-QVANTTLCAGILQ 170
Query: 373 GGKDSCQ 379
GG+D+C
Sbjct: 171 GGRDTCH 177
>pdb|1HYL|A Chain A, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|1HYL|B Chain B, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|2HLC|A Chain A, Hl Collagenase Structure At 1.7a Resolution
pdb|2HLC|B Chain B, Hl Collagenase Structure At 1.7a Resolution
Length = 230
Score = 65.1 bits (157), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 47/169 (27%), Positives = 83/169 (49%), Gaps = 25/169 (14%)
Query: 194 IVGGWTTEVNEYPWV----VALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVI 249
I+ G+ +P+ + L+ + +CGG+LI ++++LTAAHCV D + V+
Sbjct: 1 IINGYEAYTGLFPYQAGLDITLQDQRRVWCGGSLIDNKWILTAAHCVH------DAVSVV 54
Query: 250 SEHNRATVYETQ--IETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVC 307
A YE + + + R++ +H +N ++ +D+AL+K+ +E+ + P+
Sbjct: 55 VYLGSAVQYEGEAVVNSERII---SHSMFN---PDTYLNDVALIKI-PHVEYTDNIQPIR 107
Query: 308 LP---QLGEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQ 353
LP +L KF TV GWG+ I L+ T V+ N C Q
Sbjct: 108 LPSGEELNNKFENIWATVSGWGQSNTDTVI---LQYTYNLVIDNDRCAQ 153
>pdb|3S69|A Chain A, Crystal Structure Of Saxthrombin
Length = 234
Score = 65.1 bits (157), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 19/190 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
++GG +NE+ +VA + FFC GTLI++ +VLTAAHC ++ + K + H+
Sbjct: 1 VIGGDECNINEHRSLVAFFNSTGFFCSGTLINEEWVLTAAHCDNTNFQMK-----LGVHS 55
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
+ + E + +TR + P N + + D DI L+KLD+ + + +P
Sbjct: 56 KKVLNEDE-QTRNPKEKFICP--NKKNDEVLDKDIMLIKLDSRVSNSEHI----VPLSLP 108
Query: 314 KFTQRTGTV---VGWGRVEESGQIASDL-RATQVPVMSNQECRQFPGFEAKLT-GNMMCA 368
G+V +GWG + D+ + ++ + C+ G+ LT +CA
Sbjct: 109 SSPPSVGSVCHIMGWGSITPIKVTYPDVPYCAYINLLDDAVCQA--GYPELLTEYRTLCA 166
Query: 369 GYVEGGKDSC 378
G +EGGKD+C
Sbjct: 167 GILEGGKDTC 176
>pdb|1AU8|A Chain A, Human Cathepsin G
pdb|1T32|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|1CGH|A Chain A, Human Cathepsin G
Length = 224
Score = 64.7 bits (156), Expect = 2e-10, Method: Composition-based stats.
Identities = 60/184 (32%), Positives = 94/184 (51%), Gaps = 24/184 (13%)
Query: 194 IVGGWTTEVNEYPWVVALE---QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVIS 250
I+GG + + P++ L+ AG+ CGG L+ + +VLTAAHC S ++ V +
Sbjct: 1 IIGGRESRPHSRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHCWGS-----NINVTLG 55
Query: 251 EHN--RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCL 308
HN R + I RR ++ HP+YN ++ +DI LL+L + V+PV L
Sbjct: 56 AHNIQRRENTQQHITARRAIR---HPQYN---QRTIQNDIMLLQLSRRVRRNRNVNPVAL 109
Query: 309 PQLGEKFTQRT-GTVVGWGRVEESGQIASD-LRATQVPVMSNQEC-RQFPGFEAKLTGNM 365
P+ E T TV GWGRV S + +D LR Q+ V +++C R F ++ +
Sbjct: 110 PRAQEGLRPGTLCTVAGWGRV--SMRRGTDTLREVQLRVQRDRQCLRIFGSYDPR---RQ 164
Query: 366 MCAG 369
+C G
Sbjct: 165 ICVG 168
>pdb|1FQ3|A Chain A, Crystal Structure Of Human Granzyme B
pdb|1FQ3|B Chain B, Crystal Structure Of Human Granzyme B
Length = 227
Score = 64.3 bits (155), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 50/162 (30%), Positives = 80/162 (49%), Gaps = 13/162 (8%)
Query: 194 IVGGWTTEVNEYPWVVAL---EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVIS 250
I+GG + + P++ L +Q CGG LI D +VLTAAHC SS + V +
Sbjct: 1 IIGGHEAKPHSRPYMAYLMIWDQKSLKRCGGFLIQDDFVLTAAHCWGSS-----INVTLG 55
Query: 251 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQ 310
HN TQ + V + + HP YN K+ +DI LL+L+ + V P+ LP
Sbjct: 56 AHNIKEQEPTQ-QFIPVKRPIPHPAYN---PKNFSNDIMLLQLERKAKRTRAVQPLRLPS 111
Query: 311 LGEKFTQ-RTGTVVGWGRVEESGQIASDLRATQVPVMSNQEC 351
+ +T +V GWG+ G+ + L+ ++ V +++C
Sbjct: 112 NKAQVKPGQTCSVAGWGQTAPLGKHSHTLQEVKMTVQEDRKC 153
>pdb|1IAU|A Chain A, Human Granzyme B In Complex With Ac-Iepd-Cho
Length = 227
Score = 63.9 bits (154), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 50/162 (30%), Positives = 80/162 (49%), Gaps = 13/162 (8%)
Query: 194 IVGGWTTEVNEYPWVVAL---EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVIS 250
I+GG + + P++ L +Q CGG LI D +VLTAAHC SS + V +
Sbjct: 1 IIGGHEAKPHSRPYMAYLMIWDQKSLKRCGGFLIRDDFVLTAAHCWGSS-----INVTLG 55
Query: 251 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQ 310
HN TQ + V + + HP YN K+ +DI LL+L+ + V P+ LP
Sbjct: 56 AHNIKEQEPTQ-QFIPVKRPIPHPAYN---PKNFSNDIMLLQLERKAKRTRAVQPLRLPS 111
Query: 311 LGEKFTQ-RTGTVVGWGRVEESGQIASDLRATQVPVMSNQEC 351
+ +T +V GWG+ G+ + L+ ++ V +++C
Sbjct: 112 NKAQVKPGQTCSVAGWGQTAPLGKHSHTLQEVKMTVQEDRKC 153
>pdb|3H7O|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
pdb|3H7O|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
Length = 228
Score = 63.2 bits (152), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 47/164 (28%), Positives = 82/164 (50%), Gaps = 16/164 (9%)
Query: 196 GGWTTEVNEYPWVVALEQAG---KFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEH 252
GG T++ + PW VA+ CGG ++S +VLTAAHCV K + ++ ++
Sbjct: 2 GGEKTDIKQVPWTVAVRTYPGEESLTCGGAILSQWFVLTAAHCVFDQKPE----TIVIQY 57
Query: 253 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVS-PVCLPQL 311
++E ++ V +H + ++ ++DIA+L+L PL+ S P LP +
Sbjct: 58 ESTNLWEDPGKSDPYV---SHVYLSFYRQETMENDIAILELSRPLKLDGLKSKPAKLPDI 114
Query: 312 GEKFTQRTGT---VVGWGRVEESGQIASDLRATQVPVMSNQECR 352
+F +TG+ V G+G + DL++ Q+ V+ ECR
Sbjct: 115 --EFRPKTGSDVLVSGYGDGQTMDPKDHDLKSAQLTVVDLDECR 156
>pdb|3B9P|A Chain A, Spastin
Length = 297
Score = 62.4 bits (150), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 30/56 (53%), Positives = 36/56 (64%), Gaps = 1/56 (1%)
Query: 118 QPEKFVNLGIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQKYVGE 173
+PE F L P KG+LLFGPPG GKTL ARAVA A F+ + + L KYVG+
Sbjct: 43 RPELFTGLR-APAKGLLLFGPPGNGKTLLARAVATECSATFLNISAASLTSKYVGD 97
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 34/133 (25%), Positives = 61/133 (45%), Gaps = 18/133 (13%)
Query: 498 LLHLDGF--DPRGN-IKVLMATNRPDTLDPALMRPGRLDRKVEFGLPDLEGRTHIFKIHA 554
L+ DG +P G+ I VL ATNRP LD A +R R ++V LPD + R +
Sbjct: 145 LVEFDGLPGNPDGDRIVVLAATNRPQELDEAALR--RFTKRVYVSLPDEQTRELLLNRLL 202
Query: 555 RSMSVERDIR-FELLARLCPNSTGAEIRSVCTEAGMFAIR------------ARRKVASE 601
+ D LA++ +G+++ ++ +A + IR + + +E
Sbjct: 203 QKQGSPLDTEALRRLAKITDGYSGSDLTALAKDAALEPIRELNVEQVKCLDISAMRAITE 262
Query: 602 KDFLEAVNKVARC 614
+DF ++ ++ R
Sbjct: 263 QDFHSSLKRIRRS 275
Score = 30.4 bits (67), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 15/35 (42%), Positives = 20/35 (57%), Gaps = 1/35 (2%)
Query: 26 NGHKNIARGAVANRTDACFIRVIGSELVQKYVGEG 60
NG +AR AVA A F+ + + L KYVG+G
Sbjct: 65 NGKTLLAR-AVATECSATFLNISAASLTSKYVGDG 98
Score = 30.0 bits (66), Expect = 4.9, Method: Compositional matrix adjust.
Identities = 20/73 (27%), Positives = 35/73 (47%), Gaps = 11/73 (15%)
Query: 18 SVKPLDIFNGHKNIARGAVANRTDACFIRVIGSELVQKYVGEGAVANRTDACFIRVIGSE 77
SV+P ++F G + A+G + + G K + AVA A F+ + +
Sbjct: 41 SVRP-ELFTGLRAPAKGLL----------LFGPPGNGKTLLARAVATECSATFLNISAAS 89
Query: 78 LVQKYVGEGARMI 90
L KYVG+G +++
Sbjct: 90 LTSKYVGDGEKLV 102
>pdb|4F4O|C Chain C, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|F Chain F, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|I Chain I, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|L Chain L, Structure Of The Haptoglobin-Haemoglobin Complex
Length = 347
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 52/213 (24%), Positives = 86/213 (40%), Gaps = 29/213 (13%)
Query: 185 CGVP----NRMDRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSK 240
CG P +++ RI+GG +PW + G TLI+++++LT A +R
Sbjct: 90 CGKPKNPVDQVQRIMGGSLDAKGSFPWQAKMISHHNLTSGATLINEQWLLTTAKNLRLGH 149
Query: 241 RQKDLIVVISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFK 300
+ I+ R +Y + + + KV+ HP + DI L+KL +
Sbjct: 150 KNDTKAKDIAPTLR--LYVGKKQEVEIEKVIFHPDNSTV-------DIGLIKLKQKVPVN 200
Query: 301 PTVSPVCLPQLGEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFP----- 355
V P+CLP G V GWGR + L+ +PV ++C Q+
Sbjct: 201 ERVMPICLPSKDYVNVGLVGYVSGWGR-NANLNFTEHLKYVMLPVADQEKCVQYYEGSTV 259
Query: 356 ----------GFEAKLTGNMMCAGYVEGGKDSC 378
G + L + CAG + +D+C
Sbjct: 260 PEKKTPKSPVGVQPILNEHTFCAGLSKYQEDTC 292
>pdb|3VFD|A Chain A, Human Spastin Aaa Domain
Length = 389
Score = 61.2 bits (147), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 28/56 (50%), Positives = 37/56 (66%), Gaps = 1/56 (1%)
Query: 118 QPEKFVNLGIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQKYVGE 173
+PE F L P +G+LLFGPPG GKT+ A+AVA ++A F + + L KYVGE
Sbjct: 137 RPELFTGLRA-PARGLLLFGPPGNGKTMLAKAVAAESNATFFNISAASLTSKYVGE 191
Score = 40.4 bits (93), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 38/132 (28%), Positives = 62/132 (46%), Gaps = 17/132 (12%)
Query: 498 LLHLDGFDPRGNIKVLM--ATNRPDTLDPALMRPGRLDRKVEFGLPDLEGRTHIFKIHA- 554
L+ DG G+ +VL+ ATNRP LD A++R R ++V LP+ E R + K
Sbjct: 239 LIEFDGVQSAGDDRVLVMGATNRPQELDEAVLR--RFIKRVYVSLPNEETRLLLLKNLLC 296
Query: 555 RSMSVERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIR------ARRKVASE------K 602
+ S LAR+ +G+++ ++ +A + IR + ASE
Sbjct: 297 KQGSPLTQKELAQLARMTDGYSGSDLTALAKDAALGPIRELKPEQVKNMSASEMRNIRLS 356
Query: 603 DFLEAVNKVARC 614
DF E++ K+ R
Sbjct: 357 DFTESLKKIKRS 368
Score = 33.1 bits (74), Expect = 0.62, Method: Compositional matrix adjust.
Identities = 21/73 (28%), Positives = 36/73 (49%), Gaps = 11/73 (15%)
Query: 18 SVKPLDIFNGHKNIARGAVANRTDACFIRVIGSELVQKYVGEGAVANRTDACFIRVIGSE 77
S++P ++F G + ARG + + G K + AVA ++A F + +
Sbjct: 135 SLRP-ELFTGLRAPARGLL----------LFGPPGNGKTMLAKAVAAESNATFFNISAAS 183
Query: 78 LVQKYVGEGARMI 90
L KYVGEG +++
Sbjct: 184 LTSKYVGEGEKLV 196
>pdb|3D8B|A Chain A, Crystal Structure Of Human Fidgetin-Like Protein 1 In
Complex With Adp
pdb|3D8B|B Chain B, Crystal Structure Of Human Fidgetin-Like Protein 1 In
Complex With Adp
Length = 357
Score = 61.2 bits (147), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 28/56 (50%), Positives = 38/56 (67%), Gaps = 1/56 (1%)
Query: 118 QPEKFVNLGIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQKYVGE 173
+P+ F L PPKG+LLFGPPGTGKTL + +A+++ A F + S L K+VGE
Sbjct: 106 RPDIFTGLR-GPPKGILLFGPPGTGKTLIGKCIASQSGATFFSISASSLTSKWVGE 160
Score = 37.4 bits (85), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 29/110 (26%), Positives = 51/110 (46%), Gaps = 5/110 (4%)
Query: 488 EKLREVVETPLLHLDGFDPRGNIKVLM--ATNRPDTLDPALMRPGRLDRKVEFGLPDLEG 545
E R + L+ LDG ++L+ ATNRP +D A R RL +++ LP+
Sbjct: 198 ESSRRIKTEFLVQLDGATTSSEDRILVVGATNRPQEIDEAARR--RLVKRLYIPLPEASA 255
Query: 546 RTHI-FKIHARSMSVERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIRA 594
R I + ++ + E + + +GA++ +C EA + IR+
Sbjct: 256 RKQIVINLMSKEQCCLSEEEIEQIVQQSDAFSGADMTQLCREASLGPIRS 305
Score = 33.9 bits (76), Expect = 0.35, Method: Compositional matrix adjust.
Identities = 23/81 (28%), Positives = 36/81 (44%), Gaps = 13/81 (16%)
Query: 13 TFNNISVKPL---DIFNGHKNIARGAVANRTDACFIRVIGSELVQKYVGEGAVANRTDAC 69
T I V P+ DIF G + +G I + G K + +A+++ A
Sbjct: 95 TIKEIVVWPMLRPDIFTGLRGPPKG----------ILLFGPPGTGKTLIGKCIASQSGAT 144
Query: 70 FIRVIGSELVQKYVGEGARMI 90
F + S L K+VGEG +M+
Sbjct: 145 FFSISASSLTSKWVGEGEKMV 165
>pdb|1FY1|A Chain A, [r23s,F25e]hbp, A Mutant Of Human Heparin Binding Protein
(Cap37)
Length = 225
Score = 60.8 bits (146), Expect = 2e-09, Method: Composition-based stats.
Identities = 45/162 (27%), Positives = 74/162 (45%), Gaps = 10/162 (6%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG ++P++ +++ G CGG LI R+V+TAA C +S +V+ +
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGSHECGGALIHARFVMTAASCFQSQNPGVSTVVLGAYDL 60
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
R E Q + ++ Y+ Q + +D+ LL+LD +V+ + LP +
Sbjct: 61 RRR--ERQSRQTFSISSMSENGYDPQ---QNLNDLMLLQLDREANLTSSVTILPLPL--Q 113
Query: 314 KFTQRTGT---VVGWGRVEESGQIASDLRATQVPVMSNQECR 352
T GT V GWG G+++ R V V +CR
Sbjct: 114 NATVEAGTRCQVAGWGSQRSGGRLSRFPRFVNVTVTPEDQCR 155
>pdb|4GAW|A Chain A, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|B Chain B, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|C Chain C, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|D Chain D, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|E Chain E, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|F Chain F, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|G Chain G, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|H Chain H, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|I Chain I, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|J Chain J, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|K Chain K, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|L Chain L, Crystal Structure Of Active Human Granzyme H
Length = 226
Score = 60.8 bits (146), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 57/183 (31%), Positives = 89/183 (48%), Gaps = 21/183 (11%)
Query: 194 IVGGWTTEVNEYPW---VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVIS 250
I+GG + + P+ V L++ + CGG L+ +VLTAAHC SS + V +
Sbjct: 1 IIGGHEAKPHSRPYMAFVQFLQEKSRKRCGGILVRKDFVLTAAHCQGSS-----INVTLG 55
Query: 251 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQ 310
HN TQ + V + + HP YN K+ +DI LL+L+ ++ V P+ LP
Sbjct: 56 AHNIKEQERTQ-QFIPVKRPIPHPAYN---PKNFSNDIMLLQLERKAKWTTAVRPLRLPS 111
Query: 311 LGEKFTQRTG---TVVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEAKLTGNMM 366
K + G +V GWG V S +A+ L+ + V + +C R F G ++ T +
Sbjct: 112 --SKAQVKPGQLCSVAGWGYVSMS-TLATTLQEVLLTVQKDCQCERLFHGNYSRAT--EI 166
Query: 367 CAG 369
C G
Sbjct: 167 CVG 169
>pdb|3TJU|A Chain A, Crystal Structure Of Human Granzyme H With An Inhibitor
pdb|3TJV|A Chain A, Crystal Structure Of Human Granzyme H With A Peptidyl
Substrate
pdb|3TK9|A Chain A, Crystal Structure Of Human Granzyme H
Length = 226
Score = 58.9 bits (141), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 56/183 (30%), Positives = 89/183 (48%), Gaps = 21/183 (11%)
Query: 194 IVGGWTTEVNEYPW---VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVIS 250
I+GG + + P+ V L++ + CGG L+ +VLTAAHC SS + V +
Sbjct: 1 IIGGHEAKPHSRPYMAFVQFLQEKSRKRCGGILVRKDFVLTAAHCQGSS-----INVTLG 55
Query: 251 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQ 310
HN TQ + V + + HP YN K+ ++I LL+L+ ++ V P+ LP
Sbjct: 56 AHNIKEQERTQ-QFIPVKRPIPHPAYN---PKNFSNNIMLLQLERKAKWTTAVRPLRLPS 111
Query: 311 LGEKFTQRTG---TVVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEAKLTGNMM 366
K + G +V GWG V S +A+ L+ + V + +C R F G ++ T +
Sbjct: 112 --SKAQVKPGQLCSVAGWGYVSMS-TLATTLQEVLLTVQKDCQCERLFHGNYSRAT--EI 166
Query: 367 CAG 369
C G
Sbjct: 167 CVG 169
>pdb|3F1S|B Chain B, Crystal Structure Of Protein Z Complexed With Protein
Z-Dependent Inhibitor
Length = 283
Score = 57.8 bits (138), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 46/160 (28%), Positives = 77/160 (48%), Gaps = 21/160 (13%)
Query: 201 EVNEYPWVVALEQA-GKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHNRATVYE 259
++ + PW V L + GK FCGG +I + +VLT A C + I V + NR +
Sbjct: 60 DLQDLPWQVKLTNSEGKDFCGGVIIRENFVLTTAKCSLLHRN----ITVKTYFNRTSQDP 115
Query: 260 TQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGEKFTQ-- 317
I ++ V H +Y+A ++D++LL+L+ P++ PVC P+ + F +
Sbjct: 116 LMI---KITHVHVHMRYDADAG---ENDLSLLELEWPIQCPGAGLPVCTPE--KDFAEHL 167
Query: 318 ---RT-GTVVGWGRVEESGQIASDLRATQVPVMSNQECRQ 353
RT G + GW R + + L V ++ +EC Q
Sbjct: 168 LIPRTRGLLSGWAR--NGTDLGNSLTTRPVTLVEGEECGQ 205
>pdb|3H7T|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
pdb|3H7T|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
Length = 235
Score = 57.8 bits (138), Expect = 2e-08, Method: Composition-based stats.
Identities = 47/182 (25%), Positives = 85/182 (46%), Gaps = 15/182 (8%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
I+GG +++ + PW V + K FCGG++++ +V+TAA CV +K D+ +
Sbjct: 1 IIGGKKSDITKEPWAVGVLVDEKPFCGGSILTANFVITAAQCVDGTK-PSDISIHYGSSY 59
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEF-KPTVSPVCLPQLG 312
R T T + +++ V HP + ++ A+++ + P++ T + LP L
Sbjct: 60 R-TTKGTSVMAKKIYIVRYHP-------LTMQNNYAVIETEMPIKLDDKTTKKIELPSLL 111
Query: 313 EKFTQRTGTVV-GWGRVE-ESGQIASDLRATQVPVMSNQEC-RQFPGFEAK--LTGNMMC 367
T +V GWG +S + + DL V+ + C Q+ EA + + C
Sbjct: 112 YDPEPDTSVLVSGWGSTNFKSLEYSGDLMEANFTVVDRKSCEEQYKQIEADKYIYDGVFC 171
Query: 368 AG 369
AG
Sbjct: 172 AG 173
>pdb|2QP9|X Chain X, Crystal Structure Of S.Cerevisiae Vps4
pdb|2QPA|A Chain A, Crystal Structure Of S.Cerevisiae Vps4 In The Presence Of
Adp
pdb|2QPA|B Chain B, Crystal Structure Of S.Cerevisiae Vps4 In The Presence Of
Adp
pdb|2QPA|C Chain C, Crystal Structure Of S.Cerevisiae Vps4 In The Presence Of
Adp
Length = 355
Score = 57.4 bits (137), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 28/69 (40%), Positives = 42/69 (60%), Gaps = 3/69 (4%)
Query: 108 VQRTMLELINQPEKFVNL---GIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGS 164
+ + E + P KF +L +P G+LL+GPPGTGK+ A+AVA ++ F V S
Sbjct: 59 AKEALKEAVILPVKFPHLFKGNRKPTSGILLYGPPGTGKSYLAKAVATEANSTFFSVSSS 118
Query: 165 ELVQKYVGE 173
+LV K++GE
Sbjct: 119 DLVSKWMGE 127
Score = 45.8 bits (107), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 44/146 (30%), Positives = 70/146 (47%), Gaps = 12/146 (8%)
Query: 467 MQVEEKPDVTYSD----IGGCKEQ--IEKLREVVETPLLHLDGF--DPRGNIKVLMATNR 518
M E KP + + D + G + + E R + L+ ++G D +G + VL ATN
Sbjct: 138 MARENKPSIIFIDQVDALTGTRGEGESEASRRIKTELLVQMNGVGNDSQG-VLVLGATNI 196
Query: 519 PDTLDPALMRPGRLDRKVEFGLPDLEGRTHIFKIH-ARSMSVERDIRFELLARLCPNSTG 577
P LD A+ R R +R++ LPDL RT +F+I+ + SV + L + +G
Sbjct: 197 PWQLDSAIRR--RFERRIYIPLPDLAARTTMFEINVGDTPSVLTKEDYRTLGAMTEGYSG 254
Query: 578 AEIRSVCTEAGMFAIRARRKVASEKD 603
++I V +A M IR + KD
Sbjct: 255 SDIAVVVKDALMQPIRKIQSATHFKD 280
>pdb|3H5C|B Chain B, X-Ray Structure Of Protein Z-Protein Z Inhibitor Complex
Length = 317
Score = 57.4 bits (137), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 46/160 (28%), Positives = 77/160 (48%), Gaps = 21/160 (13%)
Query: 201 EVNEYPWVVALEQA-GKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHNRATVYE 259
++ + PW V L + GK FCGG +I + +VLT A C + I V + NR +
Sbjct: 101 DLQDLPWQVKLTNSEGKDFCGGVIIRENFVLTTAKCSLLHRN----ITVKTYFNRTSQDP 156
Query: 260 TQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGEKFTQ-- 317
I ++ V H +Y+A ++D++LL+L+ P++ PVC P+ + F +
Sbjct: 157 LMI---KITHVHVHMRYDADAG---ENDLSLLELEWPIQCPGAGLPVCTPE--KDFAEHL 208
Query: 318 ---RT-GTVVGWGRVEESGQIASDLRATQVPVMSNQECRQ 353
RT G + GW R + + L V ++ +EC Q
Sbjct: 209 LIPRTRGLLSGWAR--NGTDLGNSLTTRPVTLVEGEECGQ 246
>pdb|3EIE|A Chain A, Crystal Structure Of S.Cerevisiae Vps4 In The So4-Bound
State
Length = 322
Score = 57.0 bits (136), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 28/69 (40%), Positives = 42/69 (60%), Gaps = 3/69 (4%)
Query: 108 VQRTMLELINQPEKFVNL---GIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGS 164
+ + E + P KF +L +P G+LL+GPPGTGK+ A+AVA ++ F V S
Sbjct: 26 AKEALKEAVILPVKFPHLFKGNRKPTSGILLYGPPGTGKSYLAKAVATEANSTFFSVSSS 85
Query: 165 ELVQKYVGE 173
+LV K++GE
Sbjct: 86 DLVSKWMGE 94
Score = 43.5 bits (101), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 43/146 (29%), Positives = 69/146 (47%), Gaps = 12/146 (8%)
Query: 467 MQVEEKPDVTYSD----IGGCKEQ--IEKLREVVETPLLHLDGF--DPRGNIKVLMATNR 518
M E KP + + D + G + + E R + L+ ++G D +G + VL ATN
Sbjct: 105 MARENKPSIIFIDQVDALTGTRGEGESEASRRIKTELLVQMNGVGNDSQG-VLVLGATNI 163
Query: 519 PDTLDPALMRPGRLDRKVEFGLPDLEGRTHIFKIH-ARSMSVERDIRFELLARLCPNSTG 577
P LD A+ R R +R++ LPDL RT +F+I+ + V + L + +G
Sbjct: 164 PWQLDSAIRR--RFERRIYIPLPDLAARTTMFEINVGDTPCVLTKEDYRTLGAMTEGYSG 221
Query: 578 AEIRSVCTEAGMFAIRARRKVASEKD 603
++I V +A M IR + KD
Sbjct: 222 SDIAVVVKDALMQPIRKIQSATHFKD 247
>pdb|3EIH|A Chain A, Crystal Structure Of S.Cerevisiae Vps4 In The Presence Of
Atpgammas
pdb|3EIH|B Chain B, Crystal Structure Of S.Cerevisiae Vps4 In The Presence Of
Atpgammas
pdb|3EIH|C Chain C, Crystal Structure Of S.Cerevisiae Vps4 In The Presence Of
Atpgammas
Length = 340
Score = 57.0 bits (136), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 28/69 (40%), Positives = 42/69 (60%), Gaps = 3/69 (4%)
Query: 108 VQRTMLELINQPEKFVNL---GIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGS 164
+ + E + P KF +L +P G+LL+GPPGTGK+ A+AVA ++ F V S
Sbjct: 44 AKEALKEAVILPVKFPHLFKGNRKPTSGILLYGPPGTGKSYLAKAVATEANSTFFSVSSS 103
Query: 165 ELVQKYVGE 173
+LV K++GE
Sbjct: 104 DLVSKWMGE 112
Score = 43.5 bits (101), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 43/146 (29%), Positives = 69/146 (47%), Gaps = 12/146 (8%)
Query: 467 MQVEEKPDVTYSD----IGGCKEQ--IEKLREVVETPLLHLDGF--DPRGNIKVLMATNR 518
M E KP + + D + G + + E R + L+ ++G D +G + VL ATN
Sbjct: 123 MARENKPSIIFIDQVDALTGTRGEGESEASRRIKTELLVQMNGVGNDSQG-VLVLGATNI 181
Query: 519 PDTLDPALMRPGRLDRKVEFGLPDLEGRTHIFKIH-ARSMSVERDIRFELLARLCPNSTG 577
P LD A+ R R +R++ LPDL RT +F+I+ + V + L + +G
Sbjct: 182 PWQLDSAIRR--RFERRIYIPLPDLAARTTMFEINVGDTPCVLTKEDYRTLGAMTEGYSG 239
Query: 578 AEIRSVCTEAGMFAIRARRKVASEKD 603
++I V +A M IR + KD
Sbjct: 240 SDIAVVVKDALMQPIRKIQSATHFKD 265
>pdb|2RKO|A Chain A, Crystal Structure Of The Vps4p-Dimer
Length = 331
Score = 57.0 bits (136), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 28/69 (40%), Positives = 42/69 (60%), Gaps = 3/69 (4%)
Query: 108 VQRTMLELINQPEKFVNL---GIEPPKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGS 164
+ + E + P KF +L +P G+LL+GPPGTGK+ A+AVA ++ F V S
Sbjct: 35 AKEALKEAVILPVKFPHLFKGNRKPTSGILLYGPPGTGKSYLAKAVATEANSTFFSVSSS 94
Query: 165 ELVQKYVGE 173
+LV K++GE
Sbjct: 95 DLVSKWMGE 103
Score = 43.5 bits (101), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 43/146 (29%), Positives = 69/146 (47%), Gaps = 12/146 (8%)
Query: 467 MQVEEKPDVTYSD----IGGCKEQ--IEKLREVVETPLLHLDGF--DPRGNIKVLMATNR 518
M E KP + + D + G + + E R + L+ ++G D +G + VL ATN
Sbjct: 114 MARENKPSIIFIDEVDALTGTRGEGESEASRRIKTELLVQMNGVGNDSQG-VLVLGATNI 172
Query: 519 PDTLDPALMRPGRLDRKVEFGLPDLEGRTHIFKIH-ARSMSVERDIRFELLARLCPNSTG 577
P LD A+ R R +R++ LPDL RT +F+I+ + V + L + +G
Sbjct: 173 PWQLDSAIRR--RFERRIYIPLPDLAARTTMFEINVGDTPCVLTKEDYRTLGAMTEGYSG 230
Query: 578 AEIRSVCTEAGMFAIRARRKVASEKD 603
++I V +A M IR + KD
Sbjct: 231 SDIAVVVKDALMQPIRKIQSATHFKD 256
>pdb|2RDL|A Chain A, Hamster Chymase 2
pdb|2RDL|B Chain B, Hamster Chymase 2
Length = 226
Score = 56.2 bits (134), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 56/205 (27%), Positives = 86/205 (41%), Gaps = 36/205 (17%)
Query: 194 IVGGWTTEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVI 249
I+GG + P++ LE + C G LI +V+TAAHC S + V++
Sbjct: 1 IIGGTECRPHARPYMAYLEIVTPENHLSACSGFLIRRNFVMTAAHCAGRS-----ITVLL 55
Query: 250 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLP 309
HN+ V E + V K HPKY+ + + DI LLKL T+ LP
Sbjct: 56 GAHNK-KVKEDTWQKLEVEKQFPHPKYDDRLVLN---DIMLLKLKEKANL--TLGVGTLP 109
Query: 310 QLGEKFTQRTGTV---VGWGRVEESGQIASDLRATQVPVMSNQECRQFPGF--EAKLT-- 362
+ + G V VGWGR + + L+ ++ ++ Q C+ F F E +L
Sbjct: 110 ISAKSNSIPPGRVCRAVGWGRTNVNEPPSDTLQEVKMRILDPQACKHFEDFHQEPQLCVG 169
Query: 363 --------------GNMMCAGYVEG 373
G ++CAG +G
Sbjct: 170 NPKKIRNVYKGDSGGPLLCAGIAQG 194
>pdb|2BDG|A Chain A, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDG|B Chain B, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDH|A Chain A, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|B Chain B, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|C Chain C, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|D Chain D, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDI|A Chain A, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|B Chain B, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|C Chain C, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|D Chain D, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|E Chain E, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|F Chain F, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|G Chain G, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|H Chain H, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|I Chain I, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|J Chain J, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|K Chain K, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|L Chain L, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|M Chain M, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|N Chain N, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|O Chain O, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|P Chain P, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
Length = 223
Score = 56.2 bits (134), Expect = 6e-08, Method: Composition-based stats.
Identities = 49/189 (25%), Positives = 85/189 (44%), Gaps = 20/189 (10%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
I+ G + PW AL + FC G L+ ++VL+AAHC ++S + + H+
Sbjct: 1 IINGEDCSPHSQPWQAALVMENELFCSGVLVHPQWVLSAAHCFQNS-----YTIGLGLHS 55
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCL----P 309
E + + HP+YN + D+ L+KLD + T+ + + P
Sbjct: 56 LEADQEPGSQMVEASLSVRHPEYNRPLLAN---DLMLIKLDESVSESDTIRSISIASQCP 112
Query: 310 QLGEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCAG 369
G + V GWG + +G++ + L+ V V+S + C + ++ +M CAG
Sbjct: 113 TAGN-----SCLVSGWGLL-ANGRMPTVLQCVNVSVVSEEVCSKL--YDPLYHPSMFCAG 164
Query: 370 YVEGGKDSC 378
+ KDSC
Sbjct: 165 GGQDQKDSC 173
>pdb|2KAI|B Chain B, Refined 2.5 Angstroms X-Ray Crystal Structure Of The
Complex Formed By Porcine Kallikrein A And The Bovine
Pancreatic Trypsin Inhibitor. Crystallization, Patterson
Search, Structure Determination, Refinement, Structure
And Comparison With Its Components And With The Bovine
Trypsin- Pancreatic Trypsin Inhibitor Complex
pdb|2PKA|B Chain B, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|2PKA|Y Chain Y, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|1HIA|B Chain B, Kallikrein Complexed With Hirustasin
pdb|1HIA|Y Chain Y, Kallikrein Complexed With Hirustasin
Length = 152
Score = 55.5 bits (132), Expect = 1e-07, Method: Composition-based stats.
Identities = 32/105 (30%), Positives = 52/105 (49%), Gaps = 14/105 (13%)
Query: 281 AKSHDHDIALLKLDTPLEFKPTVS----PVCLPQLGEKFTQRTGTVVGWGRVE---ESGQ 333
K + HD+ LL+L +P + V P P+LG T GWG +E + +
Sbjct: 3 GKDYSHDLMLLRLQSPAKITDAVKVLELPTQEPELGS-----TCEASGWGSIEPGPDDFE 57
Query: 334 IASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCAGYVEGGKDSC 378
+++ Q+ ++ N C K+T +M+CAGY+ GGKD+C
Sbjct: 58 FPDEIQCVQLTLLQNTFCAD--AHPDKVTESMLCAGYLPGGKDTC 100
>pdb|2I6Q|A Chain A, Complement Component C2a
pdb|2I6S|A Chain A, Complement Component C2a
Length = 517
Score = 55.5 bits (132), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 39/131 (29%), Positives = 57/131 (43%), Gaps = 16/131 (12%)
Query: 185 CGVPNRMDRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKD 244
CGV N + ++ PW V ++ + C G LISD++VLTAAHC R
Sbjct: 228 CGVGN-----MSANASDQERTPWHVTIKPKSQETCRGALISDQWVLTAAHCFRDGNDHSL 282
Query: 245 LIVVISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKS------HDHDIALLKLDTPLE 298
V + + E IE K + P ++ K+ + DIALLKL ++
Sbjct: 283 WRVNVGDPKSQWGKEFLIE-----KAVISPGFDVFAKKNQGILEFYGDDIALLKLAQKVK 337
Query: 299 FKPTVSPVCLP 309
P+CLP
Sbjct: 338 MSTHARPICLP 348
>pdb|2ODP|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
pdb|2ODQ|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
Length = 509
Score = 55.1 bits (131), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 39/131 (29%), Positives = 57/131 (43%), Gaps = 16/131 (12%)
Query: 185 CGVPNRMDRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKD 244
CGV N + ++ PW V ++ + C G LISD++VLTAAHC R
Sbjct: 220 CGVGN-----MSANASDQERTPWHVTIKPKSQETCRGALISDQWVLTAAHCFRDGNDHSL 274
Query: 245 LIVVISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKS------HDHDIALLKLDTPLE 298
V + + E IE K + P ++ K+ + DIALLKL ++
Sbjct: 275 WRVNVGDPKSQWGKEFLIE-----KAVISPGFDVFAKKNQGILEFYGDDIALLKLAQKVK 329
Query: 299 FKPTVSPVCLP 309
P+CLP
Sbjct: 330 MSTHARPICLP 340
>pdb|1B0F|A Chain A, Crystal Structure Of Human Neutrophil Elastase With Mdl
101, 146
Length = 218
Score = 54.3 bits (129), Expect = 2e-07, Method: Composition-based stats.
Identities = 47/161 (29%), Positives = 80/161 (49%), Gaps = 8/161 (4%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG + +P++V+L+ AG FCG TLI+ +V++AAHCV + + + VV+ HN
Sbjct: 1 IVGGRRARPHAWPFMVSLQLAGGHFCGATLIAPNFVMSAAHCVANVNVRA-VRVVLGAHN 59
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
++ E R V + + + +DI +L+L+ V LP G
Sbjct: 60 L-----SRREPTRQVFAVQRIFEDGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGR 114
Query: 314 KFTQRTGTV-VGWGRVEESGQIASDLRATQVPVMSNQECRQ 353
+ + +GWG + + IAS L+ V V+++ CR+
Sbjct: 115 RLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSL-CRR 154
>pdb|1PPF|E Chain E, X-Ray Crystal Structure Of The Complex Of Human Leukocyte
Elastase (Pmn Elastase) And The Third Domain Of The
Turkey Ovomucoid Inhibitor
Length = 218
Score = 53.9 bits (128), Expect = 3e-07, Method: Composition-based stats.
Identities = 47/161 (29%), Positives = 79/161 (49%), Gaps = 8/161 (4%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG + +P++V+L+ G FCG TLI+ +V++AAHCV + + + VV+ HN
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRA-VRVVLGAHN 59
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
++ E R V + N + +DI +L+L+ V LP G
Sbjct: 60 L-----SRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGR 114
Query: 314 KFTQRTGTV-VGWGRVEESGQIASDLRATQVPVMSNQECRQ 353
+ + +GWG + + IAS L+ V V+++ CR+
Sbjct: 115 RLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSL-CRR 154
>pdb|1PPG|E Chain E, The Refined 2.3 Angstroms Crystal Structure Of Human
Leukocyte Elastase In A Complex With A Valine
Chloromethyl Ketone Inhibitor
pdb|1H1B|A Chain A, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|1H1B|B Chain B, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|2Z7F|E Chain E, Crystal Structure Of The Complex Of Human Neutrophil
Elastase With 12SLPI
pdb|3Q76|A Chain A, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q76|B Chain B, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q77|A Chain A, Structure Of Human Neutrophil Elastase In Complex With A
Dihydropyrimidone Inhibitor
Length = 218
Score = 53.9 bits (128), Expect = 3e-07, Method: Composition-based stats.
Identities = 47/161 (29%), Positives = 79/161 (49%), Gaps = 8/161 (4%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG + +P++V+L+ G FCG TLI+ +V++AAHCV + + + VV+ HN
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRA-VRVVLGAHN 59
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
++ E R V + N + +DI +L+L+ V LP G
Sbjct: 60 L-----SRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGR 114
Query: 314 KFTQRTGTV-VGWGRVEESGQIASDLRATQVPVMSNQECRQ 353
+ + +GWG + + IAS L+ V V+++ CR+
Sbjct: 115 RLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSL-CRR 154
>pdb|2RG3|A Chain A, Covalent Complex Structure Of Elastase
Length = 218
Score = 53.9 bits (128), Expect = 3e-07, Method: Composition-based stats.
Identities = 47/161 (29%), Positives = 79/161 (49%), Gaps = 8/161 (4%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG + +P++V+L+ G FCG TLI+ +V++AAHCV + + + VV+ HN
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRA-VRVVLGAHN 59
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
++ E R V + N + +DI +L+L+ V LP G
Sbjct: 60 L-----SRREPTRQVFAVQRIFENGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGR 114
Query: 314 KFTQRTGTV-VGWGRVEESGQIASDLRATQVPVMSNQECRQ 353
+ + +GWG + + IAS L+ V V+++ CR+
Sbjct: 115 RLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSL-CRR 154
>pdb|2ASU|B Chain B, Crystal Structure Of The Beta-Chain Of HgflMSP
Length = 234
Score = 53.9 bits (128), Expect = 3e-07, Method: Composition-based stats.
Identities = 43/160 (26%), Positives = 70/160 (43%), Gaps = 34/160 (21%)
Query: 206 PWVVALE-QAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHNRATVYETQIET 264
PW V+L + G+ FCGG+L+ ++++LTA C S H T YE + T
Sbjct: 10 PWTVSLRNRQGQHFCGGSLVKEQWILTARQCFSSC------------HMPLTGYEVWLGT 57
Query: 265 RRVVKVLTHPKYNAQGAKS----------HDHDIALLKLDTPLEFKPTVSPVCLPQLGEK 314
+ +P++ + + LLKL+ + V+ +CLP E
Sbjct: 58 -----LFQNPQHGEPSLQRVPVAKMVCGPSGSQLVLLKLERSVTLNQRVALICLPP--EW 110
Query: 315 FTQRTGT---VVGWGRVEESGQIASDLRATQVPVMSNQEC 351
+ GT + GWG + +G + L + V+SNQEC
Sbjct: 111 YVVPPGTKCEIAGWGETKGTGN-DTVLNVALLNVISNQEC 149
>pdb|1M9U|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|B Chain B, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|C Chain C, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
Length = 241
Score = 53.5 bits (127), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 43/162 (26%), Positives = 76/162 (46%), Gaps = 8/162 (4%)
Query: 194 IVGGWTTEVNEYPWVVALE-QAGKFF--CGGTLISDRYVLTAAHCVRSSKRQKDLIVVIS 250
++GG E+PW ++ + Q+G + CG +L+S L+A+HCV ++ V+
Sbjct: 1 VIGGTNASPGEFPWQLSQQRQSGSWSHSCGASLLSSTSALSASHCVDG-VLPNNIRVIAG 59
Query: 251 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLP- 309
++ TQ T V H Y A G S+ +DIA+L L T + + LP
Sbjct: 60 LWQQSDTSGTQ--TANVDSYTMHENYGA-GTASYSNDIAILHLATSISLGGNIQAAVLPA 116
Query: 310 QLGEKFTQRTGTVVGWGRVEESGQIASDLRATQVPVMSNQEC 351
+ T + GWGR + + + L+ + +PV++ +C
Sbjct: 117 NNNNDYAGTTCVISGWGRTDGTNNLPDILQKSSIPVITTAQC 158
>pdb|2ZAM|A Chain A, Crystal Structure Of Mouse Skd1VPS4B APO-Form
pdb|2ZAN|A Chain A, Crystal Structure Of Mouse Skd1VPS4B ATP-Form
pdb|2ZAO|A Chain A, Crystal Structure Of Mouse Skd1VPS4B ADP-Form
Length = 444
Score = 53.1 bits (126), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 23/46 (50%), Positives = 33/46 (71%), Gaps = 1/46 (2%)
Query: 129 PPKGVLLFGPPGTGKTLCARAVANR-TDACFIRVIGSELVQKYVGE 173
P +G+LLFGPPGTGK+ A+AVA ++ F + S+LV K++GE
Sbjct: 166 PWRGILLFGPPGTGKSYLAKAVATEANNSTFFSISSSDLVSKWLGE 211
Score = 42.0 bits (97), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 36/105 (34%), Positives = 51/105 (48%), Gaps = 11/105 (10%)
Query: 503 GFDPRGNIKVLMATNRPDTLDPALMRPGRLDRKVEFGLPDLEGRTHIFKIHARSMS---V 559
G D G I VL ATN P LD A+ R R ++++ LP+ R +F++H S
Sbjct: 266 GVDNDG-ILVLGATNIPWVLDSAIRR--RFEKRIYIPLPEAHARAAMFRLHLGSTQNSLT 322
Query: 560 ERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIRARRKVASEKDF 604
E D F+ L R +GA+I + +A M + RKV S F
Sbjct: 323 EAD--FQELGRKTDGYSGADISIIVRDALMQPV---RKVQSATHF 362
>pdb|1XWI|A Chain A, Crystal Structure Of Vps4b
Length = 322
Score = 52.8 bits (125), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 28/70 (40%), Positives = 42/70 (60%), Gaps = 4/70 (5%)
Query: 108 VQRTMLELINQPEKFVNLGI---EPPKGVLLFGPPGTGKTLCARAVANR-TDACFIRVIG 163
+ + E + P KF +L P +G+LLFGPPGTGK+ A+AVA ++ F +
Sbjct: 20 AKEALKEAVILPIKFPHLFTGKRTPWRGILLFGPPGTGKSYLAKAVATEANNSTFFSISS 79
Query: 164 SELVQKYVGE 173
S+LV K++GE
Sbjct: 80 SDLVSKWLGE 89
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 7/103 (6%)
Query: 503 GFDPRGNIKVLMATNRPDTLDPALMRPGRLDRKVEFGLPDLEGRTHIFKIH-ARSMSVER 561
G D G I VL ATN P LD A+ R R ++++ LP+ R +FK+H + +
Sbjct: 144 GVDNDG-ILVLGATNIPWVLDSAIRR--RFEKRIYIPLPEPHARAAMFKLHLGTTQNSLT 200
Query: 562 DIRFELLARLCPNSTGAEIRSVCTEAGMFAIRARRKVASEKDF 604
+ F L R +GA+I + +A M + RKV S F
Sbjct: 201 EADFRELGRKTDGYSGADISIIVRDALMQPV---RKVQSATHF 240
>pdb|1EPT|C Chain C, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
pdb|1AKS|B Chain B, Crystal Structure Of The First Active Autolysate Form Of
The Porcine Alpha Trypsin
Length = 98
Score = 52.4 bits (124), Expect = 9e-07, Method: Composition-based stats.
Identities = 22/45 (48%), Positives = 33/45 (73%), Gaps = 4/45 (8%)
Query: 336 SDLRATQVPVMSNQECRQ-FPGFEAKLTGNMMCAGYVEGGKDSCQ 379
S L+ + PV+SN C+ +PG ++TGNM+C G+++GGKDSCQ
Sbjct: 8 SLLQCLKAPVLSNSSCKSSYPG---QITGNMICVGFLQGGKDSCQ 49
>pdb|1HNE|E Chain E, Structure Of Human Neutrophil Elastase In Complex With A
Peptide Chloromethyl Ketone Inhibitor At 1.84-Angstroms
Resolution
Length = 218
Score = 52.0 bits (123), Expect = 1e-06, Method: Composition-based stats.
Identities = 46/161 (28%), Positives = 79/161 (49%), Gaps = 8/161 (4%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
IVGG + +P++V+L+ G FCG TLI+ +V++AAHCV + + + VV+ HN
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHCVANVNVRA-VRVVLGAHN 59
Query: 254 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLPQLGE 313
++ E R V + + + +DI +L+L+ V LP G
Sbjct: 60 L-----SRREPTRQVFAVQRIFEDGYDPVNLLNDIVILQLNGSATINANVQVAQLPAQGR 114
Query: 314 KFTQRTGTV-VGWGRVEESGQIASDLRATQVPVMSNQECRQ 353
+ + +GWG + + IAS L+ V V+++ CR+
Sbjct: 115 RLGNGVQCLAMGWGLLGRNRGIASVLQELNVTVVTSL-CRR 154
>pdb|2KAI|A Chain A, Refined 2.5 Angstroms X-Ray Crystal Structure Of The
Complex Formed By Porcine Kallikrein A And The Bovine
Pancreatic Trypsin Inhibitor. Crystallization, Patterson
Search, Structure Determination, Refinement, Structure
And Comparison With Its Components And With The Bovine
Trypsin- Pancreatic Trypsin Inhibitor Complex
pdb|2PKA|A Chain A, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|2PKA|X Chain X, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|1HIA|A Chain A, Kallikrein Complexed With Hirustasin
pdb|1HIA|X Chain X, Kallikrein Complexed With Hirustasin
Length = 80
Score = 52.0 bits (123), Expect = 1e-06, Method: Composition-based stats.
Identities = 29/86 (33%), Positives = 44/86 (51%), Gaps = 10/86 (11%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHN 253
I+GG E N +PW VA+ F CGG L++ ++VLTAAHC + + V + HN
Sbjct: 1 IIGGRECEKNSHPWQVAIYHYSSFQCGGVLVNPKWVLTAAHC-----KNDNYEVWLGRHN 55
Query: 254 RATVYETQIETR--RVVKVLTHPKYN 277
++E + + V HP +N
Sbjct: 56 ---LFENENTAQFFGVTADFPHPGFN 78
>pdb|1UHB|B Chain B, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A
Resolution
Length = 98
Score = 51.6 bits (122), Expect = 1e-06, Method: Composition-based stats.
Identities = 22/45 (48%), Positives = 33/45 (73%), Gaps = 4/45 (8%)
Query: 336 SDLRATQVPVMSNQECRQ-FPGFEAKLTGNMMCAGYVEGGKDSCQ 379
S L+ + PV+S+ C+ +PG ++TGNM+C G++EGGKDSCQ
Sbjct: 8 SLLQCLKAPVLSDSSCKSSYPG---QITGNMICVGFLEGGKDSCQ 49
>pdb|2HNT|E Chain E, Crystallographic Structure Of Human Gamma-Thrombin
Length = 81
Score = 50.8 bits (120), Expect = 2e-06, Method: Composition-based stats.
Identities = 28/72 (38%), Positives = 39/72 (54%), Gaps = 16/72 (22%)
Query: 269 KVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPVCLP---------QLGEKFTQRT 319
K+ HP+YN + ++ D DIAL+KL P+ F + PVCLP Q G K
Sbjct: 10 KIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYK----- 62
Query: 320 GTVVGWGRVEES 331
G V GWG ++E+
Sbjct: 63 GRVTGWGNLKET 74
>pdb|2HNT|C Chain C, Crystallographic Structure Of Human Gamma-Thrombin
Length = 70
Score = 50.1 bits (118), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 29/68 (42%), Positives = 38/68 (55%), Gaps = 7/68 (10%)
Query: 194 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRQK-----DLI 246
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 247 VVISEHNR 254
V I +H+R
Sbjct: 61 VRIGKHSR 68
>pdb|1EPT|A Chain A, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
Length = 43
Score = 49.7 bits (117), Expect = 5e-06, Method: Composition-based stats.
Identities = 21/44 (47%), Positives = 32/44 (72%), Gaps = 1/44 (2%)
Query: 194 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVR 237
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +
Sbjct: 1 IVGGYTCAANSIPYQVSL-NSGSHFCGGSLINSQWVVSAAHCYK 43
>pdb|1DO2|A Chain A, Trigonal Crystal Form Of Heat Shock Locus U (Hslu) From
Escherichia Coli
pdb|1DO2|B Chain B, Trigonal Crystal Form Of Heat Shock Locus U (Hslu) From
Escherichia Coli
pdb|1DO2|C Chain C, Trigonal Crystal Form Of Heat Shock Locus U (Hslu) From
Escherichia Coli
pdb|1DO2|D Chain D, Trigonal Crystal Form Of Heat Shock Locus U (Hslu) From
Escherichia Coli
pdb|1DO0|A Chain A, Orthorhombic Crystal Form Of Heat Shock Locus U (Hslu)
From Escherichia Coli
pdb|1DO0|B Chain B, Orthorhombic Crystal Form Of Heat Shock Locus U (Hslu)
From Escherichia Coli
pdb|1DO0|C Chain C, Orthorhombic Crystal Form Of Heat Shock Locus U (Hslu)
From Escherichia Coli
pdb|1DO0|D Chain D, Orthorhombic Crystal Form Of Heat Shock Locus U (Hslu)
From Escherichia Coli
pdb|1DO0|E Chain E, Orthorhombic Crystal Form Of Heat Shock Locus U (Hslu)
From Escherichia Coli
pdb|1DO0|F Chain F, Orthorhombic Crystal Form Of Heat Shock Locus U (Hslu)
From Escherichia Coli
Length = 442
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 29/47 (61%), Gaps = 1/47 (2%)
Query: 130 PKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQ-KYVGERV 175
PK +L+ GP G GKT AR +A +A FI+V ++ + YVG+ V
Sbjct: 49 PKNILMIGPTGVGKTEIARRLAKLANAPFIKVEATKFTEVGYVGKEV 95
>pdb|1E94|E Chain E, Hslv-Hslu From E.Coli
pdb|1E94|F Chain F, Hslv-Hslu From E.Coli
pdb|1HT2|E Chain E, Nucleotide-dependent Conformational Changes In A
Protease-associated Atpase Hslu
pdb|1HT2|F Chain F, Nucleotide-dependent Conformational Changes In A
Protease-associated Atpase Hslu
pdb|1HT2|G Chain G, Nucleotide-dependent Conformational Changes In A
Protease-associated Atpase Hslu
pdb|1HT2|H Chain H, Nucleotide-dependent Conformational Changes In A
Protease-associated Atpase Hslu
pdb|1HT1|E Chain E, Nucleotide-Dependent Conformational Changes In A
Protease-Associated Atpase Hslu
pdb|1HT1|F Chain F, Nucleotide-Dependent Conformational Changes In A
Protease-Associated Atpase Hslu
pdb|1HT1|G Chain G, Nucleotide-Dependent Conformational Changes In A
Protease-Associated Atpase Hslu
pdb|1HT1|I Chain I, Nucleotide-Dependent Conformational Changes In A
Protease-Associated Atpase Hslu
pdb|1HQY|E Chain E, Nucleotide-Dependent Conformational Changes In A
Protease-Associated Atpase Hslu
pdb|1HQY|F Chain F, Nucleotide-Dependent Conformational Changes In A
Protease-Associated Atpase Hslu
Length = 449
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 29/47 (61%), Gaps = 1/47 (2%)
Query: 130 PKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQ-KYVGERV 175
PK +L+ GP G GKT AR +A +A FI+V ++ + YVG+ V
Sbjct: 56 PKNILMIGPTGVGKTEIARRLAKLANAPFIKVEATKFTEVGYVGKEV 102
>pdb|1G4A|E Chain E, Crystal Structures Of The Hslvu Peptidase-Atpase Complex
Reveal An Atp-Dependent Proteolysis Mechanism
pdb|1G4A|F Chain F, Crystal Structures Of The Hslvu Peptidase-Atpase Complex
Reveal An Atp-Dependent Proteolysis Mechanism
pdb|1G4B|E Chain E, Crystal Structures Of The Hslvu Peptidase-Atpase Complex
Reveal An Atp-Dependent Proteolysis Mechanism
pdb|1G4B|F Chain F, Crystal Structures Of The Hslvu Peptidase-Atpase Complex
Reveal An Atp-Dependent Proteolysis Mechanism
pdb|1G4B|K Chain K, Crystal Structures Of The Hslvu Peptidase-Atpase Complex
Reveal An Atp-Dependent Proteolysis Mechanism
pdb|1G4B|L Chain L, Crystal Structures Of The Hslvu Peptidase-Atpase Complex
Reveal An Atp-Dependent Proteolysis Mechanism
pdb|1YYF|A Chain A, Correction Of X-Ray Intensities From An Hslv-Hslu Co-
Crystal Containing Lattice Translocation Defects
pdb|1YYF|B Chain B, Correction Of X-Ray Intensities From An Hslv-Hslu Co-
Crystal Containing Lattice Translocation Defects
Length = 443
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 29/47 (61%), Gaps = 1/47 (2%)
Query: 130 PKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQ-KYVGERV 175
PK +L+ GP G GKT AR +A +A FI+V ++ + YVG+ V
Sbjct: 50 PKNILMIGPTGVGKTEIARRLAKLANAPFIKVEATKFTEVGYVGKEV 96
>pdb|1G3I|A Chain A, Crystal Structure Of The Hsluv Protease-Chaperone Complex
pdb|1G3I|B Chain B, Crystal Structure Of The Hsluv Protease-Chaperone Complex
pdb|1G3I|C Chain C, Crystal Structure Of The Hsluv Protease-Chaperone Complex
pdb|1G3I|D Chain D, Crystal Structure Of The Hsluv Protease-Chaperone Complex
pdb|1G3I|E Chain E, Crystal Structure Of The Hsluv Protease-Chaperone Complex
pdb|1G3I|F Chain F, Crystal Structure Of The Hsluv Protease-Chaperone Complex
pdb|1G3I|S Chain S, Crystal Structure Of The Hsluv Protease-Chaperone Complex
pdb|1G3I|T Chain T, Crystal Structure Of The Hsluv Protease-Chaperone Complex
pdb|1G3I|U Chain U, Crystal Structure Of The Hsluv Protease-Chaperone Complex
pdb|1G3I|V Chain V, Crystal Structure Of The Hsluv Protease-Chaperone Complex
pdb|1G3I|W Chain W, Crystal Structure Of The Hsluv Protease-Chaperone Complex
pdb|1G3I|X Chain X, Crystal Structure Of The Hsluv Protease-Chaperone Complex
pdb|1G41|A Chain A, Crystal Structure Of Hslu Haemophilus Influenzae
pdb|1KYI|A Chain A, Hsluv (h. Influenzae)-nlvs Vinyl Sulfone Inhibitor Complex
pdb|1KYI|B Chain B, Hsluv (h. Influenzae)-nlvs Vinyl Sulfone Inhibitor Complex
pdb|1KYI|C Chain C, Hsluv (h. Influenzae)-nlvs Vinyl Sulfone Inhibitor Complex
pdb|1KYI|D Chain D, Hsluv (h. Influenzae)-nlvs Vinyl Sulfone Inhibitor Complex
pdb|1KYI|E Chain E, Hsluv (h. Influenzae)-nlvs Vinyl Sulfone Inhibitor Complex
pdb|1KYI|F Chain F, Hsluv (h. Influenzae)-nlvs Vinyl Sulfone Inhibitor Complex
pdb|1KYI|S Chain S, Hsluv (h. Influenzae)-nlvs Vinyl Sulfone Inhibitor Complex
pdb|1KYI|T Chain T, Hsluv (h. Influenzae)-nlvs Vinyl Sulfone Inhibitor Complex
pdb|1KYI|U Chain U, Hsluv (h. Influenzae)-nlvs Vinyl Sulfone Inhibitor Complex
pdb|1KYI|V Chain V, Hsluv (h. Influenzae)-nlvs Vinyl Sulfone Inhibitor Complex
pdb|1KYI|W Chain W, Hsluv (h. Influenzae)-nlvs Vinyl Sulfone Inhibitor Complex
pdb|1KYI|X Chain X, Hsluv (h. Influenzae)-nlvs Vinyl Sulfone Inhibitor Complex
Length = 444
Score = 41.2 bits (95), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 29/47 (61%), Gaps = 1/47 (2%)
Query: 130 PKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQ-KYVGERV 175
PK +L+ GP G GKT AR +A +A FI+V ++ + YVG+ V
Sbjct: 50 PKNILMIGPTGVGKTEIARRLAKLANAPFIKVEATKFTEVGYVGKEV 96
>pdb|1OFH|A Chain A, Asymmetric Complex Between Hslv And I-domain Deleted Hslu
(h. Influenzae)
pdb|1OFH|B Chain B, Asymmetric Complex Between Hslv And I-domain Deleted Hslu
(h. Influenzae)
pdb|1OFH|C Chain C, Asymmetric Complex Between Hslv And I-domain Deleted Hslu
(h. Influenzae)
pdb|1OFI|A Chain A, Asymmetric Complex Between Hslv And I-Domain Deleted Hslu
(H. Influenzae)
pdb|1OFI|B Chain B, Asymmetric Complex Between Hslv And I-Domain Deleted Hslu
(H. Influenzae)
pdb|1OFI|C Chain C, Asymmetric Complex Between Hslv And I-Domain Deleted Hslu
(H. Influenzae)
Length = 310
Score = 40.4 bits (93), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 29/47 (61%), Gaps = 1/47 (2%)
Query: 130 PKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQ-KYVGERV 175
PK +L+ GP G GKT AR +A +A FI+V ++ + YVG+ V
Sbjct: 50 PKNILMIGPTGVGKTEIARRLAKLANAPFIKVEATKFTEVGYVGKEV 96
>pdb|2DVW|B Chain B, Structure Of The Oncoprotein Gankyrin In Complex With S6
Atpase Of The 26s Proteasome
pdb|2DWZ|B Chain B, Structure Of The Oncoprotein Gankyrin In Complex With S6
Atpase Of The 26s Proteasome
pdb|2DWZ|D Chain D, Structure Of The Oncoprotein Gankyrin In Complex With S6
Atpase Of The 26s Proteasome
pdb|3AJI|B Chain B, Structure Of Gankyrin-S6atpase Photo-Cross-Linked
Site-Specifically, And Incoporated By Genetic Code
Expansion
pdb|3AJI|D Chain D, Structure Of Gankyrin-S6atpase Photo-Cross-Linked
Site-Specifically, And Incoporated By Genetic Code
Expansion
Length = 83
Score = 39.3 bits (90), Expect = 0.007, Method: Composition-based stats.
Identities = 20/65 (30%), Positives = 32/65 (49%)
Query: 549 IFKIHARSMSVERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIRARRKVASEKDFLEAV 608
IF M++ ++ E +GA+I S+C E+GM A+R R + KDF +A
Sbjct: 9 IFSTITSKMNLSEEVDLEDYVARPDKISGADINSICQESGMLAVRENRYIVLAKDFEKAY 68
Query: 609 NKVAR 613
V +
Sbjct: 69 KTVIK 73
>pdb|1IM2|A Chain A, Hslu, Haemophilus Influenzae, Selenomethionine Variant
Length = 444
Score = 39.3 bits (90), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 1/47 (2%)
Query: 130 PKGVLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQ-KYVGERV 175
PK +L GP G GKT AR +A +A FI+V ++ + YVG+ V
Sbjct: 50 PKNILXIGPTGVGKTEIARRLAKLANAPFIKVEATKFTEVGYVGKEV 96
>pdb|1EPT|B Chain B, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
Length = 82
Score = 38.9 bits (89), Expect = 0.011, Method: Composition-based stats.
Identities = 27/86 (31%), Positives = 40/86 (46%), Gaps = 11/86 (12%)
Query: 247 VVISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDTPLEFKPTVSPV 306
V + EHN V E + K++THP +N + D+DI L+KL +P V+ V
Sbjct: 5 VRLGEHN-IDVLEGNEQFINAAKIITHPNFNGN---TLDNDIMLIKLSSPATLNSRVATV 60
Query: 307 CLPQLGEKFTQRTGT---VVGWGRVE 329
LP + GT + GWG +
Sbjct: 61 SLP----RSCAAAGTECLISGWGNTK 82
>pdb|2C9O|A Chain A, 3d Structure Of The Human Ruvb-Like Helicase Ruvbl1
pdb|2C9O|B Chain B, 3d Structure Of The Human Ruvb-Like Helicase Ruvbl1
pdb|2C9O|C Chain C, 3d Structure Of The Human Ruvb-Like Helicase Ruvbl1
Length = 456
Score = 36.2 bits (82), Expect = 0.068, Method: Compositional matrix adjust.
Identities = 22/51 (43%), Positives = 30/51 (58%), Gaps = 3/51 (5%)
Query: 131 KGVLLFGPPGTGKTLCARAVANR--TDACFIRVIGSELVQKYVGE-RVLME 178
+ VLL GPPGTGKT A A+A + F ++GSE+ + + VLME
Sbjct: 64 RAVLLAGPPGTGKTALALAIAQELGSKVPFCPMVGSEVYSTEIKKTEVLME 114
>pdb|3HWS|A Chain A, Crystal Structure Of Nucleotide-Bound Hexameric Clpx
pdb|3HWS|B Chain B, Crystal Structure Of Nucleotide-Bound Hexameric Clpx
pdb|3HWS|C Chain C, Crystal Structure Of Nucleotide-Bound Hexameric Clpx
pdb|3HWS|D Chain D, Crystal Structure Of Nucleotide-Bound Hexameric Clpx
pdb|3HWS|E Chain E, Crystal Structure Of Nucleotide-Bound Hexameric Clpx
pdb|3HWS|F Chain F, Crystal Structure Of Nucleotide-Bound Hexameric Clpx
Length = 363
Score = 35.8 bits (81), Expect = 0.082, Method: Compositional matrix adjust.
Identities = 24/64 (37%), Positives = 33/64 (51%), Gaps = 8/64 (12%)
Query: 126 GIEPPKG-VLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQK-YVGERV------LM 177
G+E K +LL GP G+GKTL A +A D F + L + YVGE V L+
Sbjct: 46 GVELGKSNILLIGPTGSGKTLLAETLARLLDVPFTMADATTLTEAGYVGEDVENIIQKLL 105
Query: 178 EGCN 181
+ C+
Sbjct: 106 QKCD 109
>pdb|3HTE|A Chain A, Crystal Structure Of Nucleotide-Free Hexameric Clpx
pdb|3HTE|B Chain B, Crystal Structure Of Nucleotide-Free Hexameric Clpx
pdb|3HTE|C Chain C, Crystal Structure Of Nucleotide-Free Hexameric Clpx
pdb|3HTE|D Chain D, Crystal Structure Of Nucleotide-Free Hexameric Clpx
pdb|3HTE|E Chain E, Crystal Structure Of Nucleotide-Free Hexameric Clpx
pdb|3HTE|F Chain F, Crystal Structure Of Nucleotide-Free Hexameric Clpx
Length = 363
Score = 35.8 bits (81), Expect = 0.082, Method: Compositional matrix adjust.
Identities = 24/64 (37%), Positives = 33/64 (51%), Gaps = 8/64 (12%)
Query: 126 GIEPPKG-VLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQK-YVGERV------LM 177
G+E K +LL GP G+GKTL A +A D F + L + YVGE V L+
Sbjct: 46 GVELGKSNILLIGPTGSGKTLLAETLARLLDVPFTMADATTLTEAGYVGEDVENIIQKLL 105
Query: 178 EGCN 181
+ C+
Sbjct: 106 QKCD 109
>pdb|1IXR|C Chain C, Ruva-Ruvb Complex
Length = 312
Score = 33.9 bits (76), Expect = 0.31, Method: Compositional matrix adjust.
Identities = 14/25 (56%), Positives = 18/25 (72%)
Query: 128 EPPKGVLLFGPPGTGKTLCARAVAN 152
EP + +LLFGPPG GKT A +A+
Sbjct: 36 EPLEHLLLFGPPGLGKTTLAHVIAH 60
>pdb|2XSZ|A Chain A, The Dodecameric Human Ruvbl1:ruvbl2 Complex With Truncated
Domains Ii
pdb|2XSZ|B Chain B, The Dodecameric Human Ruvbl1:ruvbl2 Complex With Truncated
Domains Ii
pdb|2XSZ|C Chain C, The Dodecameric Human Ruvbl1:ruvbl2 Complex With Truncated
Domains Ii
Length = 367
Score = 33.9 bits (76), Expect = 0.32, Method: Compositional matrix adjust.
Identities = 18/38 (47%), Positives = 23/38 (60%), Gaps = 2/38 (5%)
Query: 131 KGVLLFGPPGTGKTLCARAVANR--TDACFIRVIGSEL 166
+ VLL GPPGTGKT A A+A + F +GSE+
Sbjct: 78 RAVLLAGPPGTGKTALALAIAQELGSKVPFCPXVGSEV 115
>pdb|1IXS|B Chain B, Structure Of Ruvb Complexed With Ruva Domain Iii
Length = 318
Score = 33.5 bits (75), Expect = 0.38, Method: Compositional matrix adjust.
Identities = 14/25 (56%), Positives = 18/25 (72%)
Query: 128 EPPKGVLLFGPPGTGKTLCARAVAN 152
EP + +LLFGPPG GKT A +A+
Sbjct: 36 EPLEHLLLFGPPGLGKTTLAHVIAH 60
>pdb|1HQC|A Chain A, Structure Of Ruvb From Thermus Thermophilus Hb8
pdb|1HQC|B Chain B, Structure Of Ruvb From Thermus Thermophilus Hb8
Length = 324
Score = 33.1 bits (74), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 14/25 (56%), Positives = 18/25 (72%)
Query: 128 EPPKGVLLFGPPGTGKTLCARAVAN 152
EP + +LLFGPPG GKT A +A+
Sbjct: 36 EPLEHLLLFGPPGLGKTTLAHVIAH 60
>pdb|1SXJ|C Chain C, Crystal Structure Of The Eukaryotic Clamp Loader
(Replication Factor C, Rfc) Bound To The Dna Sliding
Clamp (Proliferating Cell Nuclear Antigen, Pcna)
Length = 340
Score = 33.1 bits (74), Expect = 0.60, Method: Compositional matrix adjust.
Identities = 18/38 (47%), Positives = 23/38 (60%), Gaps = 2/38 (5%)
Query: 114 ELINQPEKFVNLGIEPPKGVLLFGPPGTGKTLCARAVA 151
E+I KFV+ G P +L +GPPGTGKT A+A
Sbjct: 32 EVITTVRKFVDEGKLP--HLLFYGPPGTGKTSTIVALA 67
>pdb|1UM8|A Chain A, Crystal Structure Of Helicobacter Pylori Clpx
Length = 376
Score = 32.7 bits (73), Expect = 0.71, Method: Compositional matrix adjust.
Identities = 18/44 (40%), Positives = 24/44 (54%), Gaps = 1/44 (2%)
Query: 133 VLLFGPPGTGKTLCARAVANRTDACFIRVIGSELVQK-YVGERV 175
+LL GP G+GKTL A+ +A D + L + YVGE V
Sbjct: 75 ILLIGPTGSGKTLMAQTLAKHLDIPIAISDATSLTEAGYVGEDV 118
>pdb|2BUF|A Chain A, Arginine Feed-Back Inhibitable Acetylglutamate Kinase
pdb|2BUF|B Chain B, Arginine Feed-Back Inhibitable Acetylglutamate Kinase
pdb|2BUF|C Chain C, Arginine Feed-Back Inhibitable Acetylglutamate Kinase
pdb|2BUF|D Chain D, Arginine Feed-Back Inhibitable Acetylglutamate Kinase
pdb|2BUF|E Chain E, Arginine Feed-Back Inhibitable Acetylglutamate Kinase
pdb|2BUF|F Chain F, Arginine Feed-Back Inhibitable Acetylglutamate Kinase
pdb|2BUF|G Chain G, Arginine Feed-Back Inhibitable Acetylglutamate Kinase
pdb|2BUF|H Chain H, Arginine Feed-Back Inhibitable Acetylglutamate Kinase
pdb|2BUF|I Chain I, Arginine Feed-Back Inhibitable Acetylglutamate Kinase
pdb|2BUF|J Chain J, Arginine Feed-Back Inhibitable Acetylglutamate Kinase
pdb|2BUF|K Chain K, Arginine Feed-Back Inhibitable Acetylglutamate Kinase
pdb|2BUF|L Chain L, Arginine Feed-Back Inhibitable Acetylglutamate Kinase
Length = 300
Score = 32.3 bits (72), Expect = 0.84, Method: Compositional matrix adjust.
Identities = 31/169 (18%), Positives = 66/169 (39%), Gaps = 14/169 (8%)
Query: 218 FCGGTLISDRYVLTAAHCVRSSKRQKDLIVVISEHNRATVYETQIETRRV-VKVLTHPKY 276
F G ++D + V + KD++ +I+ H + + T + + K LT +
Sbjct: 84 FIDGMRVTDAATMDVVEMVLGGQVNKDIVNLINRHGGSAIGLTGKDAELIRAKKLTVTRQ 143
Query: 277 NAQGAKSHDHDIA-----------LLKLDTPLEFKPTVSPVCLPQLGEKFTQRTGTVVGW 325
+ K DI LL + +F P ++P+ + GE + V
Sbjct: 144 TPEMTKPEIIDIGHVGEVTGVNVGLLNMLVKGDFIPVIAPIGVGSNGESYNINADLV--A 201
Query: 326 GRVEESGQIASDLRATQVPVMSNQECRQFPGFEAKLTGNMMCAGYVEGG 374
G+V E+ + + T + + +++ + G + ++ G + GG
Sbjct: 202 GKVAEALKAEKLMLLTNIAGLMDKQGQVLTGLSTEQVNELIADGTIYGG 250
>pdb|2V1U|A Chain A, Structure Of The Aeropyrum Pernix Orc1 Protein In Complex
With Dna
Length = 387
Score = 31.6 bits (70), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 15/29 (51%), Positives = 17/29 (58%)
Query: 128 EPPKGVLLFGPPGTGKTLCARAVANRTDA 156
E P LL+G GTGKT AR V R +A
Sbjct: 42 EKPSNALLYGLTGTGKTAVARLVLRRLEA 70
>pdb|3PVS|A Chain A, Structure And Biochemical Activities Of Escherichia Coli
Mgsa
pdb|3PVS|B Chain B, Structure And Biochemical Activities Of Escherichia Coli
Mgsa
pdb|3PVS|C Chain C, Structure And Biochemical Activities Of Escherichia Coli
Mgsa
pdb|3PVS|D Chain D, Structure And Biochemical Activities Of Escherichia Coli
Mgsa
Length = 447
Score = 31.2 bits (69), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 13/29 (44%), Positives = 19/29 (65%)
Query: 133 VLLFGPPGTGKTLCARAVANRTDACFIRV 161
++L+GPPGTGKT A +A +A R+
Sbjct: 53 MILWGPPGTGKTTLAEVIARYANADVERI 81
>pdb|1Y63|A Chain A, Initial Crystal Structural Analysis Of A Probable Kinase
From Leishmania Major Friedlin
Length = 184
Score = 31.2 bits (69), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 15/33 (45%), Positives = 19/33 (57%), Gaps = 2/33 (6%)
Query: 126 GIEPPKGV--LLFGPPGTGKTLCARAVANRTDA 156
+E PKG+ L+ G PGTGKT A +A D
Sbjct: 4 SMEQPKGINILITGTPGTGKTSMAEMIAAELDG 36
>pdb|3M6A|A Chain A, Crystal Structure Of Bacillus Subtilis Lon C-Terminal
Domain
pdb|3M6A|B Chain B, Crystal Structure Of Bacillus Subtilis Lon C-Terminal
Domain
pdb|3M6A|C Chain C, Crystal Structure Of Bacillus Subtilis Lon C-Terminal
Domain
pdb|3M6A|D Chain D, Crystal Structure Of Bacillus Subtilis Lon C-Terminal
Domain
pdb|3M6A|E Chain E, Crystal Structure Of Bacillus Subtilis Lon C-Terminal
Domain
pdb|3M6A|F Chain F, Crystal Structure Of Bacillus Subtilis Lon C-Terminal
Domain
Length = 543
Score = 31.2 bits (69), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 12/27 (44%), Positives = 17/27 (62%)
Query: 135 LFGPPGTGKTLCARAVANRTDACFIRV 161
L GPPG GKT A+++A F+R+
Sbjct: 113 LAGPPGVGKTSLAKSIAKSLGRKFVRI 139
>pdb|1NSF|A Chain A, D2 Hexamerization Domain Of N-Ethylmaleimide Sensitive
Factor (Nsf)
Length = 273
Score = 30.8 bits (68), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 14/33 (42%), Positives = 20/33 (60%)
Query: 129 PPKGVLLFGPPGTGKTLCARAVANRTDACFIRV 161
P VLL GPP +GKT A +A ++ FI++
Sbjct: 62 PLVSVLLEGPPHSGKTALAAKIAEESNFPFIKI 94
>pdb|1D2N|A Chain A, D2 Domain Of N-Ethylmaleimide-Sensitive Fusion Protein
Length = 272
Score = 30.4 bits (67), Expect = 3.5, Method: Compositional matrix adjust.
Identities = 14/33 (42%), Positives = 20/33 (60%)
Query: 129 PPKGVLLFGPPGTGKTLCARAVANRTDACFIRV 161
P VLL GPP +GKT A +A ++ FI++
Sbjct: 63 PLVSVLLEGPPHSGKTALAAKIAEESNFPFIKI 95
>pdb|3UK6|A Chain A, Crystal Structure Of The Tip48 (Tip49b) Hexamer
pdb|3UK6|B Chain B, Crystal Structure Of The Tip48 (Tip49b) Hexamer
pdb|3UK6|C Chain C, Crystal Structure Of The Tip48 (Tip49b) Hexamer
pdb|3UK6|D Chain D, Crystal Structure Of The Tip48 (Tip49b) Hexamer
pdb|3UK6|E Chain E, Crystal Structure Of The Tip48 (Tip49b) Hexamer
pdb|3UK6|F Chain F, Crystal Structure Of The Tip48 (Tip49b) Hexamer
pdb|3UK6|G Chain G, Crystal Structure Of The Tip48 (Tip49b) Hexamer
pdb|3UK6|H Chain H, Crystal Structure Of The Tip48 (Tip49b) Hexamer
pdb|3UK6|I Chain I, Crystal Structure Of The Tip48 (Tip49b) Hexamer
pdb|3UK6|J Chain J, Crystal Structure Of The Tip48 (Tip49b) Hexamer
pdb|3UK6|K Chain K, Crystal Structure Of The Tip48 (Tip49b) Hexamer
pdb|3UK6|L Chain L, Crystal Structure Of The Tip48 (Tip49b) Hexamer
Length = 368
Score = 30.0 bits (66), Expect = 5.1, Method: Compositional matrix adjust.
Identities = 16/38 (42%), Positives = 21/38 (55%), Gaps = 2/38 (5%)
Query: 131 KGVLLFGPPGTGKTLCARAVANRT--DACFIRVIGSEL 166
+ VL+ G PGTGKT A +A D F + GSE+
Sbjct: 71 RAVLIAGQPGTGKTAIAMGMAQALGPDTPFTAIAGSEI 108
>pdb|2CHQ|A Chain A, Replication Factor C Adpnp Complex
pdb|2CHQ|B Chain B, Replication Factor C Adpnp Complex
pdb|2CHQ|C Chain C, Replication Factor C Adpnp Complex
pdb|2CHV|A Chain A, Replication Factor C Adpnp Complex
pdb|2CHV|B Chain B, Replication Factor C Adpnp Complex
pdb|2CHV|C Chain C, Replication Factor C Adpnp Complex
pdb|2CHV|D Chain D, Replication Factor C Adpnp Complex
pdb|2CHV|E Chain E, Replication Factor C Adpnp Complex
pdb|2CHV|F Chain F, Replication Factor C Adpnp Complex
Length = 319
Score = 29.6 bits (65), Expect = 5.6, Method: Compositional matrix adjust.
Identities = 22/46 (47%), Positives = 27/46 (58%), Gaps = 4/46 (8%)
Query: 110 RTMLELINQPEKFVNL-GIEPPKGV--LLF-GPPGTGKTLCARAVA 151
RT+ E++ Q E L G K + LLF GPPGTGKT A A+A
Sbjct: 14 RTLDEVVGQDEVIQRLKGYVERKNIPHLLFSGPPGTGKTATAIALA 59
>pdb|1K12|A Chain A, Fucose Binding Lectin
Length = 158
Score = 29.6 bits (65), Expect = 6.1, Method: Composition-based stats.
Identities = 15/48 (31%), Positives = 24/48 (50%), Gaps = 3/48 (6%)
Query: 144 TLCARAVANRTDACFIRVIGSELVQKYVGERVLMEGCNNEGCGVPNRM 191
T+ + + NR D C R+ G+E+ +G+ + G NN C V M
Sbjct: 70 TITSVTITNRGDCCGERISGAEI---NIGQHLASNGVNNPECSVIGSM 114
>pdb|2DZN|B Chain B, Crystal Structure Analysis Of Yeast Nas6p Complexed With
The Proteasome Subunit, Rpt3
pdb|2DZN|D Chain D, Crystal Structure Analysis Of Yeast Nas6p Complexed With
The Proteasome Subunit, Rpt3
pdb|2DZN|F Chain F, Crystal Structure Analysis Of Yeast Nas6p Complexed With
The Proteasome Subunit, Rpt3
pdb|2DZO|B Chain B, Crystal Structure Analysis Of Yeast Nas6p Complexed With
The Proteasome Subunit, Rpt3
pdb|2DZO|D Chain D, Crystal Structure Analysis Of Yeast Nas6p Complexed With
The Proteasome Subunit, Rpt3
Length = 82
Score = 29.6 bits (65), Expect = 6.7, Method: Composition-based stats.
Identities = 20/62 (32%), Positives = 30/62 (48%)
Query: 546 RTHIFKIHARSMSVERDIRFELLARLCPNSTGAEIRSVCTEAGMFAIRARRKVASEKDFL 605
R IF A MS+ + + L + +GA I ++ EAG+ A+R R V + D
Sbjct: 3 RRLIFGTIASKMSLAPEADLDSLIIRNDSLSGAVIAAIMQEAGLRAVRKNRYVILQSDLE 62
Query: 606 EA 607
EA
Sbjct: 63 EA 64
>pdb|2WG6|A Chain A, Proteasome-Activating Nucleotidase (Pan) N-Domain (57-134)
From Archaeoglobus Fulgidus Fused To Gcn4, P61a Mutant
pdb|2WG6|B Chain B, Proteasome-Activating Nucleotidase (Pan) N-Domain (57-134)
From Archaeoglobus Fulgidus Fused To Gcn4, P61a Mutant
pdb|2WG6|C Chain C, Proteasome-Activating Nucleotidase (Pan) N-Domain (57-134)
From Archaeoglobus Fulgidus Fused To Gcn4, P61a Mutant
pdb|2WG6|D Chain D, Proteasome-Activating Nucleotidase (Pan) N-Domain (57-134)
From Archaeoglobus Fulgidus Fused To Gcn4, P61a Mutant
pdb|2WG6|E Chain E, Proteasome-Activating Nucleotidase (Pan) N-Domain (57-134)
From Archaeoglobus Fulgidus Fused To Gcn4, P61a Mutant
pdb|2WG6|F Chain F, Proteasome-Activating Nucleotidase (Pan) N-Domain (57-134)
From Archaeoglobus Fulgidus Fused To Gcn4, P61a Mutant
pdb|2WG6|G Chain G, Proteasome-Activating Nucleotidase (Pan) N-Domain (57-134)
From Archaeoglobus Fulgidus Fused To Gcn4, P61a Mutant
pdb|2WG6|H Chain H, Proteasome-Activating Nucleotidase (Pan) N-Domain (57-134)
From Archaeoglobus Fulgidus Fused To Gcn4, P61a Mutant
pdb|2WG6|I Chain I, Proteasome-Activating Nucleotidase (Pan) N-Domain (57-134)
From Archaeoglobus Fulgidus Fused To Gcn4, P61a Mutant
pdb|2WG6|J Chain J, Proteasome-Activating Nucleotidase (Pan) N-Domain (57-134)
From Archaeoglobus Fulgidus Fused To Gcn4, P61a Mutant
pdb|2WG6|K Chain K, Proteasome-Activating Nucleotidase (Pan) N-Domain (57-134)
From Archaeoglobus Fulgidus Fused To Gcn4, P61a Mutant
pdb|2WG6|L Chain L, Proteasome-Activating Nucleotidase (Pan) N-Domain (57-134)
From Archaeoglobus Fulgidus Fused To Gcn4, P61a Mutant
Length = 109
Score = 29.6 bits (65), Expect = 6.8, Method: Compositional matrix adjust.
Identities = 21/82 (25%), Positives = 39/82 (47%), Gaps = 6/82 (7%)
Query: 609 NKVARCTK------IINADSENPKYIINVKQFAKFVVDLADSVAPTDIEEGMRVGVDRNK 662
N+VAR +++ E+ + ++ KFVV+ + + +++ G RV +++
Sbjct: 28 NEVARLRSAPLLVGVVSDILEDGRVVVKSSTGPKFVVNTSQYINEEELKPGARVALNQQT 87
Query: 663 YQIHIPLPPKIDPTVTMMQVEE 684
I LP DP V +VEE
Sbjct: 88 LAIVNVLPTSKDPMVYGFEVEE 109
>pdb|2CHG|A Chain A, Replication Factor C Domains 1 And 2
pdb|2CHG|B Chain B, Replication Factor C Domains 1 And 2
pdb|2CHG|C Chain C, Replication Factor C Domains 1 And 2
pdb|2CHG|D Chain D, Replication Factor C Domains 1 And 2
Length = 226
Score = 29.3 bits (64), Expect = 7.1, Method: Compositional matrix adjust.
Identities = 22/46 (47%), Positives = 27/46 (58%), Gaps = 4/46 (8%)
Query: 110 RTMLELINQPEKFVNL-GIEPPKGV--LLF-GPPGTGKTLCARAVA 151
RT+ E++ Q E L G K + LLF GPPGTGKT A A+A
Sbjct: 14 RTLDEVVGQDEVIQRLKGYVERKNIPHLLFSGPPGTGKTATAIALA 59
>pdb|2WG5|A Chain A, Proteasome-Activating Nucleotidase (Pan) N-Domain (57-134)
From Archaeoglobus Fulgidus Fused To Gcn4
pdb|2WG5|B Chain B, Proteasome-Activating Nucleotidase (Pan) N-Domain (57-134)
From Archaeoglobus Fulgidus Fused To Gcn4
pdb|2WG5|C Chain C, Proteasome-Activating Nucleotidase (Pan) N-Domain (57-134)
From Archaeoglobus Fulgidus Fused To Gcn4
pdb|2WG5|D Chain D, Proteasome-Activating Nucleotidase (Pan) N-Domain (57-134)
From Archaeoglobus Fulgidus Fused To Gcn4
pdb|2WG5|E Chain E, Proteasome-Activating Nucleotidase (Pan) N-Domain (57-134)
From Archaeoglobus Fulgidus Fused To Gcn4
pdb|2WG5|F Chain F, Proteasome-Activating Nucleotidase (Pan) N-Domain (57-134)
From Archaeoglobus Fulgidus Fused To Gcn4
pdb|2WG5|G Chain G, Proteasome-Activating Nucleotidase (Pan) N-Domain (57-134)
From Archaeoglobus Fulgidus Fused To Gcn4
pdb|2WG5|H Chain H, Proteasome-Activating Nucleotidase (Pan) N-Domain (57-134)
From Archaeoglobus Fulgidus Fused To Gcn4
pdb|2WG5|I Chain I, Proteasome-Activating Nucleotidase (Pan) N-Domain (57-134)
From Archaeoglobus Fulgidus Fused To Gcn4
pdb|2WG5|J Chain J, Proteasome-Activating Nucleotidase (Pan) N-Domain (57-134)
From Archaeoglobus Fulgidus Fused To Gcn4
pdb|2WG5|K Chain K, Proteasome-Activating Nucleotidase (Pan) N-Domain (57-134)
From Archaeoglobus Fulgidus Fused To Gcn4
pdb|2WG5|L Chain L, Proteasome-Activating Nucleotidase (Pan) N-Domain (57-134)
From Archaeoglobus Fulgidus Fused To Gcn4
Length = 109
Score = 29.3 bits (64), Expect = 8.2, Method: Compositional matrix adjust.
Identities = 21/82 (25%), Positives = 39/82 (47%), Gaps = 6/82 (7%)
Query: 609 NKVARCTK------IINADSENPKYIINVKQFAKFVVDLADSVAPTDIEEGMRVGVDRNK 662
N+VAR +++ E+ + ++ KFVV+ + + +++ G RV +++
Sbjct: 28 NEVARLRSPPLLVGVVSDILEDGRVVVKSSTGPKFVVNTSQYINEEELKPGARVALNQQT 87
Query: 663 YQIHIPLPPKIDPTVTMMQVEE 684
I LP DP V +VEE
Sbjct: 88 LAIVNVLPTSKDPMVYGFEVEE 109
>pdb|2XSZ|D Chain D, The Dodecameric Human Ruvbl1:ruvbl2 Complex With Truncated
Domains Ii
pdb|2XSZ|E Chain E, The Dodecameric Human Ruvbl1:ruvbl2 Complex With Truncated
Domains Ii
pdb|2XSZ|F Chain F, The Dodecameric Human Ruvbl1:ruvbl2 Complex With Truncated
Domains Ii
Length = 378
Score = 28.9 bits (63), Expect = 9.5, Method: Compositional matrix adjust.
Identities = 16/38 (42%), Positives = 20/38 (52%), Gaps = 2/38 (5%)
Query: 131 KGVLLFGPPGTGKTLCARAVANRT--DACFIRVIGSEL 166
+ VL+ G PGTGKT A A D F + GSE+
Sbjct: 86 RAVLIAGQPGTGKTAIAXGXAQALGPDTPFTAIAGSEI 123
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.319 0.136 0.401
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 20,290,220
Number of Sequences: 62578
Number of extensions: 843897
Number of successful extensions: 3694
Number of sequences better than 100.0: 416
Number of HSP's better than 100.0 without gapping: 404
Number of HSP's successfully gapped in prelim test: 12
Number of HSP's that attempted gapping in prelim test: 2241
Number of HSP's gapped (non-prelim): 617
length of query: 713
length of database: 14,973,337
effective HSP length: 106
effective length of query: 607
effective length of database: 8,340,069
effective search space: 5062421883
effective search space used: 5062421883
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.7 bits)
S2: 55 (25.8 bits)